data_2k8i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k8i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 12.4 ptmt -106.21 156.14 18.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.332 0.586 . . . . 0.0 111.187 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.687 HG11 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -64.68 126.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.786 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.68 -169.78 3.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.168 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 7' ' ' LEU . 60.8 tttp -65.23 153.9 39.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.358 . . . . 0.0 111.662 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.63 6.1 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 141' ' ' GLU . 17.9 mt -92.85 149.42 21.28 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -115.59 142.95 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.67 HG11 HG22 ' A' ' 139' ' ' ILE . 3.2 m -142.31 155.74 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.787 0.803 . . . . 0.0 111.716 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . 16.5 m -117.9 117.59 29.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.175 -1.375 . . . . 0.0 107.962 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.724 HD23 HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -127.84 158.52 37.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.82 112.67 16.95 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.498 ' HE1' HD21 ' A' ' 32' ' ' LEU . 41.0 p90 -126.58 160.89 29.34 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.453 -171.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.5 tt0 -129.54 118.67 22.42 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p -106.33 122.46 60.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.62 0.724 . . . . 0.0 111.553 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -139.12 161.19 37.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.0 p -90.28 175.94 6.93 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.164 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.93 -21.5 66.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.19 -18.6 61.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.938 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.47 44.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.925 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.07 138.83 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 15' ' ' VAL . 55.3 tp -79.71 134.38 36.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.09 -38.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -156.93 168.49 27.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -165.54 137.49 4.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.143 0.497 . . . . 0.0 111.971 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 m -113.03 111.41 50.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -68.36 165.79 27.68 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 122.807 2.338 . . . . 0.0 113.339 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.56 -16.07 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.78 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -79.22 -33.73 43.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.07 113.01 6.27 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.327 0.584 . . . . 0.0 109.601 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.636 ' HG3' HG21 ' A' ' 137' ' ' VAL . 9.6 Cg_exo -75.59 169.22 22.79 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.572 2.848 . . . . 0.0 113.741 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD21 ' HE1' ' A' ' 13' ' ' TYR . 14.0 tp -84.1 126.35 33.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -104.85 120.6 41.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.725 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 5.4 p90 -150.34 157.39 43.0 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.169 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 147' ' ' LEU . 57.7 tp -102.69 114.61 29.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.514 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 48.6 t60 -69.84 142.39 53.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.384 0.611 . . . . 0.0 111.915 -169.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.91 56.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.473 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -129.52 -7.93 4.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.773 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.55 41.23 8.45 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.975 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.725 ' CB ' ' HB2' ' A' ' 34' ' ' TYR . 51.8 m -71.86 -38.86 70.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.577 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -113.43 -102.99 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.262 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.577 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 20.8 pt -116.35 -163.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.035 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.7 t -94.77 -49.06 5.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.391 0.615 . . . . 0.0 110.64 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -79.19 -26.45 57.69 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.984 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.688 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 mt -74.41 -52.76 11.14 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.165 -171.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 23.1 mt-10 -50.63 -49.79 55.94 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.518 0.511 . . . . 0.0 111.384 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.7 m -64.9 -31.8 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.685 0.279 . . . . 0.0 111.737 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.44 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 76.6 mt -61.62 -33.42 73.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.518 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.3 mt-10 -52.14 152.85 3.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.018 0.913 . . . . 0.0 112.819 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 78.89 -22.6 3.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.932 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.687 ' O ' HG11 ' A' ' 3' ' ' VAL . 96.8 m-70 -82.6 164.45 20.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.591 0.695 . . . . 0.0 110.782 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.0 mt-10 -127.2 160.47 31.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.412 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -49.69 143.85 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.563 0.697 . . . . 0.0 112.489 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.03 -15.64 62.61 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.149 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.04 133.91 47.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.904 0.383 . . . . 0.0 110.29 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 6.2 tmmm? -132.14 128.77 38.78 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.259 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 60' ' ' VAL . 18.0 p90 -165.43 157.17 14.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.147 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 4.8 p-10 -96.43 141.47 29.69 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.822 0.82 . . . . 0.0 110.198 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.73 HG21 ' CE2' ' A' ' 58' ' ' PHE . 8.7 t -117.1 143.91 26.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.13 -173.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.99 15.06 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.882 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.436 HG11 ' HA3' ' A' ' 44' ' ' GLY . 72.7 t -125.74 137.65 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.045 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.85 52.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.154 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.58 -20.94 3.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.3 -30.36 70.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.67 8.2 11.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.491 0.663 . . . . 0.0 111.352 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.155 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.763 179.036 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 6.3 mpt_? -115.33 114.29 24.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.737 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 83' ' ' VAL . 5.2 t -106.49 132.94 20.49 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.994 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' O ' HG22 ' A' ' 83' ' ' VAL . 29.8 Cg_exo -59.18 131.88 43.74 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.12 2.547 . . . . 0.0 111.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 26.4 mtmt -58.29 -24.41 59.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.78 -43.39 85.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.422 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 80' ' ' PRO . 3.4 m -55.67 -32.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD11 ' A' ' 90' ' ' LEU . 71.0 m-85 -90.61 40.24 1.01 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.207 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -57.47 -29.07 63.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.355 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.07 -15.43 77.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.958 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 90' ' ' LEU . 91.9 t -73.34 142.26 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.849 0.324 . . . . 0.0 110.459 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.13 -67.99 0.35 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.035 0.445 . . . . 0.0 110.952 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.654 ' O ' ' HE1' ' A' ' 94' ' ' MET . 25.1 mt-10 -142.37 115.63 8.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.397 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB3' HG12 ' A' ' 117' ' ' VAL . 88.6 mt -66.57 98.87 0.54 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.155 0.502 . . . . 0.0 110.161 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -121.5 165.7 15.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.196 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HA ' HG22 ' A' ' 109' ' ' ILE . 48.2 t -80.24 139.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.03 1.23 79.87 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.255 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.654 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 4.8 mmm -87.63 135.23 33.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.528 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -111.21 139.58 46.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.333 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.56 154.41 16.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.792 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.65 131.27 37.68 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -119.8 134.94 55.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -88.84 137.24 32.49 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.0 p -145.42 -176.19 5.01 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.024 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -35.6 65.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 110.309 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.01 25.45 6.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.313 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.66 -173.45 53.85 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.789 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 31.4 Cg_exo -58.89 123.97 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.939 . . . . 0.0 112.055 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.531 HG11 HG13 ' A' ' 107' ' ' VAL . 88.0 t -124.63 113.68 27.19 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.566 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.1 101.46 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.876 2.384 . . . . 0.0 111.347 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.1 m -117.78 173.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 111.211 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.0 136.39 40.28 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.117 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.471 ' HA ' HG11 ' A' ' 119' ' ' VAL . 27.2 mt -77.48 129.59 37.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.05 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.6 p -114.79 1.6 14.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.402 0.62 . . . . 0.0 109.937 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.35 153.86 0.35 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.595 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.724 HG13 HG11 ' A' ' 117' ' ' VAL . 61.3 t -139.39 108.55 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -87.42 -156.04 0.32 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.36 -43.97 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 8.5 p-10 -131.94 -15.1 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.007 -170.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -136.58 159.29 42.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.724 HG11 HG13 ' A' ' 112' ' ' VAL . 33.8 m -112.66 162.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.33 116.52 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.198 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -122.59 138.77 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 121.215 0.531 . . . . 0.0 111.376 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.917 177.598 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.2 mtpp -114.89 122.72 47.17 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.2 m-85 -115.29 121.19 42.11 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.541 ' N ' HD21 ' A' ' 133' ' ' ASN . 0.8 OUTLIER -92.86 107.21 19.04 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.724 HG11 HD23 ' A' ' 11' ' ' LEU . 4.0 t -99.66 139.73 20.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.369 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 42.4 mt-10 -132.96 90.84 2.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.899 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 55' ' ' GLY . 2.9 p -66.76 107.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.039 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.636 HG21 ' HG3' ' A' ' 31' ' ' PRO . 8.1 t -72.41 -47.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.86 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.59 157.27 27.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.891 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.67 HG22 HG11 ' A' ' 9' ' ' VAL . 66.0 mt -137.73 134.33 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -143.54 142.76 31.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.511 ' HA ' HD21 ' A' ' 7' ' ' LEU . 8.3 pt-20 -79.67 126.48 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.638 ' HB2' HD23 ' A' ' 147' ' ' LEU . . . -66.78 166.56 12.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 113.017 -166.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.0 p -92.19 23.06 4.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.7 -170.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 69.71 -42.65 0.51 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.184 0.594 . . . . 0.0 111.151 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 143' ' ' THR . 53.2 mt-10 -63.37 -42.25 98.84 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.486 0.66 . . . . 0.0 109.645 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.57 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.0 mt-10 -61.82 -35.02 77.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.527 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 142' ' ' ALA . 28.7 mt -73.46 -46.5 47.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.144 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.38 -31.89 70.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.536 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -93.39 -31.69 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.907 0.384 . . . . 0.0 110.802 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.16 8.35 41.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.27 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 p80 . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.667 -0.313 . . . . 0.0 110.599 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.484 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 16.7 ptpt -106.61 168.94 8.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.883 0.849 . . . . 0.0 112.064 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 49' ' ' LEU . 1.1 p -83.43 121.43 36.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.35 -171.62 3.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.945 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 7' ' ' LEU . 42.1 tttp -63.91 153.5 36.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.762 0.315 . . . . 0.0 110.417 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 147' ' ' LEU . 32.7 m-20 57.57 -5.89 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 141' ' ' GLU . 34.2 mt -90.81 104.44 17.03 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.792 -0.567 . . . . 0.0 110.425 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.4 143.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.45 0.643 . . . . 0.0 111.043 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.75 HG12 HG21 ' A' ' 139' ' ' ILE . 3.6 m -143.04 153.03 16.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.448 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -111.46 122.51 48.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.532 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.667 HD22 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -143.64 143.72 31.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 26' ' ' SER . . . -100.99 153.75 19.27 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.71 ' HE2' HD23 ' A' ' 32' ' ' LEU . 51.5 p90 -151.82 159.78 43.78 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.029 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.468 ' CG ' HD13 ' A' ' 22' ' ' LEU . 42.7 tt0 -126.8 119.45 26.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' HD11 ' A' ' 22' ' ' LEU . 21.9 t -102.21 119.45 50.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.505 -175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.54 151.68 50.74 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.0 p -82.02 -179.75 7.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -56.56 -26.31 54.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.202 0.525 . . . . 0.0 109.922 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB2' HG11 ' A' ' 21' ' ' VAL . 3.0 m-20 -67.39 -18.81 65.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.15 -11.24 72.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.469 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' A' ' 19' ' ' ASP . 10.4 p -78.4 136.44 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 111.245 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 25' ' ' GLU . 34.4 tp -69.7 131.1 44.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.478 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.45 -45.94 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.213 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -140.07 149.81 43.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.619 ' HB2' HD12 ' A' ' 22' ' ' LEU . 32.9 tt0 -156.21 134.7 11.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.301 0.572 . . . . 0.0 111.861 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.3 m -108.05 116.92 56.22 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 169.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.69 164.34 35.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.744 2.296 . . . . 0.0 113.589 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.91 -14.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.609 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.7 p -80.88 -31.56 35.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.712 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.506 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.26 113.3 5.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 109.938 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -75.63 169.16 22.89 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.625 2.883 . . . . 0.0 113.548 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD23 ' HE2' ' A' ' 13' ' ' TYR . 12.4 tp -88.89 129.51 35.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -121.57 119.85 33.11 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.543 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.747 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 24.8 m-85 -153.69 162.08 41.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.287 0.565 . . . . 0.0 111.924 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.7 tp -89.18 105.79 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.878 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.56 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 22.6 t60 -65.73 142.98 57.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.43 . . . . 0.0 110.676 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 85.77 18.81 59.21 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.183 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -136.68 18.54 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.456 0.17 . . . . 0.0 110.679 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.67 35.82 92.52 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.56 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 42.2 m -64.78 -39.63 93.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.837 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 1.1 pt? -120.53 -89.1 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.401 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.837 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 12.6 pt -129.32 -166.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 t -97.38 -49.34 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.732 0.777 . . . . 0.0 110.705 -168.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.32 29.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 114.781 -1.1 . . . . 0.0 113.376 -172.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.665 HD11 HG22 ' A' ' 134' ' ' VAL . 28.7 tp -73.34 -46.62 48.24 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 24.0 mt-10 -52.11 -45.23 64.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.127 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -63.49 -38.31 90.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.11 80.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.783 HD22 HG12 ' A' ' 134' ' ' VAL . 95.9 mt -56.88 -33.46 66.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.558 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.3 153.62 9.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.969 0.89 . . . . 0.0 113.043 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.48 -29.02 2.95 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 114.222 -1.354 . . . . 0.0 116.153 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -120.02 148.45 43.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.319 1.559 . . . . 0.0 112.852 -174.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 1' ' ' MET . 31.3 mt-10 -99.52 173.96 6.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.059 -164.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.57 ' HA ' HG11 ' A' ' 136' ' ' VAL . 1.9 m -48.94 140.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.885 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.46 61.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.746 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.07 128.79 34.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.063 176.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 2.5 tmmt? -133.63 126.06 30.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.25 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.1 p90 -165.95 160.64 16.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.196 0.522 . . . . 0.0 111.413 -175.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.612 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.1 t -133.36 142.93 40.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.026 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.6 113.05 10.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.911 0.386 . . . . 0.0 110.201 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 t -127.79 142.47 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.76 155.33 52.97 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.95 -30.5 46.95 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.77 -32.39 73.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 111.303 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.55 0.8 14.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 111.302 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.714 ' HB3' ' HZ ' ' A' ' 132' ' ' PHE . . . . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.547 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.678 0.752 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HG3' HG21 ' A' ' 118' ' ' VAL . 10.7 mpt_? -113.0 109.31 18.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.632 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.59 128.51 28.84 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.511 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.42 134.6 56.05 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.829 2.353 . . . . 0.0 112.028 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -50.8 -19.43 0.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.219 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.14 -28.92 65.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.991 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.56 -41.17 63.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.126 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' O ' HG11 ' A' ' 87' ' ' VAL . 49.3 m-85 -98.04 39.94 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 ptm -53.66 -30.45 43.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.809 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.36 13.46 61.92 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.931 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 84' ' ' PHE . 3.6 p -93.63 162.32 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.439 0.62 . . . . 0.0 109.743 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.83 -74.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 0.0 110.322 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.473 ' O ' ' HE1' ' A' ' 94' ' ' MET . 35.5 mt-10 -153.16 118.08 5.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.841 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.591 ' HB3' HG11 ' A' ' 117' ' ' VAL . 86.5 mt -60.01 109.89 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 110.958 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.77 162.47 34.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.944 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.03 146.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.988 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.58 2.27 88.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.431 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.473 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 3.5 mmm -91.69 134.41 34.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.604 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 82.3 mtt180 -113.86 134.71 54.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.196 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -164.33 170.4 16.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.342 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.802 HD12 ' HB2' ' A' ' 104' ' ' PRO . 67.7 tp -87.35 150.22 23.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' HG21 ' A' ' 100' ' ' THR . . . -144.22 89.48 2.03 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.833 0.825 . . . . 0.0 111.621 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 12.9 mt-10 -38.78 129.9 1.47 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.064 -1.425 . . . . 0.0 112.034 157.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 98' ' ' ALA . 61.2 p -145.96 -174.12 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.65 -44.77 63.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.479 0.657 . . . . 0.0 110.774 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.4 pt20 -91.64 30.23 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.787 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.62 -176.84 48.18 Favored Glycine 0 C--N 1.319 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.708 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.802 ' HB2' HD12 ' A' ' 97' ' ' LEU . 34.5 Cg_endo -73.84 125.38 9.9 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.456 2.104 . . . . 0.0 112.693 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.438 HG11 HG12 ' A' ' 107' ' ' VAL . 13.5 t -117.98 113.87 37.47 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.04 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 14.8 Cg_exo -70.56 97.29 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.611 2.208 . . . . 0.0 111.072 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.8 m -117.99 174.64 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.315 -173.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 24.5 tt0 -134.49 131.44 38.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.259 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.473 ' HA ' HG13 ' A' ' 119' ' ' VAL . 65.0 mt -69.89 124.76 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.953 0.406 . . . . 0.0 110.337 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 p -106.84 -4.6 19.09 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -172.54 155.61 3.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.915 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.556 HG11 HG13 ' A' ' 117' ' ' VAL . 61.8 t -137.43 105.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.034 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.08 -175.94 4.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.8 -53.32 58.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.209 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -121.71 5.18 10.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -146.29 139.91 26.09 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 120.831 -1.168 . . . . 0.0 112.365 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 90' ' ' LEU . 35.3 m -93.58 167.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.189 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.686 HG21 ' HG3' ' A' ' 78' ' ' ARG . 43.4 t -131.26 118.44 40.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.5 m -113.74 138.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.062 0.458 . . . . 0.0 111.144 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.825 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.233 0.233 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -118.02 132.75 56.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.087 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.714 ' HZ ' ' HB3' ' A' ' 67' ' ' ALA . 2.5 m-85 -123.4 134.96 53.91 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 133' ' ' ASN . 0.9 OUTLIER -105.84 107.74 18.89 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.783 HG12 HD22 ' A' ' 49' ' ' LEU . 4.4 t -99.81 142.93 14.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.45 0.643 . . . . 0.0 112.211 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.84 92.09 3.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.576 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -69.72 110.46 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.833 0.825 . . . . 0.0 111.685 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 31' ' ' PRO . 3.3 t -71.95 -47.66 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.13 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.06 158.56 33.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.925 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.75 HG21 HG12 ' A' ' 9' ' ' VAL . 65.5 mt -137.59 132.78 45.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -133.17 138.09 46.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.047 0.451 . . . . 0.0 110.667 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.69 ' HA ' HD23 ' A' ' 7' ' ' LEU . 9.7 pt-20 -77.44 119.29 20.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.59 169.51 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.748 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.5 p -113.26 29.51 7.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.761 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.702 ' CA ' HD22 ' A' ' 147' ' ' LEU . 31.1 mt-10 73.31 -33.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.466 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.733 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.39 -44.15 72.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.55 -178.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.733 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 8.0 mp0 -54.95 -45.65 74.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.66 0.743 . . . . 0.0 109.756 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.702 HD22 ' CA ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -65.5 -49.14 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.228 178.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.25 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.847 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -98.08 -9.09 26.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.44 2.74 90.66 Favored Glycine 0 C--N 1.329 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.865 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.925 0.363 . . . . 0.0 110.071 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.461 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -123.65 169.16 11.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 111.247 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -79.29 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.793 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.58 -172.39 4.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.432 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 7' ' ' LEU . 87.1 tttt -67.48 161.27 25.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 45.18 9.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.654 HD22 ' HA ' ' A' ' 141' ' ' GLU . 24.3 mt -97.63 108.21 20.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.957 -0.464 . . . . 0.0 110.187 170.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.52 144.01 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 110.596 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -150.86 139.34 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.755 -170.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -117.72 148.27 42.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD22 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -165.63 158.0 15.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.01 0.433 . . . . 0.0 110.33 -176.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.38 112.59 18.28 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CE1' HD11 ' A' ' 32' ' ' LEU . 46.5 p90 -123.82 154.19 39.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.924 -172.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 45.6 tt0 -125.29 118.85 26.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 23' ' ' VAL . 2.8 p -101.33 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.257 1.027 . . . . 0.0 111.141 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 10.6 ttm180 -135.66 157.15 47.59 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.681 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.596 ' OG1' HG12 ' A' ' 21' ' ' VAL . 40.8 p -78.34 169.87 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.841 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.955 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 48.7 mt-10 -65.44 -20.22 66.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.975 0.416 . . . . 0.0 110.876 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.11 -16.16 30.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.554 ' HA2' ' HD3' ' A' ' 16' ' ' ARG . . . 106.63 27.48 5.47 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.78 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.596 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.8 p -105.42 136.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.035 0.917 . . . . 0.0 109.829 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -90.53 127.36 36.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.418 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 HG13 ' A' ' 15' ' ' VAL . 22.2 m -102.93 -35.88 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.671 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -162.14 169.76 20.29 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.42 129.87 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 m -99.45 106.1 37.41 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.29 163.27 36.99 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.65 2.233 . . . . 0.0 112.882 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.31 -14.77 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.205 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 p -79.43 -30.6 42.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.626 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.47 113.74 5.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HB3' HG21 ' A' ' 137' ' ' VAL . 10.1 Cg_exo -75.32 164.7 32.27 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 -174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.643 HD12 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -73.9 139.03 44.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.408 166.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -122.25 120.2 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.72 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 13.1 p90 -157.6 168.3 27.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.141 0.496 . . . . 0.0 111.409 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -107.94 114.4 28.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.043 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.425 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 28.6 t60 -68.29 137.4 54.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.383 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 80.66 26.62 53.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.914 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.95 18.33 4.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 110.86 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.67 36.68 93.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.955 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 69.4 m -65.78 -39.94 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.142 0.496 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.643 ' HG ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.87 160.87 42.31 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 pt -27.93 137.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 123.048 1.404 . . . . 0.0 114.373 -173.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -64.46 -35.75 81.94 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.936 -1.938 . . . . 0.0 111.299 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -64.07 -34.6 90.36 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.139 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 21.6 tp -75.46 -50.58 15.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.05 -45.6 68.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.337 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.2 m -59.35 -35.71 74.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.434 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -33.98 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.622 0.725 . . . . 0.0 110.438 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.66 ' O ' HG13 ' A' ' 3' ' ' VAL . 86.9 mt -64.61 -31.71 73.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.896 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.85 155.65 4.22 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.18 -29.1 4.85 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.679 ' O ' HG12 ' A' ' 3' ' ' VAL . 27.0 p80 -106.33 178.29 4.6 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.172 1.486 . . . . 0.0 110.787 -171.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 1' ' ' MET . 81.8 mt-10 -117.35 170.82 8.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.685 0.278 . . . . 0.0 110.725 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -53.11 144.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.76 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 136' ' ' VAL . . . 95.29 -20.33 49.89 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.971 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 136' ' ' VAL . 3.4 m-20 -67.42 136.62 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.919 0.359 . . . . 0.0 110.527 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.662 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 4.3 tmmm? -136.98 125.21 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.725 ' CE2' HG22 ' A' ' 60' ' ' VAL . 15.9 p90 -154.51 -179.75 8.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.15 143.5 38.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.725 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -126.91 142.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -134.18 113.07 11.64 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.576 HG13 ' HA3' ' A' ' 44' ' ' GLY . 60.8 t -123.97 141.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.565 -174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.77 150.0 48.75 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.127 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.53 -20.42 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.74 -21.78 57.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.295 -0.253 . . . . 0.0 111.442 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -114.34 -9.46 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.954 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.264 -178.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.116 0.484 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 11.3 mpt_? -110.23 113.35 25.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.764 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.39 132.24 21.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.873 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.61 143.57 99.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.429 2.753 . . . . 0.0 112.692 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 90' ' ' LEU . 6.5 mmmm -54.02 -39.53 66.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.386 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.75 -37.67 79.64 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.683 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.22 -35.3 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.957 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HB2' HD11 ' A' ' 90' ' ' LEU . 64.4 m-85 -100.51 40.0 1.31 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.2 ptm -49.15 -32.75 10.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.421 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.78 13.18 65.02 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.617 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.628 HG12 ' HG ' ' A' ' 90' ' ' LEU . 3.6 p -85.88 162.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 117.313 0.556 . . . . 0.0 110.21 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.61 -77.86 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.42 119.67 7.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.614 171.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.628 ' HG ' HG12 ' A' ' 87' ' ' VAL . 89.9 mt -60.09 103.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.303 0.573 . . . . 0.0 110.536 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.455 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.2 tt0 -123.57 166.3 15.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.156 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.6 t -81.55 140.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.86 1.42 85.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.846 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.455 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.0 mtm -85.88 135.05 33.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 109.938 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -114.02 139.54 49.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.082 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -163.38 170.45 17.49 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.998 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -92.69 126.74 37.91 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.36 127.44 56.01 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.35 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.12 140.39 41.77 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 p -145.0 -175.66 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.999 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.3 -36.71 84.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.528 0.68 . . . . 0.0 110.623 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.2 pt20 -95.61 27.54 3.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.266 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 179.44 46.09 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.14 140.93 94.11 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 122.171 1.914 . . . . 0.0 112.603 174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 99.0 t -135.43 117.49 12.31 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.573 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 7.1 Cg_exo -73.83 108.8 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.783 2.322 . . . . 0.0 111.246 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.778 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 11.2 m -118.48 154.6 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.778 0.323 . . . . 0.0 111.084 -174.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 40.8 tt0 -115.37 132.14 56.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.25 0.548 . . . . 0.0 110.336 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.502 ' HA ' HG13 ' A' ' 119' ' ' VAL . 23.8 mt -77.53 127.9 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.02 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.407 ' C ' HG13 ' A' ' 92' ' ' VAL . 62.4 p -114.69 1.2 14.12 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.455 0.645 . . . . 0.0 109.53 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.408 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 153.52 0.21 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.3 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.72 HG12 HG12 ' A' ' 117' ' ' VAL . 49.0 t -136.32 107.7 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.25 -157.24 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.12 -50.97 71.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.29 -6.24 3.81 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.825 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 p-80 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.024 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.72 HG12 HG12 ' A' ' 112' ' ' VAL . 30.3 m -107.89 161.71 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.02 110.23 31.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.673 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.778 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 12.0 m -113.63 135.12 54.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.615 0.721 . . . . 0.0 112.133 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.666 -177.009 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 26.3 mt . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.955 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 18.4 mtpp -116.18 131.57 56.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 26.4 m-85 -117.11 137.59 52.19 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.179 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.66 106.72 17.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.697 HG13 HD22 ' A' ' 11' ' ' LEU . 8.3 t -102.94 138.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.529 -172.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.662 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 17.4 mt-10 -137.47 93.83 2.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.546 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -77.31 116.86 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.058 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 31' ' ' PRO . 11.4 t -75.84 -45.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.975 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.58 152.9 16.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.41 . . . . 0.0 111.282 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.463 HG13 HG12 ' A' ' 54' ' ' VAL . 81.6 mt -136.71 133.07 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -150.89 139.95 21.07 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.803 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.654 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.3 pt-20 -73.17 125.85 28.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 109.864 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . . . -73.01 164.96 25.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.002 -176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 145' ' ' GLU . 28.7 p -97.02 23.19 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.537 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HA ' HD11 ' A' ' 147' ' ' LEU . 44.7 mt-10 73.17 -31.46 0.23 Allowed 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.635 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 143' ' ' THR . 20.2 mm-40 -64.81 -46.64 81.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.836 0.35 . . . . 0.0 111.054 175.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 36.6 mp0 -54.78 -37.44 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.67 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.631 HD23 ' HB1' ' A' ' 142' ' ' ALA . 11.4 mt -74.37 -47.43 34.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.74 -32.55 63.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.688 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -98.77 -25.76 14.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.283 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.02 29.58 25.36 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.617 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 . . . . . 0 C--N 1.328 -0.366 0 O-C-N 122.701 -0.293 . . . . 0.0 110.505 -175.094 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' HE3' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 9.9 ptpt -96.13 168.35 10.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.53 0.681 . . . . 0.0 111.08 -176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.631 HG11 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -87.28 116.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.524 175.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.64 -170.06 3.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.184 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 54.9 tttm -64.46 162.96 14.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.4 ' HA ' HD22 ' A' ' 147' ' ' LEU . 3.9 p30 51.27 7.29 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 141' ' ' GLU . 22.2 mt -107.63 155.68 19.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 34' ' ' TYR . 7.4 p -116.31 143.16 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.755 HG12 HG21 ' A' ' 139' ' ' ILE . 3.7 m -136.86 161.18 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.486 0.66 . . . . 0.0 111.906 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.1 m -125.72 107.75 10.85 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -120.93 161.81 20.93 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.855 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.49 108.09 10.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.1 p90 -126.39 163.77 22.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.154 0.502 . . . . 0.0 110.367 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 59.9 tt0 -128.83 116.88 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' HD11 ' A' ' 22' ' ' LEU . 3.2 p -102.94 122.71 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.794 0.807 . . . . 0.0 111.169 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -142.42 164.03 31.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.311 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.74 ' HG1' HG11 ' A' ' 21' ' ' VAL . 58.7 p -83.49 174.19 10.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.461 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.1 -23.23 61.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 110.452 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -15.57 51.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.596 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.58 -16.73 40.47 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.96 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.74 HG11 ' HG1' ' A' ' 17' ' ' THR . 11.4 p -67.31 133.99 30.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 117.906 0.853 . . . . 0.0 111.051 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 25' ' ' GLU . 57.0 tp -81.03 127.79 32.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.695 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -103.33 -33.99 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.094 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.6 163.15 32.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.644 ' HB2' HD12 ' A' ' 22' ' ' LEU . 29.1 tt0 -165.3 130.29 2.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.266 0.555 . . . . 0.0 112.063 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.423 ' HB3' ' H ' ' A' ' 13' ' ' TYR . 28.7 t -103.06 107.72 56.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.95 166.75 25.49 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.364 2.043 . . . . 0.0 111.704 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.39 -17.78 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.435 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 p -79.09 -32.32 44.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.356 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.15 114.09 5.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.068 0.461 . . . . 0.0 110.628 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.736 ' HG3' HG23 ' A' ' 137' ' ' VAL . 7.8 Cg_exo -76.35 169.07 22.68 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.934 3.09 . . . . 0.0 114.38 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.13 128.4 34.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.19 168.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -118.38 119.55 34.93 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.565 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 37.1 m-85 -162.3 157.13 22.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.466 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 147' ' ' LEU . 64.0 tp -86.36 113.3 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.23 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -71.32 142.31 50.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 -170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 89.6 24.98 29.11 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.073 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.56 -18.16 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.6 0.238 . . . . 0.0 111.284 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.25 40.67 0.94 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.565 ' HB3' ' CB ' ' A' ' 34' ' ' TYR . 14.6 m -63.86 -45.59 88.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.326 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.597 HD12 HD22 ' A' ' 45' ' ' LEU . 1.8 pt? -151.65 179.25 8.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 pt -42.13 148.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.462 1.125 . . . . 0.0 112.989 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.1 t -76.53 -40.73 49.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.943 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.24 -32.16 60.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.025 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tp -77.01 -52.71 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.154 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 49' ' ' LEU . 27.4 mt-10 -55.26 -46.03 76.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.062 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.7 m -61.25 -29.58 69.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.052 0.453 . . . . 0.0 111.492 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.84 -34.34 57.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.785 0.802 . . . . 0.0 109.609 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 64.3 mt -69.58 -38.06 77.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.153 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.39 125.26 22.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 112.836 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.73 0.42 34.37 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.338 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.631 ' O ' HG11 ' A' ' 3' ' ' VAL . 98.3 m-70 -101.38 169.2 9.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 54.9 mt-10 -123.15 166.31 15.4 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -47.55 145.73 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 122.066 0.936 . . . . 0.0 112.835 -177.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' N ' HG12 ' A' ' 136' ' ' VAL . . . 85.21 -0.76 88.83 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 114.105 -1.407 . . . . 0.0 114.202 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.98 153.35 42.72 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.877 0.838 . . . . 0.0 109.297 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -149.15 128.52 12.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.245 0.545 . . . . 0.0 109.76 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CE2' HG22 ' A' ' 60' ' ' VAL . 25.6 p90 -162.96 177.87 8.85 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -120.1 147.51 44.77 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -133.39 143.01 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -169.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.0 11.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.952 0.406 . . . . 0.0 110.119 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.03 142.29 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.21 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.84 152.0 36.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.658 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.19 -21.59 66.31 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -68.57 -18.29 64.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.0 110.751 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.87 -52.95 2.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.453 -172.124 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.3 mpt_? -107.75 106.56 16.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.617 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 83' ' ' VAL . 2.8 t -105.46 133.14 20.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.313 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 83' ' ' VAL . 21.4 Cg_exo -61.94 133.79 46.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.851 2.367 . . . . 0.0 111.566 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 37.4 mtmt -56.47 -24.61 46.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.41 -43.27 83.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 80' ' ' PRO . 5.8 m -53.31 -30.03 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.091 0.472 . . . . 0.0 112.101 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 87' ' ' VAL . 43.4 m-85 -103.1 39.13 1.61 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.605 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -60.8 -30.99 70.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.57 -7.44 88.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.048 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 70.1 t -76.17 146.43 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.913 0.356 . . . . 0.0 110.858 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.48 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.557 0.535 . . . . 0.0 110.884 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.619 ' O ' ' HE2' ' A' ' 94' ' ' MET . 30.1 mt-10 -152.7 120.26 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.853 175.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 84' ' ' PHE . 97.3 mt -68.23 109.36 3.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.288 0.566 . . . . 0.0 111.076 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.544 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.8 tt0 -127.2 171.05 11.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.861 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' A' ' 111' ' ' ALA . 55.6 t -83.13 138.43 19.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.01 1.13 88.9 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.732 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.619 ' HE2' ' O ' ' A' ' 89' ' ' GLU . 3.9 mmm -84.24 134.82 34.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 5.8 ttt180 -131.91 134.35 45.58 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -159.78 162.76 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 104' ' ' PRO . 35.1 tp -80.89 127.32 32.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.46 116.22 26.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 40.1 mt-10 -93.37 100.57 12.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.964 0.888 . . . . 0.0 110.096 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.8 p -95.61 -175.79 3.56 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.192 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.27 -30.11 62.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.399 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -104.63 25.03 10.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.95 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.61 173.27 33.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.382 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.736 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 31.2 Cg_exo -62.1 138.26 71.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.993 2.462 . . . . 0.0 112.867 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.65 108.76 12.04 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.69 ' HG2' ' HB ' ' A' ' 21' ' ' VAL . 16.5 Cg_exo -69.2 103.63 1.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.664 2.243 . . . . 0.0 111.215 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.589 ' HB ' HG11 ' A' ' 119' ' ' VAL . 20.6 m -118.13 155.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.121 0.486 . . . . 0.0 111.136 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 38.3 tt0 -122.92 139.41 54.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.756 0.789 . . . . 0.0 109.846 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 119' ' ' VAL . 19.9 mt -85.81 132.16 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.471 -173.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.9 p -113.98 0.9 14.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.268 0.556 . . . . 0.0 109.866 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 172.77 156.07 0.1 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.86 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.677 HG13 HG11 ' A' ' 117' ' ' VAL . 48.1 t -139.94 114.98 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.68 -162.39 0.9 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.17 -26.39 62.95 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.247 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.758 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 24.4 m-20 -131.06 -26.03 2.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -133.11 167.15 20.85 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.98 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.677 HG11 HG13 ' A' ' 112' ' ' VAL . 35.8 m -114.39 165.04 9.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.663 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.56 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.4 t -113.79 104.57 17.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -113.24 140.17 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.2 t0 . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 5.2 mtpp -116.45 132.08 56.77 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -119.96 126.0 49.78 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 16.9 m120 -100.61 107.24 18.85 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.574 HG11 ' CD2' ' A' ' 49' ' ' LEU . 6.6 t -101.22 145.92 10.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.063 -165.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -149.29 97.14 2.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.777 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -76.05 117.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.314 0.578 . . . . 0.0 111.53 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.736 HG23 ' HG3' ' A' ' 31' ' ' PRO . 6.3 t -76.98 -45.87 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.331 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.2 155.94 23.53 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.186 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.755 HG21 HG12 ' A' ' 9' ' ' VAL . 62.0 mt -139.7 137.97 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -145.88 142.87 29.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.106 0.479 . . . . 0.0 110.934 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.567 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 pt-20 -80.75 124.82 29.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.094 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -71.4 168.15 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.453 -174.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -103.01 23.28 12.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 147' ' ' LEU . 32.3 mt-10 73.8 -33.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.101 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.99 -41.71 97.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.619 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.642 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 13.8 mp0 -57.65 -39.51 77.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.891 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 142' ' ' ALA . 16.6 mt -70.48 -44.89 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.961 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.08 -34.22 68.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.837 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -100.71 -31.22 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.182 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.16 15.78 50.06 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.286 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -174.345 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.08 174.69 5.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.58 0.705 . . . . 0.0 111.021 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -88.05 127.63 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.769 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.2 -177.64 6.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 76.6 tttt -55.75 152.0 10.28 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.083 0.24 . . . . 0.0 110.884 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 57.32 -5.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 141' ' ' GLU . 28.1 mt -95.94 104.75 16.71 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.704 -0.622 . . . . 0.0 110.89 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 34' ' ' TYR . 12.1 p -65.55 142.78 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.712 0.768 . . . . 0.0 111.816 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.758 HG12 HG23 ' A' ' 139' ' ' ILE . 1.3 m -145.32 154.93 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.832 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -120.36 119.11 32.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.585 HD13 HG13 ' A' ' 134' ' ' VAL . 4.5 pp -141.13 147.99 39.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.85 153.75 18.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.69 160.4 42.73 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 44.5 tt0 -132.46 118.33 19.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.469 HG21 HG12 ' A' ' 23' ' ' VAL . 2.6 p -106.92 124.38 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.722 0.772 . . . . 0.0 111.522 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -139.93 165.69 26.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.101 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -81.47 179.28 7.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.319 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.0 -11.76 50.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.626 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -80.41 -19.3 46.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.105 0.478 . . . . 0.0 110.41 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.32 -17.4 53.79 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.382 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.97 132.32 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 24' ' ' ASP . 50.0 tp -66.24 140.61 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.315 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 15' ' ' VAL . 2.8 p -113.66 -35.54 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.991 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' HD11 ' A' ' 22' ' ' LEU . 9.7 t70 -168.89 172.16 7.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 2.9 pt-20 -166.73 159.66 14.09 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.177 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -108.33 110.06 61.73 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 162.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.02 155.81 48.13 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 C-N-CA 122.78 2.32 . . . . 0.0 113.287 -165.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.45 -7.06 7.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -91.21 -26.27 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.888 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.32 114.59 5.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.828 ' HG3' HG22 ' A' ' 137' ' ' VAL . 6.6 Cg_exo -74.81 166.03 30.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.465 2.777 . . . . 0.0 114.366 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.06 130.28 35.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.461 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -116.33 127.98 55.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.165 0.507 . . . . 0.0 110.228 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HH ' HD22 ' A' ' 11' ' ' LEU . 54.6 p90 -160.1 164.61 32.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.416 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.565 HD22 HD21 ' A' ' 147' ' ' LEU . 54.4 tp -103.1 111.15 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.56 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.77 124.06 17.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.569 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 93.35 0.23 67.75 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.943 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -136.54 3.25 2.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.79 92.73 0.09 OUTLIER Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.674 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 m -114.36 8.84 16.76 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.938 0.875 . . . . 0.0 109.449 -166.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 53.17 -89.05 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.454 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 45' ' ' LEU . 23.5 pt -124.5 136.25 61.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 122.265 1.031 . . . . 0.0 110.627 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -48.21 -42.76 30.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.444 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 66' ' ' ASP . . . -69.25 -37.77 81.19 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.443 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 134' ' ' VAL . 16.2 tp -75.39 -52.23 11.25 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -173.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.674 ' HG3' ' O ' ' A' ' 40' ' ' SER . 2.5 mm-40 -53.16 -45.11 68.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.26 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.4 m -57.77 -35.78 71.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.257 0.551 . . . . 0.0 111.331 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 -36.1 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.819 0.819 . . . . 0.0 109.606 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.565 ' CD2' HG12 ' A' ' 134' ' ' VAL . 83.4 mt -61.63 -35.64 78.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.014 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -53.86 152.62 5.38 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.11 -6.64 48.86 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 113.408 -1.723 . . . . 0.0 116.65 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.69 ' O ' HG11 ' A' ' 3' ' ' VAL . 17.6 p80 -117.93 -177.29 3.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 119.417 1.608 . . . . 0.0 111.109 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 1' ' ' MET . 45.3 mt-10 -124.06 174.66 7.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -169.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 139' ' ' ILE . 1.4 m -54.41 145.65 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.311 172.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.73 -15.66 56.67 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.852 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.48 143.48 42.55 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 4.0 tmmm? -145.61 131.52 19.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.103 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.743 ' CE2' HG23 ' A' ' 60' ' ' VAL . 17.9 p90 -162.69 159.81 24.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.007 0.432 . . . . 0.0 110.305 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.71 141.11 32.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.014 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.743 HG23 ' CE2' ' A' ' 58' ' ' PHE . 10.5 t -127.95 143.3 41.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.09 112.99 7.75 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.664 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 132' ' ' PHE . 14.6 m -127.82 169.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.734 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.26 158.88 29.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.187 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.48 -25.02 9.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.18 0.592 . . . . 0.0 112.563 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -59.86 -27.77 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 111.06 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 1.5 m-20 -115.94 -5.76 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 130' ' ' LEU . . . . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.422 0.629 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -99.12 150.0 22.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.82 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 t -143.23 129.0 10.15 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.51 139.09 87.66 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.17 2.58 . . . . 0.0 112.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.429 ' HD3' HD13 ' A' ' 90' ' ' LEU . 20.2 mmtp -52.07 -32.42 34.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.287 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.36 -41.64 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.706 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.18 -37.48 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.052 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.725 ' HD2' HD11 ' A' ' 90' ' ' LEU . 59.1 m-85 -100.78 40.01 1.32 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.731 0.3 . . . . 0.0 111.224 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 16.3 ptm -49.67 -37.21 27.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -88.21 13.53 61.48 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.948 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 84' ' ' PHE . 3.4 p -90.01 165.79 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 117.388 0.594 . . . . 0.0 110.064 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.79 -71.19 0.12 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -166.16 128.37 1.92 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.725 HD11 ' HD2' ' A' ' 84' ' ' PHE . 92.0 mt -63.9 112.16 2.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.808 0.814 . . . . 0.0 111.359 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.494 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -125.71 161.39 27.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.648 -177.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.82 136.0 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 1.37 66.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.314 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.494 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -87.49 135.79 33.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.094 0.473 . . . . 0.0 110.634 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -113.93 134.42 54.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.728 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -163.21 173.79 12.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.006 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 104' ' ' PRO . 31.2 tp -90.91 120.94 32.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -90.1 174.0 7.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.669 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -128.19 121.79 30.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.328 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.5 p -145.52 175.27 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.731 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -55.1 -36.97 66.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.262 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -92.27 30.74 1.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.62 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.08 -177.51 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.584 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.0 Cg_exo -58.1 143.72 96.14 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.435 2.09 . . . . 0.0 112.476 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.4 HG13 HG11 ' A' ' 107' ' ' VAL . 88.1 t -133.78 116.91 13.83 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.05 101.88 0.74 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.65 2.233 . . . . 0.0 111.854 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.612 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 5.0 m -118.83 178.31 2.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.005 0.431 . . . . 0.0 111.734 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -135.66 137.41 41.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.32 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.544 ' HA ' HG11 ' A' ' 119' ' ' VAL . 23.0 mt -78.01 126.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.813 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 p -110.95 1.54 17.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.426 0.632 . . . . 0.0 109.591 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 179.94 153.11 0.49 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.032 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.649 HG11 HG12 ' A' ' 117' ' ' VAL . 94.2 t -141.37 109.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.05 -165.05 1.26 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.12 -54.28 15.81 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.491 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -109.21 -3.93 16.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -141.69 147.78 38.04 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.647 -0.658 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.649 HG12 HG11 ' A' ' 112' ' ' VAL . 35.2 m -111.38 167.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.58 114.87 44.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.612 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.7 m -113.97 137.99 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.545 0.688 . . . . 0.0 111.704 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 C--N 1.312 -1.061 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.717 175.573 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 67' ' ' ALA . 45.4 mt . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 40.7 mtpt -115.52 129.02 56.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -118.14 139.78 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.271 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -108.58 108.14 18.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.1 t -99.2 137.44 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.289 -172.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.624 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 9.3 mt-10 -136.52 96.11 3.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.86 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.528 HG21 ' CE1' ' A' ' 52' ' ' HIS . 38.9 t -76.24 115.85 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.576 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.828 HG22 ' HG3' ' A' ' 31' ' ' PRO . 6.0 t -72.96 -49.5 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.892 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.57 156.28 20.64 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.347 -0.22 . . . . 0.0 111.24 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.758 HG23 HG12 ' A' ' 9' ' ' VAL . 67.8 mt -138.99 141.96 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -147.21 141.08 25.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.976 0.417 . . . . 0.0 110.619 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 7' ' ' LEU . 8.2 pt-20 -76.23 117.14 17.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.768 ' HB2' HD23 ' A' ' 147' ' ' LEU . . . -62.18 155.28 24.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.803 0.811 . . . . 0.0 112.714 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 145' ' ' GLU . 43.2 p -84.19 18.86 1.99 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.223 -1.353 . . . . 0.0 112.066 -171.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HA ' HD11 ' A' ' 147' ' ' LEU . 30.1 mt-10 68.87 -33.0 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.082 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 143' ' ' THR . 0.4 OUTLIER -66.46 -40.43 89.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.701 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -58.06 -39.9 79.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.02 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 142' ' ' ALA . 14.9 mt -69.1 -45.55 69.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.898 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.66 67.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.853 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -97.52 -6.25 34.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.8 0.71 85.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.832 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.19 171.17 7.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.27 0.557 . . . . 0.0 110.49 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -87.02 120.47 36.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.251 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.19 -172.95 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 7' ' ' LEU . 56.8 tttm -57.73 147.41 27.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.812 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 54.65 -5.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.0 mt -85.34 104.3 15.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.807 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.758 HG22 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -60.55 143.85 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.586 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.832 ' O ' ' HB3' ' A' ' 34' ' ' TYR . 2.3 m -153.18 131.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.217 1.008 . . . . 0.0 111.999 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.544 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 2.3 m -100.2 120.92 40.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.698 HD21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -139.35 143.77 37.92 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.619 -0.833 . . . . 0.0 109.786 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 26' ' ' SER . . . -104.33 154.27 20.02 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.822 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 52.9 p90 -149.09 165.04 32.92 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.278 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 31.3 tt0 -131.91 120.77 22.99 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 22' ' ' LEU . 21.5 t -103.84 119.64 52.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.5 ptp180 -132.58 151.67 51.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 p -81.95 175.98 9.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.137 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -58.7 -32.07 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.261 0.553 . . . . 0.0 109.721 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.28 -18.23 63.82 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.933 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.89 26.72 15.84 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.563 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 9.1 t -105.17 126.32 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.786 -0.244 . . . . 0.0 110.554 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 25' ' ' GLU . 35.1 tp -67.04 123.35 19.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -109.6 -38.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.565 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.18 152.41 39.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HB2' HD11 ' A' ' 22' ' ' LEU . 30.8 tt0 -157.1 137.43 12.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 111.753 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 27.1 m -116.7 114.3 39.87 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.17 167.52 19.94 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 C-N-CA 122.824 2.349 . . . . 0.0 112.227 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.18 -17.71 22.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.269 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -78.0 -32.53 51.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.242 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.8 112.83 9.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.277 0.561 . . . . 0.0 110.75 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.697 ' HG3' HG23 ' A' ' 137' ' ' VAL . 10.6 Cg_exo -76.86 169.45 21.66 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 124.271 3.314 . . . . 0.0 114.644 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.822 ' HG ' ' HE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -70.0 158.67 35.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.383 169.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' H ' HD22 ' A' ' 32' ' ' LEU . 3.9 m-20 -91.43 149.62 21.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.085 0.945 . . . . 0.0 110.949 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.832 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.08 126.91 42.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -161.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.606 HD12 HD21 ' A' ' 147' ' ' LEU . 14.7 tp -148.44 98.54 2.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 146.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.547 ' HA ' ' HG ' ' A' ' 40' ' ' SER . 21.2 t60 -70.82 136.19 48.6 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.412 -164.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.55 27.32 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.471 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.14 18.32 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.671 0.748 . . . . 0.0 110.173 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.83 90.8 0.18 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.98 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.555 ' HB2' HD13 ' A' ' 41' ' ' LEU . 11.0 m -116.63 -52.27 2.56 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.75 -173.42 2.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 111.568 -2.56 . . . . 0.0 108.518 170.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 41' ' ' LEU . 13.7 pt -33.14 143.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -66.47 -41.08 89.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.741 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -58.14 -41.41 94.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.773 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 tp -73.95 -48.89 27.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.554 ' HA ' HD13 ' A' ' 49' ' ' LEU . 15.6 mt-10 -50.74 -47.86 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.113 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.5 m -63.45 -36.83 85.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.656 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.1 72.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.467 0.651 . . . . 0.0 110.015 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 83.9 mt -59.0 -37.07 76.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.664 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.0 mt-10 -53.32 152.04 4.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.82 -22.49 6.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.371 -1.286 . . . . 0.0 114.183 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.499 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.8 m-70 -83.39 179.26 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.451 0.643 . . . . 0.0 111.954 -175.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.6 mt-10 -134.73 161.85 34.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.483 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 136' ' ' VAL . 1.2 m -52.61 143.26 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.691 0.619 . . . . 0.0 111.11 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 136' ' ' VAL . . . 97.39 -17.13 59.56 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.689 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -64.94 132.54 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 13.7 tmtt? -137.17 130.19 30.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.656 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.684 ' CE2' HG23 ' A' ' 60' ' ' VAL . 21.0 p90 -166.57 163.49 16.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.993 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.11 143.38 26.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.598 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.684 HG23 ' CE2' ' A' ' 58' ' ' PHE . 3.9 t -131.43 142.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.122 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.97 113.49 13.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.035 0.445 . . . . 0.0 109.893 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG13 ' HA3' ' A' ' 44' ' ' GLY . 99.7 t -125.9 136.88 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.508 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.52 148.23 45.03 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.12 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.82 -21.61 66.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -68.95 -19.64 64.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.019 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.3 -42.02 4.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.922 0.391 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.602 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.9 mpt_? -111.02 111.5 22.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.207 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.49 133.28 20.25 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.461 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -60.98 135.01 56.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.76 2.307 . . . . 0.0 111.836 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 23.8 mtmt -59.11 -17.52 27.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.327 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.52 -27.37 64.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.42 0.629 . . . . 0.0 110.154 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.9 -36.4 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HB2' HD13 ' A' ' 90' ' ' LEU . 26.3 m-85 -102.1 40.02 1.4 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.179 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.7 ptm -56.54 -24.33 46.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.361 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.39 4.7 83.35 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.198 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG12 HD21 ' A' ' 90' ' ' LEU . 69.5 t -89.56 149.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.902 0.351 . . . . 0.0 110.477 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.17 -70.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 110.878 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.508 ' O ' ' HE2' ' A' ' 94' ' ' MET . 28.9 mt-10 -142.72 105.38 4.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.626 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 117' ' ' VAL . 80.8 mt -60.17 107.59 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.341 0.591 . . . . 0.0 110.392 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.27 167.52 16.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.26 140.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.05 2.43 77.86 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.483 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.508 ' HE2' ' O ' ' A' ' 89' ' ' GLU . 4.4 mmm -89.21 135.53 33.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.101 0.476 . . . . 0.0 109.718 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.83 135.39 54.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.691 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -164.15 167.45 20.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.112 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.3 tp -84.33 130.6 34.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -113.16 142.72 45.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.994 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.62 132.95 35.45 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.3 p -146.81 -175.64 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.81 -30.88 70.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.592 0.71 . . . . 0.0 109.901 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -86.71 24.45 1.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.636 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.79 -171.67 55.15 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.185 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 32.6 Cg_exo -58.63 128.57 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.231 1.954 . . . . 0.0 111.631 170.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.8 t -128.85 116.43 19.23 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.74 102.7 1.22 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.939 2.426 . . . . 0.0 111.861 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.5 m -118.37 172.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.777 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.98 131.53 40.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.452 ' HA ' HG11 ' A' ' 119' ' ' VAL . 41.4 mt -68.82 128.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 120' ' ' ASP . 39.4 p -113.66 0.31 14.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.323 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -175.52 153.27 1.45 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.093 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 117' ' ' VAL . 57.5 t -140.78 106.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.84 -172.61 3.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.31 -49.03 65.81 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.225 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.542 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 10.0 m-20 -104.83 -14.35 15.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -143.53 149.04 36.89 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.574 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 112' ' ' VAL . 34.9 m -104.58 168.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.114 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.2 t -124.0 122.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m -115.63 133.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 112.012 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' HB3' HG22 ' A' ' 110' ' ' THR . 14.3 t70 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.797 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -117.11 128.54 55.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 3.5 m-85 -119.71 133.77 55.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.472 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 133' ' ' ASN . 1.0 OUTLIER -104.33 108.69 20.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.698 HG12 HD21 ' A' ' 11' ' ' LEU . 5.6 t -98.67 142.5 14.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.505 0.669 . . . . 0.0 112.145 -170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.697 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 44.0 mt-10 -130.93 90.85 2.96 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.192 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -68.86 114.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.854 0.835 . . . . 0.0 111.957 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.697 HG23 ' HG3' ' A' ' 31' ' ' PRO . 15.8 t -71.54 -51.9 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.047 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -158.58 158.45 33.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.885 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.667 HG21 HG11 ' A' ' 9' ' ' VAL . 75.9 mt -137.35 134.58 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 8' ' ' VAL . 41.6 ttm180 -154.38 138.99 16.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.443 ' HA ' HD22 ' A' ' 7' ' ' LEU . 16.1 pt-20 -70.85 123.34 21.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.585 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -62.75 164.23 8.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.2 p -97.54 25.27 5.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -168.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.467 ' HA ' HD11 ' A' ' 147' ' ' LEU . 38.7 mt-10 72.81 -36.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.369 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 143' ' ' THR . 35.5 mt-10 -62.0 -48.71 79.1 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.565 0.221 . . . . 0.0 110.693 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 12.7 mp0 -55.68 -39.42 70.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 35' ' ' LEU . 19.2 mt -68.76 -47.32 66.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.168 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.2 73.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.19 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -84.58 -19.28 33.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.239 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 81.93 10.24 84.27 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.007 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 19.2 ptmt -133.14 166.18 23.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 52' ' ' HIS . 1.3 p -72.42 115.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.068 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.32 -171.0 3.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.008 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 7' ' ' LEU . 83.3 tttt -64.97 158.04 26.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.223 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p30 55.69 0.3 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 113.907 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.6 mt -96.45 110.51 22.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.044 0.45 . . . . 0.0 111.295 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.552 ' CG2' HD13 ' A' ' 35' ' ' LEU . 49.7 t -53.73 143.43 5.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.708 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -141.89 134.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -111.99 111.7 22.81 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 134' ' ' VAL . 2.3 pp -128.76 161.12 30.48 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.854 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.6 147.31 42.96 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.673 ' CE1' HD13 ' A' ' 32' ' ' LEU . 36.7 p90 -160.93 162.19 31.91 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.436 -0.905 . . . . 0.0 111.452 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.0 tt0 -133.57 121.07 21.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.4 p -113.7 125.93 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.598 0.713 . . . . 0.0 111.361 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -144.07 176.03 9.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.335 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.3 p -98.03 178.05 5.22 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.528 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.2 -20.86 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.263 0.554 . . . . 0.0 110.153 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB3' HG23 ' A' ' 21' ' ' VAL . 18.2 t70 -78.26 -18.07 55.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.384 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.39 6.02 53.65 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 19' ' ' ASP . 5.2 t -77.04 112.92 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 15' ' ' VAL . 58.3 tp -68.97 119.43 13.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG2' HG21 ' A' ' 15' ' ' VAL . 31.0 m -96.52 -39.19 8.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 32.5 t70 -156.56 160.15 39.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HB2' HD13 ' A' ' 22' ' ' LEU . 43.1 tt0 -159.05 133.54 7.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 0.0 111.971 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 m -116.25 105.08 51.28 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.26 168.27 18.14 Favored 'Trans proline' 0 CA--C 1.523 -0.068 0 C-N-CA 122.91 2.407 . . . . 0.0 113.035 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.02 -19.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.548 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.4 p -75.83 -38.95 57.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -133.93 112.65 12.47 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.237 0.541 . . . . 0.0 109.873 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 30' ' ' ALA . 12.9 Cg_exo -75.53 169.76 21.68 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.994 3.13 . . . . 0.0 114.723 -175.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -86.6 131.49 34.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.603 168.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.57 118.28 26.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.645 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -160.15 -179.72 7.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.263 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD22 HD23 ' A' ' 147' ' ' LEU . 60.2 tp -107.98 115.74 30.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.65 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 14.9 t60 -73.99 130.87 40.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.45 6.38 29.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.774 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -148.15 9.66 0.87 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.12 104.34 2.51 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -167.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.436 ' HB3' HD23 ' A' ' 41' ' ' LEU . 39.4 t -118.33 -50.85 2.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.2 pt? -158.09 -168.89 2.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.817 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 10.7 pt -39.77 144.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -66.51 -39.46 88.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.076 -1.874 . . . . 0.0 112.185 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -65.53 -39.48 95.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.352 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 HG22 ' A' ' 134' ' ' VAL . 16.5 tp -74.37 -49.79 21.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 109.864 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' HA ' HD23 ' A' ' 49' ' ' LEU . 23.3 mt-10 -48.5 -47.2 39.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.4 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.9 m -66.48 -32.97 74.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.7 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.41 74.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.8 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -57.91 -45.13 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.161 175.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -46.55 152.35 0.47 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.949 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.429 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 79.11 -23.59 3.17 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 114.428 -1.26 . . . . 0.0 114.594 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.562 ' O ' HG11 ' A' ' 3' ' ' VAL . 94.2 m-70 -84.49 177.55 8.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.664 0.732 . . . . 0.0 111.163 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 1' ' ' MET . 39.5 mt-10 -128.72 164.57 22.66 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' HG11 ' A' ' 136' ' ' VAL . 1.1 m -52.04 142.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.819 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.87 -13.11 66.66 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.473 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.52 131.38 44.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.941 0.4 . . . . 0.0 110.327 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 135' ' ' GLU . 1.9 tmtp? -137.96 130.33 29.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.913 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.643 ' CE2' HG21 ' A' ' 60' ' ' VAL . 13.5 p90 -167.4 162.01 14.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.037 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.77 144.11 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.626 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.643 HG21 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -134.32 142.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.31 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.95 113.2 11.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.492 HG13 ' HA3' ' A' ' 44' ' ' GLY . 80.3 t -120.78 138.22 51.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.876 0.37 . . . . 0.0 110.652 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.85 150.32 50.37 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.367 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.54 -31.39 4.33 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -65.16 -21.11 66.73 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -117.06 3.69 12.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 176.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.503 ' OE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HG3' HG21 ' A' ' 118' ' ' VAL . 8.4 mpt_? -116.26 105.36 12.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 109.737 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.17 128.62 36.28 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.952 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.32 137.1 72.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.592 2.862 . . . . 0.0 112.216 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.922 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -56.1 -25.57 46.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.113 175.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.04 -36.42 81.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.462 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -43.16 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.316 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.7 m-85 -90.4 40.21 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.401 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 14.7 ptm -52.13 -36.54 51.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.144 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -92.32 13.94 65.92 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.984 -175.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.781 HG13 ' HG ' ' A' ' 90' ' ' LEU . 7.4 p -75.79 159.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.272 0.536 . . . . 0.0 111.129 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.67 -76.03 0.1 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.859 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.625 ' O ' ' HE2' ' A' ' 94' ' ' MET . 30.7 mt-10 -149.77 110.51 4.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.217 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HG ' HG13 ' A' ' 87' ' ' VAL . 5.6 mt -64.58 119.54 10.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.652 0.739 . . . . 0.0 111.45 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -147.03 164.89 31.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.471 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.425 HG12 ' C ' ' A' ' 110' ' ' THR . 53.3 t -81.21 132.68 30.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.04 1.82 56.0 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.83 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.625 ' HE2' ' O ' ' A' ' 89' ' ' GLU . 8.6 mmm -91.09 141.86 28.37 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.226 0.536 . . . . 0.0 111.292 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 10.7 mtp180 -118.24 134.54 54.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.043 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -162.01 167.09 25.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.078 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.6 tp -91.31 137.3 32.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.192 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.84 138.14 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.09 146.91 28.42 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.5 p -145.74 -175.55 4.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.17 -23.57 67.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.84 0.828 . . . . 0.0 110.514 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.84 26.84 10.27 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.549 -171.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.89 -179.31 48.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.135 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.82 133.39 55.83 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.375 2.05 . . . . 0.0 112.903 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 88.9 t -129.53 116.39 18.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.549 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.9 Cg_exo -79.75 112.97 2.98 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.889 2.393 . . . . 0.0 111.19 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.8 m -118.23 178.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.743 0.306 . . . . 0.0 111.196 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.472 ' C ' HG13 ' A' ' 119' ' ' VAL . 36.7 tt0 -134.53 130.84 37.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.426 HG23 ' CG2' ' A' ' 112' ' ' VAL . 40.7 mt -71.89 130.44 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.327 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.425 ' C ' HG12 ' A' ' 92' ' ' VAL . 20.9 p -112.05 -1.87 15.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 0.0 110.382 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.415 ' HA ' HG23 ' A' ' 92' ' ' VAL . . . -175.34 150.24 1.11 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.485 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.593 HG13 HG13 ' A' ' 117' ' ' VAL . 60.8 t -139.08 106.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 6.9 mm-40 -86.0 -157.31 0.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -71.33 -54.09 11.97 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.866 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.465 ' C ' ' HG2' ' A' ' 81' ' ' LYS . 18.5 m-20 -118.14 5.86 12.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.401 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 33.1 p-80 -145.1 148.03 33.2 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.461 -0.774 . . . . 0.0 111.574 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.701 HG12 ' HZ1' ' A' ' 81' ' ' LYS . 30.7 m -116.35 167.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 78' ' ' ARG . 59.5 t -122.53 115.88 47.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.967 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -119.05 130.57 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.069 0.462 . . . . 0.0 110.333 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t0 . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.986 -177.245 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -124.17 122.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 110.048 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 1.6 m-85 -117.83 139.81 50.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.704 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.9 m120 -109.36 106.67 16.57 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.597 HG22 HD11 ' A' ' 45' ' ' LEU . 2.5 t -99.61 135.62 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.559 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 25.9 mt-10 -135.54 90.83 2.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.272 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 54' ' ' VAL . 2.9 p -72.69 115.0 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.846 0.831 . . . . 0.0 112.446 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 31' ' ' PRO . 3.2 t -72.91 -47.91 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.124 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.03 157.59 31.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.751 0.31 . . . . 0.0 111.147 -171.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.452 HG13 HG13 ' A' ' 54' ' ' VAL . 63.5 mt -140.34 123.46 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -146.97 137.05 23.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.999 0.428 . . . . 0.0 111.351 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 7' ' ' LEU . 7.9 pt-20 -75.49 138.66 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . . . -80.51 176.77 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.682 0.754 . . . . 0.0 112.589 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 145' ' ' GLU . 22.5 p -96.34 23.43 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.269 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 147' ' ' LEU . 41.6 mt-10 70.17 -43.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.365 0.666 . . . . 0.0 111.444 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 143' ' ' THR . 40.0 mt-10 -65.79 -40.26 91.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.365 0.602 . . . . 0.0 109.38 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 42.4 mt-10 -63.15 -34.27 77.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.381 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.624 HD23 HD22 ' A' ' 35' ' ' LEU . 47.2 mt -71.98 -47.4 52.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.139 176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.48 69.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.52 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.04 -16.76 18.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.87 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.79 40.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 114.243 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.373 0.587 . . . . 0.0 110.635 176.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 51' ' ' GLY . 15.2 ptpt -111.11 170.83 7.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.481 0.657 . . . . 0.0 111.729 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -84.94 131.96 32.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.16 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.12 -174.12 4.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.527 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 79.5 tttt -65.96 155.86 35.28 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.406 ' O ' HD23 ' A' ' 147' ' ' LEU . 28.7 m-20 60.37 -5.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 141' ' ' GLU . 19.3 mt -90.71 109.66 20.84 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.613 -0.679 . . . . 0.0 111.454 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.0 144.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.046 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -151.16 137.75 12.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -168.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 10.9 m -102.45 121.24 41.95 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.671 HD21 HG11 ' A' ' 134' ' ' VAL . 2.1 tt -136.9 154.31 50.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.425 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . . . -124.36 151.24 44.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.48 161.33 21.28 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.04 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.617 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 51.8 tt0 -132.15 118.94 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.463 ' O ' HD13 ' A' ' 22' ' ' LEU . 2.9 p -110.32 124.4 67.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.536 0.684 . . . . 0.0 111.388 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -145.41 -179.84 6.92 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.441 ' HG1' HG11 ' A' ' 21' ' ' VAL . 40.6 p -99.91 174.58 6.12 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.253 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.43 -19.22 65.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.421 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.07 -18.72 55.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.577 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.36 -12.01 43.59 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.515 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.441 HG11 ' HG1' ' A' ' 17' ' ' THR . 8.9 p -73.53 126.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 117.427 0.614 . . . . 0.0 110.588 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 15' ' ' VAL . 51.5 tp -76.96 127.97 33.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.86 -35.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -167.47 167.06 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -165.64 159.35 16.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.5 0.667 . . . . 0.0 111.212 169.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -126.07 114.59 24.04 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.42 166.06 26.86 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.789 2.326 . . . . 0.0 113.218 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.94 -22.89 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.436 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.2 p -71.41 -38.95 71.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.871 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.508 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -135.34 113.05 11.14 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-O 121.269 0.557 . . . . 0.0 110.151 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.648 ' HB3' HG22 ' A' ' 137' ' ' VAL . 11.3 Cg_exo -75.81 166.58 27.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.9 3.067 . . . . 0.0 114.439 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.62 134.17 34.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.485 170.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.07 118.18 30.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.167 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -160.69 179.75 8.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.195 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.93 117.95 35.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 31.9 t60 -70.79 128.99 37.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 96.48 8.19 57.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.889 172.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -134.31 14.58 3.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.15 103.29 2.3 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -167.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 36' ' ' HIS . 33.4 t -116.61 -52.31 2.56 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.575 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.39 -82.81 0.24 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.122 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.575 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 15.5 pt -122.59 -163.43 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 t -98.02 -50.09 4.52 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.492 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.05 -34.81 29.11 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.956 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 134' ' ' VAL . 55.5 tp -74.24 -46.55 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 109.988 -172.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 48.3 mt-10 -50.79 -41.74 57.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.259 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -65.15 -33.23 75.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.72 -35.57 65.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.015 0.912 . . . . 0.0 109.273 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.721 HD23 HG13 ' A' ' 134' ' ' VAL . 96.2 mt -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.953 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.74 152.57 5.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.997 0.903 . . . . 0.0 112.772 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 2' ' ' LYS . . . 77.9 -18.39 5.02 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.549 ' HE1' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -128.65 157.31 41.67 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.377 2.089 . . . . 0.0 112.921 -173.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 1' ' ' MET . 41.4 mt-10 -101.98 166.32 10.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -157.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.603 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.6 m -48.12 144.21 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.046 -1.433 . . . . 0.0 112.714 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.507 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.58 -10.34 66.75 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.286 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -75.43 137.06 40.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.166 0.507 . . . . 0.0 110.171 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.651 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 2.1 tmtp? -137.76 132.37 32.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.921 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 60' ' ' VAL . 7.2 p90 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.045 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.39 139.84 33.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.779 0.799 . . . . 0.0 111.305 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 58' ' ' PHE . 3.4 t -125.67 150.42 30.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.428 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.48 113.96 11.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.037 0.381 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.85 144.66 37.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.189 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.36 152.64 49.89 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.155 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.2 -28.35 52.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.979 0.512 . . . . 0.0 112.258 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -71.43 -20.74 62.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.949 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -111.73 1.35 16.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.519 0.676 . . . . 0.0 110.416 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.56 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.51 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.455 0.645 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG3' HG23 ' A' ' 118' ' ' VAL . 4.8 mpt_? -115.16 148.93 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.17 129.46 12.31 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -171.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HB2' HG22 ' A' ' 83' ' ' VAL . 29.5 Cg_exo -57.21 136.57 77.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.051 2.5 . . . . 0.0 112.422 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -54.44 -31.6 55.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.495 178.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.93 -35.14 79.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 80' ' ' PRO . 88.1 t -57.01 -36.3 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.156 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD13 ' A' ' 90' ' ' LEU . 45.6 m-85 -104.81 39.87 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.405 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.3 ptm -53.65 -27.22 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.527 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 3.07 85.7 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.387 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.0 t -92.78 144.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.091 0.446 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.01 -77.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.076 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' HE3' ' A' ' 94' ' ' MET . 29.2 mt-10 -134.2 106.64 7.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.722 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 117' ' ' VAL . 96.8 mt -59.68 105.52 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.438 0.637 . . . . 0.0 109.622 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -128.91 167.81 16.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.085 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 111' ' ' ALA . 43.8 t -79.83 135.24 25.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.5 1.19 68.98 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.137 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.503 ' HE3' ' O ' ' A' ' 89' ' ' GLU . 4.6 mmm -83.93 134.57 34.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.405 0.622 . . . . 0.0 109.688 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -119.33 136.08 54.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.09 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -163.65 165.27 23.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.762 HD22 ' HB2' ' A' ' 104' ' ' PRO . 5.6 mt -88.44 132.76 34.34 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.54 0.686 . . . . 0.0 110.518 172.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -112.61 114.07 26.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.079 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 26.2 mt-10 -87.32 96.64 10.42 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 110.788 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 p -94.67 -174.52 3.32 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.577 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.33 -43.54 61.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.308 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.468 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.5 pt20 -98.47 32.01 2.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.034 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.23 179.83 39.59 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.76 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.762 ' HB2' HD22 ' A' ' 97' ' ' LEU . 6.2 Cg_exo -66.77 147.77 81.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.516 2.144 . . . . 0.0 112.03 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -134.22 117.09 13.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.801 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.5 Cg_exo -74.01 102.34 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 111.722 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 6.2 m -118.73 151.84 20.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 110.721 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 tt0 -116.62 137.85 51.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.225 0.536 . . . . 0.0 110.318 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.473 ' HA ' HG12 ' A' ' 119' ' ' VAL . 26.5 mt -81.57 129.26 37.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.086 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.3 p -115.53 5.27 14.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.45 ' HA ' HG23 ' A' ' 92' ' ' VAL . . . 176.77 151.45 0.17 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.737 HG13 HG12 ' A' ' 117' ' ' VAL . 49.1 t -140.91 109.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -91.22 -154.1 0.34 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.05 -36.2 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -133.27 -14.83 2.58 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.179 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -139.38 157.59 45.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.536 0.208 . . . . 0.0 110.725 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.737 HG12 HG13 ' A' ' 112' ' ' VAL . 30.5 m -112.77 167.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 78' ' ' ARG . 41.4 t -117.19 117.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.7 m -120.39 140.03 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.638 0.733 . . . . 0.0 112.302 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.536 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -122.04 125.63 46.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 2.8 m-85 -116.02 134.54 54.85 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.355 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -105.44 106.62 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.721 HG13 HD23 ' A' ' 49' ' ' LEU . 4.0 t -99.09 139.65 20.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.725 0.774 . . . . 0.0 112.286 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.651 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 37.0 mt-10 -131.48 91.49 3.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.811 -1.541 . . . . 0.0 109.465 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.5 p -63.56 154.27 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 31' ' ' PRO . 76.0 t -129.44 -55.31 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 -153.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.91 38.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 110.419 -3.082 . . . . 0.0 109.876 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.458 HG13 HG13 ' A' ' 54' ' ' VAL . 74.9 mt -138.91 133.51 41.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.9 ttp-105 -139.52 154.18 47.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.0 110.171 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.611 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.1 pt-20 -91.55 132.38 36.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.659 ' HB2' HD23 ' A' ' 147' ' ' LEU . . . -73.2 163.81 27.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.749 . . . . 0.0 112.243 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -94.64 24.51 4.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.972 -171.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 70.52 -38.71 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.06 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -40.22 82.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.645 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.7 mt-10 -58.97 -37.12 76.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.999 175.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.659 HD23 ' HB2' ' A' ' 142' ' ' ALA . 23.0 mt -71.07 -46.02 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.084 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.92 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.425 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -89.76 -14.85 33.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.335 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.67 90.37 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.714 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 ptpt -111.73 174.63 5.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.43 0.633 . . . . 0.0 111.268 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -83.51 125.05 40.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.188 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.09 -171.08 3.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.781 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 34.9 tttm -63.86 151.18 43.12 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.639 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.43 ' CB ' HD23 ' A' ' 147' ' ' LEU . 30.8 m-20 52.74 7.84 0.08 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.428 ' H ' ' C ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -100.57 100.47 11.2 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 34' ' ' TYR . 14.6 p -69.77 141.09 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.55 HG11 HG21 ' A' ' 139' ' ' ILE . 4.5 m -136.46 159.04 38.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.873 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.775 ' O ' HG22 ' A' ' 137' ' ' VAL . 19.5 m -117.37 118.26 31.75 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.624 HD21 HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -134.96 161.08 36.28 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.775 -177.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.24 107.82 13.01 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.0 p90 -120.52 158.48 27.2 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.407 -173.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.867 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 tt0 -127.28 119.4 26.24 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.439 HG11 HG22 ' A' ' 23' ' ' VAL . 2.4 p -102.0 119.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 122.199 1.0 . . . . 0.0 111.021 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 16' ' ' ARG . 13.7 ttm180 -134.51 145.97 49.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.95 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 p -87.14 179.44 6.65 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -64.05 -29.99 71.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 0.0 109.929 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.69 -19.25 65.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.02 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.73 66.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.532 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.37 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.498 . . . . 0.0 110.252 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 23' ' ' VAL . 5.0 tt -83.49 124.27 30.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.659 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 HG22 HG11 ' A' ' 15' ' ' VAL . 27.0 m -94.3 -39.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.373 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -162.73 159.53 24.34 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.867 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -166.0 148.17 7.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.25 0.548 . . . . 0.0 111.226 174.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -102.32 113.98 65.63 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.84 163.72 29.72 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 m -67.24 -13.88 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.327 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.2 p -82.28 -30.49 30.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.96 114.88 5.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.342 0.591 . . . . 0.0 110.976 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.764 ' HG3' HG13 ' A' ' 137' ' ' VAL . 8.9 Cg_exo -75.03 154.36 42.28 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.729 2.952 . . . . 0.0 113.374 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD21 ' CE1' ' A' ' 13' ' ' TYR . 15.2 tp -76.57 134.9 39.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.359 170.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -110.04 120.28 41.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.653 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 7.5 p90 -150.77 148.37 28.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.292 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.508 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 41.9 tp -81.34 110.1 16.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.91 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' CE1' ' HG3' ' A' ' 50' ' ' GLU . 14.3 t60 -71.76 140.77 49.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.083 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 108.37 -27.03 14.75 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.158 -1.496 . . . . 0.0 113.85 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.45 55.48 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 35' ' ' LEU . . . -141.29 -105.71 0.59 Allowed Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.117 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 15.5 m -114.39 -54.84 2.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -166.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.956 HD22 HD22 ' A' ' 45' ' ' LEU . 84.6 mt -65.44 136.48 56.51 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.796 1.284 . . . . 0.0 112.651 173.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 67' ' ' ALA . 21.7 pt -53.33 175.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 111.749 -2.478 . . . . 0.0 114.581 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 m -66.26 -48.41 70.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.185 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.17 -45.33 96.26 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.428 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.956 HD22 HD22 ' A' ' 41' ' ' LEU . 23.7 tp -74.58 -53.33 9.61 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.809 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 6.9 mt-10 -48.29 -42.45 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 124.062 0.851 . . . . 0.0 111.834 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 m -65.53 -29.73 70.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.61 55.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 8.2 mt -65.43 -38.42 89.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.407 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 3.9 mt-10 -53.66 153.23 4.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.561 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.527 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 77.29 -14.71 8.01 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.87 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.593 ' O ' HG13 ' A' ' 3' ' ' VAL . 82.3 m-70 -88.78 165.52 14.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.265 0.533 . . . . 0.0 110.07 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 139' ' ' ILE . 69.1 mt-10 -123.11 162.5 22.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.479 HG13 HG13 ' A' ' 139' ' ' ILE . 1.5 m -46.56 143.64 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.826 0.822 . . . . 0.0 112.697 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.04 -2.88 72.55 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 114.703 -1.135 . . . . 0.0 114.079 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.45 134.01 35.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.464 0.632 . . . . 0.0 110.771 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.668 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 1.8 tmtp? -135.24 128.63 32.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.725 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' A' ' 60' ' ' VAL . 22.8 p90 -155.57 -178.2 7.1 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.81 149.69 40.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG23 ' CE2' ' A' ' 58' ' ' PHE . 2.4 t -137.47 142.54 36.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.61 -172.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.64 113.53 13.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.18 132.63 70.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.77 154.05 48.02 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -49.63 -26.13 3.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.62 -34.0 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.13 -0.357 . . . . 0.0 111.614 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.73 -24.38 18.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.393 0.616 . . . . 0.0 109.942 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.66 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.412 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.549 ' OE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.201 0 CA-C-O 121.916 0.865 . . . . 0.0 111.035 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -98.73 140.84 32.32 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.152 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -136.06 124.92 15.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -60.11 126.91 21.5 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.386 2.057 . . . . 0.0 111.632 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 22.8 mtmt -58.74 -17.26 21.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.826 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.77 -29.87 70.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 0.0 110.24 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -67.05 -45.64 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.904 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 87' ' ' VAL . 60.3 m-85 -87.74 40.86 0.96 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.0 ptm -50.82 -29.8 12.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 6.19 81.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.915 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 75.0 t -94.14 145.46 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.424 0.612 . . . . 0.0 111.224 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.81 -74.32 0.05 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.542 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.512 ' O ' ' HE1' ' A' ' 94' ' ' MET . 24.0 mt-10 -142.08 116.88 9.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.463 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 117' ' ' VAL . 95.8 mt -62.33 105.97 0.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.42 176.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -128.77 166.21 19.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.13 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 110' ' ' THR . 44.2 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.41 74.57 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.82 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.512 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 4.0 mmm -89.2 135.03 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.141 0.471 . . . . 0.0 110.038 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.548 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 49.9 mtt180 -115.49 135.5 54.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.87 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.17 171.37 13.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.003 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 104' ' ' PRO . 64.3 tp -98.09 150.98 20.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' O ' HG22 ' A' ' 100' ' ' THR . . . -148.88 90.97 1.81 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 112.041 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 16.2 mt-10 -49.11 111.16 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.367 1.08 . . . . 0.0 112.87 162.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 98' ' ' ALA . 68.2 p -113.18 -172.63 2.1 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.747 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -50.83 -35.24 31.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.973 0.416 . . . . 0.0 111.005 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -98.55 28.32 4.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.04 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.21 -177.25 45.81 Favored Glycine 0 C--N 1.322 -0.203 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.453 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.764 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.7 Cg_endo -69.79 121.93 8.61 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 122.379 2.053 . . . . 0.0 112.411 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.83 116.1 47.95 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.931 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.8 120.94 8.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.011 1.807 . . . . 0.0 109.99 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.731 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 10.8 m -142.77 154.21 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.833 0.825 . . . . 0.0 112.524 -168.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 28.6 tt0 -130.44 127.8 40.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.866 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.526 ' HA ' HG13 ' A' ' 119' ' ' VAL . 62.8 mt -66.01 129.1 30.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.434 ' C ' HG13 ' A' ' 92' ' ' VAL . 36.3 p -116.34 0.7 12.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -175.34 152.65 1.42 Allowed 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.525 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.72 HG13 HG11 ' A' ' 117' ' ' VAL . 45.9 t -139.67 111.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -87.62 -166.63 1.63 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.439 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 5.1 m-20 -63.36 -53.54 50.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.307 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.576 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 5.0 m-20 -99.71 -18.3 17.32 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -143.25 146.76 33.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.704 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.72 HG11 HG13 ' A' ' 112' ' ' VAL . 33.1 m -92.44 168.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.388 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.68 108.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.731 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.4 m -115.66 141.6 32.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.889 0.852 . . . . 0.0 112.872 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.169 -175.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -115.39 133.81 55.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.735 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 36.9 m-85 -121.02 142.09 50.13 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.404 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -108.84 106.71 16.83 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 166.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.653 HG13 HD22 ' A' ' 49' ' ' LEU . 3.1 t -100.85 140.28 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.95 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 59.1 mt-10 -138.14 100.7 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.968 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 p -80.42 110.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.13 0.49 . . . . 0.0 110.928 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 10' ' ' SER . 2.7 m -75.92 -39.53 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.013 0.435 . . . . 0.0 111.538 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 137' ' ' VAL . . . -162.41 156.95 21.84 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -168.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.55 HG21 HG11 ' A' ' 9' ' ' VAL . 73.3 mt -136.63 131.96 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -146.76 141.31 26.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.789 0.328 . . . . 0.0 110.144 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -87.71 125.31 34.34 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.74 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.732 ' HB1' HD21 ' A' ' 147' ' ' LEU . . . -63.61 165.5 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.774 -170.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 145' ' ' GLU . 56.3 p -79.49 15.36 1.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.422 -170.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.486 ' HA ' HD11 ' A' ' 147' ' ' LEU . 41.6 mt-10 69.94 -35.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 111.481 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 143' ' ' THR . 46.4 mt-10 -62.23 -46.89 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 109.708 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 25.4 mt-10 -59.22 -35.53 73.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.237 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.732 HD21 ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt -71.92 -46.89 56.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.401 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.87 70.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.211 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -88.93 -11.92 43.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.789 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.23 4.21 84.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.994 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.592 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.7 ptpt -129.59 179.48 5.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -85.56 116.06 28.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.383 0.611 . . . . 0.0 111.563 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -149.89 -167.37 2.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.084 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 7' ' ' LEU . 20.2 tttm -61.56 153.31 28.0 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.108 0.255 . . . . 0.0 110.691 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 50.3 3.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.145 1.378 . . . . 0.0 114.519 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 5' ' ' LYS . 1.2 mt -93.91 98.43 11.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -63.61 144.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.204 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.753 HG11 HG21 ' A' ' 139' ' ' ILE . 2.1 m -148.84 152.29 12.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.473 0.654 . . . . 0.0 111.24 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.0 m -103.03 117.72 35.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD23 HG11 ' A' ' 134' ' ' VAL . 9.5 tt -133.01 147.59 52.26 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.522 -172.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.8 152.4 37.32 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.615 ' HE1' HD22 ' A' ' 32' ' ' LEU . 52.1 p90 -161.77 157.51 24.33 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.168 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' CG ' HD11 ' A' ' 22' ' ' LEU . 36.1 tt0 -131.08 122.86 27.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.385 172.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.83 119.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.581 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -139.29 155.46 47.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 p -78.08 179.8 6.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.012 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 131' ' ' LYS . 5.8 mm-40 -51.64 -31.68 26.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.543 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -19.0 63.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.151 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.34 -2.54 81.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.538 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.63 136.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.486 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 25' ' ' GLU . 58.8 tp -72.8 131.37 42.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.733 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.84 -40.56 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.688 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -144.93 149.45 35.27 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.625 ' HB2' HD13 ' A' ' 22' ' ' LEU . 24.1 tt0 -164.12 139.51 6.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.1 m -119.18 114.84 34.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 167.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.37 167.44 26.3 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.588 2.192 . . . . 0.0 113.389 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -18.96 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.215 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -73.15 -34.83 66.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.508 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.99 112.72 5.74 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 30' ' ' ALA . 11.2 Cg_exo -75.44 159.7 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.285 2.657 . . . . 0.0 113.952 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.704 HD23 ' HG ' ' A' ' 41' ' ' LEU . 14.0 tp -79.57 126.19 30.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.046 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.2 120.78 42.96 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 40' ' ' SER . 46.2 p90 -144.54 161.86 38.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.497 HD21 HD21 ' A' ' 147' ' ' LEU . 46.7 tp -108.29 105.64 15.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 6.4 t60 -61.14 130.51 46.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.81 56.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.219 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -134.62 2.8 3.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 94.73 0.14 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.772 ' O ' HD13 ' A' ' 41' ' ' LEU . 12.7 m -116.11 15.21 16.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.512 1.149 . . . . 0.0 108.511 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 40' ' ' SER 0.396 0.0 OUTLIER 41.81 109.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.473 2.709 . . . . 0.0 115.397 -170.467 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.8 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 pt 51.57 127.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 110.148 -3.205 . . . . 0.0 115.61 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.528 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 43.5 t -50.66 -47.63 58.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.564 -2.107 . . . . 0.0 113.387 -170.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -67.97 -36.54 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.345 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 44.8 tp -75.03 -46.96 31.48 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.8 ' HG3' ' O ' ' A' ' 42' ' ' ILE . 31.8 mt-10 -48.9 -49.51 39.47 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.911 0.757 . . . . 0.0 109.989 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.4 m -60.57 -37.41 81.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.954 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.15 63.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.696 0.76 . . . . 0.0 110.039 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 88.0 mt -62.46 -36.57 82.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.724 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -54.54 153.98 5.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 78.17 -15.2 9.13 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 113.498 -1.683 . . . . 0.0 117.096 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.729 ' O ' HG12 ' A' ' 3' ' ' VAL . 14.4 p80 -102.19 174.24 6.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.661 1.731 . . . . 0.0 110.263 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HA ' HD13 ' A' ' 139' ' ' ILE . 4.1 mp0 -119.82 171.48 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.73 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG11 HG13 ' A' ' 139' ' ' ILE . 2.0 m -52.16 142.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.309 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 97.56 -15.26 62.28 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.007 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' O ' HG11 ' A' ' 136' ' ' VAL . 32.5 m-20 -74.32 130.65 40.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.341 0.591 . . . . 0.0 111.42 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 5.5 tmtm? -133.24 124.6 27.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.052 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.679 ' CE2' HG21 ' A' ' 60' ' ' VAL . 13.3 p90 -148.85 -178.26 6.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.392 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.54 145.85 39.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.679 HG21 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -135.22 142.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 113.09 12.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.128 0.49 . . . . 0.0 110.341 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.549 HG13 ' HA3' ' A' ' 44' ' ' GLY . 58.2 t -126.57 144.17 37.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.421 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.64 153.24 50.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.96 -20.6 24.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.15 -19.65 53.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 110.817 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -115.71 -18.45 10.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.575 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.931 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 118' ' ' VAL . 6.5 mpt_? -107.62 114.7 28.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.886 -175.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -111.95 129.23 24.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.639 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 12.3 Cg_exo -61.91 134.41 49.83 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 111.426 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 18.8 mtmt -59.39 -14.66 12.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.09 -28.12 65.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.525 0.679 . . . . 0.0 110.259 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.22 -38.08 77.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.128 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 87' ' ' VAL . 61.2 m-85 -90.85 41.38 1.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -176.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 ptm -51.37 -25.82 6.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.093 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.33 11.01 73.16 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 84' ' ' PHE . 2.6 p -100.5 160.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.258 0.529 . . . . 0.0 109.922 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -75.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' O ' ' HE1' ' A' ' 94' ' ' MET . 26.8 mt-10 -145.41 121.57 10.81 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.12 175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' HB3' HG13 ' A' ' 117' ' ' VAL . 95.0 mt -62.12 103.88 0.42 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.934 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.61 155.62 40.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.562 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 109' ' ' ILE . 42.7 t -67.1 134.07 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.055 0.455 . . . . 0.0 110.922 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.62 -28.44 15.97 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.51 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.442 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 11.6 mmm -52.92 135.53 36.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 20.2 mtp85 -116.72 137.35 52.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.943 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -163.26 167.57 21.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.423 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 104' ' ' PRO . 52.0 tp -82.7 143.75 30.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.0 110.015 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -131.76 147.53 52.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.778 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -97.64 142.66 29.17 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.7 p -148.92 -175.92 5.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.82 -27.47 69.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.565 0.698 . . . . 0.0 109.696 171.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -89.72 23.23 2.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.861 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.99 -173.71 52.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.495 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 39.8 Cg_exo -59.25 125.61 18.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 111.568 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.54 109.28 30.78 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.014 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.88 107.11 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.62 2.213 . . . . 0.0 110.694 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.4 m -117.75 176.22 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.187 0.517 . . . . 0.0 111.782 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 39.2 tt0 -137.06 129.6 30.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.592 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.709 HG22 ' HA ' ' A' ' 92' ' ' VAL . 32.1 mt -70.95 122.58 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -103.6 -7.42 20.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -173.1 156.73 3.3 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 117' ' ' VAL . 88.1 t -136.75 104.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.235 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 24.1 mm-40 -75.8 -166.82 0.61 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.769 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.22 -56.14 24.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.691 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.513 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 24.6 t70 -128.08 16.96 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.894 176.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.486 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 50.9 p-80 -146.22 146.33 30.74 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 121.436 -0.79 . . . . 0.0 111.68 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 90' ' ' LEU . 26.9 m -104.54 167.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.999 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 78' ' ' ARG . 48.3 t -130.86 119.53 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 5.0 m -114.35 131.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.865 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -175.442 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 mt . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.459 0.647 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.491 ' HZ2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 mtpt -112.07 132.37 54.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.163 175.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.575 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 11.6 m-85 -121.17 142.19 50.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.903 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -108.61 107.61 18.16 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 167.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.708 HG11 HD23 ' A' ' 11' ' ' LEU . 3.6 t -100.29 137.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.558 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 33.4 mt-10 -134.03 98.08 4.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.494 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.453 HG13 ' H ' ' A' ' 55' ' ' GLY . 3.8 p -78.57 114.63 19.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.693 . . . . 0.0 111.669 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 31' ' ' PRO . 5.5 t -71.67 -50.31 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.47 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . . . -162.82 154.48 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.753 HG21 HG11 ' A' ' 9' ' ' VAL . 66.7 mt -132.94 138.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -149.25 140.92 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.07 126.28 34.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . . . -66.75 166.16 13.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.449 -168.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.1 p -82.05 20.74 0.96 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.477 -170.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HA ' HD13 ' A' ' 147' ' ' LEU . 45.0 mt-10 67.71 -37.88 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.363 0.665 . . . . 0.0 111.327 -174.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 143' ' ' THR . 45.7 mt-10 -64.28 -45.2 89.1 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.693 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 37.6 mt-10 -59.54 -34.91 73.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.508 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.69 HD23 ' HB3' ' A' ' 142' ' ' ALA . 35.6 mt -74.14 -44.27 54.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.688 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.73 -29.6 70.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.346 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -94.99 -32.08 13.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.93 13.03 35.25 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.594 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 p80 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 117.565 0.682 . . . . 0.0 111.455 -178.737 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 12.4 ptmt -106.21 156.14 18.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.332 0.586 . . . . 0.0 111.187 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.687 HG11 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -64.68 126.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.786 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.68 -169.78 3.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.168 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 7' ' ' LEU . 60.8 tttp -65.23 153.9 39.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.358 . . . . 0.0 111.662 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 51.63 6.1 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 141' ' ' GLU . 17.9 mt -92.85 149.42 21.28 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -115.59 142.95 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.67 HG11 HG22 ' A' ' 139' ' ' ILE . 3.2 m -142.31 155.74 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.787 0.803 . . . . 0.0 111.716 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . 16.5 m -117.9 117.59 29.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.175 -1.375 . . . . 0.0 107.962 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.724 HD23 HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -127.84 158.52 37.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.82 112.67 16.95 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.498 ' HE1' HD21 ' A' ' 32' ' ' LEU . 41.0 p90 -126.58 160.89 29.34 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.453 -171.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.5 tt0 -129.54 118.67 22.42 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p -106.33 122.46 60.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.62 0.724 . . . . 0.0 111.553 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -139.12 161.19 37.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.0 p -90.28 175.94 6.93 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.164 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.93 -21.5 66.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.19 -18.6 61.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.938 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.47 44.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.925 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.07 138.83 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 15' ' ' VAL . 55.3 tp -79.71 134.38 36.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.09 -38.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -156.93 168.49 27.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -165.54 137.49 4.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.143 0.497 . . . . 0.0 111.971 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 m -113.03 111.41 50.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -68.36 165.79 27.68 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 122.807 2.338 . . . . 0.0 113.339 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.56 -16.07 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.78 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -79.22 -33.73 43.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.07 113.01 6.27 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.327 0.584 . . . . 0.0 109.601 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.636 ' HG3' HG21 ' A' ' 137' ' ' VAL . 9.6 Cg_exo -75.59 169.22 22.79 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.572 2.848 . . . . 0.0 113.741 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD21 ' HE1' ' A' ' 13' ' ' TYR . 14.0 tp -84.1 126.35 33.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -104.85 120.6 41.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.725 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 5.4 p90 -150.34 157.39 43.0 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.169 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 147' ' ' LEU . 57.7 tp -102.69 114.61 29.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.514 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 48.6 t60 -69.84 142.39 53.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.384 0.611 . . . . 0.0 111.915 -169.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.91 56.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.473 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -129.52 -7.93 4.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.773 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.55 41.23 8.45 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.975 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.725 ' CB ' ' HB2' ' A' ' 34' ' ' TYR . 51.8 m -71.86 -38.86 70.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.577 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -113.43 -102.99 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.262 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.577 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 20.8 pt -116.35 -163.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.035 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.7 t -94.77 -49.06 5.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.391 0.615 . . . . 0.0 110.64 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -79.19 -26.45 57.69 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.984 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.688 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 mt -74.41 -52.76 11.14 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.165 -171.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 23.1 mt-10 -50.63 -49.79 55.94 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.518 0.511 . . . . 0.0 111.384 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.7 m -64.9 -31.8 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.685 0.279 . . . . 0.0 111.737 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.44 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 76.6 mt -61.62 -33.42 73.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.518 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.3 mt-10 -52.14 152.85 3.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.018 0.913 . . . . 0.0 112.819 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 78.89 -22.6 3.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.932 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.687 ' O ' HG11 ' A' ' 3' ' ' VAL . 96.8 m-70 -82.6 164.45 20.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.591 0.695 . . . . 0.0 110.782 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.0 mt-10 -127.2 160.47 31.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.412 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -49.69 143.85 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.563 0.697 . . . . 0.0 112.489 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.03 -15.64 62.61 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.149 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.04 133.91 47.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.904 0.383 . . . . 0.0 110.29 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 6.2 tmmm? -132.14 128.77 38.78 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.259 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 60' ' ' VAL . 18.0 p90 -165.43 157.17 14.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.147 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 4.8 p-10 -96.43 141.47 29.69 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.822 0.82 . . . . 0.0 110.198 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.73 HG21 ' CE2' ' A' ' 58' ' ' PHE . 8.7 t -117.1 143.91 26.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.13 -173.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.99 15.06 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.882 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.436 HG11 ' HA3' ' A' ' 44' ' ' GLY . 72.7 t -125.74 137.65 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.045 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.85 52.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.154 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -52.58 -20.94 3.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.3 -30.36 70.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.67 8.2 11.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.491 0.663 . . . . 0.0 111.352 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.9 -156.09 0.65 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.763 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 1.5 m-85 -80.56 -169.35 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.21 20.91 12.47 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 119.359 -1.401 . . . . 0.0 112.805 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -59.0 168.57 1.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 20.3 t80 -44.74 123.15 3.54 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.965 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -130.6 113.36 14.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.102 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . 8.8 pt-20 -74.91 -2.54 27.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -77.89 -12.24 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 tp -91.79 -9.99 41.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.383 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 ' HB ' ' OD1' ' A' ' 120' ' ' ASP . 4.7 p -106.37 132.61 53.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.398 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -157.98 177.39 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.248 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.408 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 6.3 mpt_? -115.33 114.29 24.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.737 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 83' ' ' VAL . 5.2 t -106.49 132.94 20.49 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.994 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' O ' HG22 ' A' ' 83' ' ' VAL . 29.8 Cg_exo -59.18 131.88 43.74 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.12 2.547 . . . . 0.0 111.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 26.4 mtmt -58.29 -24.41 59.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.78 -43.39 85.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.422 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 80' ' ' PRO . 3.4 m -55.67 -32.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HB2' HD11 ' A' ' 90' ' ' LEU . 71.0 m-85 -90.61 40.24 1.01 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.207 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -57.47 -29.07 63.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.355 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.07 -15.43 77.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.958 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 90' ' ' LEU . 91.9 t -73.34 142.26 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.849 0.324 . . . . 0.0 110.459 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.13 -67.99 0.35 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.035 0.445 . . . . 0.0 110.952 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.654 ' O ' ' HE1' ' A' ' 94' ' ' MET . 25.1 mt-10 -142.37 115.63 8.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.397 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' HB3' HG12 ' A' ' 117' ' ' VAL . 88.6 mt -66.57 98.87 0.54 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.155 0.502 . . . . 0.0 110.161 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -121.5 165.7 15.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.196 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HA ' HG22 ' A' ' 109' ' ' ILE . 48.2 t -80.24 139.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.03 1.23 79.87 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.255 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.654 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 4.8 mmm -87.63 135.23 33.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.528 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -111.21 139.58 46.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.333 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.56 154.41 16.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.792 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.65 131.27 37.68 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -119.8 134.94 55.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -88.84 137.24 32.49 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.0 p -145.42 -176.19 5.01 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.024 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -35.6 65.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 110.309 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.01 25.45 6.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.313 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.66 -173.45 53.85 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.789 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 31.4 Cg_exo -58.89 123.97 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.939 . . . . 0.0 112.055 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG11 HG13 ' A' ' 107' ' ' VAL . 88.0 t -124.63 113.68 27.19 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.566 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.1 101.46 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.876 2.384 . . . . 0.0 111.347 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.1 m -117.78 173.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 111.211 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.0 136.39 40.28 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.117 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.471 ' HA ' HG11 ' A' ' 119' ' ' VAL . 27.2 mt -77.48 129.59 37.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.05 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.6 p -114.79 1.6 14.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.402 0.62 . . . . 0.0 109.937 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.35 153.86 0.35 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.595 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.724 HG13 HG11 ' A' ' 117' ' ' VAL . 61.3 t -139.39 108.55 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -87.42 -156.04 0.32 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.36 -43.97 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.582 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 8.5 p-10 -131.94 -15.1 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.007 -170.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -136.58 159.29 42.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.724 HG11 HG13 ' A' ' 112' ' ' VAL . 33.8 m -112.66 162.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.33 116.52 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.198 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -122.59 138.77 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 121.215 0.531 . . . . 0.0 111.376 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.442 ' OD1' ' HB ' ' A' ' 76' ' ' VAL . 57.9 t0 -124.2 126.44 46.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.917 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.66 -22.03 78.74 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.115 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 12.8 m-80 -87.21 111.17 20.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -95.1 -82.18 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.794 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.686 ' HG3' ' H ' ' A' ' 125' ' ' LEU . 19.6 ptt? -76.79 -61.98 1.79 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.24 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.686 ' H ' ' HG3' ' A' ' 124' ' ' MET . 4.8 mp -118.98 -20.34 8.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 170.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' ASN . . . 179.97 -61.36 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.23 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.75 -32.42 4.82 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.858 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -55.78 136.41 51.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.451 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -89.52 156.41 18.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.046 0.451 . . . . 0.0 109.92 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 68' ' ' TYR . 64.1 mt -112.46 147.44 36.5 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.2 mtpp -114.89 122.72 47.17 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.2 m-85 -115.29 121.19 42.11 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.541 ' N ' HD21 ' A' ' 133' ' ' ASN . 0.8 OUTLIER -92.86 107.21 19.04 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.724 HG11 HD23 ' A' ' 11' ' ' LEU . 4.0 t -99.66 139.73 20.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.369 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 42.4 mt-10 -132.96 90.84 2.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.899 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 55' ' ' GLY . 2.9 p -66.76 107.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.039 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.636 HG21 ' HG3' ' A' ' 31' ' ' PRO . 8.1 t -72.41 -47.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.86 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.59 157.27 27.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.891 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.67 HG22 HG11 ' A' ' 9' ' ' VAL . 66.0 mt -137.73 134.33 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -143.54 142.76 31.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.511 ' HA ' HD21 ' A' ' 7' ' ' LEU . 8.3 pt-20 -79.67 126.48 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.638 ' HB2' HD23 ' A' ' 147' ' ' LEU . . . -66.78 166.56 12.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 113.017 -166.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.0 p -92.19 23.06 4.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.7 -170.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 69.71 -42.65 0.51 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.184 0.594 . . . . 0.0 111.151 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 143' ' ' THR . 53.2 mt-10 -63.37 -42.25 98.84 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.486 0.66 . . . . 0.0 109.645 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.57 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.0 mt-10 -61.82 -35.02 77.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.527 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 142' ' ' ALA . 28.7 mt -73.46 -46.5 47.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.144 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.38 -31.89 70.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.536 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -93.39 -31.69 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.907 0.384 . . . . 0.0 110.802 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.16 8.35 41.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.27 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -161.53 179.16 8.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.667 -0.313 . . . . 0.0 110.599 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 155' ' ' ALA . 2.1 t -67.23 152.9 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -113.08 -5.02 13.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.779 0.323 . . . . 0.0 111.676 -172.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -168.88 64.79 0.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.536 ' HB3' HG11 ' A' ' 152' ' ' VAL . . . -104.31 -38.54 6.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.833 0.349 . . . . 0.0 111.426 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -78.95 122.88 26.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.138 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.7 159.29 19.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.506 . . . . 0.0 110.899 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -96.35 -3.79 43.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.651 -172.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -147.0 -70.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.739 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 169.28 -46.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -160.41 159.88 31.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.326 -1.306 . . . . 0.0 108.633 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -117.6 -46.21 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 109.836 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.08 47.69 1.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.488 -169.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -73.74 123.35 23.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.396 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -128.21 22.77 6.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -106.4 -166.22 1.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.644 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -94.57 100.66 12.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -73.42 -23.05 60.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -85.36 130.91 34.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.763 -176.511 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 16.7 ptpt -106.61 168.94 8.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.883 0.849 . . . . 0.0 112.064 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 49' ' ' LEU . 1.1 p -83.43 121.43 36.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.35 -171.62 3.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.945 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 7' ' ' LEU . 42.1 tttp -63.91 153.5 36.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.762 0.315 . . . . 0.0 110.417 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 147' ' ' LEU . 32.7 m-20 57.57 -5.89 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.69 HD23 ' HA ' ' A' ' 141' ' ' GLU . 34.2 mt -90.81 104.44 17.03 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.792 -0.567 . . . . 0.0 110.425 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.4 143.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.45 0.643 . . . . 0.0 111.043 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG12 HG21 ' A' ' 139' ' ' ILE . 3.6 m -143.04 153.03 16.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.448 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -111.46 122.51 48.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.532 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.667 HD22 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -143.64 143.72 31.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 26' ' ' SER . . . -100.99 153.75 19.27 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.71 ' HE2' HD23 ' A' ' 32' ' ' LEU . 51.5 p90 -151.82 159.78 43.78 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.029 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.468 ' CG ' HD13 ' A' ' 22' ' ' LEU . 42.7 tt0 -126.8 119.45 26.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' HD11 ' A' ' 22' ' ' LEU . 21.9 t -102.21 119.45 50.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.505 -175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.54 151.68 50.74 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.0 p -82.02 -179.75 7.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -56.56 -26.31 54.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.202 0.525 . . . . 0.0 109.922 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.476 ' HB2' HG11 ' A' ' 21' ' ' VAL . 3.0 m-20 -67.39 -18.81 65.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.15 -11.24 72.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.469 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG11 ' HB2' ' A' ' 19' ' ' ASP . 10.4 p -78.4 136.44 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 111.245 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 25' ' ' GLU . 34.4 tp -69.7 131.1 44.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.478 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.45 -45.94 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.213 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -140.07 149.81 43.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.619 ' HB2' HD12 ' A' ' 22' ' ' LEU . 32.9 tt0 -156.21 134.7 11.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.301 0.572 . . . . 0.0 111.861 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 28.3 m -108.05 116.92 56.22 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 169.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.69 164.34 35.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.744 2.296 . . . . 0.0 113.589 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.91 -14.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.609 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.47 ' O ' ' HE1' ' A' ' 159' ' ' HIS . 23.7 p -80.88 -31.56 35.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.712 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.506 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.26 113.3 5.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 109.938 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -75.63 169.16 22.89 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.625 2.883 . . . . 0.0 113.548 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD23 ' HE2' ' A' ' 13' ' ' TYR . 12.4 tp -88.89 129.51 35.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -121.57 119.85 33.11 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.543 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.747 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 24.8 m-85 -153.69 162.08 41.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.287 0.565 . . . . 0.0 111.924 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.7 tp -89.18 105.79 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.878 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.56 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 22.6 t60 -65.73 142.98 57.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.43 . . . . 0.0 110.676 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 85.77 18.81 59.21 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.183 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -136.68 18.54 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.456 0.17 . . . . 0.0 110.679 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.67 35.82 92.52 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.56 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.747 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 42.2 m -64.78 -39.63 93.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.837 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 1.1 pt? -120.53 -89.1 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.401 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.837 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 12.6 pt -129.32 -166.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 t -97.38 -49.34 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.732 0.777 . . . . 0.0 110.705 -168.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.32 29.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 114.781 -1.1 . . . . 0.0 113.376 -172.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.665 HD11 HG22 ' A' ' 134' ' ' VAL . 28.7 tp -73.34 -46.62 48.24 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.56 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 24.0 mt-10 -52.11 -45.23 64.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.127 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -63.49 -38.31 90.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.11 80.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.783 HD22 HG12 ' A' ' 134' ' ' VAL . 95.9 mt -56.88 -33.46 66.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.558 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.3 153.62 9.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.969 0.89 . . . . 0.0 113.043 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.48 -29.02 2.95 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 114.222 -1.354 . . . . 0.0 116.153 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -120.02 148.45 43.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.319 1.559 . . . . 0.0 112.852 -174.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 1' ' ' MET . 31.3 mt-10 -99.52 173.96 6.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.059 -164.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.57 ' HA ' HG11 ' A' ' 136' ' ' VAL . 1.9 m -48.94 140.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.885 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.46 61.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.746 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.07 128.79 34.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.063 176.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 2.5 tmmt? -133.63 126.06 30.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.25 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.1 p90 -165.95 160.64 16.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.196 0.522 . . . . 0.0 111.413 -175.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.612 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.1 t -133.36 142.93 40.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.026 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.6 113.05 10.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.911 0.386 . . . . 0.0 110.201 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 t -127.79 142.47 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.76 155.33 52.97 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.95 -30.5 46.95 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.77 -32.39 73.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 111.303 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.55 0.8 14.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 111.302 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.714 ' HB3' ' HZ ' ' A' ' 132' ' ' PHE . . . -126.83 -157.05 0.78 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.547 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.646 ' HB2' ' CD1' ' A' ' 130' ' ' LEU . 9.4 m-85 -79.91 -161.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.08 53.3 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.182 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.97 -178.77 6.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.761 -0.72 . . . . 0.0 109.484 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.449 ' CD1' HG23 ' A' ' 76' ' ' VAL . 54.0 p90 -48.75 151.16 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.286 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.75 90.54 0.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.173 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -74.58 -0.67 18.51 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.26 -8.3 57.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 119.175 0.898 . . . . 0.0 110.518 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 122' ' ' ASN . 33.1 tp -95.07 -10.16 31.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.649 1.214 . . . . 0.0 109.057 167.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.449 HG23 ' CD1' ' A' ' 71' ' ' TYR . 42.1 t -108.65 150.78 11.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.892 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -164.25 173.03 12.81 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.752 . . . . 0.0 110.98 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HG3' HG21 ' A' ' 118' ' ' VAL . 10.7 mpt_? -113.0 109.31 18.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.632 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.59 128.51 28.84 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.511 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.42 134.6 56.05 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.829 2.353 . . . . 0.0 112.028 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -50.8 -19.43 0.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.219 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.14 -28.92 65.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.991 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.56 -41.17 63.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.126 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' O ' HG11 ' A' ' 87' ' ' VAL . 49.3 m-85 -98.04 39.94 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 ptm -53.66 -30.45 43.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.809 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.36 13.46 61.92 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.931 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 84' ' ' PHE . 3.6 p -93.63 162.32 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.439 0.62 . . . . 0.0 109.743 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.83 -74.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 0.0 110.322 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.473 ' O ' ' HE1' ' A' ' 94' ' ' MET . 35.5 mt-10 -153.16 118.08 5.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.841 176.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' HB3' HG11 ' A' ' 117' ' ' VAL . 86.5 mt -60.01 109.89 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 110.958 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -138.77 162.47 34.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.944 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.03 146.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.988 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.58 2.27 88.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.431 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.473 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 3.5 mmm -91.69 134.41 34.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.604 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 82.3 mtt180 -113.86 134.71 54.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.196 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -164.33 170.4 16.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.342 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.802 HD12 ' HB2' ' A' ' 104' ' ' PRO . 67.7 tp -87.35 150.22 23.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.556 ' O ' HG21 ' A' ' 100' ' ' THR . . . -144.22 89.48 2.03 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.833 0.825 . . . . 0.0 111.621 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 12.9 mt-10 -38.78 129.9 1.47 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.064 -1.425 . . . . 0.0 112.034 157.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 98' ' ' ALA . 61.2 p -145.96 -174.12 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.65 -44.77 63.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.479 0.657 . . . . 0.0 110.774 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.407 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.4 pt20 -91.64 30.23 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.787 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.62 -176.84 48.18 Favored Glycine 0 C--N 1.319 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.708 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.802 ' HB2' HD12 ' A' ' 97' ' ' LEU . 34.5 Cg_endo -73.84 125.38 9.9 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.456 2.104 . . . . 0.0 112.693 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.438 HG11 HG12 ' A' ' 107' ' ' VAL . 13.5 t -117.98 113.87 37.47 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.04 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 14.8 Cg_exo -70.56 97.29 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.611 2.208 . . . . 0.0 111.072 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.8 m -117.99 174.64 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.315 -173.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.539 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 24.5 tt0 -134.49 131.44 38.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.259 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.473 ' HA ' HG13 ' A' ' 119' ' ' VAL . 65.0 mt -69.89 124.76 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.953 0.406 . . . . 0.0 110.337 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 p -106.84 -4.6 19.09 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -172.54 155.61 3.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.915 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.556 HG11 HG13 ' A' ' 117' ' ' VAL . 61.8 t -137.43 105.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.034 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.08 -175.94 4.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.8 -53.32 58.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.209 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -121.71 5.18 10.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -146.29 139.91 26.09 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 120.831 -1.168 . . . . 0.0 112.365 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 90' ' ' LEU . 35.3 m -93.58 167.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.189 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.686 HG21 ' HG3' ' A' ' 78' ' ' ARG . 43.4 t -131.26 118.44 40.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.575 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.5 m -113.74 138.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.062 0.458 . . . . 0.0 111.144 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -136.56 142.75 43.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.825 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.07 7.04 2.34 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.346 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.817 ' HB3' HD22 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -130.8 135.35 47.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.738 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -147.58 -42.05 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.206 -0.309 . . . . 0.0 110.953 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -68.08 -5.73 19.16 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.701 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 122' ' ' ASN . 3.6 mm? -79.46 -12.8 59.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.577 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.57 -178.25 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.45 33.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 114.322 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.7 123.08 39.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.748 0.774 . . . . 0.0 110.644 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -79.52 158.9 27.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.237 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.646 ' CD1' ' HB2' ' A' ' 68' ' ' TYR . 90.3 mt -128.46 156.99 42.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -118.02 132.75 56.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.087 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.714 ' HZ ' ' HB3' ' A' ' 67' ' ' ALA . 2.5 m-85 -123.4 134.96 53.91 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.489 ' N ' HD21 ' A' ' 133' ' ' ASN . 0.9 OUTLIER -105.84 107.74 18.89 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.783 HG12 HD22 ' A' ' 49' ' ' LEU . 4.4 t -99.81 142.93 14.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.45 0.643 . . . . 0.0 112.211 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.84 92.09 3.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.576 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.57 HG11 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -69.72 110.46 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.833 0.825 . . . . 0.0 111.685 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.499 HG21 ' HG3' ' A' ' 31' ' ' PRO . 3.3 t -71.95 -47.66 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.13 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.06 158.56 33.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.925 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.75 HG21 HG12 ' A' ' 9' ' ' VAL . 65.5 mt -137.59 132.78 45.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -133.17 138.09 46.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.047 0.451 . . . . 0.0 110.667 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.69 ' HA ' HD23 ' A' ' 7' ' ' LEU . 9.7 pt-20 -77.44 119.29 20.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.59 169.51 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.748 -171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.5 p -113.26 29.51 7.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.761 -167.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.702 ' CA ' HD22 ' A' ' 147' ' ' LEU . 31.1 mt-10 73.31 -33.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.466 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.733 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.39 -44.15 72.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.55 -178.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.733 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 8.0 mp0 -54.95 -45.65 74.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.66 0.743 . . . . 0.0 109.756 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.702 HD22 ' CA ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -65.5 -49.14 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.228 178.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.25 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.847 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -98.08 -9.09 26.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.44 2.74 90.66 Favored Glycine 0 C--N 1.329 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.865 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.29 179.79 6.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.925 0.363 . . . . 0.0 110.071 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 155' ' ' ALA . 10.6 t -57.59 -48.31 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.213 0.321 . . . . 0.0 111.641 -173.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 75.16 -21.09 0.31 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.581 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 152' ' ' VAL . . . -172.91 125.52 1.16 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.546 ' HB3' HG13 ' A' ' 152' ' ' VAL . . . -145.62 172.08 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.561 -176.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.1 m170 61.53 30.74 18.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -70.54 -49.9 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 110.733 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -103.03 42.2 1.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.296 0.569 . . . . 0.0 110.775 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 29' ' ' SER . 25.9 t-80 -120.22 106.54 12.02 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -76.0 144.43 40.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.95 151.09 27.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.046 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -98.2 83.62 3.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.698 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t70 60.94 70.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.587 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -53.74 131.75 39.95 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.189 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.89 147.48 33.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.838 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 68.4 m80 69.26 116.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.043 0.839 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.41 -19.97 21.51 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -93.99 99.84 12.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.855 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.2 -43.37 2.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -90.95 92.12 8.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.735 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.943 0 O-C-N 123.8 0.688 . . . . 0.0 110.062 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -123.65 169.16 11.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 111.247 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.679 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -79.29 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.793 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.58 -172.39 4.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.432 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 7' ' ' LEU . 87.1 tttt -67.48 161.27 25.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 45.18 9.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.654 HD22 ' HA ' ' A' ' 141' ' ' GLU . 24.3 mt -97.63 108.21 20.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.957 -0.464 . . . . 0.0 110.187 170.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG23 HG21 ' A' ' 152' ' ' VAL . 14.6 p -55.52 144.01 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 110.596 174.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -150.86 139.34 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.755 -170.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -117.72 148.27 42.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD22 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -165.63 158.0 15.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.01 0.433 . . . . 0.0 110.33 -176.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.38 112.59 18.28 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CE1' HD11 ' A' ' 32' ' ' LEU . 46.5 p90 -123.82 154.19 39.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.924 -172.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 45.6 tt0 -125.29 118.85 26.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 23' ' ' VAL . 2.8 p -101.33 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.257 1.027 . . . . 0.0 111.141 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 10.6 ttm180 -135.66 157.15 47.59 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.681 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.596 ' OG1' HG12 ' A' ' 21' ' ' VAL . 40.8 p -78.34 169.87 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.841 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.955 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 48.7 mt-10 -65.44 -20.22 66.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.975 0.416 . . . . 0.0 110.876 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.11 -16.16 30.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.554 ' HA2' ' HD3' ' A' ' 16' ' ' ARG . . . 106.63 27.48 5.47 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.78 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.596 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.8 p -105.42 136.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.035 0.917 . . . . 0.0 109.829 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.0 tp -90.53 127.36 36.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.418 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.493 HG22 HG13 ' A' ' 15' ' ' VAL . 22.2 m -102.93 -35.88 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.671 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -162.14 169.76 20.29 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.42 129.87 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 m -99.45 106.1 37.41 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.29 163.27 36.99 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.65 2.233 . . . . 0.0 112.882 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.31 -14.77 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.205 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 p -79.43 -30.6 42.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.626 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.47 113.74 5.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HB3' HG21 ' A' ' 137' ' ' VAL . 10.1 Cg_exo -75.32 164.7 32.27 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 -174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.643 HD12 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -73.9 139.03 44.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.408 166.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.419 ' HB3' HG12 ' A' ' 152' ' ' VAL . 41.9 m-20 -122.25 120.2 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.72 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 13.1 p90 -157.6 168.3 27.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.141 0.496 . . . . 0.0 111.409 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -107.94 114.4 28.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.043 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.425 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 28.6 t60 -68.29 137.4 54.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.383 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 80.66 26.62 53.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.914 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.95 18.33 4.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 110.86 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.67 36.68 93.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.955 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.72 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 69.4 m -65.78 -39.94 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.142 0.496 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.643 ' HG ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.87 160.87 42.31 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 pt -27.93 137.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 123.048 1.404 . . . . 0.0 114.373 -173.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -64.46 -35.75 81.94 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.936 -1.938 . . . . 0.0 111.299 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -64.07 -34.6 90.36 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.139 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 21.6 tp -75.46 -50.58 15.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.05 -45.6 68.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.337 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.2 m -59.35 -35.71 74.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.434 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -33.98 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.622 0.725 . . . . 0.0 110.438 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.66 ' O ' HG13 ' A' ' 3' ' ' VAL . 86.9 mt -64.61 -31.71 73.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.896 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.85 155.65 4.22 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.18 -29.1 4.85 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.679 ' O ' HG12 ' A' ' 3' ' ' VAL . 27.0 p80 -106.33 178.29 4.6 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.172 1.486 . . . . 0.0 110.787 -171.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 1' ' ' MET . 81.8 mt-10 -117.35 170.82 8.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.685 0.278 . . . . 0.0 110.725 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -53.11 144.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.76 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 136' ' ' VAL . . . 95.29 -20.33 49.89 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.971 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 136' ' ' VAL . 3.4 m-20 -67.42 136.62 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.919 0.359 . . . . 0.0 110.527 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.662 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 4.3 tmmm? -136.98 125.21 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.725 ' CE2' HG22 ' A' ' 60' ' ' VAL . 15.9 p90 -154.51 -179.75 8.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.15 143.5 38.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.725 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -126.91 142.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -134.18 113.07 11.64 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.576 HG13 ' HA3' ' A' ' 44' ' ' GLY . 60.8 t -123.97 141.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.565 -174.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.77 150.0 48.75 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.127 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -52.53 -20.42 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.74 -21.78 57.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.295 -0.253 . . . . 0.0 111.442 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -114.34 -9.46 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.954 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.08 -155.68 0.7 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.264 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.53 ' HB2' HD12 ' A' ' 130' ' ' LEU . 7.4 m-85 -81.5 -168.29 1.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.83 20.59 12.58 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.402 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -65.19 170.99 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.822 0.311 . . . . 0.0 111.299 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.596 ' HH ' ' HB3' ' A' ' 73' ' ' GLU . 76.4 t80 -44.19 123.73 3.58 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -132.1 126.49 33.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.019 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB3' ' HH ' ' A' ' 71' ' ' TYR . 11.9 pt-20 -74.31 -10.11 59.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -81.44 -9.1 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.728 -0.607 . . . . 0.0 110.877 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 122' ' ' ASN . 54.1 tp -87.73 -10.33 51.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' HB ' HD22 ' A' ' 122' ' ' ASN . 8.8 p -106.17 132.25 53.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.159 0.504 . . . . 0.0 110.665 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -157.78 173.02 17.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.98 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.413 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 11.3 mpt_? -110.23 113.35 25.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.764 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.39 132.24 21.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.873 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.61 143.57 99.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.429 2.753 . . . . 0.0 112.692 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 90' ' ' LEU . 6.5 mmmm -54.02 -39.53 66.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.386 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.75 -37.67 79.64 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.683 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.22 -35.3 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.957 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HB2' HD11 ' A' ' 90' ' ' LEU . 64.4 m-85 -100.51 40.0 1.31 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.2 ptm -49.15 -32.75 10.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.421 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.78 13.18 65.02 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.617 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.628 HG12 ' HG ' ' A' ' 90' ' ' LEU . 3.6 p -85.88 162.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 117.313 0.556 . . . . 0.0 110.21 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.61 -77.86 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.42 119.67 7.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.614 171.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.628 ' HG ' HG12 ' A' ' 87' ' ' VAL . 89.9 mt -60.09 103.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.303 0.573 . . . . 0.0 110.536 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.455 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.2 tt0 -123.57 166.3 15.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.156 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.6 t -81.55 140.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.86 1.42 85.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.846 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.455 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.0 mtm -85.88 135.05 33.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 109.938 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -114.02 139.54 49.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.082 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -163.38 170.45 17.49 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.998 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -92.69 126.74 37.91 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.36 127.44 56.01 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.35 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.12 140.39 41.77 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 p -145.0 -175.66 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.999 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.3 -36.71 84.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.528 0.68 . . . . 0.0 110.623 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.2 pt20 -95.61 27.54 3.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.266 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 179.44 46.09 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.14 140.93 94.11 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 122.171 1.914 . . . . 0.0 112.603 174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 99.0 t -135.43 117.49 12.31 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.573 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 7.1 Cg_exo -73.83 108.8 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.783 2.322 . . . . 0.0 111.246 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.778 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 11.2 m -118.48 154.6 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.778 0.323 . . . . 0.0 111.084 -174.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 40.8 tt0 -115.37 132.14 56.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.25 0.548 . . . . 0.0 110.336 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.502 ' HA ' HG13 ' A' ' 119' ' ' VAL . 23.8 mt -77.53 127.9 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.02 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.407 ' C ' HG13 ' A' ' 92' ' ' VAL . 62.4 p -114.69 1.2 14.12 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.455 0.645 . . . . 0.0 109.53 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.408 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 153.52 0.21 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.3 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.72 HG12 HG12 ' A' ' 117' ' ' VAL . 49.0 t -136.32 107.7 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.25 -157.24 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.12 -50.97 71.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.29 -6.24 3.81 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.825 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.413 ' CD2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 p-80 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.024 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.72 HG12 HG12 ' A' ' 112' ' ' VAL . 30.3 m -107.89 161.71 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.02 110.23 31.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.673 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.778 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 12.0 m -113.63 135.12 54.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.615 0.721 . . . . 0.0 112.133 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -135.79 141.32 44.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.666 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.43 18.47 3.06 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.632 ' HB3' HD21 ' A' ' 75' ' ' LEU . 1.6 p-10 -130.51 111.56 12.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.945 0.878 . . . . 0.0 111.34 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.818 ' H ' ' HA ' ' A' ' 126' ' ' ALA . 91.3 m-70 -133.04 -174.97 3.63 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.499 ' HG2' HD21 ' A' ' 125' ' ' LEU . 22.8 ttt -54.83 -48.73 72.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.622 0.646 . . . . 0.0 110.717 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 ' HG2' ' A' ' 124' ' ' MET . 4.1 mm? -87.91 -12.69 43.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.818 ' HA ' ' H ' ' A' ' 123' ' ' HIS . . . 62.99 -69.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.445 1.098 . . . . 0.0 112.849 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.58 -8.68 37.55 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.831 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -80.28 143.9 33.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.406 ' HB2' ' CD ' ' A' ' 18' ' ' GLU . 39.4 m-80 -103.25 162.15 13.22 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.351 0.596 . . . . 0.0 110.595 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 68' ' ' TYR . 26.3 mt -115.67 147.79 40.45 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.465 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.955 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 18.4 mtpp -116.18 131.57 56.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 26.4 m-85 -117.11 137.59 52.19 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.179 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.66 106.72 17.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.697 HG13 HD22 ' A' ' 11' ' ' LEU . 8.3 t -102.94 138.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.529 -172.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.662 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 17.4 mt-10 -137.47 93.83 2.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.546 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -77.31 116.86 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.058 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 31' ' ' PRO . 11.4 t -75.84 -45.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.975 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.58 152.9 16.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.41 . . . . 0.0 111.282 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.463 HG13 HG12 ' A' ' 54' ' ' VAL . 81.6 mt -136.71 133.07 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -150.89 139.95 21.07 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.803 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.654 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.3 pt-20 -73.17 125.85 28.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 109.864 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 146' ' ' GLU . . . -73.01 164.96 25.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.002 -176.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 145' ' ' GLU . 28.7 p -97.02 23.19 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.537 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HA ' HD11 ' A' ' 147' ' ' LEU . 44.7 mt-10 73.17 -31.46 0.23 Allowed 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.635 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 143' ' ' THR . 20.2 mm-40 -64.81 -46.64 81.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.836 0.35 . . . . 0.0 111.054 175.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 36.6 mp0 -54.78 -37.44 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.67 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.631 HD23 ' HB1' ' A' ' 142' ' ' ALA . 11.4 mt -74.37 -47.43 34.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.74 -32.55 63.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.688 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -98.77 -25.76 14.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.283 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.02 29.58 25.36 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.617 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.84 164.36 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.701 -0.293 . . . . 0.0 110.505 -175.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.544 HG21 HG23 ' A' ' 8' ' ' VAL . 3.3 p -74.9 -28.07 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.276 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.3 t60 73.61 -75.3 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.666 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.58 -37.82 9.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.179 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 56.48 -104.08 0.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.963 0.505 . . . . 0.0 111.051 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -144.77 -62.08 0.36 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -120.48 84.16 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.309 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -62.53 115.83 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -67.25 104.16 1.41 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.084 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -84.29 96.43 9.01 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.6 162.14 29.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.784 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -141.36 -18.23 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.747 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -80.19 152.52 29.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.083 0.468 . . . . 0.0 111.057 -175.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -157.64 35.66 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.636 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -69.61 114.27 7.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.946 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.73 42.85 3.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -81.69 39.26 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.135 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -95.58 69.43 2.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.171 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 170' ' ' HIS . 8.5 t60 -109.09 137.27 47.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.706 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.564 ' HB2' ' HD2' ' A' ' 169' ' ' HIS . 3.7 t60 73.33 2.09 4.2 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.943 0.777 . . . . 0.0 111.168 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.289 -178.881 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HE3' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 9.9 ptpt -96.13 168.35 10.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.53 0.681 . . . . 0.0 111.08 -176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.631 HG11 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -87.28 116.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.524 175.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.64 -170.06 3.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.184 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 54.9 tttm -64.46 162.96 14.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.4 ' HA ' HD22 ' A' ' 147' ' ' LEU . 3.9 p30 51.27 7.29 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 141' ' ' GLU . 22.2 mt -107.63 155.68 19.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 34' ' ' TYR . 7.4 p -116.31 143.16 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.755 HG12 HG21 ' A' ' 139' ' ' ILE . 3.7 m -136.86 161.18 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.486 0.66 . . . . 0.0 111.906 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.1 m -125.72 107.75 10.85 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -120.93 161.81 20.93 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.855 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.49 108.09 10.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.1 p90 -126.39 163.77 22.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.154 0.502 . . . . 0.0 110.367 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 59.9 tt0 -128.83 116.88 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' HD11 ' A' ' 22' ' ' LEU . 3.2 p -102.94 122.71 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.794 0.807 . . . . 0.0 111.169 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -142.42 164.03 31.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.311 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.74 ' HG1' HG11 ' A' ' 21' ' ' VAL . 58.7 p -83.49 174.19 10.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.461 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.1 -23.23 61.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 110.452 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -15.57 51.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.596 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.58 -16.73 40.47 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.96 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.74 HG11 ' HG1' ' A' ' 17' ' ' THR . 11.4 p -67.31 133.99 30.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 117.906 0.853 . . . . 0.0 111.051 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.644 HD12 ' HB2' ' A' ' 25' ' ' GLU . 57.0 tp -81.03 127.79 32.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.695 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -103.33 -33.99 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.094 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.6 163.15 32.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.644 ' HB2' HD12 ' A' ' 22' ' ' LEU . 29.1 tt0 -165.3 130.29 2.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.266 0.555 . . . . 0.0 112.063 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.423 ' HB3' ' H ' ' A' ' 13' ' ' TYR . 28.7 t -103.06 107.72 56.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.95 166.75 25.49 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.364 2.043 . . . . 0.0 111.704 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.39 -17.78 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.435 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 p -79.09 -32.32 44.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.356 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.687 ' HB1' ' HE2' ' A' ' 158' ' ' HIS . . . -143.15 114.09 5.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.068 0.461 . . . . 0.0 110.628 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.736 ' HG3' HG23 ' A' ' 137' ' ' VAL . 7.8 Cg_exo -76.35 169.07 22.68 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.934 3.09 . . . . 0.0 114.38 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.0 tp -86.13 128.4 34.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.19 168.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -118.38 119.55 34.93 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.565 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 37.1 m-85 -162.3 157.13 22.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.466 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.538 HD22 HD21 ' A' ' 147' ' ' LEU . 64.0 tp -86.36 113.3 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.23 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -71.32 142.31 50.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 -170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 89.6 24.98 29.11 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.073 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.56 -18.16 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.6 0.238 . . . . 0.0 111.284 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.25 40.67 0.94 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.565 ' HB3' ' CB ' ' A' ' 34' ' ' TYR . 14.6 m -63.86 -45.59 88.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.326 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.597 HD12 HD22 ' A' ' 45' ' ' LEU . 1.8 pt? -151.65 179.25 8.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 pt -42.13 148.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.462 1.125 . . . . 0.0 112.989 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.1 t -76.53 -40.73 49.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.943 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.24 -32.16 60.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.025 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.657 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tp -77.01 -52.71 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.154 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 49' ' ' LEU . 27.4 mt-10 -55.26 -46.03 76.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.062 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.7 m -61.25 -29.58 69.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.052 0.453 . . . . 0.0 111.492 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.84 -34.34 57.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.785 0.802 . . . . 0.0 109.609 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 64.3 mt -69.58 -38.06 77.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.153 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.39 125.26 22.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 112.836 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.73 0.42 34.37 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.338 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.631 ' O ' HG11 ' A' ' 3' ' ' VAL . 98.3 m-70 -101.38 169.2 9.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 54.9 mt-10 -123.15 166.31 15.4 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.477 HG13 HG13 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -47.55 145.73 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 122.066 0.936 . . . . 0.0 112.835 -177.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' N ' HG12 ' A' ' 136' ' ' VAL . . . 85.21 -0.76 88.83 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 114.105 -1.407 . . . . 0.0 114.202 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.98 153.35 42.72 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.877 0.838 . . . . 0.0 109.297 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -149.15 128.52 12.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.245 0.545 . . . . 0.0 109.76 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CE2' HG22 ' A' ' 60' ' ' VAL . 25.6 p90 -162.96 177.87 8.85 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -120.1 147.51 44.77 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -133.39 143.01 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -169.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.0 11.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.952 0.406 . . . . 0.0 110.119 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.03 142.29 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.21 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.84 152.0 36.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.658 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.19 -21.59 66.31 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -68.57 -18.29 64.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.0 110.751 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.87 -52.95 2.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.97 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.453 -172.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -178.62 -166.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.34 20.29 14.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.83 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -64.68 171.74 3.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.0 111.795 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 74.3 t80 -68.28 123.48 20.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.265 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -122.18 110.49 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.03 -1.7 21.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.12 -16.64 61.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.549 0.69 . . . . 0.0 109.183 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.603 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 6.9 mp -85.29 -10.72 56.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.643 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.25 124.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.42 166.24 25.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.365 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.3 mpt_? -107.75 106.56 16.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.617 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 83' ' ' VAL . 2.8 t -105.46 133.14 20.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.313 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 83' ' ' VAL . 21.4 Cg_exo -61.94 133.79 46.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.851 2.367 . . . . 0.0 111.566 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 37.4 mtmt -56.47 -24.61 46.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.41 -43.27 83.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.647 HG21 ' O ' ' A' ' 80' ' ' PRO . 5.8 m -53.31 -30.03 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.091 0.472 . . . . 0.0 112.101 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 87' ' ' VAL . 43.4 m-85 -103.1 39.13 1.61 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.605 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -60.8 -30.99 70.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.57 -7.44 88.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.048 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 70.1 t -76.17 146.43 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.913 0.356 . . . . 0.0 110.858 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.48 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.557 0.535 . . . . 0.0 110.884 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.619 ' O ' ' HE2' ' A' ' 94' ' ' MET . 30.1 mt-10 -152.7 120.26 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.853 175.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 84' ' ' PHE . 97.3 mt -68.23 109.36 3.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.288 0.566 . . . . 0.0 111.076 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.544 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.8 tt0 -127.2 171.05 11.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.861 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' A' ' 111' ' ' ALA . 55.6 t -83.13 138.43 19.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.01 1.13 88.9 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.732 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.619 ' HE2' ' O ' ' A' ' 89' ' ' GLU . 3.9 mmm -84.24 134.82 34.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.633 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 5.8 ttt180 -131.91 134.35 45.58 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -159.78 162.76 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 104' ' ' PRO . 35.1 tp -80.89 127.32 32.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.46 116.22 26.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 40.1 mt-10 -93.37 100.57 12.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.964 0.888 . . . . 0.0 110.096 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.8 p -95.61 -175.79 3.56 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.192 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.27 -30.11 62.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.399 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -104.63 25.03 10.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.95 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.61 173.27 33.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.382 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.736 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 31.2 Cg_exo -62.1 138.26 71.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.993 2.462 . . . . 0.0 112.867 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.65 108.76 12.04 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.69 ' HG2' ' HB ' ' A' ' 21' ' ' VAL . 16.5 Cg_exo -69.2 103.63 1.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.664 2.243 . . . . 0.0 111.215 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.589 ' HB ' HG11 ' A' ' 119' ' ' VAL . 20.6 m -118.13 155.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.121 0.486 . . . . 0.0 111.136 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 38.3 tt0 -122.92 139.41 54.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.756 0.789 . . . . 0.0 109.846 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 119' ' ' VAL . 19.9 mt -85.81 132.16 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.471 -173.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.626 HG23 ' SD ' ' A' ' 124' ' ' MET . 64.9 p -113.98 0.9 14.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.268 0.556 . . . . 0.0 109.866 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 172.77 156.07 0.1 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.86 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.677 HG13 HG11 ' A' ' 117' ' ' VAL . 48.1 t -139.94 114.98 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.68 -162.39 0.9 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.17 -26.39 62.95 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.247 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.758 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 24.4 m-20 -131.06 -26.03 2.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -133.11 167.15 20.85 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.98 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.677 HG11 HG13 ' A' ' 112' ' ' VAL . 35.8 m -114.39 165.04 9.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.663 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.56 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.4 t -113.79 104.57 17.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.589 HG11 ' HB ' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -113.24 140.17 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -109.14 145.43 35.76 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 75' ' ' LEU . . . -82.29 -5.5 89.55 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -120.4 167.17 12.61 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -73.63 115.29 12.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.626 ' SD ' HG23 ' A' ' 110' ' ' THR . 20.4 ptt? -61.58 -28.74 69.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.706 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -3.66 55.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.465 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.14 -148.77 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.856 0.722 . . . . 0.0 110.809 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.05 0.85 84.0 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 161.76 29.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.334 0.588 . . . . 0.0 111.415 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.424 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -108.43 148.12 30.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.535 173.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.88 147.85 31.53 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 5.2 mtpp -116.45 132.08 56.77 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -119.96 126.0 49.78 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 16.9 m120 -100.61 107.24 18.85 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.574 HG11 ' CD2' ' A' ' 49' ' ' LEU . 6.6 t -101.22 145.92 10.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.063 -165.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -149.29 97.14 2.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.777 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -76.05 117.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.314 0.578 . . . . 0.0 111.53 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.736 HG23 ' HG3' ' A' ' 31' ' ' PRO . 6.3 t -76.98 -45.87 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.331 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.2 155.94 23.53 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.186 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.755 HG21 HG12 ' A' ' 9' ' ' VAL . 62.0 mt -139.7 137.97 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -145.88 142.87 29.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.106 0.479 . . . . 0.0 110.934 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.567 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 pt-20 -80.75 124.82 29.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.094 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -71.4 168.15 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.453 -174.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -103.01 23.28 12.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 147' ' ' LEU . 32.3 mt-10 73.8 -33.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.101 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.99 -41.71 97.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.619 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.642 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 13.8 mp0 -57.65 -39.51 77.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.891 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 142' ' ' ALA . 16.6 mt -70.48 -44.89 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.961 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.08 -34.22 68.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.837 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -100.71 -31.22 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.182 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.16 15.78 50.06 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.286 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -140.01 148.97 42.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.4 p -91.45 -35.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.1 m80 64.13 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.03 31.03 5.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.529 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -114.5 165.82 12.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.3 t60 65.35 43.73 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.404 0.621 . . . . 0.0 109.957 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -101.13 140.81 34.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.732 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.687 ' HE2' ' HB1' ' A' ' 30' ' ' ALA . 51.2 m-70 -134.31 -48.52 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 m170 61.03 75.64 0.4 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.981 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -122.69 140.24 53.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.241 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.19 81.62 6.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.145 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.07 86.49 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.642 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 125.23 26.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.192 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -125.66 40.85 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.97 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.27 -24.74 60.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.059 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -71.67 109.49 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 111.582 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -140.06 118.88 12.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.085 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.53 -26.79 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.759 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -142.38 -76.1 0.27 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.631 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 55.73 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.775 0.672 . . . . 0.0 112.138 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.209 176.466 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.08 174.69 5.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.58 0.705 . . . . 0.0 111.021 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -88.05 127.63 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.769 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.2 -177.64 6.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 76.6 tttt -55.75 152.0 10.28 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.083 0.24 . . . . 0.0 110.884 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 57.32 -5.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 141' ' ' GLU . 28.1 mt -95.94 104.75 16.71 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.704 -0.622 . . . . 0.0 110.89 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.641 HG21 HG23 ' A' ' 152' ' ' VAL . 12.1 p -65.55 142.78 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.712 0.768 . . . . 0.0 111.816 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.758 HG12 HG23 ' A' ' 139' ' ' ILE . 1.3 m -145.32 154.93 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.832 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -120.36 119.11 32.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.585 HD13 HG13 ' A' ' 134' ' ' VAL . 4.5 pp -141.13 147.99 39.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.85 153.75 18.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.69 160.4 42.73 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.628 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 44.5 tt0 -132.46 118.33 19.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.469 HG21 HG12 ' A' ' 23' ' ' VAL . 2.6 p -106.92 124.38 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.722 0.772 . . . . 0.0 111.522 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -139.93 165.69 26.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.101 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -81.47 179.28 7.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.319 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' CD ' ' HB2' ' A' ' 129' ' ' ASN . 42.9 mt-10 -66.0 -11.76 50.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.626 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -80.41 -19.3 46.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.105 0.478 . . . . 0.0 110.41 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.32 -17.4 53.79 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.382 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.97 132.32 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 24' ' ' ASP . 50.0 tp -66.24 140.61 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.315 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG12 HG21 ' A' ' 15' ' ' VAL . 2.8 p -113.66 -35.54 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.991 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' HD11 ' A' ' 22' ' ' LEU . 9.7 t70 -168.89 172.16 7.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 2.9 pt-20 -166.73 159.66 14.09 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.177 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -108.33 110.06 61.73 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 162.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.02 155.81 48.13 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 C-N-CA 122.78 2.32 . . . . 0.0 113.287 -165.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.45 -7.06 7.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.8 p -91.21 -26.27 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.888 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.32 114.59 5.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.828 ' HG3' HG22 ' A' ' 137' ' ' VAL . 6.6 Cg_exo -74.81 166.03 30.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.465 2.777 . . . . 0.0 114.366 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.06 130.28 35.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.461 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -116.33 127.98 55.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.165 0.507 . . . . 0.0 110.228 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HH ' HD22 ' A' ' 11' ' ' LEU . 54.6 p90 -160.1 164.61 32.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.416 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.565 HD22 HD21 ' A' ' 147' ' ' LEU . 54.4 tp -103.1 111.15 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.56 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.77 124.06 17.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.569 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 93.35 0.23 67.75 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.943 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -136.54 3.25 2.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.79 92.73 0.09 OUTLIER Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.674 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 m -114.36 8.84 16.76 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.938 0.875 . . . . 0.0 109.449 -166.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 53.17 -89.05 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.454 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 45' ' ' LEU . 23.5 pt -124.5 136.25 61.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 122.265 1.031 . . . . 0.0 110.627 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -48.21 -42.76 30.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.444 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' N ' ' HB3' ' A' ' 66' ' ' ASP . . . -69.25 -37.77 81.19 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.443 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 134' ' ' VAL . 16.2 tp -75.39 -52.23 11.25 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -173.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.674 ' HG3' ' O ' ' A' ' 40' ' ' SER . 2.5 mm-40 -53.16 -45.11 68.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.26 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.4 m -57.77 -35.78 71.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.257 0.551 . . . . 0.0 111.331 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 -36.1 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.819 0.819 . . . . 0.0 109.606 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.565 ' CD2' HG12 ' A' ' 134' ' ' VAL . 83.4 mt -61.63 -35.64 78.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.014 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -53.86 152.62 5.38 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.11 -6.64 48.86 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 113.408 -1.723 . . . . 0.0 116.65 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.69 ' O ' HG11 ' A' ' 3' ' ' VAL . 17.6 p80 -117.93 -177.29 3.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 119.417 1.608 . . . . 0.0 111.109 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 1' ' ' MET . 45.3 mt-10 -124.06 174.66 7.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -169.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 139' ' ' ILE . 1.4 m -54.41 145.65 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.311 172.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.73 -15.66 56.67 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.852 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.48 143.48 42.55 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 4.0 tmmm? -145.61 131.52 19.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.103 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.743 ' CE2' HG23 ' A' ' 60' ' ' VAL . 17.9 p90 -162.69 159.81 24.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.007 0.432 . . . . 0.0 110.305 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.71 141.11 32.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.014 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.743 HG23 ' CE2' ' A' ' 58' ' ' PHE . 10.5 t -127.95 143.3 41.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.09 112.99 7.75 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.664 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 132' ' ' PHE . 14.6 m -127.82 169.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.734 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.26 158.88 29.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.187 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.48 -25.02 9.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.18 0.592 . . . . 0.0 112.563 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -59.86 -27.77 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 111.06 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 1.5 m-20 -115.94 -5.76 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 130' ' ' LEU . . . -145.72 61.31 1.27 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 p90 39.34 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.352 0.661 . . . . 0.0 111.976 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.21 20.49 48.99 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.592 -1.289 . . . . 0.0 111.833 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -59.93 -179.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -44.6 127.23 5.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.683 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -131.15 119.17 21.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.407 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.93 -8.31 56.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.67 -14.07 52.69 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.664 ' HG ' ' HA3' ' A' ' 121' ' ' GLY . 52.7 tp -88.32 -9.82 51.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.913 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.14 129.76 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.869 174.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -163.18 177.64 8.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.422 0.629 . . . . 0.0 112.341 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -99.12 150.0 22.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.82 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 t -143.23 129.0 10.15 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.51 139.09 87.66 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.17 2.58 . . . . 0.0 112.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.429 ' HD3' HD13 ' A' ' 90' ' ' LEU . 20.2 mmtp -52.07 -32.42 34.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.287 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.36 -41.64 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.706 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.18 -37.48 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.052 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.725 ' HD2' HD11 ' A' ' 90' ' ' LEU . 59.1 m-85 -100.78 40.01 1.32 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.731 0.3 . . . . 0.0 111.224 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 16.3 ptm -49.67 -37.21 27.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -88.21 13.53 61.48 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.948 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 84' ' ' PHE . 3.4 p -90.01 165.79 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 117.388 0.594 . . . . 0.0 110.064 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.79 -71.19 0.12 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -166.16 128.37 1.92 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.725 HD11 ' HD2' ' A' ' 84' ' ' PHE . 92.0 mt -63.9 112.16 2.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.808 0.814 . . . . 0.0 111.359 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.494 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -125.71 161.39 27.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.648 -177.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.82 136.0 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 1.37 66.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.314 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.494 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -87.49 135.79 33.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.094 0.473 . . . . 0.0 110.634 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -113.93 134.42 54.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.728 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -163.21 173.79 12.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.006 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 104' ' ' PRO . 31.2 tp -90.91 120.94 32.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -90.1 174.0 7.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.669 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -128.19 121.79 30.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.328 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.5 p -145.52 175.27 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.731 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -55.1 -36.97 66.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.262 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -92.27 30.74 1.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.62 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.08 -177.51 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.584 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.0 Cg_exo -58.1 143.72 96.14 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.435 2.09 . . . . 0.0 112.476 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.4 HG13 HG11 ' A' ' 107' ' ' VAL . 88.1 t -133.78 116.91 13.83 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.05 101.88 0.74 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.65 2.233 . . . . 0.0 111.854 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.612 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 5.0 m -118.83 178.31 2.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.005 0.431 . . . . 0.0 111.734 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -135.66 137.41 41.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.32 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.544 ' HA ' HG11 ' A' ' 119' ' ' VAL . 23.0 mt -78.01 126.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.813 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 p -110.95 1.54 17.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.426 0.632 . . . . 0.0 109.591 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 179.94 153.11 0.49 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.032 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.649 HG11 HG12 ' A' ' 117' ' ' VAL . 94.2 t -141.37 109.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.05 -165.05 1.26 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.12 -54.28 15.81 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.491 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -109.21 -3.93 16.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -141.69 147.78 38.04 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.647 -0.658 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.649 HG12 HG11 ' A' ' 112' ' ' VAL . 35.2 m -111.38 167.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.58 114.87 44.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.612 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.7 m -113.97 137.99 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.545 0.688 . . . . 0.0 111.704 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -118.41 134.2 55.26 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.717 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.664 ' HA3' ' HG ' ' A' ' 75' ' ' LEU . . . -85.16 -20.58 57.05 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.042 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.995 ' HB2' ' HA ' ' A' ' 126' ' ' ALA . 5.3 p30 -100.49 135.37 42.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -91.66 -81.35 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.565 ' HG3' ' H ' ' A' ' 125' ' ' LEU . 26.9 ptt? -83.85 -61.54 1.8 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.599 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.565 ' H ' ' HG3' ' A' ' 124' ' ' MET . 3.1 mm? -119.55 -20.24 7.83 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.492 0.663 . . . . 0.0 109.321 170.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.995 ' HA ' ' HB2' ' A' ' 122' ' ' ASN . . . -171.45 -71.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.542 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.53 -22.0 4.18 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.97 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -57.39 134.51 56.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.441 ' HB2' ' CD ' ' A' ' 18' ' ' GLU . 49.0 m-80 -87.51 156.3 19.6 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.693 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 67' ' ' ALA . 45.4 mt -124.39 143.14 50.77 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.677 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 40.7 mtpt -115.52 129.02 56.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -118.14 139.78 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.271 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -108.58 108.14 18.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.1 t -99.2 137.44 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.289 -172.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.624 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 9.3 mt-10 -136.52 96.11 3.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.86 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.528 HG21 ' CE1' ' A' ' 52' ' ' HIS . 38.9 t -76.24 115.85 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.576 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.828 HG22 ' HG3' ' A' ' 31' ' ' PRO . 6.0 t -72.96 -49.5 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.892 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.57 156.28 20.64 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.347 -0.22 . . . . 0.0 111.24 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.758 HG23 HG12 ' A' ' 9' ' ' VAL . 67.8 mt -138.99 141.96 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -147.21 141.08 25.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.976 0.417 . . . . 0.0 110.619 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 7' ' ' LEU . 8.2 pt-20 -76.23 117.14 17.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.768 ' HB2' HD23 ' A' ' 147' ' ' LEU . . . -62.18 155.28 24.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.803 0.811 . . . . 0.0 112.714 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.45 ' C ' ' H ' ' A' ' 145' ' ' GLU . 43.2 p -84.19 18.86 1.99 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.223 -1.353 . . . . 0.0 112.066 -171.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HA ' HD11 ' A' ' 147' ' ' LEU . 30.1 mt-10 68.87 -33.0 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.082 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 143' ' ' THR . 0.4 OUTLIER -66.46 -40.43 89.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.701 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -58.06 -39.9 79.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.02 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 142' ' ' ALA . 14.9 mt -69.1 -45.55 69.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.898 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.66 67.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.853 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -97.52 -6.25 34.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.8 0.71 85.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.832 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.79 173.34 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.641 HG23 HG21 ' A' ' 8' ' ' VAL . 22.8 t -50.23 -61.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.854 0.722 . . . . 0.0 112.62 -172.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 19.4 t-80 70.18 91.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.254 0.549 . . . . 0.0 110.508 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 113.4 -103.61 1.4 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.29 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.489 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . 67.1 19.69 10.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.968 0.507 . . . . 0.0 111.287 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.25 39.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.397 0.618 . . . . 0.0 109.511 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.8 47.1 1.1 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.549 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -91.45 24.19 3.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.446 0.641 . . . . 0.0 110.014 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -107.05 0.94 23.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -120.33 78.34 1.35 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -107.5 -43.68 4.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.873 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -103.93 64.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.247 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -141.75 88.84 2.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -168.88 155.75 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.976 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -130.46 168.55 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.2 m80 69.72 -179.54 0.23 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.659 0.6 . . . . 0.0 111.479 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.26 18.38 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.496 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -107.74 105.4 15.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.036 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -100.9 151.12 22.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.843 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -120.12 -25.34 5.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 167.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 11.5 m80 . . . . . 0 C--O 1.246 0.876 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.562 172.653 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.19 171.17 7.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.27 0.557 . . . . 0.0 110.49 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -87.02 120.47 36.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.251 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.19 -172.95 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 7' ' ' LEU . 56.8 tttm -57.73 147.41 27.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.812 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 54.65 -5.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.0 mt -85.34 104.3 15.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.807 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.758 HG22 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -60.55 143.85 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.586 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.832 ' O ' ' HB3' ' A' ' 34' ' ' TYR . 2.3 m -153.18 131.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.217 1.008 . . . . 0.0 111.999 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.544 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 2.3 m -100.2 120.92 40.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD21 HG12 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -139.35 143.77 37.92 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.619 -0.833 . . . . 0.0 109.786 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 26' ' ' SER . . . -104.33 154.27 20.02 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.822 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 52.9 p90 -149.09 165.04 32.92 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.278 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 31.3 tt0 -131.91 120.77 22.99 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 22' ' ' LEU . 21.5 t -103.84 119.64 52.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.5 ptp180 -132.58 151.67 51.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 p -81.95 175.98 9.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.137 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -58.7 -32.07 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.261 0.553 . . . . 0.0 109.721 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.28 -18.23 63.82 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.933 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.89 26.72 15.84 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.563 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 9.1 t -105.17 126.32 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.786 -0.244 . . . . 0.0 110.554 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 25' ' ' GLU . 35.1 tp -67.04 123.35 19.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -109.6 -38.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.565 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.18 152.41 39.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HB2' HD11 ' A' ' 22' ' ' LEU . 30.8 tt0 -157.1 137.43 12.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 111.753 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 27.1 m -116.7 114.3 39.87 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.17 167.52 19.94 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 C-N-CA 122.824 2.349 . . . . 0.0 112.227 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.18 -17.71 22.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.269 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -78.0 -32.53 51.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.242 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.8 112.83 9.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.277 0.561 . . . . 0.0 110.75 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.697 ' HG3' HG23 ' A' ' 137' ' ' VAL . 10.6 Cg_exo -76.86 169.45 21.66 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 124.271 3.314 . . . . 0.0 114.644 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.822 ' HG ' ' HE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -70.0 158.67 35.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.383 169.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' H ' HD22 ' A' ' 32' ' ' LEU . 3.9 m-20 -91.43 149.62 21.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.085 0.945 . . . . 0.0 110.949 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.832 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.08 126.91 42.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -161.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.606 HD12 HD21 ' A' ' 147' ' ' LEU . 14.7 tp -148.44 98.54 2.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 146.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.547 ' HA ' ' HG ' ' A' ' 40' ' ' SER . 21.2 t60 -70.82 136.19 48.6 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.412 -164.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.55 27.32 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.471 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.14 18.32 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.671 0.748 . . . . 0.0 110.173 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.83 90.8 0.18 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.98 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.555 ' HB2' HD13 ' A' ' 41' ' ' LEU . 11.0 m -116.63 -52.27 2.56 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.683 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.75 -173.42 2.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 111.568 -2.56 . . . . 0.0 108.518 170.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.448 HG12 HD22 ' A' ' 41' ' ' LEU . 13.7 pt -33.14 143.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -66.47 -41.08 89.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.741 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -58.14 -41.41 94.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.773 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 tp -73.95 -48.89 27.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.554 ' HA ' HD13 ' A' ' 49' ' ' LEU . 15.6 mt-10 -50.74 -47.86 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.113 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.5 m -63.45 -36.83 85.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.656 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.1 72.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.467 0.651 . . . . 0.0 110.015 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 83.9 mt -59.0 -37.07 76.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.664 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.0 mt-10 -53.32 152.04 4.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.82 -22.49 6.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.371 -1.286 . . . . 0.0 114.183 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.499 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.8 m-70 -83.39 179.26 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.451 0.643 . . . . 0.0 111.954 -175.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.6 mt-10 -134.73 161.85 34.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.483 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 136' ' ' VAL . 1.2 m -52.61 143.26 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.691 0.619 . . . . 0.0 111.11 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' N ' HG12 ' A' ' 136' ' ' VAL . . . 97.39 -17.13 59.56 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.689 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -64.94 132.54 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 13.7 tmtt? -137.17 130.19 30.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.656 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.684 ' CE2' HG23 ' A' ' 60' ' ' VAL . 21.0 p90 -166.57 163.49 16.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.993 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.11 143.38 26.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.598 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.684 HG23 ' CE2' ' A' ' 58' ' ' PHE . 3.9 t -131.43 142.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.122 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.97 113.49 13.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.035 0.445 . . . . 0.0 109.893 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG13 ' HA3' ' A' ' 44' ' ' GLY . 99.7 t -125.9 136.88 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.508 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.52 148.23 45.03 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.12 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 128' ' ' GLN . . . -62.82 -21.61 66.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -68.95 -19.64 64.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.019 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.3 -42.02 4.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.922 0.391 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 42' ' ' ILE . . . -81.81 -88.35 0.08 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.943 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -166.74 172.72 10.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.82 21.05 11.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.348 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -72.59 148.21 45.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 73' ' ' GLU . 58.4 t80 -95.56 110.0 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.093 0.473 . . . . 0.0 110.32 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -85.87 84.66 7.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.47 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.524 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 4.8 pt-20 -70.54 -14.99 62.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.057 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.09 -4.04 59.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.893 0.378 . . . . 0.0 110.577 174.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.6 tp -102.58 -10.41 19.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.461 0.648 . . . . 0.0 110.135 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 73' ' ' GLU . 4.3 p -115.44 117.68 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.454 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -161.81 176.81 10.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.523 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.602 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.9 mpt_? -111.02 111.5 22.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.207 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.49 133.28 20.25 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.461 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -60.98 135.01 56.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.76 2.307 . . . . 0.0 111.836 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 23.8 mtmt -59.11 -17.52 27.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.327 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.52 -27.37 64.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.42 0.629 . . . . 0.0 110.154 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.9 -36.4 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' HB2' HD13 ' A' ' 90' ' ' LEU . 26.3 m-85 -102.1 40.02 1.4 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.179 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.7 ptm -56.54 -24.33 46.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.361 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.39 4.7 83.35 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.198 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG12 HD21 ' A' ' 90' ' ' LEU . 69.5 t -89.56 149.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.902 0.351 . . . . 0.0 110.477 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.17 -70.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 110.878 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.508 ' O ' ' HE2' ' A' ' 94' ' ' MET . 28.9 mt-10 -142.72 105.38 4.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.626 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB3' HG13 ' A' ' 117' ' ' VAL . 80.8 mt -60.17 107.59 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.341 0.591 . . . . 0.0 110.392 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.27 167.52 16.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.26 140.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.05 2.43 77.86 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.483 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.508 ' HE2' ' O ' ' A' ' 89' ' ' GLU . 4.4 mmm -89.21 135.53 33.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.101 0.476 . . . . 0.0 109.718 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.83 135.39 54.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.691 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -164.15 167.45 20.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.112 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.3 tp -84.33 130.6 34.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -113.16 142.72 45.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.994 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.62 132.95 35.45 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.3 p -146.81 -175.64 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.81 -30.88 70.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.592 0.71 . . . . 0.0 109.901 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -86.71 24.45 1.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.636 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.79 -171.67 55.15 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.185 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 32.6 Cg_exo -58.63 128.57 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.231 1.954 . . . . 0.0 111.631 170.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 64.8 t -128.85 116.43 19.23 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.74 102.7 1.22 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.939 2.426 . . . . 0.0 111.861 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.5 m -118.37 172.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.777 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.98 131.53 40.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.452 ' HA ' HG11 ' A' ' 119' ' ' VAL . 41.4 mt -68.82 128.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 120' ' ' ASP . 39.4 p -113.66 0.31 14.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.323 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -175.52 153.27 1.45 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.093 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 117' ' ' VAL . 57.5 t -140.78 106.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.84 -172.61 3.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.31 -49.03 65.81 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.225 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.542 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 10.0 m-20 -104.83 -14.35 15.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -143.53 149.04 36.89 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.574 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 112' ' ' VAL . 34.9 m -104.58 168.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.114 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.2 t -124.0 122.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.609 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m -115.63 133.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 112.012 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' HB3' HG22 ' A' ' 110' ' ' THR . 14.3 t70 -144.36 106.83 4.39 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.797 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.97 14.2 55.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.431 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -113.09 168.86 9.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -109.2 136.23 49.01 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.24 -5.69 5.46 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.901 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.0 mp -84.17 11.5 8.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.149 0.499 . . . . 0.0 110.216 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.33 148.31 35.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.759 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 106.01 -29.96 10.42 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.67 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 7.0 mt-30 -72.74 162.98 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -96.93 162.5 13.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -128.17 145.77 50.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.028 -169.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -117.11 128.54 55.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 3.5 m-85 -119.71 133.77 55.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.472 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 133' ' ' ASN . 1.0 OUTLIER -104.33 108.69 20.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.698 HG12 HD21 ' A' ' 11' ' ' LEU . 5.6 t -98.67 142.5 14.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.505 0.669 . . . . 0.0 112.145 -170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.697 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 44.0 mt-10 -130.93 90.85 2.96 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.192 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -68.86 114.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.854 0.835 . . . . 0.0 111.957 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.697 HG23 ' HG3' ' A' ' 31' ' ' PRO . 15.8 t -71.54 -51.9 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.047 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -158.58 158.45 33.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.885 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.667 HG21 HG11 ' A' ' 9' ' ' VAL . 75.9 mt -137.35 134.58 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 8' ' ' VAL . 41.6 ttm180 -154.38 138.99 16.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.443 ' HA ' HD22 ' A' ' 7' ' ' LEU . 16.1 pt-20 -70.85 123.34 21.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.585 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -62.75 164.23 8.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.2 p -97.54 25.27 5.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -168.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.467 ' HA ' HD11 ' A' ' 147' ' ' LEU . 38.7 mt-10 72.81 -36.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.369 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 143' ' ' THR . 35.5 mt-10 -62.0 -48.71 79.1 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.565 0.221 . . . . 0.0 110.693 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 12.7 mp0 -55.68 -39.42 70.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.606 HD21 HD12 ' A' ' 35' ' ' LEU . 19.2 mt -68.76 -47.32 66.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.168 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.2 73.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.19 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -84.58 -19.28 33.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.239 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 81.93 10.24 84.27 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.007 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.02 172.93 1.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.439 HG12 ' HB1' ' A' ' 155' ' ' ALA . 21.0 t -65.44 -65.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.508 ' HA ' ' OD2' ' A' ' 157' ' ' ASP . 43.0 t60 59.15 86.64 0.09 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.409 0.623 . . . . 0.0 109.908 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.36 2.38 1.55 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.387 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.439 ' HB1' HG12 ' A' ' 152' ' ' VAL . . . -109.2 -74.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.005 0.431 . . . . 0.0 110.584 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -80.36 -10.36 59.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.573 0.702 . . . . 0.0 109.833 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.508 ' OD2' ' HA ' ' A' ' 153' ' ' HIS . 20.0 p-10 -128.05 69.53 1.34 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.987 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -117.01 -23.27 8.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.387 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -81.77 122.1 27.25 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.16 -27.42 0.07 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -170.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -73.38 -24.47 60.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.686 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -85.38 135.74 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.097 0.475 . . . . 0.0 109.739 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.98 40.58 0.73 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.619 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.36 110.81 1.17 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 111.124 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -110.03 34.1 4.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.189 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -97.33 -36.65 10.32 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.784 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.451 ' C ' ' H ' ' A' ' 170' ' ' HIS . 1.8 m170 58.53 78.99 0.23 Allowed 'General case' 0 C--O 1.237 0.423 0 O-C-N 123.723 0.64 . . . . 0.0 111.197 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.09 45.14 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.546 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.451 ' H ' ' C ' ' A' ' 168' ' ' HIS . 54.6 t-80 -157.76 124.27 4.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 107.633 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.497 -178.63 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.429 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 19.2 ptmt -133.14 166.18 23.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 52' ' ' HIS . 1.3 p -72.42 115.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.068 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.32 -171.0 3.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.008 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 7' ' ' LEU . 83.3 tttt -64.97 158.04 26.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.223 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p30 55.69 0.3 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 113.907 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.6 mt -96.45 110.51 22.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.044 0.45 . . . . 0.0 111.295 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.552 ' CG2' HD13 ' A' ' 35' ' ' LEU . 49.7 t -53.73 143.43 5.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.708 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -141.89 134.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -111.99 111.7 22.81 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD12 HG11 ' A' ' 134' ' ' VAL . 2.3 pp -128.76 161.12 30.48 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.854 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.6 147.31 42.96 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.673 ' CE1' HD13 ' A' ' 32' ' ' LEU . 36.7 p90 -160.93 162.19 31.91 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.436 -0.905 . . . . 0.0 111.452 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.0 tt0 -133.57 121.07 21.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.4 p -113.7 125.93 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.598 0.713 . . . . 0.0 111.361 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -144.07 176.03 9.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.335 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.3 p -98.03 178.05 5.22 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.528 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.2 -20.86 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.263 0.554 . . . . 0.0 110.153 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB3' HG23 ' A' ' 21' ' ' VAL . 18.2 t70 -78.26 -18.07 55.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.384 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.39 6.02 53.65 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 19' ' ' ASP . 5.2 t -77.04 112.92 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 15' ' ' VAL . 58.3 tp -68.97 119.43 13.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' CG2' HG21 ' A' ' 15' ' ' VAL . 31.0 m -96.52 -39.19 8.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 32.5 t70 -156.56 160.15 39.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' HB2' HD13 ' A' ' 22' ' ' LEU . 43.1 tt0 -159.05 133.54 7.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 0.0 111.971 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 m -116.25 105.08 51.28 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.26 168.27 18.14 Favored 'Trans proline' 0 CA--C 1.523 -0.068 0 C-N-CA 122.91 2.407 . . . . 0.0 113.035 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.02 -19.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.548 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.4 p -75.83 -38.95 57.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -133.93 112.65 12.47 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.237 0.541 . . . . 0.0 109.873 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 30' ' ' ALA . 12.9 Cg_exo -75.53 169.76 21.68 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.994 3.13 . . . . 0.0 114.723 -175.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -86.6 131.49 34.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.603 168.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.57 118.28 26.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.645 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -160.15 -179.72 7.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.263 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD22 HD23 ' A' ' 147' ' ' LEU . 60.2 tp -107.98 115.74 30.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.65 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 14.9 t60 -73.99 130.87 40.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.45 6.38 29.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.774 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -148.15 9.66 0.87 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.12 104.34 2.51 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -167.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.436 ' HB3' HD23 ' A' ' 41' ' ' LEU . 39.4 t -118.33 -50.85 2.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.2 pt? -158.09 -168.89 2.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.817 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 10.7 pt -39.77 144.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -66.51 -39.46 88.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.076 -1.874 . . . . 0.0 112.185 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.492 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -65.53 -39.48 95.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.352 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 HG22 ' A' ' 134' ' ' VAL . 16.5 tp -74.37 -49.79 21.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 109.864 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' HA ' HD23 ' A' ' 49' ' ' LEU . 23.3 mt-10 -48.5 -47.2 39.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.4 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.9 m -66.48 -32.97 74.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.7 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.41 74.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.8 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -57.91 -45.13 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.161 175.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -46.55 152.35 0.47 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.949 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.429 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 79.11 -23.59 3.17 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 114.428 -1.26 . . . . 0.0 114.594 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.562 ' O ' HG11 ' A' ' 3' ' ' VAL . 94.2 m-70 -84.49 177.55 8.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.664 0.732 . . . . 0.0 111.163 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 1' ' ' MET . 39.5 mt-10 -128.72 164.57 22.66 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' HG11 ' A' ' 136' ' ' VAL . 1.1 m -52.04 142.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.819 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.87 -13.11 66.66 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.473 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.52 131.38 44.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.941 0.4 . . . . 0.0 110.327 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.559 ' CG ' ' HG2' ' A' ' 135' ' ' GLU . 1.9 tmtp? -137.96 130.33 29.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.913 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.643 ' CE2' HG21 ' A' ' 60' ' ' VAL . 13.5 p90 -167.4 162.01 14.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.037 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.77 144.11 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.626 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.643 HG21 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -134.32 142.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.31 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.95 113.2 11.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.492 HG13 ' HA3' ' A' ' 44' ' ' GLY . 80.3 t -120.78 138.22 51.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.876 0.37 . . . . 0.0 110.652 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.85 150.32 50.37 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.367 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.54 -31.39 4.33 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -65.16 -21.11 66.73 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -117.06 3.69 12.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 176.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -132.15 -152.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.543 ' HB2' HD13 ' A' ' 130' ' ' LEU . 44.6 m-85 -76.32 157.45 32.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.11 22.2 10.96 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.604 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -57.45 120.6 8.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.202 1.001 . . . . 0.0 112.731 -169.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.898 ' HB2' HD22 ' A' ' 122' ' ' ASN . 54.9 p90 -63.4 152.54 37.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.06 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.51 116.09 14.8 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.32 -13.28 61.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -66.31 -3.67 6.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 122' ' ' ASN . 88.0 mt -112.66 -10.41 13.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.227 0.536 . . . . 0.0 110.975 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.5 p -100.46 154.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.336 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.503 ' OE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -161.7 171.86 17.19 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HG3' HG21 ' A' ' 118' ' ' VAL . 8.4 mpt_? -116.26 105.36 12.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 109.737 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.17 128.62 36.28 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.952 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.32 137.1 72.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.592 2.862 . . . . 0.0 112.216 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.922 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -56.1 -25.57 46.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.113 175.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.04 -36.42 81.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.462 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -43.16 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.316 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.7 m-85 -90.4 40.21 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.401 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 14.7 ptm -52.13 -36.54 51.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.144 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.401 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -92.32 13.94 65.92 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.984 -175.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.781 HG13 ' HG ' ' A' ' 90' ' ' LEU . 7.4 p -75.79 159.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.272 0.536 . . . . 0.0 111.129 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -68.67 -76.03 0.1 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.859 174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.625 ' O ' ' HE2' ' A' ' 94' ' ' MET . 30.7 mt-10 -149.77 110.51 4.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.217 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HG ' HG13 ' A' ' 87' ' ' VAL . 5.6 mt -64.58 119.54 10.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.652 0.739 . . . . 0.0 111.45 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -147.03 164.89 31.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.471 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.425 HG12 ' C ' ' A' ' 110' ' ' THR . 53.3 t -81.21 132.68 30.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.04 1.82 56.0 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.83 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.625 ' HE2' ' O ' ' A' ' 89' ' ' GLU . 8.6 mmm -91.09 141.86 28.37 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.226 0.536 . . . . 0.0 111.292 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 10.7 mtp180 -118.24 134.54 54.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.043 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -162.01 167.09 25.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.078 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.6 tp -91.31 137.3 32.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.192 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.84 138.14 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.09 146.91 28.42 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.5 p -145.74 -175.55 4.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.17 -23.57 67.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.84 0.828 . . . . 0.0 110.514 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.84 26.84 10.27 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.549 -171.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.89 -179.31 48.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.135 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.82 133.39 55.83 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.375 2.05 . . . . 0.0 112.903 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 88.9 t -129.53 116.39 18.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.549 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.9 Cg_exo -79.75 112.97 2.98 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.889 2.393 . . . . 0.0 111.19 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.8 m -118.23 178.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.743 0.306 . . . . 0.0 111.196 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.472 ' C ' HG13 ' A' ' 119' ' ' VAL . 36.7 tt0 -134.53 130.84 37.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.426 HG23 ' CG2' ' A' ' 112' ' ' VAL . 40.7 mt -71.89 130.44 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.327 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.425 ' C ' HG12 ' A' ' 92' ' ' VAL . 20.9 p -112.05 -1.87 15.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 0.0 110.382 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.415 ' HA ' HG23 ' A' ' 92' ' ' VAL . . . -175.34 150.24 1.11 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.485 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.593 HG13 HG13 ' A' ' 117' ' ' VAL . 60.8 t -139.08 106.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 6.9 mm-40 -86.0 -157.31 0.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -71.33 -54.09 11.97 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.866 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.465 ' C ' ' HG2' ' A' ' 81' ' ' LYS . 18.5 m-20 -118.14 5.86 12.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.401 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 33.1 p-80 -145.1 148.03 33.2 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.461 -0.774 . . . . 0.0 111.574 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.701 HG12 ' HZ1' ' A' ' 81' ' ' LYS . 30.7 m -116.35 167.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 78' ' ' ARG . 59.5 t -122.53 115.88 47.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.967 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -119.05 130.57 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.069 0.462 . . . . 0.0 110.333 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -108.38 153.19 23.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.986 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.17 2.73 40.55 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.898 HD22 ' HB2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -127.39 162.2 26.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.8 -35.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.5 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -8.3 56.96 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.393 -0.192 . . . . 0.0 111.511 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.463 ' HB2' ' OD1' ' A' ' 122' ' ' ASN . 7.3 mp -83.37 -10.95 58.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.416 0.627 . . . . 0.0 109.489 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -137.42 -153.6 0.5 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.96 -12.99 59.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.17 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.15 106.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.92 0.39 . . . . 0.0 111.053 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -82.52 126.55 32.39 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 68' ' ' TYR . 92.1 mt -106.08 154.99 19.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.742 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -124.17 122.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 110.048 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 1.6 m-85 -117.83 139.81 50.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.704 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.9 m120 -109.36 106.67 16.57 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.597 HG22 HD11 ' A' ' 45' ' ' LEU . 2.5 t -99.61 135.62 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.559 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 25.9 mt-10 -135.54 90.83 2.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.272 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 54' ' ' VAL . 2.9 p -72.69 115.0 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.846 0.831 . . . . 0.0 112.446 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 31' ' ' PRO . 3.2 t -72.91 -47.91 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.124 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.03 157.59 31.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.751 0.31 . . . . 0.0 111.147 -171.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.452 HG13 HG13 ' A' ' 54' ' ' VAL . 63.5 mt -140.34 123.46 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -146.97 137.05 23.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.999 0.428 . . . . 0.0 111.351 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 7' ' ' LEU . 7.9 pt-20 -75.49 138.66 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . . . -80.51 176.77 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.682 0.754 . . . . 0.0 112.589 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 145' ' ' GLU . 22.5 p -96.34 23.43 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.269 -171.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 147' ' ' LEU . 41.6 mt-10 70.17 -43.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.365 0.666 . . . . 0.0 111.444 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 143' ' ' THR . 40.0 mt-10 -65.79 -40.26 91.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.365 0.602 . . . . 0.0 109.38 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 42.4 mt-10 -63.15 -34.27 77.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.381 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.624 HD23 HD22 ' A' ' 35' ' ' LEU . 47.2 mt -71.98 -47.4 52.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.139 176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.48 69.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.52 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.04 -16.76 18.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.87 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.79 40.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 114.243 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -169.87 166.0 9.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.373 0.587 . . . . 0.0 110.635 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.2 133.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 123.576 0.548 . . . . 0.0 111.007 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -124.67 80.07 1.82 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 153.74 43.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.949 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -99.08 -76.06 0.55 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.12 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.0 t60 66.45 120.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.728 0.643 . . . . 0.0 110.952 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.83 132.66 35.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.179 0.514 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -121.19 86.36 2.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.04 0.924 . . . . 0.0 109.157 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -87.67 157.86 18.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.36 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -113.36 123.1 49.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.177 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.407 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . 5.8 m-20 -106.96 177.23 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.476 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -150.09 147.56 27.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.014 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 65.58 31.57 9.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.212 171.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 161' ' ' ASP . 1.5 p-80 -107.41 151.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.87 171.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -155.67 126.36 6.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.834 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -127.19 29.06 5.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -116.78 -21.05 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.51 98.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.527 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -166.04 -40.98 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.035 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -135.15 97.36 3.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.553 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.569 -177.192 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 51' ' ' GLY . 15.2 ptpt -111.11 170.83 7.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.481 0.657 . . . . 0.0 111.729 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -84.94 131.96 32.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.16 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.12 -174.12 4.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.527 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 79.5 tttt -65.96 155.86 35.28 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' O ' HD23 ' A' ' 147' ' ' LEU . 28.7 m-20 60.37 -5.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 141' ' ' GLU . 19.3 mt -90.71 109.66 20.84 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.613 -0.679 . . . . 0.0 111.454 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.0 144.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.046 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -151.16 137.75 12.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -168.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 10.9 m -102.45 121.24 41.95 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.671 HD21 HG11 ' A' ' 134' ' ' VAL . 2.1 tt -136.9 154.31 50.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.425 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . . . -124.36 151.24 44.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.48 161.33 21.28 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.04 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.617 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 51.8 tt0 -132.15 118.94 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.549 HG13 ' OH ' ' A' ' 68' ' ' TYR . 2.9 p -110.32 124.4 67.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.536 0.684 . . . . 0.0 111.388 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -145.41 -179.84 6.92 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.441 ' HG1' HG11 ' A' ' 21' ' ' VAL . 40.6 p -99.91 174.58 6.12 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.253 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -65.43 -19.22 65.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.421 175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.07 -18.72 55.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.577 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.36 -12.01 43.59 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.515 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.441 HG11 ' HG1' ' A' ' 17' ' ' THR . 8.9 p -73.53 126.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 117.427 0.614 . . . . 0.0 110.588 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 15' ' ' VAL . 51.5 tp -76.96 127.97 33.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.86 -35.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -167.47 167.06 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -165.64 159.35 16.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.5 0.667 . . . . 0.0 111.212 169.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -126.07 114.59 24.04 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.42 166.06 26.86 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.789 2.326 . . . . 0.0 113.218 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.94 -22.89 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.436 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.2 p -71.41 -38.95 71.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.871 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.508 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -135.34 113.05 11.14 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-O 121.269 0.557 . . . . 0.0 110.151 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.648 ' HB3' HG22 ' A' ' 137' ' ' VAL . 11.3 Cg_exo -75.81 166.58 27.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.9 3.067 . . . . 0.0 114.439 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.8 tp -85.62 134.17 34.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.485 170.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.07 118.18 30.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.167 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -160.69 179.75 8.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.195 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.93 117.95 35.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 31.9 t60 -70.79 128.99 37.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.489 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 96.48 8.19 57.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.889 172.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -134.31 14.58 3.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.15 103.29 2.3 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -167.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 36' ' ' HIS . 33.4 t -116.61 -52.31 2.56 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.575 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.39 -82.81 0.24 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.122 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.575 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 15.5 pt -122.59 -163.43 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 t -98.02 -50.09 4.52 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.492 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.05 -34.81 29.11 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.956 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 134' ' ' VAL . 55.5 tp -74.24 -46.55 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 109.988 -172.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 48.3 mt-10 -50.79 -41.74 57.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.259 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -65.15 -33.23 75.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.72 -35.57 65.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.015 0.912 . . . . 0.0 109.273 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.721 HD23 HG13 ' A' ' 134' ' ' VAL . 96.2 mt -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.953 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.74 152.57 5.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.997 0.903 . . . . 0.0 112.772 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.427 ' O ' ' HE2' ' A' ' 2' ' ' LYS . . . 77.9 -18.39 5.02 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.549 ' HE1' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -128.65 157.31 41.67 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.377 2.089 . . . . 0.0 112.921 -173.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 1' ' ' MET . 41.4 mt-10 -101.98 166.32 10.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -157.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.603 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.6 m -48.12 144.21 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.046 -1.433 . . . . 0.0 112.714 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.507 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.58 -10.34 66.75 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.286 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -75.43 137.06 40.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.166 0.507 . . . . 0.0 110.171 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.651 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 2.1 tmtp? -137.76 132.37 32.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.921 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 60' ' ' VAL . 7.2 p90 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.045 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.39 139.84 33.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.779 0.799 . . . . 0.0 111.305 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 58' ' ' PHE . 3.4 t -125.67 150.42 30.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.428 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.48 113.96 11.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.037 0.381 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.85 144.66 37.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.189 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.36 152.64 49.89 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.155 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.692 ' HB3' ' HG3' ' A' ' 70' ' ' GLN . . . -55.2 -28.35 52.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.979 0.512 . . . . 0.0 112.258 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -71.43 -20.74 62.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.949 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -111.73 1.35 16.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.519 0.676 . . . . 0.0 110.416 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.56 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -128.01 -98.99 0.37 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.51 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.549 ' OH ' HG13 ' A' ' 15' ' ' VAL . 3.3 p90 -179.42 -173.68 0.28 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.5 19.57 51.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.622 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.692 ' HG3' ' HB3' ' A' ' 64' ' ' ALA . 21.1 mp0 -65.09 111.18 2.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 2.1 t80 -108.0 110.78 22.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 165.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.643 ' HB3' ' HA ' ' A' ' 122' ' ' ASN . 12.8 t0 -101.07 80.59 2.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.114 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' O ' HG13 ' A' ' 76' ' ' VAL . 6.1 pt-20 -74.76 -11.36 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.669 HD22 ' HB2' ' A' ' 125' ' ' LEU . 8.4 p30 -87.04 -19.66 28.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.191 174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.55 -11.19 38.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.991 0.424 . . . . 0.0 111.64 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 73' ' ' GLU . 14.2 p -79.15 142.27 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -158.74 176.67 12.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.455 0.645 . . . . 0.0 111.606 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG3' HG23 ' A' ' 118' ' ' VAL . 4.8 mpt_? -115.16 148.93 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.17 129.46 12.31 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -171.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.434 ' HB2' HG22 ' A' ' 83' ' ' VAL . 29.5 Cg_exo -57.21 136.57 77.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.051 2.5 . . . . 0.0 112.422 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -54.44 -31.6 55.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.495 178.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.93 -35.14 79.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 80' ' ' PRO . 88.1 t -57.01 -36.3 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.156 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HB2' HD13 ' A' ' 90' ' ' LEU . 45.6 m-85 -104.81 39.87 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.405 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.3 ptm -53.65 -27.22 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.527 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 3.07 85.7 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.387 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 95.0 t -92.78 144.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.091 0.446 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.01 -77.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.076 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' HE3' ' A' ' 94' ' ' MET . 29.2 mt-10 -134.2 106.64 7.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.722 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 117' ' ' VAL . 96.8 mt -59.68 105.52 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.438 0.637 . . . . 0.0 109.622 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -128.91 167.81 16.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.085 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 111' ' ' ALA . 43.8 t -79.83 135.24 25.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.5 1.19 68.98 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.137 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.503 ' HE3' ' O ' ' A' ' 89' ' ' GLU . 4.6 mmm -83.93 134.57 34.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.405 0.622 . . . . 0.0 109.688 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -119.33 136.08 54.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.09 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -163.65 165.27 23.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.762 HD22 ' HB2' ' A' ' 104' ' ' PRO . 5.6 mt -88.44 132.76 34.34 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.54 0.686 . . . . 0.0 110.518 172.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -112.61 114.07 26.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.079 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.717 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 26.2 mt-10 -87.32 96.64 10.42 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 110.788 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 p -94.67 -174.52 3.32 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.577 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.33 -43.54 61.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.308 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.468 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.5 pt20 -98.47 32.01 2.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.034 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.23 179.83 39.59 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.76 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.762 ' HB2' HD22 ' A' ' 97' ' ' LEU . 6.2 Cg_exo -66.77 147.77 81.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.516 2.144 . . . . 0.0 112.03 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -134.22 117.09 13.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.801 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.5 Cg_exo -74.01 102.34 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 111.722 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 6.2 m -118.73 151.84 20.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 110.721 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 23.7 tt0 -116.62 137.85 51.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.225 0.536 . . . . 0.0 110.318 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.473 ' HA ' HG12 ' A' ' 119' ' ' VAL . 26.5 mt -81.57 129.26 37.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.086 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.3 p -115.53 5.27 14.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.45 ' HA ' HG23 ' A' ' 92' ' ' VAL . . . 176.77 151.45 0.17 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.737 HG13 HG12 ' A' ' 117' ' ' VAL . 49.1 t -140.91 109.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -91.22 -154.1 0.34 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.05 -36.2 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -133.27 -14.83 2.58 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.179 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -139.38 157.59 45.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.536 0.208 . . . . 0.0 110.725 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.737 HG12 HG13 ' A' ' 112' ' ' VAL . 30.5 m -112.77 167.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 78' ' ' ARG . 41.4 t -117.19 117.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.7 m -120.39 140.03 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.638 0.733 . . . . 0.0 112.302 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.89 145.85 47.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.536 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.27 46.49 0.54 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 111.942 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 9.7 m120 -38.65 130.24 1.4 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.949 0.9 . . . . 0.0 112.929 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.636 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 11.2 t-80 -156.88 -81.42 0.07 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.866 ' HG3' ' HG ' ' A' ' 125' ' ' LEU . 23.3 ptt? -84.27 -49.64 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -162.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.866 ' HG ' ' HG3' ' A' ' 124' ' ' MET . 39.9 mt -108.92 32.98 4.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -165.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 71' ' ' TYR . . . -47.79 -66.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.678 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.14 -3.68 82.54 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.396 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -55.17 121.14 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.08 125.62 41.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.7 mt -104.23 152.73 21.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -122.04 125.63 46.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 2.8 m-85 -116.02 134.54 54.85 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.355 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -105.44 106.62 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.721 HG13 HD23 ' A' ' 49' ' ' LEU . 4.0 t -99.09 139.65 20.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.725 0.774 . . . . 0.0 112.286 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.651 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 37.0 mt-10 -131.48 91.49 3.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.811 -1.541 . . . . 0.0 109.465 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.5 p -63.56 154.27 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 31' ' ' PRO . 76.0 t -129.44 -55.31 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 -153.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.91 38.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 110.419 -3.082 . . . . 0.0 109.876 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.458 HG13 HG13 ' A' ' 54' ' ' VAL . 74.9 mt -138.91 133.51 41.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.9 ttp-105 -139.52 154.18 47.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.0 110.171 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.611 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.1 pt-20 -91.55 132.38 36.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.659 ' HB2' HD23 ' A' ' 147' ' ' LEU . . . -73.2 163.81 27.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.749 . . . . 0.0 112.243 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -94.64 24.51 4.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.972 -171.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 70.52 -38.71 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.06 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -40.22 82.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.684 ' HG2' ' HA ' ' A' ' 152' ' ' VAL . 25.7 mt-10 -58.97 -37.12 76.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.999 175.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.659 HD23 ' HB2' ' A' ' 142' ' ' ALA . 23.0 mt -71.07 -46.02 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.084 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.92 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.425 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -89.76 -14.85 33.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.335 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.67 90.37 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.714 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -169.12 169.36 9.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.684 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 38.9 t -53.32 -71.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 123.697 0.623 . . . . 0.0 112.452 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.3 t60 56.91 72.61 0.5 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.561 -174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.6 -99.93 2.07 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.731 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 59.68 -168.15 0.16 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.829 0.452 . . . . 0.0 110.838 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -142.14 110.43 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -146.07 -70.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.896 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.51 119.43 39.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.026 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -142.22 148.83 38.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.374 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.594 ' HB3' ' HB2' ' A' ' 163' ' ' ASP . 31.7 m170 -106.96 135.52 48.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.374 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -131.76 123.93 28.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 56.32 41.17 29.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 109.85 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 160' ' ' HIS . 19.1 t70 -77.74 -40.77 39.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -104.32 139.3 39.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.68 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.444 ' OD1' ' HB2' ' A' ' 168' ' ' HIS . 33.9 t70 60.59 65.97 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.945 0.778 . . . . 0.0 110.709 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -106.63 -19.21 13.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.666 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -97.55 17.77 16.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.717 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.444 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 92.3 m-70 -136.49 160.07 39.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.8 m80 73.42 -53.79 0.69 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.873 0.733 . . . . 0.0 111.783 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -135.14 126.83 29.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.693 0.283 . . . . 0.0 110.444 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 119.034 -0.508 . . . . 0.0 110.096 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 ptpt -111.73 174.63 5.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.43 0.633 . . . . 0.0 111.268 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -83.51 125.05 40.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.188 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.09 -171.08 3.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.781 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 34.9 tttm -63.86 151.18 43.12 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.639 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.43 ' CB ' HD23 ' A' ' 147' ' ' LEU . 30.8 m-20 52.74 7.84 0.08 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.428 ' H ' ' C ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -100.57 100.47 11.2 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 34' ' ' TYR . 14.6 p -69.77 141.09 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.55 HG11 HG21 ' A' ' 139' ' ' ILE . 4.5 m -136.46 159.04 38.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.873 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.775 ' O ' HG22 ' A' ' 137' ' ' VAL . 19.5 m -117.37 118.26 31.75 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.624 HD21 HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -134.96 161.08 36.28 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.775 -177.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.24 107.82 13.01 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.0 p90 -120.52 158.48 27.2 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.407 -173.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.867 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 tt0 -127.28 119.4 26.24 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.439 HG11 HG22 ' A' ' 23' ' ' VAL . 2.4 p -102.0 119.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 122.199 1.0 . . . . 0.0 111.021 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 16' ' ' ARG . 13.7 ttm180 -134.51 145.97 49.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.95 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 p -87.14 179.44 6.65 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -64.05 -29.99 71.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 0.0 109.929 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.69 -19.25 65.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.02 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.73 66.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.532 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.37 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.498 . . . . 0.0 110.252 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 23' ' ' VAL . 5.0 tt -83.49 124.27 30.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.659 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 HG22 HG11 ' A' ' 15' ' ' VAL . 27.0 m -94.3 -39.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.373 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -162.73 159.53 24.34 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.867 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -166.0 148.17 7.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.25 0.548 . . . . 0.0 111.226 174.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -102.32 113.98 65.63 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.84 163.72 29.72 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 m -67.24 -13.88 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.327 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.2 p -82.28 -30.49 30.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.96 114.88 5.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.342 0.591 . . . . 0.0 110.976 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.764 ' HG3' HG13 ' A' ' 137' ' ' VAL . 8.9 Cg_exo -75.03 154.36 42.28 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.729 2.952 . . . . 0.0 113.374 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD21 ' CE1' ' A' ' 13' ' ' TYR . 15.2 tp -76.57 134.9 39.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.359 170.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -110.04 120.28 41.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.653 ' CZ ' HD11 ' A' ' 41' ' ' LEU . 7.5 p90 -150.77 148.37 28.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.292 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.508 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 41.9 tp -81.34 110.1 16.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.91 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' CE1' ' HG3' ' A' ' 50' ' ' GLU . 14.3 t60 -71.76 140.77 49.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.083 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 108.37 -27.03 14.75 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.158 -1.496 . . . . 0.0 113.85 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.45 55.48 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 35' ' ' LEU . . . -141.29 -105.71 0.59 Allowed Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.117 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 15.5 m -114.39 -54.84 2.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -166.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.956 HD22 HD22 ' A' ' 45' ' ' LEU . 84.6 mt -65.44 136.48 56.51 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.796 1.284 . . . . 0.0 112.651 173.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 67' ' ' ALA . 21.7 pt -53.33 175.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 111.749 -2.478 . . . . 0.0 114.581 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 m -66.26 -48.41 70.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.185 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.17 -45.33 96.26 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.428 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.956 HD22 HD22 ' A' ' 41' ' ' LEU . 23.7 tp -74.58 -53.33 9.61 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.809 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 6.9 mt-10 -48.29 -42.45 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 124.062 0.851 . . . . 0.0 111.834 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 m -65.53 -29.73 70.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.61 55.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 8.2 mt -65.43 -38.42 89.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.407 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.459 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 3.9 mt-10 -53.66 153.23 4.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.561 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.527 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 77.29 -14.71 8.01 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.87 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.593 ' O ' HG13 ' A' ' 3' ' ' VAL . 82.3 m-70 -88.78 165.52 14.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.265 0.533 . . . . 0.0 110.07 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 139' ' ' ILE . 69.1 mt-10 -123.11 162.5 22.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.479 HG13 HG13 ' A' ' 139' ' ' ILE . 1.5 m -46.56 143.64 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.826 0.822 . . . . 0.0 112.697 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.04 -2.88 72.55 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 114.703 -1.135 . . . . 0.0 114.079 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.45 134.01 35.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.464 0.632 . . . . 0.0 110.771 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.668 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 1.8 tmtp? -135.24 128.63 32.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.725 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CE2' HG23 ' A' ' 60' ' ' VAL . 22.8 p90 -155.57 -178.2 7.1 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.81 149.69 40.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG23 ' CE2' ' A' ' 58' ' ' PHE . 2.4 t -137.47 142.54 36.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.61 -172.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.64 113.53 13.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.18 132.63 70.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.77 154.05 48.02 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.742 ' HB2' ' HA2' ' A' ' 69' ' ' GLY . . . -49.63 -26.13 3.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.62 -34.0 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.13 -0.357 . . . . 0.0 111.614 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.73 -24.38 18.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.393 0.616 . . . . 0.0 109.942 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 42' ' ' ILE . . . -87.14 -138.51 0.09 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.412 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -76.3 -83.29 0.07 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 64' ' ' ALA . . . 86.97 -32.25 4.1 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 116.218 -0.447 . . . . 0.0 112.45 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -94.96 -178.14 4.39 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.791 ' HD2' HD22 ' A' ' 122' ' ' ASN . 14.0 p90 -44.96 144.22 1.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.622 0.576 . . . . 0.0 109.949 172.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.54 96.27 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.226 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.704 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 3.8 pt-20 -67.93 -0.73 4.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.63 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -86.07 -11.61 52.33 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.119 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 21.3 tp -86.5 -10.21 54.58 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 122.377 1.084 . . . . 0.0 108.395 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.704 ' HB ' ' O ' ' A' ' 73' ' ' GLU . 83.9 t -72.64 146.99 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.549 ' OE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -153.08 170.05 21.43 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.742 -1.583 . . . . 0.0 111.035 -170.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -98.73 140.84 32.32 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.152 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -136.06 124.92 15.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -60.11 126.91 21.5 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.386 2.057 . . . . 0.0 111.632 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 22.8 mtmt -58.74 -17.26 21.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.826 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.77 -29.87 70.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 0.0 110.24 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -67.05 -45.64 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.904 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 87' ' ' VAL . 60.3 m-85 -87.74 40.86 0.96 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.0 ptm -50.82 -29.8 12.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 6.19 81.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.915 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 75.0 t -94.14 145.46 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.424 0.612 . . . . 0.0 111.224 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.81 -74.32 0.05 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.542 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.512 ' O ' ' HE1' ' A' ' 94' ' ' MET . 24.0 mt-10 -142.08 116.88 9.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.463 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HB3' HG12 ' A' ' 117' ' ' VAL . 95.8 mt -62.33 105.97 0.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.42 176.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -128.77 166.21 19.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.13 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 110' ' ' THR . 44.2 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.41 74.57 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.82 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.512 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 4.0 mmm -89.2 135.03 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.141 0.471 . . . . 0.0 110.038 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.548 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 49.9 mtt180 -115.49 135.5 54.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.87 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.17 171.37 13.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.003 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 104' ' ' PRO . 64.3 tp -98.09 150.98 20.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' O ' HG22 ' A' ' 100' ' ' THR . . . -148.88 90.97 1.81 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 112.041 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 16.2 mt-10 -49.11 111.16 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.367 1.08 . . . . 0.0 112.87 162.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 98' ' ' ALA . 68.2 p -113.18 -172.63 2.1 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.747 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -50.83 -35.24 31.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.973 0.416 . . . . 0.0 111.005 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -98.55 28.32 4.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.04 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.21 -177.25 45.81 Favored Glycine 0 C--N 1.322 -0.203 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.453 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.764 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.7 Cg_endo -69.79 121.93 8.61 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 122.379 2.053 . . . . 0.0 112.411 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.83 116.1 47.95 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.931 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.8 120.94 8.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.011 1.807 . . . . 0.0 109.99 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.731 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 10.8 m -142.77 154.21 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.833 0.825 . . . . 0.0 112.524 -168.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 28.6 tt0 -130.44 127.8 40.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.866 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.526 ' HA ' HG13 ' A' ' 119' ' ' VAL . 62.8 mt -66.01 129.1 30.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.434 ' C ' HG13 ' A' ' 92' ' ' VAL . 36.3 p -116.34 0.7 12.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -175.34 152.65 1.42 Allowed 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.525 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.72 HG13 HG11 ' A' ' 117' ' ' VAL . 45.9 t -139.67 111.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -87.62 -166.63 1.63 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.439 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 5.1 m-20 -63.36 -53.54 50.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.307 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.576 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 5.0 m-20 -99.71 -18.3 17.32 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -143.25 146.76 33.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.704 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.72 HG11 HG13 ' A' ' 112' ' ' VAL . 33.1 m -92.44 168.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.388 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG13 HG11 ' A' ' 76' ' ' VAL . 2.3 t -129.68 108.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.731 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.4 m -115.66 141.6 32.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.889 0.852 . . . . 0.0 112.872 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.589 ' HA ' HG22 ' A' ' 76' ' ' VAL . 8.7 t70 -87.09 147.22 25.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.169 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.4 10.25 1.72 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.061 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.791 HD22 ' HD2' ' A' ' 71' ' ' TYR . 1.4 p30 -105.56 168.25 9.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.246 0.546 . . . . 0.0 110.948 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -132.89 169.25 17.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.605 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -67.43 0.3 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.847 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.23 20.45 1.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.09 -126.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . 83.24 1.79 90.42 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.002 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -78.41 129.88 35.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.01 143.92 37.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 167.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.9 mt -130.62 152.65 49.76 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -115.39 133.81 55.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.735 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 36.9 m-85 -121.02 142.09 50.13 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.404 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -108.84 106.71 16.83 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 166.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.653 HG13 HD22 ' A' ' 49' ' ' LEU . 3.1 t -100.85 140.28 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.95 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 59.1 mt-10 -138.14 100.7 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.968 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 p -80.42 110.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.13 0.49 . . . . 0.0 110.928 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 10' ' ' SER . 2.7 m -75.92 -39.53 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.013 0.435 . . . . 0.0 111.538 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 137' ' ' VAL . . . -162.41 156.95 21.84 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -168.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.55 HG21 HG11 ' A' ' 9' ' ' VAL . 73.3 mt -136.63 131.96 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -146.76 141.31 26.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.789 0.328 . . . . 0.0 110.144 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -87.71 125.31 34.34 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.74 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.732 ' HB1' HD21 ' A' ' 147' ' ' LEU . . . -63.61 165.5 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.774 -170.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 145' ' ' GLU . 56.3 p -79.49 15.36 1.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.422 -170.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.486 ' HA ' HD11 ' A' ' 147' ' ' LEU . 41.6 mt-10 69.94 -35.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 111.481 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 143' ' ' THR . 46.4 mt-10 -62.23 -46.89 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 109.708 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 142' ' ' ALA . 25.4 mt-10 -59.22 -35.53 73.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.237 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.732 HD21 ' HB1' ' A' ' 142' ' ' ALA . 24.0 mt -71.92 -46.89 56.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.401 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.87 70.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.211 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -88.93 -11.92 43.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.789 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.23 4.21 84.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.994 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -174.03 167.4 4.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' A' ' 155' ' ' ALA . 41.4 t -55.99 -73.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 123.732 0.645 . . . . 0.0 112.159 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 50.92 48.94 22.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.532 0.682 . . . . 0.0 109.72 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.83 -101.84 0.16 Allowed Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.554 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . 55.06 72.3 0.48 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.073 0.463 . . . . 0.0 111.166 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -146.09 93.39 2.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.895 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.14 123.5 34.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -147.8 55.45 1.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.947 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -57.31 -42.02 80.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.745 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -107.88 73.7 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.504 . . . . 0.0 110.178 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.62 142.18 35.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.174 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -147.59 76.35 1.39 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.872 0.367 . . . . 0.0 111.7 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -81.7 151.48 27.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 167.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -134.25 122.45 22.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.978 0.418 . . . . 0.0 110.849 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -86.17 -26.35 25.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.763 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -98.14 105.52 17.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.883 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -128.53 121.44 28.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.482 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -98.22 -51.24 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -137.61 160.11 40.09 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.048 -0.408 . . . . 0.0 110.71 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 58.52 71.73 0.57 Allowed 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 109.618 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.388 -171.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.7 ptpt -129.59 179.48 5.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -85.56 116.06 28.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.383 0.611 . . . . 0.0 111.563 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -149.89 -167.37 2.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.084 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 7' ' ' LEU . 20.2 tttm -61.56 153.31 28.0 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.108 0.255 . . . . 0.0 110.691 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 50.3 3.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.145 1.378 . . . . 0.0 114.519 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 5' ' ' LYS . 1.2 mt -93.91 98.43 11.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -63.61 144.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.204 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.753 HG11 HG21 ' A' ' 139' ' ' ILE . 2.1 m -148.84 152.29 12.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.473 0.654 . . . . 0.0 111.24 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.0 m -103.03 117.72 35.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD23 HG11 ' A' ' 134' ' ' VAL . 9.5 tt -133.01 147.59 52.26 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.522 -172.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.8 152.4 37.32 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.615 ' HE1' HD22 ' A' ' 32' ' ' LEU . 52.1 p90 -161.77 157.51 24.33 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.168 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' CG ' HD11 ' A' ' 22' ' ' LEU . 36.1 tt0 -131.08 122.86 27.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.385 172.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -103.83 119.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.581 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -139.29 155.46 47.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 p -78.08 179.8 6.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.012 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 131' ' ' LYS . 5.8 mm-40 -51.64 -31.68 26.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.543 172.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -19.0 63.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.151 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.34 -2.54 81.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.538 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.63 136.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.486 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' A' ' 25' ' ' GLU . 58.8 tp -72.8 131.37 42.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.733 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.84 -40.56 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.688 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -144.93 149.45 35.27 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.625 ' HB2' HD13 ' A' ' 22' ' ' LEU . 24.1 tt0 -164.12 139.51 6.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.1 m -119.18 114.84 34.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 167.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.37 167.44 26.3 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.588 2.192 . . . . 0.0 113.389 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -18.96 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.215 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -73.15 -34.83 66.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.508 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.99 112.72 5.74 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 30' ' ' ALA . 11.2 Cg_exo -75.44 159.7 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.285 2.657 . . . . 0.0 113.952 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.704 HD23 ' HG ' ' A' ' 41' ' ' LEU . 14.0 tp -79.57 126.19 30.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.046 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.2 120.78 42.96 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.505 ' CD2' ' HA ' ' A' ' 40' ' ' SER . 46.2 p90 -144.54 161.86 38.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.497 HD21 HD21 ' A' ' 147' ' ' LEU . 46.7 tp -108.29 105.64 15.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 6.4 t60 -61.14 130.51 46.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.81 56.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.219 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -134.62 2.8 3.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 94.73 0.14 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.772 ' O ' HD13 ' A' ' 41' ' ' LEU . 12.7 m -116.11 15.21 16.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.512 1.149 . . . . 0.0 108.511 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 40' ' ' SER 0.396 0.0 OUTLIER 41.81 109.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.473 2.709 . . . . 0.0 115.397 -170.467 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.8 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 pt 51.57 127.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 110.148 -3.205 . . . . 0.0 115.61 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.528 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 43.5 t -50.66 -47.63 58.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.564 -2.107 . . . . 0.0 113.387 -170.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA3' HG13 ' A' ' 62' ' ' VAL . . . -67.97 -36.54 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.345 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.687 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 44.8 tp -75.03 -46.96 31.48 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.8 ' HG3' ' O ' ' A' ' 42' ' ' ILE . 31.8 mt-10 -48.9 -49.51 39.47 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.911 0.757 . . . . 0.0 109.989 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.4 m -60.57 -37.41 81.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.954 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.15 63.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.696 0.76 . . . . 0.0 110.039 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 88.0 mt -62.46 -36.57 82.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.724 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -54.54 153.98 5.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 78.17 -15.2 9.13 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 113.498 -1.683 . . . . 0.0 117.096 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.729 ' O ' HG12 ' A' ' 3' ' ' VAL . 14.4 p80 -102.19 174.24 6.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.661 1.731 . . . . 0.0 110.263 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HA ' HD13 ' A' ' 139' ' ' ILE . 4.1 mp0 -119.82 171.48 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.73 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG11 HG13 ' A' ' 139' ' ' ILE . 2.0 m -52.16 142.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.309 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 97.56 -15.26 62.28 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.007 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' O ' HG11 ' A' ' 136' ' ' VAL . 32.5 m-20 -74.32 130.65 40.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.341 0.591 . . . . 0.0 111.42 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 5.5 tmtm? -133.24 124.6 27.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.052 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.679 ' CE2' HG21 ' A' ' 60' ' ' VAL . 13.3 p90 -148.85 -178.26 6.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.392 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.54 145.85 39.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.679 HG21 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -135.22 142.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 113.09 12.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.128 0.49 . . . . 0.0 110.341 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.549 HG13 ' HA3' ' A' ' 44' ' ' GLY . 58.2 t -126.57 144.17 37.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.421 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.64 153.24 50.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -56.96 -20.6 24.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.15 -19.65 53.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 110.817 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -115.71 -18.45 10.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.575 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . -113.89 -151.03 0.47 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.931 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.604 ' HB2' ' CD1' ' A' ' 130' ' ' LEU . 6.8 m-85 -78.14 -170.88 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.28 19.02 43.58 Favored Glycine 0 CA--C 1.502 -0.735 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -76.71 -179.57 5.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.36 -0.92 . . . . 0.0 110.762 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' HB2' ' CG ' ' A' ' 122' ' ' ASN . 17.2 p90 -58.42 152.2 18.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.291 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -75.0 105.28 5.93 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.971 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.637 ' HA ' HG12 ' A' ' 76' ' ' VAL . 8.5 pt-20 -72.17 -0.52 12.17 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -62.61 -9.67 9.72 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.575 -0.703 . . . . 0.0 111.292 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 HD11 ' HB3' ' A' ' 122' ' ' ASN . 19.2 mt -111.01 -11.0 14.35 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.098 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 73' ' ' GLU . 3.1 p -127.78 130.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.571 0.7 . . . . 0.0 110.908 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.36 169.0 19.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HG3' HG23 ' A' ' 118' ' ' VAL . 6.5 mpt_? -107.62 114.7 28.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.886 -175.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -111.95 129.23 24.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.639 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 12.3 Cg_exo -61.91 134.41 49.83 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 111.426 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 18.8 mtmt -59.39 -14.66 12.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.09 -28.12 65.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.525 0.679 . . . . 0.0 110.259 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.22 -38.08 77.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.128 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' O ' HG13 ' A' ' 87' ' ' VAL . 61.2 m-85 -90.85 41.38 1.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -176.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 ptm -51.37 -25.82 6.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.093 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.33 11.01 73.16 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 84' ' ' PHE . 2.6 p -100.5 160.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.258 0.529 . . . . 0.0 109.922 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -75.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' O ' ' HE1' ' A' ' 94' ' ' MET . 26.8 mt-10 -145.41 121.57 10.81 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.12 175.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' HB3' HG13 ' A' ' 117' ' ' VAL . 95.0 mt -62.12 103.88 0.42 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.934 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.61 155.62 40.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.562 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 109' ' ' ILE . 42.7 t -67.1 134.07 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.055 0.455 . . . . 0.0 110.922 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.62 -28.44 15.97 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.51 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.442 ' HE1' ' O ' ' A' ' 89' ' ' GLU . 11.6 mmm -52.92 135.53 36.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 20.2 mtp85 -116.72 137.35 52.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.943 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -163.26 167.57 21.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.423 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.469 HD12 ' CB ' ' A' ' 104' ' ' PRO . 52.0 tp -82.7 143.75 30.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.0 110.015 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -131.76 147.53 52.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.778 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -97.64 142.66 29.17 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.7 p -148.92 -175.92 5.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.82 -27.47 69.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.565 0.698 . . . . 0.0 109.696 171.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -89.72 23.23 2.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.861 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.99 -173.71 52.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.495 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 39.8 Cg_exo -59.25 125.61 18.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 111.568 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.54 109.28 30.78 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.014 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.88 107.11 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.62 2.213 . . . . 0.0 110.694 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.4 m -117.75 176.22 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.187 0.517 . . . . 0.0 111.782 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.437 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 39.2 tt0 -137.06 129.6 30.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.592 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.709 HG22 ' HA ' ' A' ' 92' ' ' VAL . 32.1 mt -70.95 122.58 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -103.6 -7.42 20.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -173.1 156.73 3.3 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 117' ' ' VAL . 88.1 t -136.75 104.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.235 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 24.1 mm-40 -75.8 -166.82 0.61 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.769 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.22 -56.14 24.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.691 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.513 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 24.6 t70 -128.08 16.96 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.894 176.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.486 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 50.9 p-80 -146.22 146.33 30.74 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 121.436 -0.79 . . . . 0.0 111.68 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 90' ' ' LEU . 26.9 m -104.54 167.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.999 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.405 HG23 ' HG3' ' A' ' 78' ' ' ARG . 48.3 t -130.86 119.53 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 5.0 m -114.35 131.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.865 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.591 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 11.3 m-20 -110.99 147.7 34.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.74 13.46 6.47 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.446 ' HB3' HD11 ' A' ' 75' ' ' LEU . 27.9 p30 -130.77 166.56 20.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.01 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 179.64 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.629 0.58 . . . . 0.0 111.252 166.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -83.45 -8.85 59.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.702 0.287 . . . . 0.0 111.438 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.9 mt -91.33 18.91 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.342 . . . . 0.0 111.78 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.35 179.61 3.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.689 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.42 0.88 33.0 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.049 171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -88.86 120.39 30.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.54 1.17 . . . . 0.0 110.589 177.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -78.79 163.02 25.7 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.604 ' CD1' ' HB2' ' A' ' 68' ' ' TYR . 57.5 mt -132.74 152.13 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 112.679 -173.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.491 ' HZ2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 mtpt -112.07 132.37 54.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.163 175.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.575 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 11.6 m-85 -121.17 142.19 50.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.903 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -108.61 107.61 18.16 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 167.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.708 HG11 HD23 ' A' ' 11' ' ' LEU . 3.6 t -100.29 137.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.558 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 33.4 mt-10 -134.03 98.08 4.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.494 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG13 ' H ' ' A' ' 55' ' ' GLY . 3.8 p -78.57 114.63 19.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.693 . . . . 0.0 111.669 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 31' ' ' PRO . 5.5 t -71.67 -50.31 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.47 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . . . -162.82 154.48 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.753 HG21 HG11 ' A' ' 9' ' ' VAL . 66.7 mt -132.94 138.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -149.25 140.92 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.07 126.28 34.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.693 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . . . -66.75 166.16 13.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.449 -168.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.1 p -82.05 20.74 0.96 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.477 -170.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HA ' HD13 ' A' ' 147' ' ' LEU . 45.0 mt-10 67.71 -37.88 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.363 0.665 . . . . 0.0 111.327 -174.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 143' ' ' THR . 45.7 mt-10 -64.28 -45.2 89.1 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.693 ' HB2' ' HB2' ' A' ' 142' ' ' ALA . 37.6 mt-10 -59.54 -34.91 73.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.508 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.69 HD23 ' HB3' ' A' ' 142' ' ' ALA . 35.6 mt -74.14 -44.27 54.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.688 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.73 -29.6 70.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.346 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -94.99 -32.08 13.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.93 13.03 35.25 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.594 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -153.12 170.91 19.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.565 0.682 . . . . 0.0 111.455 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.8 t -78.29 135.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.107 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -97.95 -36.13 10.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.897 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -137.93 110.29 0.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.424 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -151.34 -56.08 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -121.38 85.37 2.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 158' ' ' HIS . 24.5 m-20 -84.3 -71.1 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.213 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 95.3 m-70 65.71 -168.58 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -171.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 64.39 50.46 2.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 110.935 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -72.41 -8.16 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.266 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -54.39 -44.82 72.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.143 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -96.4 82.71 3.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.59 112.13 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.877 0.846 . . . . 0.0 111.044 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.47 64.57 4.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.156 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.98 -56.38 22.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.812 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.39 83.45 6.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.335 0.588 . . . . 0.0 112.28 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -132.2 82.16 2.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.219 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.425 ' HE1' ' O ' ' A' ' 171' ' ' HIS . 1.5 p80 -61.46 135.26 57.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.358 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.066 -172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 47.4 t60 68.72 107.79 0.05 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.042 0.838 . . . . 0.0 112.37 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.425 ' O ' ' HE1' ' A' ' 168' ' ' HIS . 44.9 t-80 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.226 172.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 12.4 ptmt -106.21 156.14 18.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.332 0.586 . . . . 0.0 111.187 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -64.68 126.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.786 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.68 -169.78 3.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.168 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 7' ' ' LEU . 60.8 tttp -65.23 153.9 39.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.358 . . . . 0.0 111.662 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' O ' HD21 ' A' ' 147' ' ' LEU . 79.2 m-20 51.63 6.1 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 141' ' ' GLU . 17.9 mt -92.85 149.42 21.28 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -115.59 142.95 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HG23 ' A' ' 139' ' ' ILE . 3.2 m -142.31 155.74 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.787 0.803 . . . . 0.0 111.716 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . 16.5 m -117.9 117.59 29.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.175 -1.375 . . . . 0.0 107.962 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.76 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -127.84 158.52 37.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.82 112.67 16.95 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HE1' HD22 ' A' ' 32' ' ' LEU . 41.0 p90 -126.58 160.89 29.34 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.453 -171.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.5 tt0 -129.54 118.67 22.42 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p -106.33 122.46 60.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.62 0.724 . . . . 0.0 111.553 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -139.12 161.19 37.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.0 p -90.28 175.94 6.93 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.164 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.93 -21.5 66.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.19 -18.6 61.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.938 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.47 44.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.925 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.07 138.83 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 15' ' ' VAL . 55.3 tp -79.71 134.38 36.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.09 -38.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -156.93 168.49 27.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -165.54 137.49 4.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.143 0.497 . . . . 0.0 111.971 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 m -113.03 111.41 50.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -68.36 165.79 27.68 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 122.807 2.338 . . . . 0.0 113.339 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.56 -16.07 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.78 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -79.22 -33.73 43.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.07 113.01 6.27 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.327 0.584 . . . . 0.0 109.601 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 137' ' ' VAL . 9.6 Cg_exo -75.59 169.22 22.79 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.572 2.848 . . . . 0.0 113.741 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.507 HD22 ' HE1' ' A' ' 13' ' ' TYR . 14.0 tp -84.1 126.35 33.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -104.85 120.6 41.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.732 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 5.4 p90 -150.34 157.39 43.0 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.169 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 147' ' ' LEU . 57.7 tp -102.69 114.61 29.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.511 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 48.6 t60 -69.84 142.39 53.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.384 0.611 . . . . 0.0 111.915 -169.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.91 56.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.473 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -129.52 -7.93 4.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.773 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.55 41.23 8.45 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.975 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.732 ' CB ' ' HB2' ' A' ' 34' ' ' TYR . 51.8 m -71.86 -38.86 70.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -113.43 -102.99 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.262 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.596 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 20.8 pt -116.35 -163.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.035 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.7 t -94.77 -49.06 5.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.391 0.615 . . . . 0.0 110.64 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -79.19 -26.45 57.69 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.984 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.704 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 mt -74.41 -52.76 11.14 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.165 -171.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 23.1 mt-10 -50.63 -49.79 55.94 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.518 0.511 . . . . 0.0 111.384 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.7 m -64.9 -31.8 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.685 0.279 . . . . 0.0 111.737 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.44 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 76.6 mt -61.62 -33.42 73.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.518 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.3 mt-10 -52.14 152.85 3.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.018 0.913 . . . . 0.0 112.819 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.447 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 78.89 -22.6 3.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.932 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.692 ' O ' HG12 ' A' ' 3' ' ' VAL . 96.8 m-70 -82.6 164.45 20.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.591 0.695 . . . . 0.0 110.782 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 46.0 mt-10 -127.2 160.47 31.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.412 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -49.69 143.85 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.563 0.697 . . . . 0.0 112.489 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.03 -15.64 62.61 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.149 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.04 133.91 47.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.904 0.383 . . . . 0.0 110.29 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 6.2 tmmm? -132.14 128.77 38.78 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.259 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.0 p90 -165.43 157.17 14.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.147 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 4.8 p-10 -96.43 141.47 29.69 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.822 0.82 . . . . 0.0 110.198 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 58' ' ' PHE . 8.7 t -117.1 143.91 26.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.13 -173.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -126.5 111.99 15.06 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.882 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' HA3' ' A' ' 44' ' ' GLY . 72.7 t -125.74 137.65 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.045 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.85 52.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.154 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.58 -20.94 3.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.3 -30.36 70.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.67 8.2 11.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.491 0.663 . . . . 0.0 111.352 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.155 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.763 179.036 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 78' ' ' ARG . 6.3 mpt_? -115.33 114.29 24.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.737 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG1' HG21 ' A' ' 83' ' ' VAL . 5.2 t -106.49 132.94 20.49 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.994 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 83' ' ' VAL . 29.8 Cg_exo -59.18 131.88 43.74 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.12 2.547 . . . . 0.0 111.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 26.4 mtmt -58.29 -24.41 59.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.78 -43.39 85.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.422 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 80' ' ' PRO . 3.4 m -55.67 -32.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HB2' HD11 ' A' ' 90' ' ' LEU . 71.0 m-85 -90.61 40.24 1.01 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.207 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -57.47 -29.07 63.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.355 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.07 -15.43 77.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.958 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.43 HG11 HD23 ' A' ' 90' ' ' LEU . 91.9 t -73.34 142.26 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.849 0.324 . . . . 0.0 110.459 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.13 -67.99 0.35 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.035 0.445 . . . . 0.0 110.952 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -142.37 115.63 8.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.397 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 117' ' ' VAL . 88.6 mt -66.57 98.87 0.54 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.155 0.502 . . . . 0.0 110.161 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 24.5 tt0 -121.5 165.7 15.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.196 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 109' ' ' ILE . 48.2 t -80.24 139.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.03 1.23 79.87 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.255 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 mmm -87.63 135.23 33.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.528 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -111.21 139.58 46.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.333 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.56 154.41 16.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.792 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.65 131.27 37.68 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -119.8 134.94 55.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -88.84 137.24 32.49 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.0 p -145.42 -176.19 5.01 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.024 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -35.6 65.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 110.309 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.01 25.45 6.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.313 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.66 -173.45 53.85 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.789 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 31.4 Cg_exo -58.89 123.97 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.939 . . . . 0.0 112.055 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 107' ' ' VAL . 88.0 t -124.63 113.68 27.19 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.566 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.1 101.46 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.876 2.384 . . . . 0.0 111.347 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.1 m -117.78 173.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 111.211 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.0 136.39 40.28 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.117 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 90' ' ' LEU . 27.2 mt -77.48 129.59 37.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.05 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.6 p -114.79 1.6 14.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.402 0.62 . . . . 0.0 109.937 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.35 153.86 0.35 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.595 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.741 HG13 HG12 ' A' ' 117' ' ' VAL . 61.3 t -139.39 108.55 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -87.42 -156.04 0.32 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.36 -43.97 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 8.5 p-10 -131.94 -15.1 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.007 -170.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -136.58 159.29 42.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.741 HG12 HG13 ' A' ' 112' ' ' VAL . 33.8 m -112.66 162.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.33 116.52 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.198 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -122.59 138.77 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 121.215 0.531 . . . . 0.0 111.376 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.917 177.598 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 64.1 mt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.2 mtpp -114.89 122.72 47.17 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.2 m-85 -115.29 121.19 42.11 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 2.9 m-20 -92.86 107.21 19.04 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.76 HG13 HD23 ' A' ' 11' ' ' LEU . 4.0 t -99.66 139.73 20.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.369 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 42.4 mt-10 -132.96 90.84 2.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.899 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 55' ' ' GLY . 2.9 p -66.76 107.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.039 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 31' ' ' PRO . 8.1 t -72.41 -47.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.86 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.59 157.27 27.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.891 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 9' ' ' VAL . 66.0 mt -137.73 134.33 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -143.54 142.76 31.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.3 pt-20 -79.67 126.48 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.78 166.56 12.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 113.017 -166.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p -92.19 23.06 4.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.7 -170.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 69.71 -42.65 0.51 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.184 0.594 . . . . 0.0 111.151 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -63.37 -42.25 98.84 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.486 0.66 . . . . 0.0 109.645 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.59 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.0 mt-10 -61.82 -35.02 77.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.527 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 142' ' ' ALA . 28.7 mt -73.46 -46.5 47.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.144 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.38 -31.89 70.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.536 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -93.39 -31.69 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.907 0.384 . . . . 0.0 110.802 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.16 8.35 41.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.27 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 p80 . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.667 -0.313 . . . . 0.0 110.599 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.551 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 16.7 ptpt -106.61 168.94 8.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.883 0.849 . . . . 0.0 112.064 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.672 HG11 ' O ' ' A' ' 49' ' ' LEU . 1.1 p -83.43 121.43 36.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.35 -171.62 3.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.945 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 42.1 tttp -63.91 153.5 36.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.762 0.315 . . . . 0.0 110.417 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 147' ' ' LEU . 32.7 m-20 57.57 -5.89 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 141' ' ' GLU . 34.2 mt -90.81 104.44 17.03 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.792 -0.567 . . . . 0.0 110.425 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.4 143.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.45 0.643 . . . . 0.0 111.043 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 139' ' ' ILE . 3.6 m -143.04 153.03 16.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.448 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -111.46 122.51 48.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.532 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -143.64 143.72 31.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -100.99 153.75 19.27 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.717 ' HE2' HD22 ' A' ' 32' ' ' LEU . 51.5 p90 -151.82 159.78 43.78 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.029 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' HD13 ' A' ' 22' ' ' LEU . 42.7 tt0 -126.8 119.45 26.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.435 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.9 t -102.21 119.45 50.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.505 -175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.54 151.68 50.74 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.0 p -82.02 -179.75 7.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -56.56 -26.31 54.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.202 0.525 . . . . 0.0 109.922 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.0 m-20 -67.39 -18.81 65.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.15 -11.24 72.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.469 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 19' ' ' ASP . 10.4 p -78.4 136.44 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 111.245 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 25' ' ' GLU . 34.4 tp -69.7 131.1 44.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.478 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.45 -45.94 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.213 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -140.07 149.81 43.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 22' ' ' LEU . 32.9 tt0 -156.21 134.7 11.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.301 0.572 . . . . 0.0 111.861 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.3 m -108.05 116.92 56.22 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 169.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.69 164.34 35.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.744 2.296 . . . . 0.0 113.589 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.91 -14.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.609 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.7 p -80.88 -31.56 35.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.712 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.26 113.3 5.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 109.938 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' A' ' 137' ' ' VAL . 8.8 Cg_exo -75.63 169.16 22.89 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.625 2.883 . . . . 0.0 113.548 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD22 ' HE2' ' A' ' 13' ' ' TYR . 12.4 tp -88.89 129.51 35.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -121.57 119.85 33.11 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.543 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 24.8 m-85 -153.69 162.08 41.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.287 0.565 . . . . 0.0 111.924 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.7 tp -89.18 105.79 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.878 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.559 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 22.6 t60 -65.73 142.98 57.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.43 . . . . 0.0 110.676 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 85.77 18.81 59.21 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.183 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -136.68 18.54 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.456 0.17 . . . . 0.0 110.679 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.67 35.82 92.52 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.56 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 42.2 m -64.78 -39.63 93.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.879 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 1.1 pt? -120.53 -89.1 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.401 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.879 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 12.6 pt -129.32 -166.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 t -97.38 -49.34 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.732 0.777 . . . . 0.0 110.705 -168.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.32 29.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 114.781 -1.1 . . . . 0.0 113.376 -172.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.697 HD11 HG21 ' A' ' 134' ' ' VAL . 28.7 tp -73.34 -46.62 48.24 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 24.0 mt-10 -52.11 -45.23 64.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.127 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -63.49 -38.31 90.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.11 80.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.817 HD21 HG11 ' A' ' 134' ' ' VAL . 95.9 mt -56.88 -33.46 66.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.558 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HA ' HG13 ' A' ' 3' ' ' VAL . 5.8 mt-10 -56.3 153.62 9.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.969 0.89 . . . . 0.0 113.043 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.48 -29.02 2.95 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 114.222 -1.354 . . . . 0.0 116.153 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -120.02 148.45 43.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.319 1.559 . . . . 0.0 112.852 -174.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 1' ' ' MET . 31.3 mt-10 -99.52 173.96 6.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.059 -164.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.9 m -48.94 140.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.885 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.46 61.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.746 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.07 128.79 34.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.063 176.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 2.5 tmmt? -133.63 126.06 30.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.25 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.1 p90 -165.95 160.64 16.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.196 0.522 . . . . 0.0 111.413 -175.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.612 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.691 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.1 t -133.36 142.93 40.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.026 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.6 113.05 10.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.911 0.386 . . . . 0.0 110.201 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 t -127.79 142.47 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.76 155.33 52.97 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.95 -30.5 46.95 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.77 -32.39 73.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 111.303 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.55 0.8 14.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 111.302 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.547 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.678 0.752 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.7 mpt_? -113.0 109.31 18.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.632 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.5 t -101.59 128.51 28.84 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.511 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.0 Cg_exo -60.42 134.6 56.05 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.829 2.353 . . . . 0.0 112.028 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -50.8 -19.43 0.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.219 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.14 -28.92 65.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.991 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.56 -41.17 63.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.126 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.3 m-85 -98.04 39.94 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 ptm -53.66 -30.45 43.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.809 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.36 13.46 61.92 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.931 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.6 p -93.63 162.32 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.439 0.62 . . . . 0.0 109.743 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.83 -74.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 0.0 110.322 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -153.16 118.08 5.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.841 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.617 ' HB3' HG11 ' A' ' 117' ' ' VAL . 86.5 mt -60.01 109.89 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 110.958 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -138.77 162.47 34.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.944 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.03 146.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.988 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.58 2.27 88.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.431 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.5 mmm -91.69 134.41 34.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.604 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 82.3 mtt180 -113.86 134.71 54.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.196 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -164.33 170.4 16.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.342 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.877 HD11 ' HB2' ' A' ' 104' ' ' PRO . 67.7 tp -87.35 150.22 23.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 100' ' ' THR . . . -144.22 89.48 2.03 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.833 0.825 . . . . 0.0 111.621 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 12.9 mt-10 -38.78 129.9 1.47 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.064 -1.425 . . . . 0.0 112.034 157.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 98' ' ' ALA . 61.2 p -145.96 -174.12 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.65 -44.77 63.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.479 0.657 . . . . 0.0 110.774 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' GLN . 7.4 pt20 -91.64 30.23 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.787 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.62 -176.84 48.18 Favored Glycine 0 C--N 1.319 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.708 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.877 ' HB2' HD11 ' A' ' 97' ' ' LEU . 34.5 Cg_endo -73.84 125.38 9.9 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.456 2.104 . . . . 0.0 112.693 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 107' ' ' VAL . 13.5 t -117.98 113.87 37.47 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.04 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 14.8 Cg_exo -70.56 97.29 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.611 2.208 . . . . 0.0 111.072 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.8 m -117.99 174.64 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.315 -173.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.55 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 24.5 tt0 -134.49 131.44 38.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.259 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.89 124.76 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.953 0.406 . . . . 0.0 110.337 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 p -106.84 -4.6 19.09 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -172.54 155.61 3.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.915 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.573 HG13 HG12 ' A' ' 117' ' ' VAL . 61.8 t -137.43 105.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.034 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.08 -175.94 4.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.8 -53.32 58.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.209 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -121.71 5.18 10.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -146.29 139.91 26.09 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 120.831 -1.168 . . . . 0.0 112.365 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 90' ' ' LEU . 35.3 m -93.58 167.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.189 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 78' ' ' ARG . 43.4 t -131.26 118.44 40.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.5 m -113.74 138.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.062 0.458 . . . . 0.0 111.144 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.825 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.233 0.233 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 18.9 mtpp -118.02 132.75 56.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.087 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.719 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 2.5 m-85 -123.4 134.96 53.91 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.84 107.74 18.89 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.817 HG11 HD21 ' A' ' 49' ' ' LEU . 4.4 t -99.81 142.93 14.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.45 0.643 . . . . 0.0 112.211 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 37.2 mt-10 -131.84 92.09 3.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.576 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -69.72 110.46 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.833 0.825 . . . . 0.0 111.685 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.3 t -71.95 -47.66 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.13 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.06 158.56 33.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.925 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.757 HG23 HG12 ' A' ' 9' ' ' VAL . 65.5 mt -137.59 132.78 45.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -133.17 138.09 46.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.047 0.451 . . . . 0.0 110.667 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.766 ' HA ' HD22 ' A' ' 7' ' ' LEU . 9.7 pt-20 -77.44 119.29 20.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -64.59 169.51 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.748 -171.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p -113.26 29.51 7.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.761 -167.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.89 ' HA ' HD23 ' A' ' 147' ' ' LEU . 31.1 mt-10 73.31 -33.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.466 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.39 -44.15 72.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.55 -178.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 8.0 mp0 -54.95 -45.65 74.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.66 0.743 . . . . 0.0 109.756 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -65.5 -49.14 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.228 178.055 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.25 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.847 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -98.08 -9.09 26.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.44 2.74 90.66 Favored Glycine 0 C--N 1.329 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.865 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.925 0.363 . . . . 0.0 110.071 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -123.65 169.16 11.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 111.247 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -79.29 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.793 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.58 -172.39 4.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.432 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 87.1 tttt -67.48 161.27 25.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 45.18 9.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.716 HD22 ' HA ' ' A' ' 141' ' ' GLU . 24.3 mt -97.63 108.21 20.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.957 -0.464 . . . . 0.0 110.187 170.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.52 144.01 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 110.596 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -150.86 139.34 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.755 -170.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -117.72 148.27 42.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.714 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -165.63 158.0 15.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.01 0.433 . . . . 0.0 110.33 -176.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.38 112.59 18.28 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 32' ' ' LEU . 46.5 p90 -123.82 154.19 39.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.924 -172.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 45.6 tt0 -125.29 118.85 26.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG13 HG23 ' A' ' 23' ' ' VAL . 2.8 p -101.33 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.257 1.027 . . . . 0.0 111.141 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 10.6 ttm180 -135.66 157.15 47.59 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.681 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.611 ' OG1' HG12 ' A' ' 21' ' ' VAL . 40.8 p -78.34 169.87 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.841 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.986 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 48.7 mt-10 -65.44 -20.22 66.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.975 0.416 . . . . 0.0 110.876 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.11 -16.16 30.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 16' ' ' ARG . . . 106.63 27.48 5.47 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.78 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.8 p -105.42 136.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.035 0.917 . . . . 0.0 109.829 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 15' ' ' VAL . 57.0 tp -90.53 127.36 36.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.418 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 15' ' ' VAL . 22.2 m -102.93 -35.88 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.671 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -162.14 169.76 20.29 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.42 129.87 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 m -99.45 106.1 37.41 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.29 163.27 36.99 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.65 2.233 . . . . 0.0 112.882 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.31 -14.77 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.205 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 p -79.43 -30.6 42.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.626 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.47 113.74 5.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.671 ' HB3' HG21 ' A' ' 137' ' ' VAL . 10.1 Cg_exo -75.32 164.7 32.27 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 -174.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.674 ' HB3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -73.9 139.03 44.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.408 166.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -122.25 120.2 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 13.1 p90 -157.6 168.3 27.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.141 0.496 . . . . 0.0 111.409 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -107.94 114.4 28.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.043 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 28.6 t60 -68.29 137.4 54.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.383 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 80.66 26.62 53.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.914 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.95 18.33 4.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 110.86 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.67 36.68 93.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.955 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 69.4 m -65.78 -39.94 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.142 0.496 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.87 160.87 42.31 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 45' ' ' LEU . 5.0 pt -27.93 137.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 123.048 1.404 . . . . 0.0 114.373 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -64.46 -35.75 81.94 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.936 -1.938 . . . . 0.0 111.299 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.602 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -64.07 -34.6 90.36 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.139 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 21.6 tp -75.46 -50.58 15.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.05 -45.6 68.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.337 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.2 m -59.35 -35.71 74.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.434 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -33.98 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.622 0.725 . . . . 0.0 110.438 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 86.9 mt -64.61 -31.71 73.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.896 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.85 155.65 4.22 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.18 -29.1 4.85 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HG12 ' A' ' 3' ' ' VAL . 27.0 p80 -106.33 178.29 4.6 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.172 1.486 . . . . 0.0 110.787 -171.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 1' ' ' MET . 81.8 mt-10 -117.35 170.82 8.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.685 0.278 . . . . 0.0 110.725 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -53.11 144.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.76 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.503 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.29 -20.33 49.89 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.971 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 136' ' ' VAL . 3.4 m-20 -67.42 136.62 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.919 0.359 . . . . 0.0 110.527 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.682 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 4.3 tmmm? -136.98 125.21 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.738 ' CE2' HG22 ' A' ' 60' ' ' VAL . 15.9 p90 -154.51 -179.75 8.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.15 143.5 38.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.738 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -126.91 142.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -134.18 113.07 11.64 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG11 ' HA3' ' A' ' 44' ' ' GLY . 60.8 t -123.97 141.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.565 -174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.77 150.0 48.75 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.127 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.53 -20.42 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.74 -21.78 57.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.295 -0.253 . . . . 0.0 111.442 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -114.34 -9.46 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.954 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.264 -178.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.116 0.484 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 11.3 mpt_? -110.23 113.35 25.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.764 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.39 132.24 21.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.873 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.61 143.57 99.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.429 2.753 . . . . 0.0 112.692 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 90' ' ' LEU . 6.5 mmmm -54.02 -39.53 66.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.386 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.75 -37.67 79.64 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.683 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.22 -35.3 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.957 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB2' HD11 ' A' ' 90' ' ' LEU . 64.4 m-85 -100.51 40.0 1.31 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.2 ptm -49.15 -32.75 10.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.421 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.78 13.18 65.02 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.617 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.63 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.6 p -85.88 162.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 117.313 0.556 . . . . 0.0 110.21 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.61 -77.86 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.42 119.67 7.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.614 171.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.63 ' HG ' HG11 ' A' ' 87' ' ' VAL . 89.9 mt -60.09 103.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.303 0.573 . . . . 0.0 110.536 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.476 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 32.5 tt0 -123.57 166.3 15.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.156 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.6 t -81.55 140.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.86 1.42 85.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.846 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.476 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.0 mtm -85.88 135.05 33.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 109.938 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -114.02 139.54 49.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.082 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -163.38 170.45 17.49 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.998 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -92.69 126.74 37.91 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.36 127.44 56.01 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.35 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.12 140.39 41.77 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 p -145.0 -175.66 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.999 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.3 -36.71 84.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.528 0.68 . . . . 0.0 110.623 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.2 pt20 -95.61 27.54 3.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.266 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 179.44 46.09 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.14 140.93 94.11 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 122.171 1.914 . . . . 0.0 112.603 174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 99.0 t -135.43 117.49 12.31 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.573 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 7.1 Cg_exo -73.83 108.8 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.783 2.322 . . . . 0.0 111.246 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 11.2 m -118.48 154.6 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.778 0.323 . . . . 0.0 111.084 -174.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 40.8 tt0 -115.37 132.14 56.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.25 0.548 . . . . 0.0 110.336 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 90' ' ' LEU . 23.8 mt -77.53 127.9 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.02 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.401 ' C ' HG13 ' A' ' 92' ' ' VAL . 62.4 p -114.69 1.2 14.12 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.455 0.645 . . . . 0.0 109.53 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 153.52 0.21 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.3 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 117' ' ' VAL . 49.0 t -136.32 107.7 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.25 -157.24 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.12 -50.97 71.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.29 -6.24 3.81 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.825 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 p-80 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.024 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.697 HG12 HG13 ' A' ' 112' ' ' VAL . 30.3 m -107.89 161.71 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.02 110.23 31.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.673 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 12.0 m -113.63 135.12 54.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.615 0.721 . . . . 0.0 112.133 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.666 -177.009 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 26.3 mt . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.986 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 18.4 mtpp -116.18 131.57 56.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 26.4 m-85 -117.11 137.59 52.19 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.179 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.1 m120 -104.66 106.72 17.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 171.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.714 HG13 HD23 ' A' ' 11' ' ' LEU . 8.3 t -102.94 138.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.529 -172.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 17.4 mt-10 -137.47 93.83 2.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.546 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -77.31 116.86 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.058 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 31' ' ' PRO . 11.4 t -75.84 -45.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.975 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.58 152.9 16.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.41 . . . . 0.0 111.282 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 54' ' ' VAL . 81.6 mt -136.71 133.07 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -150.89 139.95 21.07 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.803 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.716 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.3 pt-20 -73.17 125.85 28.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 109.864 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.01 164.96 25.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.002 -176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p -97.02 23.19 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.537 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.595 ' HA ' HD12 ' A' ' 147' ' ' LEU . 44.7 mt-10 73.17 -31.46 0.23 Allowed 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.635 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.81 -46.64 81.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.836 0.35 . . . . 0.0 111.054 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 36.6 mp0 -54.78 -37.44 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.67 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 142' ' ' ALA . 11.4 mt -74.37 -47.43 34.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.74 -32.55 63.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.688 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -98.77 -25.76 14.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.283 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.02 29.58 25.36 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.617 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 75.4 m80 . . . . . 0 C--N 1.328 -0.366 0 O-C-N 122.701 -0.293 . . . . 0.0 110.505 -175.094 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 9.9 ptpt -96.13 168.35 10.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.53 0.681 . . . . 0.0 111.08 -176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -87.28 116.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.524 175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.64 -170.06 3.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.184 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 54.9 tttm -64.46 162.96 14.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 51.27 7.29 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 141' ' ' GLU . 22.2 mt -107.63 155.68 19.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 34' ' ' TYR . 7.4 p -116.31 143.16 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 139' ' ' ILE . 3.7 m -136.86 161.18 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.486 0.66 . . . . 0.0 111.906 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.1 m -125.72 107.75 10.85 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -120.93 161.81 20.93 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.855 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.49 108.09 10.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.1 p90 -126.39 163.77 22.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.154 0.502 . . . . 0.0 110.367 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 59.9 tt0 -128.83 116.88 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.485 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 p -102.94 122.71 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.794 0.807 . . . . 0.0 111.169 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -142.42 164.03 31.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.311 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.509 ' OG1' HG12 ' A' ' 21' ' ' VAL . 58.7 p -83.49 174.19 10.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.461 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.1 -23.23 61.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 110.452 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -15.57 51.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.596 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.58 -16.73 40.47 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.96 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.725 ' HB ' ' HG2' ' A' ' 106' ' ' PRO . 11.4 p -67.31 133.99 30.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 117.906 0.853 . . . . 0.0 111.051 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 25' ' ' GLU . 57.0 tp -81.03 127.79 32.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.695 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 15' ' ' VAL . 29.7 m -103.33 -33.99 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.094 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.6 163.15 32.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.674 ' HB2' HD11 ' A' ' 22' ' ' LEU . 29.1 tt0 -165.3 130.29 2.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.266 0.555 . . . . 0.0 112.063 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 31' ' ' PRO . 28.7 t -103.06 107.72 56.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.95 166.75 25.49 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.364 2.043 . . . . 0.0 111.704 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.39 -17.78 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.435 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 p -79.09 -32.32 44.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.356 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.15 114.09 5.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.068 0.461 . . . . 0.0 110.628 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.759 ' HG3' HG21 ' A' ' 137' ' ' VAL . 7.8 Cg_exo -76.35 169.07 22.68 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.934 3.09 . . . . 0.0 114.38 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.434 HD11 ' HE2' ' A' ' 34' ' ' TYR . 12.0 tp -86.13 128.4 34.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.19 168.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -118.38 119.55 34.93 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 37.1 m-85 -162.3 157.13 22.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.466 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 147' ' ' LEU . 64.0 tp -86.36 113.3 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.23 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -71.32 142.31 50.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 -170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 89.6 24.98 29.11 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.073 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.56 -18.16 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.6 0.238 . . . . 0.0 111.284 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.25 40.67 0.94 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB3' ' CB ' ' A' ' 34' ' ' TYR . 14.6 m -63.86 -45.59 88.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.326 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 45' ' ' LEU . 1.8 pt? -151.65 179.25 8.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 67' ' ' ALA . 11.0 pt -42.13 148.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.462 1.125 . . . . 0.0 112.989 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.1 t -76.53 -40.73 49.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.943 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.24 -32.16 60.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.025 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tp -77.01 -52.71 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.154 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 49' ' ' LEU . 27.4 mt-10 -55.26 -46.03 76.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.062 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.7 m -61.25 -29.58 69.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.052 0.453 . . . . 0.0 111.492 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.84 -34.34 57.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.785 0.802 . . . . 0.0 109.609 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 64.3 mt -69.58 -38.06 77.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.153 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.39 125.26 22.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 112.836 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.73 0.42 34.37 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.338 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 3' ' ' VAL . 98.3 m-70 -101.38 169.2 9.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 54.9 mt-10 -123.15 166.31 15.4 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -47.55 145.73 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 122.066 0.936 . . . . 0.0 112.835 -177.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 85.21 -0.76 88.83 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 114.105 -1.407 . . . . 0.0 114.202 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.98 153.35 42.72 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.877 0.838 . . . . 0.0 109.297 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -149.15 128.52 12.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.245 0.545 . . . . 0.0 109.76 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.662 ' CE2' HG22 ' A' ' 60' ' ' VAL . 25.6 p90 -162.96 177.87 8.85 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -120.1 147.51 44.77 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.662 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -133.39 143.01 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -169.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.0 11.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.952 0.406 . . . . 0.0 110.119 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 44' ' ' GLY . 69.5 t -120.03 142.29 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.21 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.84 152.0 36.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.658 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.19 -21.59 66.31 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -68.57 -18.29 64.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.0 110.751 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.87 -52.95 2.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.453 -172.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.583 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.3 mpt_? -107.75 106.56 16.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.617 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.555 ' CG1' HG21 ' A' ' 83' ' ' VAL . 2.8 t -105.46 133.14 20.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.313 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 83' ' ' VAL . 21.4 Cg_exo -61.94 133.79 46.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.851 2.367 . . . . 0.0 111.566 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 37.4 mtmt -56.47 -24.61 46.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.41 -43.27 83.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 80' ' ' PRO . 5.8 m -53.31 -30.03 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.091 0.472 . . . . 0.0 112.101 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HD11 ' A' ' 90' ' ' LEU . 43.4 m-85 -103.1 39.13 1.61 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.605 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -60.8 -30.99 70.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.57 -7.44 88.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.048 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 70.1 t -76.17 146.43 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.913 0.356 . . . . 0.0 110.858 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.48 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.557 0.535 . . . . 0.0 110.884 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -152.7 120.26 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.853 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 84' ' ' PHE . 97.3 mt -68.23 109.36 3.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.288 0.566 . . . . 0.0 111.076 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 36.6 tt0 -127.2 171.05 11.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.861 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 111' ' ' ALA . 55.6 t -83.13 138.43 19.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.01 1.13 88.9 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.732 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.581 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.9 mmm -84.24 134.82 34.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.609 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 5.8 ttt180 -131.91 134.35 45.58 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -159.78 162.76 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.403 HD11 ' CB ' ' A' ' 104' ' ' PRO . 35.1 tp -80.89 127.32 32.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.46 116.22 26.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 40.1 mt-10 -93.37 100.57 12.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.964 0.888 . . . . 0.0 110.096 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.8 p -95.61 -175.79 3.56 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.192 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.27 -30.11 62.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.399 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.0 pt20 -104.63 25.03 10.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.95 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.61 173.27 33.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.382 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 31.2 Cg_exo -62.1 138.26 71.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.993 2.462 . . . . 0.0 112.867 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.65 108.76 12.04 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.725 ' HG2' ' HB ' ' A' ' 21' ' ' VAL . 16.5 Cg_exo -69.2 103.63 1.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.664 2.243 . . . . 0.0 111.215 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.612 ' HB ' HG13 ' A' ' 119' ' ' VAL . 20.6 m -118.13 155.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.121 0.486 . . . . 0.0 111.136 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 38.3 tt0 -122.92 139.41 54.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.756 0.789 . . . . 0.0 109.846 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.672 HG12 HG23 ' A' ' 119' ' ' VAL . 19.9 mt -85.81 132.16 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.471 -173.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.9 p -113.98 0.9 14.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.268 0.556 . . . . 0.0 109.866 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.493 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 172.77 156.07 0.1 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.86 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 117' ' ' VAL . 48.1 t -139.94 114.98 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.68 -162.39 0.9 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.17 -26.39 62.95 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.247 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.758 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 24.4 m-20 -131.06 -26.03 2.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -133.11 167.15 20.85 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.98 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 112' ' ' VAL . 35.8 m -114.39 165.04 9.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.663 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.4 t -113.79 104.57 17.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.672 HG23 HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -113.24 140.17 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.2 t0 . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.893 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 5.2 mtpp -116.45 132.08 56.77 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -119.96 126.0 49.78 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 16.9 m120 -100.61 107.24 18.85 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 49' ' ' LEU . 6.6 t -101.22 145.92 10.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.063 -165.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -149.29 97.14 2.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.777 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -76.05 117.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.314 0.578 . . . . 0.0 111.53 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.3 t -76.98 -45.87 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.331 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.2 155.94 23.53 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.186 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 9' ' ' VAL . 62.0 mt -139.7 137.97 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -145.88 142.87 29.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.106 0.479 . . . . 0.0 110.934 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.598 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 pt-20 -80.75 124.82 29.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.094 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -71.4 168.15 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.453 -174.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -103.01 23.28 12.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 147' ' ' LEU . 32.3 mt-10 73.8 -33.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.101 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.99 -41.71 97.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.619 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.647 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 13.8 mp0 -57.65 -39.51 77.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.891 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 142' ' ' ALA . 16.6 mt -70.48 -44.89 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.961 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.08 -34.22 68.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.837 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -100.71 -31.22 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.182 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.16 15.78 50.06 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.286 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.0 m80 . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -174.345 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.08 174.69 5.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.58 0.705 . . . . 0.0 111.021 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -88.05 127.63 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.769 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.2 -177.64 6.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 76.6 tttt -55.75 152.0 10.28 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.083 0.24 . . . . 0.0 110.884 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 57.32 -5.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 141' ' ' GLU . 28.1 mt -95.94 104.75 16.71 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.704 -0.622 . . . . 0.0 110.89 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 34' ' ' TYR . 12.1 p -65.55 142.78 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.712 0.768 . . . . 0.0 111.816 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.865 HG12 HG23 ' A' ' 139' ' ' ILE . 1.3 m -145.32 154.93 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.832 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -120.36 119.11 32.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD13 HG13 ' A' ' 134' ' ' VAL . 4.5 pp -141.13 147.99 39.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -97.85 153.75 18.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.69 160.4 42.73 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.663 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 44.5 tt0 -132.46 118.33 19.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 23' ' ' VAL . 2.6 p -106.92 124.38 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.722 0.772 . . . . 0.0 111.522 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -139.93 165.69 26.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.101 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -81.47 179.28 7.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.319 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 42.9 mt-10 -66.0 -11.76 50.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.626 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -80.41 -19.3 46.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.105 0.478 . . . . 0.0 110.41 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.32 -17.4 53.79 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.382 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.97 132.32 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.24 140.61 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.315 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 15' ' ' VAL . 2.8 p -113.66 -35.54 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.991 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -168.89 172.16 7.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.663 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 2.9 pt-20 -166.73 159.66 14.09 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.177 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 52.8 m -108.33 110.06 61.73 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 162.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 38.3 Cg_endo -61.02 155.81 48.13 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 C-N-CA 122.78 2.32 . . . . 0.0 113.287 -165.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.45 -7.06 7.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 27' ' ' PRO . 5.8 p -91.21 -26.27 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.32 114.59 5.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.827 ' HG3' HG21 ' A' ' 137' ' ' VAL . 6.6 Cg_exo -74.81 166.03 30.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.465 2.777 . . . . 0.0 114.366 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.06 130.28 35.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.461 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -116.33 127.98 55.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.165 0.507 . . . . 0.0 110.228 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' VAL . 54.6 p90 -160.1 164.61 32.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.416 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' A' ' 147' ' ' LEU . 54.4 tp -103.1 111.15 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.56 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.77 124.06 17.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.569 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 93.35 0.23 67.75 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.943 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -136.54 3.25 2.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.79 92.73 0.09 OUTLIER Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.693 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 m -114.36 8.84 16.76 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.938 0.875 . . . . 0.0 109.449 -166.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 53.17 -89.05 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.454 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 45' ' ' LEU . 23.5 pt -124.5 136.25 61.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 122.265 1.031 . . . . 0.0 110.627 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -48.21 -42.76 30.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.444 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 66' ' ' ASP . . . -69.25 -37.77 81.19 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.443 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 HG21 ' A' ' 134' ' ' VAL . 16.2 tp -75.39 -52.23 11.25 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -173.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.693 ' HG3' ' O ' ' A' ' 40' ' ' SER . 2.5 mm-40 -53.16 -45.11 68.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.26 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.4 m -57.77 -35.78 71.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.257 0.551 . . . . 0.0 111.331 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 -36.1 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.819 0.819 . . . . 0.0 109.606 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.573 ' CD2' HG11 ' A' ' 134' ' ' VAL . 83.4 mt -61.63 -35.64 78.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.014 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -53.86 152.62 5.38 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.11 -6.64 48.86 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 113.408 -1.723 . . . . 0.0 116.65 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.701 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.6 p80 -117.93 -177.29 3.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 119.417 1.608 . . . . 0.0 111.109 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 1' ' ' MET . 45.3 mt-10 -124.06 174.66 7.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -169.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 139' ' ' ILE . 1.4 m -54.41 145.65 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.311 172.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.73 -15.66 56.67 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.852 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.48 143.48 42.55 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 4.0 tmmm? -145.61 131.52 19.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.103 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.756 ' CE2' HG22 ' A' ' 60' ' ' VAL . 17.9 p90 -162.69 159.81 24.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.007 0.432 . . . . 0.0 110.305 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.71 141.11 32.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.014 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.756 HG22 ' CE2' ' A' ' 58' ' ' PHE . 10.5 t -127.95 143.3 41.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.09 112.99 7.75 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.664 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' A' ' 132' ' ' PHE . 14.6 m -127.82 169.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.734 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.26 158.88 29.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.187 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.48 -25.02 9.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.18 0.592 . . . . 0.0 112.563 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -59.86 -27.77 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 111.06 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.447 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 1.5 m-20 -115.94 -5.76 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.422 0.629 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HG2' HG22 ' A' ' 118' ' ' VAL . 68.1 mtt180 -99.12 150.0 22.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.82 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 t -143.23 129.0 10.15 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.51 139.09 87.66 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.17 2.58 . . . . 0.0 112.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.674 ' HD3' HD12 ' A' ' 90' ' ' LEU . 20.2 mmtp -52.07 -32.42 34.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.287 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.36 -41.64 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.706 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.18 -37.48 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.052 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HD2' HD11 ' A' ' 90' ' ' LEU . 59.1 m-85 -100.78 40.01 1.32 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.731 0.3 . . . . 0.0 111.224 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.411 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 16.3 ptm -49.67 -37.21 27.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -88.21 13.53 61.48 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.948 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.4 p -90.01 165.79 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 117.388 0.594 . . . . 0.0 110.064 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.79 -71.19 0.12 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -166.16 128.37 1.92 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.674 HD12 ' HD3' ' A' ' 81' ' ' LYS . 92.0 mt -63.9 112.16 2.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.808 0.814 . . . . 0.0 111.359 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.532 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -125.71 161.39 27.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.648 -177.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 109' ' ' ILE . 59.1 t -80.82 136.0 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 1.37 66.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.314 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -87.49 135.79 33.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.094 0.473 . . . . 0.0 110.634 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -113.93 134.42 54.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.728 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -163.21 173.79 12.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.006 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 104' ' ' PRO . 31.2 tp -90.91 120.94 32.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -90.1 174.0 7.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.669 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -128.19 121.79 30.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.328 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.5 p -145.52 175.27 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.731 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -55.1 -36.97 66.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.262 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.0 pt20 -92.27 30.74 1.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.62 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.08 -177.51 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.584 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.0 Cg_exo -58.1 143.72 96.14 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.435 2.09 . . . . 0.0 112.476 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 107' ' ' VAL . 88.1 t -133.78 116.91 13.83 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.05 101.88 0.74 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.65 2.233 . . . . 0.0 111.854 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 5.0 m -118.83 178.31 2.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.005 0.431 . . . . 0.0 111.734 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -135.66 137.41 41.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.32 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 90' ' ' LEU . 23.0 mt -78.01 126.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.813 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 p -110.95 1.54 17.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.426 0.632 . . . . 0.0 109.591 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 179.94 153.11 0.49 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.032 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 117' ' ' VAL . 94.2 t -141.37 109.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.05 -165.05 1.26 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.12 -54.28 15.81 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.491 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -109.21 -3.93 16.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -141.69 147.78 38.04 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.647 -0.658 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 112' ' ' VAL . 35.2 m -111.38 167.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 78' ' ' ARG . 58.8 t -121.58 114.87 44.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.7 m -113.97 137.99 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.545 0.688 . . . . 0.0 111.704 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 C--N 1.312 -1.061 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.717 175.573 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 67' ' ' ALA . 45.4 mt . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 40.7 mtpt -115.52 129.02 56.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -118.14 139.78 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.271 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -108.58 108.14 18.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.1 t -99.2 137.44 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.289 -172.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 9.3 mt-10 -136.52 96.11 3.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.86 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 52' ' ' HIS . 38.9 t -76.24 115.85 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.576 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.827 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.0 t -72.96 -49.5 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.892 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.57 156.28 20.64 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.347 -0.22 . . . . 0.0 111.24 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.865 HG23 HG12 ' A' ' 9' ' ' VAL . 67.8 mt -138.99 141.96 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -147.21 141.08 25.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.976 0.417 . . . . 0.0 110.619 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.2 pt-20 -76.23 117.14 17.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.717 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -62.18 155.28 24.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.803 0.811 . . . . 0.0 112.714 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 145' ' ' GLU . 43.2 p -84.19 18.86 1.99 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.223 -1.353 . . . . 0.0 112.066 -171.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 147' ' ' LEU . 30.1 mt-10 68.87 -33.0 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.082 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 143' ' ' THR . 0.4 OUTLIER -66.46 -40.43 89.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.717 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -58.06 -39.9 79.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.02 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 142' ' ' ALA . 14.9 mt -69.1 -45.55 69.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.898 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.66 67.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.853 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -97.52 -6.25 34.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.8 0.71 85.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.832 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 16.0 ptmt -106.19 171.17 7.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.27 0.557 . . . . 0.0 110.49 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -87.02 120.47 36.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.251 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.19 -172.95 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 7' ' ' LEU . 56.8 tttm -57.73 147.41 27.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.812 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 54.65 -5.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.0 mt -85.34 104.3 15.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.807 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.766 HG22 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -60.55 143.85 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.586 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.835 ' O ' ' HB3' ' A' ' 34' ' ' TYR . 2.3 m -153.18 131.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.217 1.008 . . . . 0.0 111.999 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 2.3 m -100.2 120.92 40.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.737 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -139.35 143.77 37.92 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.619 -0.833 . . . . 0.0 109.786 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -104.33 154.27 20.02 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.796 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 52.9 p90 -149.09 165.04 32.92 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.278 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 31.3 tt0 -131.91 120.77 22.99 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.5 t -103.84 119.64 52.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.5 ptp180 -132.58 151.67 51.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 p -81.95 175.98 9.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.137 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -58.7 -32.07 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.261 0.553 . . . . 0.0 109.721 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.28 -18.23 63.82 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.933 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.89 26.72 15.84 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.563 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 9.1 t -105.17 126.32 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.786 -0.244 . . . . 0.0 110.554 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' GLU . 35.1 tp -67.04 123.35 19.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -109.6 -38.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.565 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.18 152.41 39.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 22' ' ' LEU . 30.8 tt0 -157.1 137.43 12.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 111.753 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 27.1 m -116.7 114.3 39.87 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.17 167.52 19.94 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 C-N-CA 122.824 2.349 . . . . 0.0 112.227 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.18 -17.71 22.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.269 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -78.0 -32.53 51.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.242 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.8 112.83 9.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.277 0.561 . . . . 0.0 110.75 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.726 ' HG3' HG21 ' A' ' 137' ' ' VAL . 10.6 Cg_exo -76.86 169.45 21.66 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 124.271 3.314 . . . . 0.0 114.644 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.796 ' HG ' ' HE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -70.0 158.67 35.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.383 169.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.536 ' H ' HD23 ' A' ' 32' ' ' LEU . 3.9 m-20 -91.43 149.62 21.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.085 0.945 . . . . 0.0 110.949 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.835 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.08 126.91 42.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -161.182 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.625 HD11 HD23 ' A' ' 147' ' ' LEU . 14.7 tp -148.44 98.54 2.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 146.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.515 ' HA ' ' OG ' ' A' ' 40' ' ' SER . 21.2 t60 -70.82 136.19 48.6 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.412 -164.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.55 27.32 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.471 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.14 18.32 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.671 0.748 . . . . 0.0 110.173 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.83 90.8 0.18 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.98 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 41' ' ' LEU . 11.0 m -116.63 -52.27 2.56 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.726 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.75 -173.42 2.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 111.568 -2.56 . . . . 0.0 108.518 170.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 41' ' ' LEU . 13.7 pt -33.14 143.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -66.47 -41.08 89.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.741 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.14 -41.41 94.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.773 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 134' ' ' VAL . 29.8 tp -73.95 -48.89 27.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.6 mt-10 -50.74 -47.86 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.113 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.5 m -63.45 -36.83 85.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.656 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.1 72.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.467 0.651 . . . . 0.0 110.015 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 134' ' ' VAL . 83.9 mt -59.0 -37.07 76.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.664 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.0 mt-10 -53.32 152.04 4.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . 82.82 -22.49 6.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.371 -1.286 . . . . 0.0 114.183 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.509 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.8 m-70 -83.39 179.26 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.451 0.643 . . . . 0.0 111.954 -175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.6 mt-10 -134.73 161.85 34.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.483 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.2 m -52.61 143.26 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.691 0.619 . . . . 0.0 111.11 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 97.39 -17.13 59.56 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.689 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -64.94 132.54 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.742 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 13.7 tmtt? -137.17 130.19 30.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.656 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 60' ' ' VAL . 21.0 p90 -166.57 163.49 16.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.993 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.11 143.38 26.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.598 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.713 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.9 t -131.43 142.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.122 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.97 113.49 13.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.035 0.445 . . . . 0.0 109.893 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 44' ' ' GLY . 99.7 t -125.9 136.88 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.508 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.52 148.23 45.03 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.12 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.82 -21.61 66.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -68.95 -19.64 64.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.019 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.3 -42.02 4.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.922 0.391 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.9 mpt_? -111.02 111.5 22.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.207 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.49 133.28 20.25 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.461 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -60.98 135.01 56.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.76 2.307 . . . . 0.0 111.836 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 23.8 mtmt -59.11 -17.52 27.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.327 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.52 -27.37 64.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.42 0.629 . . . . 0.0 110.154 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.9 -36.4 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HB2' HD11 ' A' ' 90' ' ' LEU . 26.3 m-85 -102.1 40.02 1.4 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.179 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.7 ptm -56.54 -24.33 46.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.361 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.39 4.7 83.35 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.198 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 HD23 ' A' ' 90' ' ' LEU . 69.5 t -89.56 149.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.902 0.351 . . . . 0.0 110.477 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.17 -70.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 110.878 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.72 105.38 4.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.626 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 84' ' ' PHE . 80.8 mt -60.17 107.59 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.341 0.591 . . . . 0.0 110.392 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -128.27 167.52 16.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.26 140.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.05 2.43 77.86 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.483 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 mmm -89.21 135.53 33.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.101 0.476 . . . . 0.0 109.718 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.83 135.39 54.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.691 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -164.15 167.45 20.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.112 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.3 tp -84.33 130.6 34.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -113.16 142.72 45.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.994 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.62 132.95 35.45 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.3 p -146.81 -175.64 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.81 -30.88 70.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.592 0.71 . . . . 0.0 109.901 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -86.71 24.45 1.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.636 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.79 -171.67 55.15 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.185 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 32.6 Cg_exo -58.63 128.57 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.231 1.954 . . . . 0.0 111.631 170.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -128.85 116.43 19.23 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 14.8 Cg_exo -70.74 102.7 1.22 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.939 2.426 . . . . 0.0 111.861 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.5 m -118.37 172.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.777 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.98 131.53 40.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.82 128.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 120' ' ' ASP . 39.4 p -113.66 0.31 14.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.323 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -175.52 153.27 1.45 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.093 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.766 HG13 HG12 ' A' ' 117' ' ' VAL . 57.5 t -140.78 106.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.84 -172.61 3.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.31 -49.03 65.81 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.225 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.547 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 10.0 m-20 -104.83 -14.35 15.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -143.53 149.04 36.89 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.574 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -104.58 168.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.114 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.2 t -124.0 122.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m -115.63 133.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 112.012 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 110' ' ' THR . 14.3 t70 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.797 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -117.11 128.54 55.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 3.5 m-85 -119.71 133.77 55.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.472 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -104.33 108.69 20.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.737 HG13 HD23 ' A' ' 11' ' ' LEU . 5.6 t -98.67 142.5 14.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.505 0.669 . . . . 0.0 112.145 -170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.742 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 44.0 mt-10 -130.93 90.85 2.96 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.192 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -68.86 114.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.854 0.835 . . . . 0.0 111.957 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 31' ' ' PRO . 15.8 t -71.54 -51.9 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.047 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -158.58 158.45 33.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.885 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.682 HG23 HG12 ' A' ' 9' ' ' VAL . 75.9 mt -137.35 134.58 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 41.6 ttm180 -154.38 138.99 16.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' HD22 ' A' ' 7' ' ' LEU . 16.1 pt-20 -70.85 123.34 21.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -62.75 164.23 8.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.2 p -97.54 25.27 5.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' LEU . 38.7 mt-10 72.81 -36.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.369 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.0 -48.71 79.1 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.565 0.221 . . . . 0.0 110.693 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 12.7 mp0 -55.68 -39.42 70.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.625 HD23 HD11 ' A' ' 35' ' ' LEU . 19.2 mt -68.76 -47.32 66.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.168 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.2 73.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.19 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -84.58 -19.28 33.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.239 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 81.93 10.24 84.27 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.007 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 19.2 ptmt -133.14 166.18 23.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.3 p -72.42 115.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.068 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.32 -171.0 3.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.008 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 83.3 tttt -64.97 158.04 26.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.223 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' O ' HD21 ' A' ' 147' ' ' LEU . 3.6 p30 55.69 0.3 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 113.907 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 141' ' ' GLU . 15.6 mt -96.45 110.51 22.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.044 0.45 . . . . 0.0 111.295 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 HD13 ' A' ' 35' ' ' LEU . 49.7 t -53.73 143.43 5.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.708 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -141.89 134.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -111.99 111.7 22.81 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD13 HG13 ' A' ' 134' ' ' VAL . 2.3 pp -128.76 161.12 30.48 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.854 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.6 147.31 42.96 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.667 ' CE1' HD12 ' A' ' 32' ' ' LEU . 36.7 p90 -160.93 162.19 31.91 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.436 -0.905 . . . . 0.0 111.452 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.0 tt0 -133.57 121.07 21.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.4 p -113.7 125.93 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.598 0.713 . . . . 0.0 111.361 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -144.07 176.03 9.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.335 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.3 p -98.03 178.05 5.22 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.528 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.2 -20.86 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.263 0.554 . . . . 0.0 110.153 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' HG23 ' A' ' 21' ' ' VAL . 18.2 t70 -78.26 -18.07 55.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.384 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.39 6.02 53.65 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 19' ' ' ASP . 5.2 t -77.04 112.92 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 15' ' ' VAL . 58.3 tp -68.97 119.43 13.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 15' ' ' VAL . 31.0 m -96.52 -39.19 8.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 32.5 t70 -156.56 160.15 39.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 43.1 tt0 -159.05 133.54 7.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 0.0 111.971 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 m -116.25 105.08 51.28 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.26 168.27 18.14 Favored 'Trans proline' 0 CA--C 1.523 -0.068 0 C-N-CA 122.91 2.407 . . . . 0.0 113.035 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.02 -19.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.548 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.4 p -75.83 -38.95 57.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -133.93 112.65 12.47 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.237 0.541 . . . . 0.0 109.873 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.493 ' HB3' HG21 ' A' ' 137' ' ' VAL . 12.9 Cg_exo -75.53 169.76 21.68 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.994 3.13 . . . . 0.0 114.723 -175.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -86.6 131.49 34.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.603 168.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.57 118.28 26.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.645 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 23.1 m-85 -160.15 -179.72 7.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.263 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 147' ' ' LEU . 60.2 tp -107.98 115.74 30.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.65 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 14.9 t60 -73.99 130.87 40.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 109.45 6.38 29.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.774 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -148.15 9.66 0.87 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.12 104.34 2.51 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -167.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 34' ' ' TYR . 39.4 t -118.33 -50.85 2.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.2 pt? -158.09 -168.89 2.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.817 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 10.7 pt -39.77 144.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -66.51 -39.46 88.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.076 -1.874 . . . . 0.0 112.185 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.506 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -65.53 -39.48 95.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.352 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 134' ' ' VAL . 16.5 tp -74.37 -49.79 21.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 109.864 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 49' ' ' LEU . 23.3 mt-10 -48.5 -47.2 39.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.4 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.9 m -66.48 -32.97 74.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.7 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.41 74.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.8 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -57.91 -45.13 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.161 175.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.2 mt-10 -46.55 152.35 0.47 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.949 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 79.11 -23.59 3.17 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 114.428 -1.26 . . . . 0.0 114.594 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.2 m-70 -84.49 177.55 8.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.664 0.732 . . . . 0.0 111.163 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 1' ' ' MET . 39.5 mt-10 -128.72 164.57 22.66 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.1 m -52.04 142.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.819 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.87 -13.11 66.66 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.473 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.52 131.38 44.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.941 0.4 . . . . 0.0 110.327 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.565 ' CG ' ' HG2' ' A' ' 135' ' ' GLU . 1.9 tmtp? -137.96 130.33 29.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.913 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.5 p90 -167.4 162.01 14.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.037 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.77 144.11 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.626 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -134.32 142.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.31 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.95 113.2 11.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG11 ' HA3' ' A' ' 44' ' ' GLY . 80.3 t -120.78 138.22 51.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.876 0.37 . . . . 0.0 110.652 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.85 150.32 50.37 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.367 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.54 -31.39 4.33 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -65.16 -21.11 66.73 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -117.06 3.69 12.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 176.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 118' ' ' VAL . 8.4 mpt_? -116.26 105.36 12.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 109.737 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.17 128.62 36.28 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.952 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.32 137.1 72.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.592 2.862 . . . . 0.0 112.216 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.903 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -56.1 -25.57 46.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.113 175.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.04 -36.42 81.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.462 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -43.16 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.316 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.7 m-85 -90.4 40.21 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 14.7 ptm -52.13 -36.54 51.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.144 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -92.32 13.94 65.92 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.984 -175.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.781 HG11 ' HG ' ' A' ' 90' ' ' LEU . 7.4 p -75.79 159.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.272 0.536 . . . . 0.0 111.129 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 87' ' ' VAL . 19.5 t70 -68.67 -76.03 0.1 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.859 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -149.77 110.51 4.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.217 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HG ' HG11 ' A' ' 87' ' ' VAL . 5.6 mt -64.58 119.54 10.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.652 0.739 . . . . 0.0 111.45 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 30.5 tt0 -147.03 164.89 31.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.471 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 111' ' ' ALA . 53.3 t -81.21 132.68 30.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.04 1.82 56.0 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.83 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.42 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 mmm -91.09 141.86 28.37 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.226 0.536 . . . . 0.0 111.292 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 10.7 mtp180 -118.24 134.54 54.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.043 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -162.01 167.09 25.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.078 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 104' ' ' PRO . 44.6 tp -91.31 137.3 32.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.192 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.84 138.14 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.09 146.91 28.42 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.5 p -145.74 -175.55 4.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.17 -23.57 67.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.84 0.828 . . . . 0.0 110.514 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.84 26.84 10.27 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.549 -171.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.89 -179.31 48.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.135 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 97' ' ' LEU . 42.3 Cg_exo -57.82 133.39 55.83 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.375 2.05 . . . . 0.0 112.903 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 88.9 t -129.53 116.39 18.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.549 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.9 Cg_exo -79.75 112.97 2.98 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.889 2.393 . . . . 0.0 111.19 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.8 m -118.23 178.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.743 0.306 . . . . 0.0 111.196 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' C ' HG12 ' A' ' 119' ' ' VAL . 36.7 tt0 -134.53 130.84 37.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 112' ' ' VAL . 40.7 mt -71.89 130.44 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.327 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.9 p -112.05 -1.87 15.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 0.0 110.382 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . -175.34 150.24 1.11 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.485 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.624 HG13 HG12 ' A' ' 117' ' ' VAL . 60.8 t -139.08 106.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 6.9 mm-40 -86.0 -157.31 0.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -71.33 -54.09 11.97 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.866 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.492 ' C ' ' HG2' ' A' ' 81' ' ' LYS . 18.5 m-20 -118.14 5.86 12.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.41 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 33.1 p-80 -145.1 148.03 33.2 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.461 -0.774 . . . . 0.0 111.574 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.755 HG13 ' HZ3' ' A' ' 81' ' ' LYS . 30.7 m -116.35 167.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.5 t -122.53 115.88 47.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.967 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -119.05 130.57 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.069 0.462 . . . . 0.0 110.333 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t0 . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.986 -177.245 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -124.17 122.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 110.048 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 1.6 m-85 -117.83 139.81 50.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.704 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.9 m120 -109.36 106.67 16.57 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 45' ' ' LEU . 2.5 t -99.61 135.62 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.565 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 25.9 mt-10 -135.54 90.83 2.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.272 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 54' ' ' VAL . 2.9 p -72.69 115.0 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.846 0.831 . . . . 0.0 112.446 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.2 t -72.91 -47.91 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.124 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.03 157.59 31.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.751 0.31 . . . . 0.0 111.147 -171.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 54' ' ' VAL . 63.5 mt -140.34 123.46 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -146.97 137.05 23.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.999 0.428 . . . . 0.0 111.351 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.449 ' HB3' HD22 ' A' ' 7' ' ' LEU . 7.9 pt-20 -75.49 138.66 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -80.51 176.77 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.682 0.754 . . . . 0.0 112.589 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p -96.34 23.43 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.269 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 70.17 -43.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.365 0.666 . . . . 0.0 111.444 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.79 -40.26 91.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.365 0.602 . . . . 0.0 109.38 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.581 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 42.4 mt-10 -63.15 -34.27 77.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.381 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 35' ' ' LEU . 47.2 mt -71.98 -47.4 52.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.139 176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.48 69.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.52 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.04 -16.76 18.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.87 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.79 40.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 114.243 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.373 0.587 . . . . 0.0 110.635 176.87 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 51' ' ' GLY . 15.2 ptpt -111.11 170.83 7.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.481 0.657 . . . . 0.0 111.729 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -84.94 131.96 32.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.16 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.12 -174.12 4.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.527 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 79.5 tttt -65.96 155.86 35.28 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 147' ' ' LEU . 28.7 m-20 60.37 -5.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 141' ' ' GLU . 19.3 mt -90.71 109.66 20.84 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.613 -0.679 . . . . 0.0 111.454 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.0 144.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.046 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -151.16 137.75 12.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -168.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 10.9 m -102.45 121.24 41.95 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 134' ' ' VAL . 2.1 tt -136.9 154.31 50.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.425 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . . . -124.36 151.24 44.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.48 161.33 21.28 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.04 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 51.8 tt0 -132.15 118.94 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.496 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.9 p -110.32 124.4 67.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.536 0.684 . . . . 0.0 111.388 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -145.41 -179.84 6.92 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 p -99.91 174.58 6.12 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.253 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 43.6 mt-10 -65.43 -19.22 65.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.421 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.07 -18.72 55.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.577 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.36 -12.01 43.59 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.515 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.53 126.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 117.427 0.614 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 15' ' ' VAL . 51.5 tp -76.96 127.97 33.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.86 -35.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -167.47 167.06 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.665 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -165.64 159.35 16.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.5 0.667 . . . . 0.0 111.212 169.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -126.07 114.59 24.04 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.42 166.06 26.86 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.789 2.326 . . . . 0.0 113.218 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.94 -22.89 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.436 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.2 p -71.41 -38.95 71.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.871 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -135.34 113.05 11.14 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-O 121.269 0.557 . . . . 0.0 110.151 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.3 Cg_exo -75.81 166.58 27.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.9 3.067 . . . . 0.0 114.439 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD11 ' HE2' ' A' ' 34' ' ' TYR . 14.8 tp -85.62 134.17 34.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.485 170.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.07 118.18 30.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.167 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' HD11 ' A' ' 32' ' ' LEU . 50.0 m-85 -160.69 179.75 8.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.195 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.93 117.95 35.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 31.9 t60 -70.79 128.99 37.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 96.48 8.19 57.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.889 172.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -134.31 14.58 3.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.15 103.29 2.3 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -167.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 36' ' ' HIS . 33.4 t -116.61 -52.31 2.56 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.39 -82.81 0.24 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.122 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.585 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 15.5 pt -122.59 -163.43 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 t -98.02 -50.09 4.52 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.492 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.05 -34.81 29.11 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.956 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.693 HD11 HG21 ' A' ' 134' ' ' VAL . 55.5 tp -74.24 -46.55 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 109.988 -172.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 48.3 mt-10 -50.79 -41.74 57.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.259 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -65.15 -33.23 75.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.72 -35.57 65.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.015 0.912 . . . . 0.0 109.273 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.916 HD21 HG11 ' A' ' 134' ' ' VAL . 96.2 mt -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.953 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.74 152.57 5.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.997 0.903 . . . . 0.0 112.772 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' O ' ' HE2' ' A' ' 2' ' ' LYS . . . 77.9 -18.39 5.02 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.749 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 4.7 p-80 -128.65 157.31 41.67 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.377 2.089 . . . . 0.0 112.921 -173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 1' ' ' MET . 41.4 mt-10 -101.98 166.32 10.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -157.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.628 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.6 m -48.12 144.21 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.046 -1.433 . . . . 0.0 112.714 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.58 -10.34 66.75 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.286 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.749 ' OD2' ' HD2' ' A' ' 52' ' ' HIS . 2.8 t0 -75.43 137.06 40.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.166 0.507 . . . . 0.0 110.171 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 2.1 tmtp? -137.76 132.37 32.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.921 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 60' ' ' VAL . 7.2 p90 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.045 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.39 139.84 33.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.779 0.799 . . . . 0.0 111.305 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.4 t -125.67 150.42 30.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.428 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.48 113.96 11.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.037 0.381 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.85 144.66 37.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.189 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.36 152.64 49.89 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.155 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.2 -28.35 52.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.979 0.512 . . . . 0.0 112.258 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -71.43 -20.74 62.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.949 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -111.73 1.35 16.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.519 0.676 . . . . 0.0 110.416 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.51 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.455 0.645 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.611 ' HG3' HG22 ' A' ' 118' ' ' VAL . 4.8 mpt_? -115.16 148.93 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.17 129.46 12.31 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -171.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.5 Cg_exo -57.21 136.57 77.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.051 2.5 . . . . 0.0 112.422 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -54.44 -31.6 55.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.495 178.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.93 -35.14 79.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 80' ' ' PRO . 88.1 t -57.01 -36.3 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.156 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HB2' HD11 ' A' ' 90' ' ' LEU . 45.6 m-85 -104.81 39.87 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.405 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.3 ptm -53.65 -27.22 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.527 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 3.07 85.7 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.387 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 95.0 t -92.78 144.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.091 0.446 . . . . 0.0 111.098 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.01 -77.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.076 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -134.2 106.64 7.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.722 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 117' ' ' VAL . 96.8 mt -59.68 105.52 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.438 0.637 . . . . 0.0 109.622 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -128.91 167.81 16.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.085 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 111' ' ' ALA . 43.8 t -79.83 135.24 25.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.5 1.19 68.98 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.137 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mmm -83.93 134.57 34.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.405 0.622 . . . . 0.0 109.688 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -119.33 136.08 54.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.09 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -163.65 165.27 23.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 104' ' ' PRO . 5.6 mt -88.44 132.76 34.34 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.54 0.686 . . . . 0.0 110.518 172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -112.61 114.07 26.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.079 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 26.2 mt-10 -87.32 96.64 10.42 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 110.788 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 p -94.67 -174.52 3.32 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.577 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.33 -43.54 61.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.308 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.5 pt20 -98.47 32.01 2.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.034 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.23 179.83 39.59 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.76 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HB2' HD22 ' A' ' 97' ' ' LEU . 6.2 Cg_exo -66.77 147.77 81.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.516 2.144 . . . . 0.0 112.03 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -134.22 117.09 13.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.801 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.5 Cg_exo -74.01 102.34 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 111.722 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 6.2 m -118.73 151.84 20.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 110.721 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.62 137.85 51.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.225 0.536 . . . . 0.0 110.318 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.5 mt -81.57 129.26 37.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.086 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.3 p -115.53 5.27 14.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 151.45 0.17 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 117' ' ' VAL . 49.1 t -140.91 109.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -91.22 -154.1 0.34 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.05 -36.2 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -133.27 -14.83 2.58 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.179 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -139.38 157.59 45.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.536 0.208 . . . . 0.0 110.725 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 112' ' ' VAL . 30.5 m -112.77 167.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 78' ' ' ARG . 41.4 t -117.19 117.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.7 m -120.39 140.03 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.638 0.733 . . . . 0.0 112.302 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.536 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 23.0 mtpp -122.04 125.63 46.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 2.8 m-85 -116.02 134.54 54.85 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.355 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -105.44 106.62 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.916 HG11 HD21 ' A' ' 49' ' ' LEU . 4.0 t -99.09 139.65 20.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.725 0.774 . . . . 0.0 112.286 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.697 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 37.0 mt-10 -131.48 91.49 3.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.811 -1.541 . . . . 0.0 109.465 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.628 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.5 p -63.56 154.27 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 11' ' ' LEU . 76.0 t -129.44 -55.31 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 -153.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.91 38.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 110.419 -3.082 . . . . 0.0 109.876 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 54' ' ' VAL . 74.9 mt -138.91 133.51 41.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.9 ttp-105 -139.52 154.18 47.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.0 110.171 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.651 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.1 pt-20 -91.55 132.38 36.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.2 163.81 27.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.749 . . . . 0.0 112.243 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -94.64 24.51 4.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.972 -171.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 70.52 -38.71 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.06 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -40.22 82.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.67 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.7 mt-10 -58.97 -37.12 76.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.999 175.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 142' ' ' ALA . 23.0 mt -71.07 -46.02 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.084 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.92 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.425 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -89.76 -14.85 33.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.335 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.67 90.37 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.714 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.537 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 ptpt -111.73 174.63 5.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.43 0.633 . . . . 0.0 111.268 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -83.51 125.05 40.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.188 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.09 -171.08 3.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.781 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 34.9 tttm -63.86 151.18 43.12 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.639 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' OD1' HD22 ' A' ' 147' ' ' LEU . 30.8 m-20 52.74 7.84 0.08 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.57 100.47 11.2 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 34' ' ' TYR . 14.6 p -69.77 141.09 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG12 HG23 ' A' ' 139' ' ' ILE . 4.5 m -136.46 159.04 38.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.873 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.787 ' O ' HG22 ' A' ' 137' ' ' VAL . 19.5 m -117.37 118.26 31.75 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -134.96 161.08 36.28 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.775 -177.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.24 107.82 13.01 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.0 p90 -120.52 158.48 27.2 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.407 -173.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.903 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 tt0 -127.28 119.4 26.24 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 23' ' ' VAL . 2.4 p -102.0 119.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 122.199 1.0 . . . . 0.0 111.021 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 13.7 ttm180 -134.51 145.97 49.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.95 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 p -87.14 179.44 6.65 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -64.05 -29.99 71.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 0.0 109.929 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.69 -19.25 65.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.02 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.73 66.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.532 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.37 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.498 . . . . 0.0 110.252 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 25' ' ' GLU . 5.0 tt -83.49 124.27 30.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.659 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.487 HG23 HG13 ' A' ' 15' ' ' VAL . 27.0 m -94.3 -39.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.373 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -162.73 159.53 24.34 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.903 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -166.0 148.17 7.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.25 0.548 . . . . 0.0 111.226 174.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -102.32 113.98 65.63 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.84 163.72 29.72 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 m -67.24 -13.88 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.327 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.2 p -82.28 -30.49 30.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.96 114.88 5.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.342 0.591 . . . . 0.0 110.976 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.775 ' HG3' HG11 ' A' ' 137' ' ' VAL . 8.9 Cg_exo -75.03 154.36 42.28 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.729 2.952 . . . . 0.0 113.374 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 13' ' ' TYR . 15.2 tp -76.57 134.9 39.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.359 170.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -110.04 120.28 41.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 7.5 p90 -150.77 148.37 28.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.292 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 41.9 tp -81.34 110.1 16.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.91 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.468 ' CE1' ' HG3' ' A' ' 50' ' ' GLU . 14.3 t60 -71.76 140.77 49.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.083 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 108.37 -27.03 14.75 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.158 -1.496 . . . . 0.0 113.85 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.45 55.48 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 35' ' ' LEU . . . -141.29 -105.71 0.59 Allowed Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.117 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 15.5 m -114.39 -54.84 2.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -166.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.942 HD22 HD23 ' A' ' 45' ' ' LEU . 84.6 mt -65.44 136.48 56.51 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.796 1.284 . . . . 0.0 112.651 173.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 67' ' ' ALA . 21.7 pt -53.33 175.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 111.749 -2.478 . . . . 0.0 114.581 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 m -66.26 -48.41 70.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.185 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.17 -45.33 96.26 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.428 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.942 HD23 HD22 ' A' ' 41' ' ' LEU . 23.7 tp -74.58 -53.33 9.61 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.809 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 6.9 mt-10 -48.29 -42.45 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 124.062 0.851 . . . . 0.0 111.834 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 m -65.53 -29.73 70.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.61 55.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 8.2 mt -65.43 -38.42 89.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.407 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 3.9 mt-10 -53.66 153.23 4.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.561 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 77.29 -14.71 8.01 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.87 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' VAL . 82.3 m-70 -88.78 165.52 14.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.265 0.533 . . . . 0.0 110.07 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 69.1 mt-10 -123.11 162.5 22.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 1.5 m -46.56 143.64 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.826 0.822 . . . . 0.0 112.697 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.04 -2.88 72.55 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 114.703 -1.135 . . . . 0.0 114.079 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.45 134.01 35.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.464 0.632 . . . . 0.0 110.771 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.703 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 1.8 tmtp? -135.24 128.63 32.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.725 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 60' ' ' VAL . 22.8 p90 -155.57 -178.2 7.1 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.81 149.69 40.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.4 t -137.47 142.54 36.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.61 -172.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.64 113.53 13.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.18 132.63 70.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.77 154.05 48.02 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -49.63 -26.13 3.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.62 -34.0 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.13 -0.357 . . . . 0.0 111.614 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.73 -24.38 18.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.393 0.616 . . . . 0.0 109.942 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.66 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.412 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.201 0 CA-C-O 121.916 0.865 . . . . 0.0 111.035 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -98.73 140.84 32.32 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.152 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -136.06 124.92 15.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -60.11 126.91 21.5 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.386 2.057 . . . . 0.0 111.632 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 22.8 mtmt -58.74 -17.26 21.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.826 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.77 -29.87 70.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 0.0 110.24 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -67.05 -45.64 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.904 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 90' ' ' LEU . 60.3 m-85 -87.74 40.86 0.96 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.0 ptm -50.82 -29.8 12.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 6.19 81.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.915 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 75.0 t -94.14 145.46 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.424 0.612 . . . . 0.0 111.224 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.81 -74.32 0.05 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.542 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -142.08 116.88 9.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.463 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.56 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.8 mt -62.33 105.97 0.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.42 176.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -128.77 166.21 19.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.13 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.41 74.57 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.82 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.0 mmm -89.2 135.03 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.141 0.471 . . . . 0.0 110.038 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 49.9 mtt180 -115.49 135.5 54.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.87 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.17 171.37 13.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.003 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' PRO . 64.3 tp -98.09 150.98 20.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 100' ' ' THR . . . -148.88 90.97 1.81 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 112.041 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 16.2 mt-10 -49.11 111.16 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.367 1.08 . . . . 0.0 112.87 162.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 98' ' ' ALA . 68.2 p -113.18 -172.63 2.1 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.747 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -50.83 -35.24 31.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.973 0.416 . . . . 0.0 111.005 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.469 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.1 pt20 -98.55 28.32 4.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.04 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.21 -177.25 45.81 Favored Glycine 0 C--N 1.322 -0.203 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.453 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.781 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.7 Cg_endo -69.79 121.93 8.61 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 122.379 2.053 . . . . 0.0 112.411 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.83 116.1 47.95 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.931 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.8 120.94 8.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.011 1.807 . . . . 0.0 109.99 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 10.8 m -142.77 154.21 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.833 0.825 . . . . 0.0 112.524 -168.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 28.6 tt0 -130.44 127.8 40.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.866 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 119' ' ' VAL . 62.8 mt -66.01 129.1 30.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -116.34 0.7 12.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -175.34 152.65 1.42 Allowed 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.525 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 117' ' ' VAL . 45.9 t -139.67 111.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -87.62 -166.63 1.63 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 5.1 m-20 -63.36 -53.54 50.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.307 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 5.0 m-20 -99.71 -18.3 17.32 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -143.25 146.76 33.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.704 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 112' ' ' VAL . 33.1 m -92.44 168.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.388 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.68 108.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.4 m -115.66 141.6 32.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.889 0.852 . . . . 0.0 112.872 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.169 -175.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -115.39 133.81 55.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.735 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 36.9 m-85 -121.02 142.09 50.13 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.404 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 2.8 m-20 -108.84 106.71 16.83 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 166.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.725 HG11 HD22 ' A' ' 49' ' ' LEU . 3.1 t -100.85 140.28 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.95 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.703 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 59.1 mt-10 -138.14 100.7 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.968 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 p -80.42 110.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.13 0.49 . . . . 0.0 110.928 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 10' ' ' SER . 2.7 m -75.92 -39.53 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.013 0.435 . . . . 0.0 111.538 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.41 156.95 21.84 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -168.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 9' ' ' VAL . 73.3 mt -136.63 131.96 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -146.76 141.31 26.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.789 0.328 . . . . 0.0 110.144 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -87.71 125.31 34.34 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.74 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -63.61 165.5 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.774 -170.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 145' ' ' GLU . 56.3 p -79.49 15.36 1.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.422 -170.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 69.94 -35.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 111.481 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 143' ' ' THR . 46.4 mt-10 -62.23 -46.89 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 109.708 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.4 mt-10 -59.22 -35.53 73.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.237 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 142' ' ' ALA . 24.0 mt -71.92 -46.89 56.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.401 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.87 70.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.211 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -88.93 -11.92 43.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.789 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.23 4.21 84.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.994 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.592 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.7 ptpt -129.59 179.48 5.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -85.56 116.06 28.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.383 0.611 . . . . 0.0 111.563 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -149.89 -167.37 2.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.084 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' LEU . 20.2 tttm -61.56 153.31 28.0 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.108 0.255 . . . . 0.0 110.691 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 50.3 3.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.145 1.378 . . . . 0.0 114.519 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 2' ' ' LYS . 1.2 mt -93.91 98.43 11.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -63.61 144.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.204 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 139' ' ' ILE . 2.1 m -148.84 152.29 12.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.473 0.654 . . . . 0.0 111.24 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.0 m -103.03 117.72 35.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 134' ' ' VAL . 9.5 tt -133.01 147.59 52.26 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.522 -172.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.8 152.4 37.32 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.621 ' HE1' HD22 ' A' ' 32' ' ' LEU . 52.1 p90 -161.77 157.51 24.33 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.168 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.438 ' CG ' HD13 ' A' ' 22' ' ' LEU . 36.1 tt0 -131.08 122.86 27.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.385 172.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.431 HG13 ' CE1' ' A' ' 132' ' ' PHE . 37.2 t -103.83 119.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.581 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -139.29 155.46 47.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 p -78.08 179.8 6.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.012 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.64 -31.68 26.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.543 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -19.0 63.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.151 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.34 -2.54 81.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.538 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.63 136.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.486 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 25' ' ' GLU . 58.8 tp -72.8 131.37 42.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.733 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.84 -40.56 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.688 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -144.93 149.45 35.27 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.1 tt0 -164.12 139.51 6.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.1 m -119.18 114.84 34.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 167.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.37 167.44 26.3 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.588 2.192 . . . . 0.0 113.389 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -18.96 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.215 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -73.15 -34.83 66.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.99 112.72 5.74 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.2 Cg_exo -75.44 159.7 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.285 2.657 . . . . 0.0 113.952 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 41' ' ' LEU . 14.0 tp -79.57 126.19 30.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.046 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.2 120.78 42.96 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.512 ' CD2' ' HA ' ' A' ' 40' ' ' SER . 46.2 p90 -144.54 161.86 38.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 147' ' ' LEU . 46.7 tp -108.29 105.64 15.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 6.4 t60 -61.14 130.51 46.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 101.46 -7.81 56.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.219 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -134.62 2.8 3.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 94.73 0.14 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.779 ' O ' HD13 ' A' ' 41' ' ' LEU . 12.7 m -116.11 15.21 16.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.512 1.149 . . . . 0.0 108.511 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 40' ' ' SER 0.396 0.0 OUTLIER 41.81 109.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.473 2.709 . . . . 0.0 115.397 -170.467 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.812 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 pt 51.57 127.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 110.148 -3.205 . . . . 0.0 115.61 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.545 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 43.5 t -50.66 -47.63 58.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.564 -2.107 . . . . 0.0 113.387 -170.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.607 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -67.97 -36.54 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.345 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 44.8 tp -75.03 -46.96 31.48 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HG3' ' O ' ' A' ' 42' ' ' ILE . 31.8 mt-10 -48.9 -49.51 39.47 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.911 0.757 . . . . 0.0 109.989 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.4 m -60.57 -37.41 81.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.954 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.15 63.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.696 0.76 . . . . 0.0 110.039 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 88.0 mt -62.46 -36.57 82.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.724 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -54.54 153.98 5.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 78.17 -15.2 9.13 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 113.498 -1.683 . . . . 0.0 117.096 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 3' ' ' VAL . 14.4 p80 -102.19 174.24 6.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.661 1.731 . . . . 0.0 110.263 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 139' ' ' ILE . 4.1 mp0 -119.82 171.48 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.73 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 139' ' ' ILE . 2.0 m -52.16 142.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.309 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.457 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 97.56 -15.26 62.28 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.007 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 136' ' ' VAL . 32.5 m-20 -74.32 130.65 40.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.341 0.591 . . . . 0.0 111.42 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 5.5 tmtm? -133.24 124.6 27.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.052 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.3 p90 -148.85 -178.26 6.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.392 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.54 145.85 39.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -135.22 142.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 113.09 12.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.128 0.49 . . . . 0.0 110.341 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG11 ' HA3' ' A' ' 44' ' ' GLY . 58.2 t -126.57 144.17 37.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.421 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.64 153.24 50.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.96 -20.6 24.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -19.65 53.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 110.817 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -115.71 -18.45 10.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.931 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 118' ' ' VAL . 6.5 mpt_? -107.62 114.7 28.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.886 -175.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -111.95 129.23 24.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.639 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 12.3 Cg_exo -61.91 134.41 49.83 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 111.426 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 18.8 mtmt -59.39 -14.66 12.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.09 -28.12 65.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.525 0.679 . . . . 0.0 110.259 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.22 -38.08 77.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.128 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.2 m-85 -90.85 41.38 1.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -176.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 ptm -51.37 -25.82 6.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.093 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.33 11.01 73.16 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 84' ' ' PHE . 2.6 p -100.5 160.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.258 0.529 . . . . 0.0 109.922 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -75.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -145.41 121.57 10.81 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.12 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.58 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.0 mt -62.12 103.88 0.42 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.934 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -125.61 155.62 40.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.562 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.679 ' HA ' HG22 ' A' ' 109' ' ' ILE . 42.7 t -67.1 134.07 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.055 0.455 . . . . 0.0 110.922 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.62 -28.44 15.97 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.51 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.6 mmm -52.92 135.53 36.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 20.2 mtp85 -116.72 137.35 52.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.943 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -163.26 167.57 21.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.423 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 104' ' ' PRO . 52.0 tp -82.7 143.75 30.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.0 110.015 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -131.76 147.53 52.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.778 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -97.64 142.66 29.17 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.7 p -148.92 -175.92 5.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.82 -27.47 69.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.565 0.698 . . . . 0.0 109.696 171.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -89.72 23.23 2.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.861 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.99 -173.71 52.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.495 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 39.8 Cg_exo -59.25 125.61 18.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 111.568 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.54 109.28 30.78 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.014 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.88 107.11 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.62 2.213 . . . . 0.0 110.694 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.4 m -117.75 176.22 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.187 0.517 . . . . 0.0 111.782 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 39.2 tt0 -137.06 129.6 30.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.592 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 92' ' ' VAL . 32.1 mt -70.95 122.58 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -103.6 -7.42 20.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -173.1 156.73 3.3 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 117' ' ' VAL . 88.1 t -136.75 104.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.235 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 24.1 mm-40 -75.8 -166.82 0.61 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.769 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.22 -56.14 24.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.691 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.527 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 24.6 t70 -128.08 16.96 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.894 176.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.492 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 50.9 p-80 -146.22 146.33 30.74 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 121.436 -0.79 . . . . 0.0 111.68 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 90' ' ' LEU . 26.9 m -104.54 167.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.999 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.3 t -130.86 119.53 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 5.0 m -114.35 131.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.865 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -175.442 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.407 HD13 ' CG1' ' A' ' 15' ' ' VAL . 57.5 mt . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.459 0.647 . . . . 0.0 112.679 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -112.07 132.37 54.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.163 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.554 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 11.6 m-85 -121.17 142.19 50.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.903 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 3.5 m-20 -108.61 107.61 18.16 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 167.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 HD21 ' A' ' 11' ' ' LEU . 3.6 t -100.29 137.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.558 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 33.4 mt-10 -134.03 98.08 4.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.494 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' H ' ' A' ' 55' ' ' GLY . 3.8 p -78.57 114.63 19.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.693 . . . . 0.0 111.669 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 31' ' ' PRO . 5.5 t -71.67 -50.31 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.47 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -162.82 154.48 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.762 HG23 HG12 ' A' ' 9' ' ' VAL . 66.7 mt -132.94 138.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -149.25 140.92 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.07 126.28 34.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.714 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.75 166.16 13.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.449 -168.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.1 p -82.05 20.74 0.96 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.477 -170.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 147' ' ' LEU . 45.0 mt-10 67.71 -37.88 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.363 0.665 . . . . 0.0 111.327 -174.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 143' ' ' THR . 45.7 mt-10 -64.28 -45.2 89.1 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.714 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 37.6 mt-10 -59.54 -34.91 73.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.508 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 142' ' ' ALA . 35.6 mt -74.14 -44.27 54.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.688 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.73 -29.6 70.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.346 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -94.99 -32.08 13.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.93 13.03 35.25 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.594 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 p80 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 117.565 0.682 . . . . 0.0 111.455 -178.737 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 12.4 ptmt -106.21 156.14 18.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.332 0.586 . . . . 0.0 111.187 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -64.68 126.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.786 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.68 -169.78 3.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.168 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 7' ' ' LEU . 60.8 tttp -65.23 153.9 39.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.358 . . . . 0.0 111.662 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' O ' HD21 ' A' ' 147' ' ' LEU . 79.2 m-20 51.63 6.1 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 141' ' ' GLU . 17.9 mt -92.85 149.42 21.28 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -115.59 142.95 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HG23 ' A' ' 139' ' ' ILE . 3.2 m -142.31 155.74 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.787 0.803 . . . . 0.0 111.716 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . 16.5 m -117.9 117.59 29.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.175 -1.375 . . . . 0.0 107.962 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.76 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -127.84 158.52 37.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.82 112.67 16.95 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HE1' HD22 ' A' ' 32' ' ' LEU . 41.0 p90 -126.58 160.89 29.34 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.453 -171.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.5 tt0 -129.54 118.67 22.42 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p -106.33 122.46 60.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.62 0.724 . . . . 0.0 111.553 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -139.12 161.19 37.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.0 p -90.28 175.94 6.93 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.164 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.93 -21.5 66.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.19 -18.6 61.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.938 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.47 44.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.925 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.07 138.83 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 15' ' ' VAL . 55.3 tp -79.71 134.38 36.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.09 -38.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -156.93 168.49 27.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -165.54 137.49 4.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.143 0.497 . . . . 0.0 111.971 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 m -113.03 111.41 50.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -68.36 165.79 27.68 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 122.807 2.338 . . . . 0.0 113.339 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.56 -16.07 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.78 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -79.22 -33.73 43.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.07 113.01 6.27 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.327 0.584 . . . . 0.0 109.601 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 137' ' ' VAL . 9.6 Cg_exo -75.59 169.22 22.79 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.572 2.848 . . . . 0.0 113.741 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.507 HD22 ' HE1' ' A' ' 13' ' ' TYR . 14.0 tp -84.1 126.35 33.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 152' ' ' VAL . 20.5 m-20 -104.85 120.6 41.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.732 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 5.4 p90 -150.34 157.39 43.0 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.169 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 147' ' ' LEU . 57.7 tp -102.69 114.61 29.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.511 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 48.6 t60 -69.84 142.39 53.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.384 0.611 . . . . 0.0 111.915 -169.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.91 56.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.473 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -129.52 -7.93 4.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.773 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.55 41.23 8.45 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.975 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.732 ' CB ' ' HB2' ' A' ' 34' ' ' TYR . 51.8 m -71.86 -38.86 70.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -113.43 -102.99 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.262 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.596 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 20.8 pt -116.35 -163.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.035 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.7 t -94.77 -49.06 5.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.391 0.615 . . . . 0.0 110.64 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -79.19 -26.45 57.69 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.984 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.704 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 mt -74.41 -52.76 11.14 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.165 -171.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 23.1 mt-10 -50.63 -49.79 55.94 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.518 0.511 . . . . 0.0 111.384 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.7 m -64.9 -31.8 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.685 0.279 . . . . 0.0 111.737 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.44 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 76.6 mt -61.62 -33.42 73.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.518 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.3 mt-10 -52.14 152.85 3.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.018 0.913 . . . . 0.0 112.819 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.447 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 78.89 -22.6 3.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.932 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.692 ' O ' HG12 ' A' ' 3' ' ' VAL . 96.8 m-70 -82.6 164.45 20.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.591 0.695 . . . . 0.0 110.782 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 46.0 mt-10 -127.2 160.47 31.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.412 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -49.69 143.85 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.563 0.697 . . . . 0.0 112.489 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.03 -15.64 62.61 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.149 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.04 133.91 47.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.904 0.383 . . . . 0.0 110.29 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 6.2 tmmm? -132.14 128.77 38.78 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.259 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.0 p90 -165.43 157.17 14.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.147 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 4.8 p-10 -96.43 141.47 29.69 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.822 0.82 . . . . 0.0 110.198 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 58' ' ' PHE . 8.7 t -117.1 143.91 26.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.13 -173.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -126.5 111.99 15.06 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.882 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' HA3' ' A' ' 44' ' ' GLY . 72.7 t -125.74 137.65 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.045 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 129' ' ' ASN . . . -67.96 152.85 52.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.154 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -52.58 -20.94 3.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.3 -30.36 70.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.67 8.2 11.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.491 0.663 . . . . 0.0 111.352 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.9 -156.09 0.65 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.763 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.5 ' HB2' HD11 ' A' ' 130' ' ' LEU . 1.5 m-85 -80.56 -169.35 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.21 20.91 12.47 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 119.359 -1.401 . . . . 0.0 112.805 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -59.0 168.57 1.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.557 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 20.3 t80 -44.74 123.15 3.54 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.965 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -130.6 113.36 14.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.102 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . 8.8 pt-20 -74.91 -2.54 27.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -77.89 -12.24 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 tp -91.79 -9.99 41.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.383 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' HB ' ' OD1' ' A' ' 120' ' ' ASP . 4.7 p -106.37 132.61 53.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.398 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -157.98 177.39 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.248 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 78' ' ' ARG . 6.3 mpt_? -115.33 114.29 24.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.737 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG1' HG21 ' A' ' 83' ' ' VAL . 5.2 t -106.49 132.94 20.49 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.994 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 83' ' ' VAL . 29.8 Cg_exo -59.18 131.88 43.74 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.12 2.547 . . . . 0.0 111.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 26.4 mtmt -58.29 -24.41 59.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.78 -43.39 85.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.422 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 80' ' ' PRO . 3.4 m -55.67 -32.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HB2' HD11 ' A' ' 90' ' ' LEU . 71.0 m-85 -90.61 40.24 1.01 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.207 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -57.47 -29.07 63.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.355 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.07 -15.43 77.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.958 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.43 HG11 HD23 ' A' ' 90' ' ' LEU . 91.9 t -73.34 142.26 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.849 0.324 . . . . 0.0 110.459 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.13 -67.99 0.35 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.035 0.445 . . . . 0.0 110.952 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -142.37 115.63 8.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.397 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 117' ' ' VAL . 88.6 mt -66.57 98.87 0.54 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.155 0.502 . . . . 0.0 110.161 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 24.5 tt0 -121.5 165.7 15.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.196 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 109' ' ' ILE . 48.2 t -80.24 139.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.03 1.23 79.87 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.255 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 mmm -87.63 135.23 33.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.528 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -111.21 139.58 46.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.333 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.56 154.41 16.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.792 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.65 131.27 37.68 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -119.8 134.94 55.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -88.84 137.24 32.49 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.0 p -145.42 -176.19 5.01 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.024 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -35.6 65.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 110.309 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.01 25.45 6.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.313 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.66 -173.45 53.85 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.789 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 31.4 Cg_exo -58.89 123.97 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.939 . . . . 0.0 112.055 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 107' ' ' VAL . 88.0 t -124.63 113.68 27.19 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.566 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.1 101.46 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.876 2.384 . . . . 0.0 111.347 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.1 m -117.78 173.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 111.211 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.0 136.39 40.28 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.117 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 90' ' ' LEU . 27.2 mt -77.48 129.59 37.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.05 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.6 p -114.79 1.6 14.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.402 0.62 . . . . 0.0 109.937 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.35 153.86 0.35 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.595 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.741 HG13 HG12 ' A' ' 117' ' ' VAL . 61.3 t -139.39 108.55 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -87.42 -156.04 0.32 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.36 -43.97 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 8.5 p-10 -131.94 -15.1 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.007 -170.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -136.58 159.29 42.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.741 HG12 HG13 ' A' ' 112' ' ' VAL . 33.8 m -112.66 162.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.33 116.52 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.198 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -122.59 138.77 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 121.215 0.531 . . . . 0.0 111.376 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 76' ' ' VAL . 57.9 t0 -124.2 126.44 46.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.917 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.66 -22.03 78.74 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.115 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 12.8 m-80 -87.21 111.17 20.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -95.1 -82.18 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.794 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.69 ' HG3' ' H ' ' A' ' 125' ' ' LEU . 19.6 ptt? -76.79 -61.98 1.79 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.24 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.69 ' H ' ' HG3' ' A' ' 124' ' ' MET . 4.8 mp -118.98 -20.34 8.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 170.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 122' ' ' ASN . . . 179.97 -61.36 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.23 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.75 -32.42 4.82 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.858 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -55.78 136.41 51.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.403 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 3.4 m-20 -89.52 156.41 18.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.046 0.451 . . . . 0.0 109.92 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 68' ' ' TYR . 64.1 mt -112.46 147.44 36.5 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.2 mtpp -114.89 122.72 47.17 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.2 m-85 -115.29 121.19 42.11 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 2.9 m-20 -92.86 107.21 19.04 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.76 HG13 HD23 ' A' ' 11' ' ' LEU . 4.0 t -99.66 139.73 20.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.369 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 42.4 mt-10 -132.96 90.84 2.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.899 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 55' ' ' GLY . 2.9 p -66.76 107.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.039 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 31' ' ' PRO . 8.1 t -72.41 -47.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.86 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.59 157.27 27.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.891 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 9' ' ' VAL . 66.0 mt -137.73 134.33 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -143.54 142.76 31.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.3 pt-20 -79.67 126.48 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.78 166.56 12.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 113.017 -166.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p -92.19 23.06 4.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.7 -170.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 69.71 -42.65 0.51 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.184 0.594 . . . . 0.0 111.151 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -63.37 -42.25 98.84 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.486 0.66 . . . . 0.0 109.645 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.59 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.0 mt-10 -61.82 -35.02 77.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.527 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 142' ' ' ALA . 28.7 mt -73.46 -46.5 47.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.144 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.38 -31.89 70.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.536 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -93.39 -31.69 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.907 0.384 . . . . 0.0 110.802 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.16 8.35 41.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.27 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -161.53 179.16 8.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.667 -0.313 . . . . 0.0 110.599 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 155' ' ' ALA . 2.1 t -67.23 152.9 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -113.08 -5.02 13.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.779 0.323 . . . . 0.0 111.676 -172.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -168.88 64.79 0.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.613 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -104.31 -38.54 6.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.833 0.349 . . . . 0.0 111.426 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -78.95 122.88 26.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.138 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.7 159.29 19.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.506 . . . . 0.0 110.899 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -96.35 -3.79 43.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.651 -172.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -147.0 -70.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.739 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 169.28 -46.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -160.41 159.88 31.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.326 -1.306 . . . . 0.0 108.633 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -117.6 -46.21 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 109.836 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.08 47.69 1.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.488 -169.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -73.74 123.35 23.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.396 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -128.21 22.77 6.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -106.4 -166.22 1.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.644 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -94.57 100.66 12.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -73.42 -23.05 60.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -85.36 130.91 34.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.763 -176.511 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.551 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 16.7 ptpt -106.61 168.94 8.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.883 0.849 . . . . 0.0 112.064 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.672 HG11 ' O ' ' A' ' 49' ' ' LEU . 1.1 p -83.43 121.43 36.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.35 -171.62 3.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.945 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 42.1 tttp -63.91 153.5 36.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.762 0.315 . . . . 0.0 110.417 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 147' ' ' LEU . 32.7 m-20 57.57 -5.89 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 141' ' ' GLU . 34.2 mt -90.81 104.44 17.03 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.792 -0.567 . . . . 0.0 110.425 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.4 143.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.45 0.643 . . . . 0.0 111.043 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 139' ' ' ILE . 3.6 m -143.04 153.03 16.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.448 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -111.46 122.51 48.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.532 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -143.64 143.72 31.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -100.99 153.75 19.27 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.717 ' HE2' HD22 ' A' ' 32' ' ' LEU . 51.5 p90 -151.82 159.78 43.78 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.029 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' HD13 ' A' ' 22' ' ' LEU . 42.7 tt0 -126.8 119.45 26.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.9 t -102.21 119.45 50.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.505 -175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.54 151.68 50.74 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.0 p -82.02 -179.75 7.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -56.56 -26.31 54.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.202 0.525 . . . . 0.0 109.922 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.0 m-20 -67.39 -18.81 65.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.15 -11.24 72.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.469 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 19' ' ' ASP . 10.4 p -78.4 136.44 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 111.245 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 25' ' ' GLU . 34.4 tp -69.7 131.1 44.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.478 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.45 -45.94 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.213 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -140.07 149.81 43.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 22' ' ' LEU . 32.9 tt0 -156.21 134.7 11.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.301 0.572 . . . . 0.0 111.861 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.3 m -108.05 116.92 56.22 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 169.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.69 164.34 35.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.744 2.296 . . . . 0.0 113.589 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.91 -14.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.609 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.7 p -80.88 -31.56 35.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.712 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.26 113.3 5.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 109.938 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' A' ' 137' ' ' VAL . 8.8 Cg_exo -75.63 169.16 22.89 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.625 2.883 . . . . 0.0 113.548 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD22 ' HE2' ' A' ' 13' ' ' TYR . 12.4 tp -88.89 129.51 35.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -121.57 119.85 33.11 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.543 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 24.8 m-85 -153.69 162.08 41.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.287 0.565 . . . . 0.0 111.924 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.7 tp -89.18 105.79 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.878 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.559 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 22.6 t60 -65.73 142.98 57.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.43 . . . . 0.0 110.676 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 85.77 18.81 59.21 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.183 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -136.68 18.54 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.456 0.17 . . . . 0.0 110.679 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.67 35.82 92.52 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.56 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 42.2 m -64.78 -39.63 93.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.879 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 1.1 pt? -120.53 -89.1 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.401 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.879 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 12.6 pt -129.32 -166.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 t -97.38 -49.34 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.732 0.777 . . . . 0.0 110.705 -168.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.32 29.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 114.781 -1.1 . . . . 0.0 113.376 -172.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.697 HD11 HG21 ' A' ' 134' ' ' VAL . 28.7 tp -73.34 -46.62 48.24 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 24.0 mt-10 -52.11 -45.23 64.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.127 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -63.49 -38.31 90.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.11 80.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.817 HD21 HG11 ' A' ' 134' ' ' VAL . 95.9 mt -56.88 -33.46 66.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.558 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HA ' HG13 ' A' ' 3' ' ' VAL . 5.8 mt-10 -56.3 153.62 9.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.969 0.89 . . . . 0.0 113.043 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.48 -29.02 2.95 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 114.222 -1.354 . . . . 0.0 116.153 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -120.02 148.45 43.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.319 1.559 . . . . 0.0 112.852 -174.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 1' ' ' MET . 31.3 mt-10 -99.52 173.96 6.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.059 -164.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.9 m -48.94 140.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.885 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.46 61.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.746 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.07 128.79 34.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.063 176.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 2.5 tmmt? -133.63 126.06 30.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.25 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.1 p90 -165.95 160.64 16.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.196 0.522 . . . . 0.0 111.413 -175.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.612 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.691 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.1 t -133.36 142.93 40.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.026 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.6 113.05 10.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.911 0.386 . . . . 0.0 110.201 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 t -127.79 142.47 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.76 155.33 52.97 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.95 -30.5 46.95 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.77 -32.39 73.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 111.303 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.55 0.8 14.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 111.302 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . -126.83 -157.05 0.78 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.547 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.647 ' HB2' ' CD1' ' A' ' 130' ' ' LEU . 9.4 m-85 -79.91 -161.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.08 53.3 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.182 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.97 -178.77 6.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.761 -0.72 . . . . 0.0 109.484 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.454 ' CD1' HG21 ' A' ' 76' ' ' VAL . 54.0 p90 -48.75 151.16 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.286 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.75 90.54 0.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.173 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -74.58 -0.67 18.51 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.26 -8.3 57.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 119.175 0.898 . . . . 0.0 110.518 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.847 HD23 ' HB3' ' A' ' 122' ' ' ASN . 33.1 tp -95.07 -10.16 31.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.649 1.214 . . . . 0.0 109.057 167.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG21 ' CD1' ' A' ' 71' ' ' TYR . 42.1 t -108.65 150.78 11.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.892 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -164.25 173.03 12.81 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.752 . . . . 0.0 110.98 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.7 mpt_? -113.0 109.31 18.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.632 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.5 t -101.59 128.51 28.84 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.511 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.0 Cg_exo -60.42 134.6 56.05 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.829 2.353 . . . . 0.0 112.028 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -50.8 -19.43 0.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.219 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.14 -28.92 65.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.991 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.56 -41.17 63.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.126 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.3 m-85 -98.04 39.94 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 ptm -53.66 -30.45 43.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.809 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.36 13.46 61.92 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.931 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.6 p -93.63 162.32 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.439 0.62 . . . . 0.0 109.743 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.83 -74.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 0.0 110.322 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -153.16 118.08 5.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.841 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.617 ' HB3' HG11 ' A' ' 117' ' ' VAL . 86.5 mt -60.01 109.89 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 110.958 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -138.77 162.47 34.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.944 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.03 146.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.988 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.58 2.27 88.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.431 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.5 mmm -91.69 134.41 34.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.604 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 82.3 mtt180 -113.86 134.71 54.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.196 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -164.33 170.4 16.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.342 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.877 HD11 ' HB2' ' A' ' 104' ' ' PRO . 67.7 tp -87.35 150.22 23.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 100' ' ' THR . . . -144.22 89.48 2.03 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.833 0.825 . . . . 0.0 111.621 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 12.9 mt-10 -38.78 129.9 1.47 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.064 -1.425 . . . . 0.0 112.034 157.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 98' ' ' ALA . 61.2 p -145.96 -174.12 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.65 -44.77 63.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.479 0.657 . . . . 0.0 110.774 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' GLN . 7.4 pt20 -91.64 30.23 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.787 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.62 -176.84 48.18 Favored Glycine 0 C--N 1.319 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.708 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.877 ' HB2' HD11 ' A' ' 97' ' ' LEU . 34.5 Cg_endo -73.84 125.38 9.9 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.456 2.104 . . . . 0.0 112.693 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 107' ' ' VAL . 13.5 t -117.98 113.87 37.47 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.04 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 14.8 Cg_exo -70.56 97.29 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.611 2.208 . . . . 0.0 111.072 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.8 m -117.99 174.64 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.315 -173.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.55 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 24.5 tt0 -134.49 131.44 38.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.259 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.89 124.76 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.953 0.406 . . . . 0.0 110.337 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 p -106.84 -4.6 19.09 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -172.54 155.61 3.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.915 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.573 HG13 HG12 ' A' ' 117' ' ' VAL . 61.8 t -137.43 105.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.034 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.08 -175.94 4.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.8 -53.32 58.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.209 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -121.71 5.18 10.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -146.29 139.91 26.09 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 120.831 -1.168 . . . . 0.0 112.365 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 90' ' ' LEU . 35.3 m -93.58 167.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.189 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 78' ' ' ARG . 43.4 t -131.26 118.44 40.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.5 m -113.74 138.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.062 0.458 . . . . 0.0 111.144 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -136.56 142.75 43.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.825 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.07 7.04 2.34 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.346 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.847 ' HB3' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -130.8 135.35 47.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.738 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -147.58 -42.05 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.206 -0.309 . . . . 0.0 110.953 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -68.08 -5.73 19.16 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.701 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 122' ' ' ASN . 3.6 mm? -79.46 -12.8 59.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.577 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.57 -178.25 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.45 33.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 114.322 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.7 123.08 39.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.748 0.774 . . . . 0.0 110.644 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -79.52 158.9 27.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.237 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.647 ' CD1' ' HB2' ' A' ' 68' ' ' TYR . 90.3 mt -128.46 156.99 42.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 18.9 mtpp -118.02 132.75 56.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.087 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.719 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 2.5 m-85 -123.4 134.96 53.91 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.84 107.74 18.89 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.817 HG11 HD21 ' A' ' 49' ' ' LEU . 4.4 t -99.81 142.93 14.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.45 0.643 . . . . 0.0 112.211 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 37.2 mt-10 -131.84 92.09 3.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.576 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -69.72 110.46 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.833 0.825 . . . . 0.0 111.685 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.3 t -71.95 -47.66 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.13 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.06 158.56 33.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.925 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.757 HG23 HG12 ' A' ' 9' ' ' VAL . 65.5 mt -137.59 132.78 45.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -133.17 138.09 46.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.047 0.451 . . . . 0.0 110.667 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.766 ' HA ' HD22 ' A' ' 7' ' ' LEU . 9.7 pt-20 -77.44 119.29 20.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -64.59 169.51 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.748 -171.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p -113.26 29.51 7.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.761 -167.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.89 ' HA ' HD23 ' A' ' 147' ' ' LEU . 31.1 mt-10 73.31 -33.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.466 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.39 -44.15 72.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.55 -178.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 8.0 mp0 -54.95 -45.65 74.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.66 0.743 . . . . 0.0 109.756 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -65.5 -49.14 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.228 178.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.25 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.847 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -98.08 -9.09 26.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.44 2.74 90.66 Favored Glycine 0 C--N 1.329 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.865 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -164.29 179.79 6.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.925 0.363 . . . . 0.0 110.071 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 155' ' ' ALA . 10.6 t -57.59 -48.31 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.213 0.321 . . . . 0.0 111.641 -173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 75.16 -21.09 0.31 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.581 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.91 125.52 1.16 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -145.62 172.08 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.561 -176.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.1 m170 61.53 30.74 18.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -70.54 -49.9 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 110.733 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -103.03 42.2 1.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.296 0.569 . . . . 0.0 110.775 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -120.22 106.54 12.02 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -76.0 144.43 40.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.95 151.09 27.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.046 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -98.2 83.62 3.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.698 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t70 60.94 70.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.587 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -53.74 131.75 39.95 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.189 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.89 147.48 33.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.838 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 68.4 m80 69.26 116.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.043 0.839 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.41 -19.97 21.51 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -93.99 99.84 12.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.855 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.2 -43.37 2.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -90.95 92.12 8.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.735 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.943 0 O-C-N 123.8 0.688 . . . . 0.0 110.062 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -123.65 169.16 11.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 111.247 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -79.29 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.793 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.58 -172.39 4.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.432 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 87.1 tttt -67.48 161.27 25.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 45.18 9.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.716 HD22 ' HA ' ' A' ' 141' ' ' GLU . 24.3 mt -97.63 108.21 20.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.957 -0.464 . . . . 0.0 110.187 170.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.561 HG21 HG23 ' A' ' 152' ' ' VAL . 14.6 p -55.52 144.01 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 110.596 174.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -150.86 139.34 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.755 -170.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -117.72 148.27 42.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.714 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -165.63 158.0 15.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.01 0.433 . . . . 0.0 110.33 -176.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.38 112.59 18.28 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 32' ' ' LEU . 46.5 p90 -123.82 154.19 39.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.924 -172.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 45.6 tt0 -125.29 118.85 26.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG13 HG23 ' A' ' 23' ' ' VAL . 2.8 p -101.33 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.257 1.027 . . . . 0.0 111.141 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 10.6 ttm180 -135.66 157.15 47.59 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.681 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.611 ' OG1' HG12 ' A' ' 21' ' ' VAL . 40.8 p -78.34 169.87 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.841 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.986 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 48.7 mt-10 -65.44 -20.22 66.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.975 0.416 . . . . 0.0 110.876 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.11 -16.16 30.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 16' ' ' ARG . . . 106.63 27.48 5.47 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.78 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.8 p -105.42 136.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.035 0.917 . . . . 0.0 109.829 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 15' ' ' VAL . 57.0 tp -90.53 127.36 36.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.418 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 15' ' ' VAL . 22.2 m -102.93 -35.88 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.671 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -162.14 169.76 20.29 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.42 129.87 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 m -99.45 106.1 37.41 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.29 163.27 36.99 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.65 2.233 . . . . 0.0 112.882 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.31 -14.77 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.205 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 p -79.43 -30.6 42.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.626 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.47 113.74 5.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.671 ' HB3' HG21 ' A' ' 137' ' ' VAL . 10.1 Cg_exo -75.32 164.7 32.27 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 -174.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.674 ' HB3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -73.9 139.03 44.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.408 166.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.454 ' HB3' HG11 ' A' ' 152' ' ' VAL . 41.9 m-20 -122.25 120.2 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 13.1 p90 -157.6 168.3 27.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.141 0.496 . . . . 0.0 111.409 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -107.94 114.4 28.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.043 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 28.6 t60 -68.29 137.4 54.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.383 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 80.66 26.62 53.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.914 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.95 18.33 4.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 110.86 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.67 36.68 93.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.955 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 69.4 m -65.78 -39.94 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.142 0.496 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.87 160.87 42.31 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 45' ' ' LEU . 5.0 pt -27.93 137.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 123.048 1.404 . . . . 0.0 114.373 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -64.46 -35.75 81.94 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.936 -1.938 . . . . 0.0 111.299 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.602 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -64.07 -34.6 90.36 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.139 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 21.6 tp -75.46 -50.58 15.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.05 -45.6 68.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.337 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.2 m -59.35 -35.71 74.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.434 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -33.98 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.622 0.725 . . . . 0.0 110.438 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 86.9 mt -64.61 -31.71 73.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.896 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.85 155.65 4.22 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.18 -29.1 4.85 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HG12 ' A' ' 3' ' ' VAL . 27.0 p80 -106.33 178.29 4.6 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.172 1.486 . . . . 0.0 110.787 -171.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 1' ' ' MET . 81.8 mt-10 -117.35 170.82 8.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.685 0.278 . . . . 0.0 110.725 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -53.11 144.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.76 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.503 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.29 -20.33 49.89 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.971 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 136' ' ' VAL . 3.4 m-20 -67.42 136.62 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.919 0.359 . . . . 0.0 110.527 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.682 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 4.3 tmmm? -136.98 125.21 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.738 ' CE2' HG22 ' A' ' 60' ' ' VAL . 15.9 p90 -154.51 -179.75 8.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.15 143.5 38.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.738 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -126.91 142.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -134.18 113.07 11.64 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG11 ' HA3' ' A' ' 44' ' ' GLY . 60.8 t -123.97 141.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.565 -174.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.77 150.0 48.75 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.127 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -52.53 -20.42 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.74 -21.78 57.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.295 -0.253 . . . . 0.0 111.442 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -114.34 -9.46 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.954 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.08 -155.68 0.7 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.264 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.556 ' HB2' HD11 ' A' ' 130' ' ' LEU . 7.4 m-85 -81.5 -168.29 1.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.83 20.59 12.58 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.402 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -65.19 170.99 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.822 0.311 . . . . 0.0 111.299 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 76.4 t80 -44.19 123.73 3.58 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -132.1 126.49 33.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.019 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.31 -10.11 59.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -81.44 -9.1 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.728 -0.607 . . . . 0.0 110.877 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 122' ' ' ASN . 54.1 tp -87.73 -10.33 51.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' HB ' HD21 ' A' ' 122' ' ' ASN . 8.8 p -106.17 132.25 53.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.159 0.504 . . . . 0.0 110.665 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -157.78 173.02 17.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.98 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 11.3 mpt_? -110.23 113.35 25.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.764 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.39 132.24 21.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.873 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.61 143.57 99.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.429 2.753 . . . . 0.0 112.692 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 90' ' ' LEU . 6.5 mmmm -54.02 -39.53 66.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.386 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.75 -37.67 79.64 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.683 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.22 -35.3 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.957 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB2' HD11 ' A' ' 90' ' ' LEU . 64.4 m-85 -100.51 40.0 1.31 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.2 ptm -49.15 -32.75 10.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.421 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.78 13.18 65.02 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.617 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.63 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.6 p -85.88 162.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 117.313 0.556 . . . . 0.0 110.21 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.61 -77.86 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.42 119.67 7.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.614 171.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.63 ' HG ' HG11 ' A' ' 87' ' ' VAL . 89.9 mt -60.09 103.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.303 0.573 . . . . 0.0 110.536 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.476 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 32.5 tt0 -123.57 166.3 15.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.156 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.6 t -81.55 140.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.86 1.42 85.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.846 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.476 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.0 mtm -85.88 135.05 33.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 109.938 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -114.02 139.54 49.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.082 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -163.38 170.45 17.49 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.998 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -92.69 126.74 37.91 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.36 127.44 56.01 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.35 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.12 140.39 41.77 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 p -145.0 -175.66 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.999 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.3 -36.71 84.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.528 0.68 . . . . 0.0 110.623 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.2 pt20 -95.61 27.54 3.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.266 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 179.44 46.09 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.14 140.93 94.11 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 122.171 1.914 . . . . 0.0 112.603 174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 99.0 t -135.43 117.49 12.31 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.573 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 7.1 Cg_exo -73.83 108.8 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.783 2.322 . . . . 0.0 111.246 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 11.2 m -118.48 154.6 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.778 0.323 . . . . 0.0 111.084 -174.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 40.8 tt0 -115.37 132.14 56.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.25 0.548 . . . . 0.0 110.336 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 90' ' ' LEU . 23.8 mt -77.53 127.9 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.02 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.401 ' C ' HG13 ' A' ' 92' ' ' VAL . 62.4 p -114.69 1.2 14.12 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.455 0.645 . . . . 0.0 109.53 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 153.52 0.21 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.3 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 117' ' ' VAL . 49.0 t -136.32 107.7 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.25 -157.24 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.12 -50.97 71.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.29 -6.24 3.81 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.825 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 p-80 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.024 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.697 HG12 HG13 ' A' ' 112' ' ' VAL . 30.3 m -107.89 161.71 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.02 110.23 31.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.673 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 12.0 m -113.63 135.12 54.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.615 0.721 . . . . 0.0 112.133 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -135.79 141.32 44.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.666 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.43 18.47 3.06 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.612 ' HB3' HD23 ' A' ' 75' ' ' LEU . 1.6 p-10 -130.51 111.56 12.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.945 0.878 . . . . 0.0 111.34 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.895 ' H ' ' HA ' ' A' ' 126' ' ' ALA . 91.3 m-70 -133.04 -174.97 3.63 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.504 ' HG2' HD22 ' A' ' 125' ' ' LEU . 22.8 ttt -54.83 -48.73 72.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.622 0.646 . . . . 0.0 110.717 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.504 HD22 ' HG2' ' A' ' 124' ' ' MET . 4.1 mm? -87.91 -12.69 43.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.895 ' HA ' ' H ' ' A' ' 123' ' ' HIS . . . 62.99 -69.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.445 1.098 . . . . 0.0 112.849 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.58 -8.68 37.55 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.831 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -80.28 143.9 33.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' HB2' ' CD ' ' A' ' 18' ' ' GLU . 39.4 m-80 -103.25 162.15 13.22 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.351 0.596 . . . . 0.0 110.595 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 68' ' ' TYR . 26.3 mt -115.67 147.79 40.45 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.465 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.986 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 18.4 mtpp -116.18 131.57 56.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 26.4 m-85 -117.11 137.59 52.19 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.179 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.1 m120 -104.66 106.72 17.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 171.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.714 HG13 HD23 ' A' ' 11' ' ' LEU . 8.3 t -102.94 138.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.529 -172.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 17.4 mt-10 -137.47 93.83 2.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.546 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -77.31 116.86 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.058 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 31' ' ' PRO . 11.4 t -75.84 -45.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.975 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.58 152.9 16.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.41 . . . . 0.0 111.282 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 54' ' ' VAL . 81.6 mt -136.71 133.07 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -150.89 139.95 21.07 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.803 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.716 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.3 pt-20 -73.17 125.85 28.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 109.864 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.01 164.96 25.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.002 -176.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p -97.02 23.19 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.537 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.595 ' HA ' HD12 ' A' ' 147' ' ' LEU . 44.7 mt-10 73.17 -31.46 0.23 Allowed 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.635 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.81 -46.64 81.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.836 0.35 . . . . 0.0 111.054 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 36.6 mp0 -54.78 -37.44 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.67 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 142' ' ' ALA . 11.4 mt -74.37 -47.43 34.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.74 -32.55 63.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.688 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -98.77 -25.76 14.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.283 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.02 29.58 25.36 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.617 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -141.84 164.36 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.701 -0.293 . . . . 0.0 110.505 -175.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 8' ' ' VAL . 3.3 p -74.9 -28.07 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.276 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.3 t60 73.61 -75.3 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.666 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.58 -37.82 9.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.179 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 56.48 -104.08 0.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.963 0.505 . . . . 0.0 111.051 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -144.77 -62.08 0.36 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -120.48 84.16 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.309 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -62.53 115.83 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -67.25 104.16 1.41 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.084 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -84.29 96.43 9.01 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.6 162.14 29.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.784 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -141.36 -18.23 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.747 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -80.19 152.52 29.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.083 0.468 . . . . 0.0 111.057 -175.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -157.64 35.66 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.636 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -69.61 114.27 7.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.946 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.73 42.85 3.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -81.69 39.26 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.135 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -95.58 69.43 2.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.171 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -109.09 137.27 47.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.706 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 3.7 t60 73.33 2.09 4.2 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.943 0.777 . . . . 0.0 111.168 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.289 -178.881 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 9.9 ptpt -96.13 168.35 10.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.53 0.681 . . . . 0.0 111.08 -176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -87.28 116.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.524 175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.64 -170.06 3.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.184 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 54.9 tttm -64.46 162.96 14.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 51.27 7.29 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 141' ' ' GLU . 22.2 mt -107.63 155.68 19.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 34' ' ' TYR . 7.4 p -116.31 143.16 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 139' ' ' ILE . 3.7 m -136.86 161.18 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.486 0.66 . . . . 0.0 111.906 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.1 m -125.72 107.75 10.85 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -120.93 161.81 20.93 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.855 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.49 108.09 10.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.1 p90 -126.39 163.77 22.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.154 0.502 . . . . 0.0 110.367 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 59.9 tt0 -128.83 116.88 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.485 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 p -102.94 122.71 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.794 0.807 . . . . 0.0 111.169 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -142.42 164.03 31.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.311 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.509 ' OG1' HG12 ' A' ' 21' ' ' VAL . 58.7 p -83.49 174.19 10.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.461 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.1 -23.23 61.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 110.452 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -15.57 51.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.596 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.58 -16.73 40.47 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.96 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.725 ' HB ' ' HG2' ' A' ' 106' ' ' PRO . 11.4 p -67.31 133.99 30.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 117.906 0.853 . . . . 0.0 111.051 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 25' ' ' GLU . 57.0 tp -81.03 127.79 32.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.695 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 15' ' ' VAL . 29.7 m -103.33 -33.99 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.094 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.6 163.15 32.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.674 ' HB2' HD11 ' A' ' 22' ' ' LEU . 29.1 tt0 -165.3 130.29 2.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.266 0.555 . . . . 0.0 112.063 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 31' ' ' PRO . 28.7 t -103.06 107.72 56.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.95 166.75 25.49 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.364 2.043 . . . . 0.0 111.704 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.39 -17.78 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.435 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 p -79.09 -32.32 44.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.356 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.15 114.09 5.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.068 0.461 . . . . 0.0 110.628 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.759 ' HG3' HG21 ' A' ' 137' ' ' VAL . 7.8 Cg_exo -76.35 169.07 22.68 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.934 3.09 . . . . 0.0 114.38 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.434 HD11 ' HE2' ' A' ' 34' ' ' TYR . 12.0 tp -86.13 128.4 34.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.19 168.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -118.38 119.55 34.93 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 37.1 m-85 -162.3 157.13 22.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.466 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 147' ' ' LEU . 64.0 tp -86.36 113.3 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.23 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -71.32 142.31 50.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 -170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 89.6 24.98 29.11 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.073 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.56 -18.16 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.6 0.238 . . . . 0.0 111.284 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.25 40.67 0.94 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB3' ' CB ' ' A' ' 34' ' ' TYR . 14.6 m -63.86 -45.59 88.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.326 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 45' ' ' LEU . 1.8 pt? -151.65 179.25 8.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 67' ' ' ALA . 11.0 pt -42.13 148.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.462 1.125 . . . . 0.0 112.989 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.1 t -76.53 -40.73 49.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.943 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.24 -32.16 60.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.025 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tp -77.01 -52.71 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.154 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 49' ' ' LEU . 27.4 mt-10 -55.26 -46.03 76.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.062 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.7 m -61.25 -29.58 69.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.052 0.453 . . . . 0.0 111.492 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.84 -34.34 57.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.785 0.802 . . . . 0.0 109.609 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 64.3 mt -69.58 -38.06 77.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.153 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.39 125.26 22.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 112.836 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.73 0.42 34.37 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.338 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 3' ' ' VAL . 98.3 m-70 -101.38 169.2 9.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 54.9 mt-10 -123.15 166.31 15.4 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -47.55 145.73 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 122.066 0.936 . . . . 0.0 112.835 -177.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 85.21 -0.76 88.83 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 114.105 -1.407 . . . . 0.0 114.202 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.98 153.35 42.72 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.877 0.838 . . . . 0.0 109.297 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -149.15 128.52 12.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.245 0.545 . . . . 0.0 109.76 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.662 ' CE2' HG22 ' A' ' 60' ' ' VAL . 25.6 p90 -162.96 177.87 8.85 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -120.1 147.51 44.77 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.662 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -133.39 143.01 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -169.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.0 11.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.952 0.406 . . . . 0.0 110.119 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 44' ' ' GLY . 69.5 t -120.03 142.29 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.21 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.84 152.0 36.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.658 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.19 -21.59 66.31 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -68.57 -18.29 64.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.0 110.751 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.87 -52.95 2.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . -76.97 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.453 -172.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -178.62 -166.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.34 20.29 14.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.83 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -64.68 171.74 3.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.0 111.795 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.539 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 74.3 t80 -68.28 123.48 20.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.265 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -122.18 110.49 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.03 -1.7 21.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.12 -16.64 61.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.549 0.69 . . . . 0.0 109.183 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.674 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 6.9 mp -85.29 -10.72 56.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.643 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.25 124.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.42 166.24 25.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.365 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.583 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.3 mpt_? -107.75 106.56 16.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.617 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.555 ' CG1' HG21 ' A' ' 83' ' ' VAL . 2.8 t -105.46 133.14 20.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.313 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 83' ' ' VAL . 21.4 Cg_exo -61.94 133.79 46.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.851 2.367 . . . . 0.0 111.566 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 37.4 mtmt -56.47 -24.61 46.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.41 -43.27 83.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 80' ' ' PRO . 5.8 m -53.31 -30.03 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.091 0.472 . . . . 0.0 112.101 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HD11 ' A' ' 90' ' ' LEU . 43.4 m-85 -103.1 39.13 1.61 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.605 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -60.8 -30.99 70.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.57 -7.44 88.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.048 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 70.1 t -76.17 146.43 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.913 0.356 . . . . 0.0 110.858 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.48 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.557 0.535 . . . . 0.0 110.884 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -152.7 120.26 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.853 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 84' ' ' PHE . 97.3 mt -68.23 109.36 3.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.288 0.566 . . . . 0.0 111.076 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 36.6 tt0 -127.2 171.05 11.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.861 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 111' ' ' ALA . 55.6 t -83.13 138.43 19.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.01 1.13 88.9 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.732 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.581 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.9 mmm -84.24 134.82 34.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.609 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 5.8 ttt180 -131.91 134.35 45.58 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -159.78 162.76 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.403 HD11 ' CB ' ' A' ' 104' ' ' PRO . 35.1 tp -80.89 127.32 32.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.46 116.22 26.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 40.1 mt-10 -93.37 100.57 12.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.964 0.888 . . . . 0.0 110.096 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.8 p -95.61 -175.79 3.56 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.192 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.27 -30.11 62.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.399 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.0 pt20 -104.63 25.03 10.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.95 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.61 173.27 33.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.382 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 31.2 Cg_exo -62.1 138.26 71.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.993 2.462 . . . . 0.0 112.867 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.65 108.76 12.04 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.725 ' HG2' ' HB ' ' A' ' 21' ' ' VAL . 16.5 Cg_exo -69.2 103.63 1.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.664 2.243 . . . . 0.0 111.215 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.612 ' HB ' HG13 ' A' ' 119' ' ' VAL . 20.6 m -118.13 155.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.121 0.486 . . . . 0.0 111.136 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 38.3 tt0 -122.92 139.41 54.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.756 0.789 . . . . 0.0 109.846 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.672 HG12 HG23 ' A' ' 119' ' ' VAL . 19.9 mt -85.81 132.16 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.471 -173.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.635 HG22 ' SD ' ' A' ' 124' ' ' MET . 64.9 p -113.98 0.9 14.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.268 0.556 . . . . 0.0 109.866 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.493 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 172.77 156.07 0.1 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.86 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 117' ' ' VAL . 48.1 t -139.94 114.98 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.68 -162.39 0.9 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.17 -26.39 62.95 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.247 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.758 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 24.4 m-20 -131.06 -26.03 2.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -133.11 167.15 20.85 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.98 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 112' ' ' VAL . 35.8 m -114.39 165.04 9.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.663 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.4 t -113.79 104.57 17.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.672 HG23 HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -113.24 140.17 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -109.14 145.43 35.76 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.674 ' H ' ' HB3' ' A' ' 75' ' ' LEU . . . -82.29 -5.5 89.55 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -120.4 167.17 12.61 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -73.63 115.29 12.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.635 ' SD ' HG22 ' A' ' 110' ' ' THR . 20.4 ptt? -61.58 -28.74 69.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.706 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -3.66 55.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.465 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.14 -148.77 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.856 0.722 . . . . 0.0 110.809 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.05 0.85 84.0 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 161.76 29.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.334 0.588 . . . . 0.0 111.415 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -108.43 148.12 30.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.535 173.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.88 147.85 31.53 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 5.2 mtpp -116.45 132.08 56.77 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -119.96 126.0 49.78 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 16.9 m120 -100.61 107.24 18.85 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 49' ' ' LEU . 6.6 t -101.22 145.92 10.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.063 -165.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -149.29 97.14 2.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.777 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -76.05 117.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.314 0.578 . . . . 0.0 111.53 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.3 t -76.98 -45.87 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.331 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.2 155.94 23.53 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.186 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 9' ' ' VAL . 62.0 mt -139.7 137.97 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -145.88 142.87 29.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.106 0.479 . . . . 0.0 110.934 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.598 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 pt-20 -80.75 124.82 29.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.094 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -71.4 168.15 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.453 -174.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -103.01 23.28 12.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 147' ' ' LEU . 32.3 mt-10 73.8 -33.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.101 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.99 -41.71 97.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.619 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.647 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 13.8 mp0 -57.65 -39.51 77.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.891 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 142' ' ' ALA . 16.6 mt -70.48 -44.89 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.961 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.08 -34.22 68.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.837 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -100.71 -31.22 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.182 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.16 15.78 50.06 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.286 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -140.01 148.97 42.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.4 p -91.45 -35.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.1 m80 64.13 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.03 31.03 5.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.529 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -114.5 165.82 12.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.3 t60 65.35 43.73 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.404 0.621 . . . . 0.0 109.957 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -101.13 140.81 34.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.732 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -134.31 -48.52 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 m170 61.03 75.64 0.4 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.981 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -122.69 140.24 53.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.241 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.19 81.62 6.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.145 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.07 86.49 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.642 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 125.23 26.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.192 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -125.66 40.85 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.97 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.27 -24.74 60.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.059 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -71.67 109.49 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 111.582 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -140.06 118.88 12.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.085 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.53 -26.79 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.759 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -142.38 -76.1 0.27 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.631 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 55.73 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.775 0.672 . . . . 0.0 112.138 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.209 176.466 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.08 174.69 5.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.58 0.705 . . . . 0.0 111.021 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -88.05 127.63 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.769 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.2 -177.64 6.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 76.6 tttt -55.75 152.0 10.28 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.083 0.24 . . . . 0.0 110.884 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 57.32 -5.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 141' ' ' GLU . 28.1 mt -95.94 104.75 16.71 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.704 -0.622 . . . . 0.0 110.89 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG21 HG22 ' A' ' 152' ' ' VAL . 12.1 p -65.55 142.78 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.712 0.768 . . . . 0.0 111.816 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.865 HG12 HG23 ' A' ' 139' ' ' ILE . 1.3 m -145.32 154.93 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.832 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -120.36 119.11 32.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD13 HG13 ' A' ' 134' ' ' VAL . 4.5 pp -141.13 147.99 39.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -97.85 153.75 18.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.69 160.4 42.73 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.663 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 44.5 tt0 -132.46 118.33 19.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 23' ' ' VAL . 2.6 p -106.92 124.38 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.722 0.772 . . . . 0.0 111.522 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -139.93 165.69 26.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.101 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -81.47 179.28 7.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.319 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' CD ' ' HB2' ' A' ' 129' ' ' ASN . 42.9 mt-10 -66.0 -11.76 50.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.626 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -80.41 -19.3 46.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.105 0.478 . . . . 0.0 110.41 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.32 -17.4 53.79 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.382 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.97 132.32 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.24 140.61 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.315 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 15' ' ' VAL . 2.8 p -113.66 -35.54 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.991 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -168.89 172.16 7.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.663 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 2.9 pt-20 -166.73 159.66 14.09 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.177 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 52.8 m -108.33 110.06 61.73 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 162.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 38.3 Cg_endo -61.02 155.81 48.13 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 C-N-CA 122.78 2.32 . . . . 0.0 113.287 -165.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.45 -7.06 7.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 27' ' ' PRO . 5.8 p -91.21 -26.27 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.32 114.59 5.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.827 ' HG3' HG21 ' A' ' 137' ' ' VAL . 6.6 Cg_exo -74.81 166.03 30.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.465 2.777 . . . . 0.0 114.366 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.06 130.28 35.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.461 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -116.33 127.98 55.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.165 0.507 . . . . 0.0 110.228 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' VAL . 54.6 p90 -160.1 164.61 32.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.416 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' A' ' 147' ' ' LEU . 54.4 tp -103.1 111.15 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.56 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.77 124.06 17.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.569 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 93.35 0.23 67.75 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.943 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -136.54 3.25 2.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.79 92.73 0.09 OUTLIER Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.693 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 m -114.36 8.84 16.76 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.938 0.875 . . . . 0.0 109.449 -166.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 53.17 -89.05 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.454 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 45' ' ' LEU . 23.5 pt -124.5 136.25 61.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 122.265 1.031 . . . . 0.0 110.627 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -48.21 -42.76 30.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.444 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 66' ' ' ASP . . . -69.25 -37.77 81.19 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.443 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 HG21 ' A' ' 134' ' ' VAL . 16.2 tp -75.39 -52.23 11.25 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -173.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.693 ' HG3' ' O ' ' A' ' 40' ' ' SER . 2.5 mm-40 -53.16 -45.11 68.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.26 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.4 m -57.77 -35.78 71.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.257 0.551 . . . . 0.0 111.331 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 -36.1 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.819 0.819 . . . . 0.0 109.606 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.573 ' CD2' HG11 ' A' ' 134' ' ' VAL . 83.4 mt -61.63 -35.64 78.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.014 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -53.86 152.62 5.38 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.11 -6.64 48.86 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 113.408 -1.723 . . . . 0.0 116.65 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.701 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.6 p80 -117.93 -177.29 3.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 119.417 1.608 . . . . 0.0 111.109 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 1' ' ' MET . 45.3 mt-10 -124.06 174.66 7.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -169.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 139' ' ' ILE . 1.4 m -54.41 145.65 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.311 172.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.73 -15.66 56.67 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.852 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.48 143.48 42.55 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 4.0 tmmm? -145.61 131.52 19.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.103 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.756 ' CE2' HG22 ' A' ' 60' ' ' VAL . 17.9 p90 -162.69 159.81 24.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.007 0.432 . . . . 0.0 110.305 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.71 141.11 32.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.014 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.756 HG22 ' CE2' ' A' ' 58' ' ' PHE . 10.5 t -127.95 143.3 41.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.09 112.99 7.75 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.664 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' A' ' 132' ' ' PHE . 14.6 m -127.82 169.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.734 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.26 158.88 29.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.187 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.48 -25.02 9.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.18 0.592 . . . . 0.0 112.563 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -59.86 -27.77 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 111.06 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.447 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 1.5 m-20 -115.94 -5.76 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 42' ' ' ILE . . . -145.72 61.31 1.27 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 p90 39.34 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.352 0.661 . . . . 0.0 111.976 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.21 20.49 48.99 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.592 -1.289 . . . . 0.0 111.833 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -59.93 -179.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -44.6 127.23 5.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.683 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -131.15 119.17 21.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.407 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.93 -8.31 56.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.67 -14.07 52.69 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.665 ' HG ' ' HA3' ' A' ' 121' ' ' GLY . 52.7 tp -88.32 -9.82 51.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.913 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.14 129.76 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.869 174.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -163.18 177.64 8.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.422 0.629 . . . . 0.0 112.341 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HG2' HG22 ' A' ' 118' ' ' VAL . 68.1 mtt180 -99.12 150.0 22.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.82 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 t -143.23 129.0 10.15 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.51 139.09 87.66 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.17 2.58 . . . . 0.0 112.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.674 ' HD3' HD12 ' A' ' 90' ' ' LEU . 20.2 mmtp -52.07 -32.42 34.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.287 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.36 -41.64 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.706 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.18 -37.48 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.052 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HD2' HD11 ' A' ' 90' ' ' LEU . 59.1 m-85 -100.78 40.01 1.32 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.731 0.3 . . . . 0.0 111.224 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.411 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 16.3 ptm -49.67 -37.21 27.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -88.21 13.53 61.48 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.948 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.4 p -90.01 165.79 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 117.388 0.594 . . . . 0.0 110.064 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.79 -71.19 0.12 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -166.16 128.37 1.92 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.674 HD12 ' HD3' ' A' ' 81' ' ' LYS . 92.0 mt -63.9 112.16 2.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.808 0.814 . . . . 0.0 111.359 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.532 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -125.71 161.39 27.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.648 -177.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 109' ' ' ILE . 59.1 t -80.82 136.0 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 1.37 66.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.314 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -87.49 135.79 33.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.094 0.473 . . . . 0.0 110.634 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -113.93 134.42 54.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.728 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -163.21 173.79 12.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.006 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 104' ' ' PRO . 31.2 tp -90.91 120.94 32.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -90.1 174.0 7.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.669 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -128.19 121.79 30.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.328 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.5 p -145.52 175.27 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.731 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -55.1 -36.97 66.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.262 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.0 pt20 -92.27 30.74 1.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.62 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.08 -177.51 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.584 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.0 Cg_exo -58.1 143.72 96.14 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.435 2.09 . . . . 0.0 112.476 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 107' ' ' VAL . 88.1 t -133.78 116.91 13.83 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.05 101.88 0.74 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.65 2.233 . . . . 0.0 111.854 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 5.0 m -118.83 178.31 2.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.005 0.431 . . . . 0.0 111.734 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -135.66 137.41 41.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.32 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 90' ' ' LEU . 23.0 mt -78.01 126.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.813 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 p -110.95 1.54 17.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.426 0.632 . . . . 0.0 109.591 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 179.94 153.11 0.49 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.032 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 117' ' ' VAL . 94.2 t -141.37 109.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.05 -165.05 1.26 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.12 -54.28 15.81 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.491 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -109.21 -3.93 16.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -141.69 147.78 38.04 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.647 -0.658 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 112' ' ' VAL . 35.2 m -111.38 167.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 78' ' ' ARG . 58.8 t -121.58 114.87 44.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.7 m -113.97 137.99 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.545 0.688 . . . . 0.0 111.704 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -118.41 134.2 55.26 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.717 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.665 ' HA3' ' HG ' ' A' ' 75' ' ' LEU . . . -85.16 -20.58 57.05 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.042 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 1.01 ' HB2' ' HA ' ' A' ' 126' ' ' ALA . 5.3 p30 -100.49 135.37 42.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -91.66 -81.35 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.565 ' HG3' ' H ' ' A' ' 125' ' ' LEU . 26.9 ptt? -83.85 -61.54 1.8 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.599 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.565 ' H ' ' HG3' ' A' ' 124' ' ' MET . 3.1 mm? -119.55 -20.24 7.83 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.492 0.663 . . . . 0.0 109.321 170.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 1.01 ' HA ' ' HB2' ' A' ' 122' ' ' ASN . . . -171.45 -71.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.542 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.53 -22.0 4.18 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.97 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -57.39 134.51 56.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.446 ' HB2' ' CD ' ' A' ' 18' ' ' GLU . 49.0 m-80 -87.51 156.3 19.6 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.693 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 67' ' ' ALA . 45.4 mt -124.39 143.14 50.77 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.677 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 40.7 mtpt -115.52 129.02 56.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -118.14 139.78 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.271 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -108.58 108.14 18.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.1 t -99.2 137.44 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.289 -172.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 9.3 mt-10 -136.52 96.11 3.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.86 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 52' ' ' HIS . 38.9 t -76.24 115.85 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.576 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.827 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.0 t -72.96 -49.5 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.892 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.57 156.28 20.64 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.347 -0.22 . . . . 0.0 111.24 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.865 HG23 HG12 ' A' ' 9' ' ' VAL . 67.8 mt -138.99 141.96 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -147.21 141.08 25.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.976 0.417 . . . . 0.0 110.619 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.2 pt-20 -76.23 117.14 17.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.717 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -62.18 155.28 24.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.803 0.811 . . . . 0.0 112.714 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 145' ' ' GLU . 43.2 p -84.19 18.86 1.99 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.223 -1.353 . . . . 0.0 112.066 -171.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 147' ' ' LEU . 30.1 mt-10 68.87 -33.0 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.082 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 143' ' ' THR . 0.4 OUTLIER -66.46 -40.43 89.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.717 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -58.06 -39.9 79.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.02 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 142' ' ' ALA . 14.9 mt -69.1 -45.55 69.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.898 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.66 67.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.853 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -97.52 -6.25 34.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.8 0.71 85.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.832 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.79 173.34 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 8' ' ' VAL . 22.8 t -50.23 -61.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.854 0.722 . . . . 0.0 112.62 -172.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 19.4 t-80 70.18 91.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.254 0.549 . . . . 0.0 110.508 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 113.4 -103.61 1.4 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.29 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . 67.1 19.69 10.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.968 0.507 . . . . 0.0 111.287 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.25 39.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.397 0.618 . . . . 0.0 109.511 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.8 47.1 1.1 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.549 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -91.45 24.19 3.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.446 0.641 . . . . 0.0 110.014 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -107.05 0.94 23.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -120.33 78.34 1.35 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -107.5 -43.68 4.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.873 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -103.93 64.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.247 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -141.75 88.84 2.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -168.88 155.75 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.976 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -130.46 168.55 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.2 m80 69.72 -179.54 0.23 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.659 0.6 . . . . 0.0 111.479 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.26 18.38 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.496 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -107.74 105.4 15.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.036 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -100.9 151.12 22.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.843 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -120.12 -25.34 5.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 167.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 11.5 m80 . . . . . 0 C--O 1.246 0.876 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.562 172.653 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 16.0 ptmt -106.19 171.17 7.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.27 0.557 . . . . 0.0 110.49 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -87.02 120.47 36.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.251 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.19 -172.95 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 7' ' ' LEU . 56.8 tttm -57.73 147.41 27.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.812 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 54.65 -5.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.0 mt -85.34 104.3 15.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.807 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.766 HG22 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -60.55 143.85 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.586 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.835 ' O ' ' HB3' ' A' ' 34' ' ' TYR . 2.3 m -153.18 131.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.217 1.008 . . . . 0.0 111.999 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 2.3 m -100.2 120.92 40.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.737 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -139.35 143.77 37.92 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.619 -0.833 . . . . 0.0 109.786 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -104.33 154.27 20.02 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.796 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 52.9 p90 -149.09 165.04 32.92 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.278 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 31.3 tt0 -131.91 120.77 22.99 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.5 t -103.84 119.64 52.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.5 ptp180 -132.58 151.67 51.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 p -81.95 175.98 9.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.137 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -58.7 -32.07 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.261 0.553 . . . . 0.0 109.721 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.28 -18.23 63.82 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.933 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.89 26.72 15.84 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.563 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 9.1 t -105.17 126.32 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.786 -0.244 . . . . 0.0 110.554 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' GLU . 35.1 tp -67.04 123.35 19.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -109.6 -38.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.565 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.18 152.41 39.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 22' ' ' LEU . 30.8 tt0 -157.1 137.43 12.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 111.753 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 27.1 m -116.7 114.3 39.87 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.17 167.52 19.94 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 C-N-CA 122.824 2.349 . . . . 0.0 112.227 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.18 -17.71 22.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.269 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -78.0 -32.53 51.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.242 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.8 112.83 9.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.277 0.561 . . . . 0.0 110.75 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.726 ' HG3' HG21 ' A' ' 137' ' ' VAL . 10.6 Cg_exo -76.86 169.45 21.66 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 124.271 3.314 . . . . 0.0 114.644 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.796 ' HG ' ' HE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -70.0 158.67 35.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.383 169.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.536 ' H ' HD23 ' A' ' 32' ' ' LEU . 3.9 m-20 -91.43 149.62 21.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.085 0.945 . . . . 0.0 110.949 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.835 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.08 126.91 42.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -161.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.625 HD11 HD23 ' A' ' 147' ' ' LEU . 14.7 tp -148.44 98.54 2.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 146.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.515 ' HA ' ' OG ' ' A' ' 40' ' ' SER . 21.2 t60 -70.82 136.19 48.6 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.412 -164.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.55 27.32 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.471 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.14 18.32 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.671 0.748 . . . . 0.0 110.173 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.83 90.8 0.18 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.98 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 41' ' ' LEU . 11.0 m -116.63 -52.27 2.56 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.726 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.75 -173.42 2.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 111.568 -2.56 . . . . 0.0 108.518 170.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 41' ' ' LEU . 13.7 pt -33.14 143.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -66.47 -41.08 89.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.741 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.14 -41.41 94.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.773 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 134' ' ' VAL . 29.8 tp -73.95 -48.89 27.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.6 mt-10 -50.74 -47.86 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.113 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.5 m -63.45 -36.83 85.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.656 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.1 72.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.467 0.651 . . . . 0.0 110.015 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 134' ' ' VAL . 83.9 mt -59.0 -37.07 76.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.664 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.0 mt-10 -53.32 152.04 4.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . 82.82 -22.49 6.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.371 -1.286 . . . . 0.0 114.183 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.509 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.8 m-70 -83.39 179.26 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.451 0.643 . . . . 0.0 111.954 -175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.6 mt-10 -134.73 161.85 34.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.483 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.2 m -52.61 143.26 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.691 0.619 . . . . 0.0 111.11 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 97.39 -17.13 59.56 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.689 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -64.94 132.54 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.742 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 13.7 tmtt? -137.17 130.19 30.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.656 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 60' ' ' VAL . 21.0 p90 -166.57 163.49 16.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.993 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.11 143.38 26.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.598 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.713 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.9 t -131.43 142.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.122 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.97 113.49 13.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.035 0.445 . . . . 0.0 109.893 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 44' ' ' GLY . 99.7 t -125.9 136.88 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.508 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.52 148.23 45.03 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.12 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 128' ' ' GLN . . . -62.82 -21.61 66.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -68.95 -19.64 64.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.019 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.3 -42.02 4.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.922 0.391 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . -81.81 -88.35 0.08 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.943 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -166.74 172.72 10.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.82 21.05 11.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.348 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -72.59 148.21 45.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.534 ' CE2' ' HB3' ' A' ' 73' ' ' GLU . 58.4 t80 -95.56 110.0 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.093 0.473 . . . . 0.0 110.32 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -85.87 84.66 7.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.47 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 4.8 pt-20 -70.54 -14.99 62.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.057 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -86.09 -4.04 59.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.893 0.378 . . . . 0.0 110.577 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.6 tp -102.58 -10.41 19.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.461 0.648 . . . . 0.0 110.135 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 73' ' ' GLU . 4.3 p -115.44 117.68 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.454 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -161.81 176.81 10.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.523 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.9 mpt_? -111.02 111.5 22.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.207 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.49 133.28 20.25 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.461 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -60.98 135.01 56.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.76 2.307 . . . . 0.0 111.836 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 23.8 mtmt -59.11 -17.52 27.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.327 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.52 -27.37 64.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.42 0.629 . . . . 0.0 110.154 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.9 -36.4 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HB2' HD11 ' A' ' 90' ' ' LEU . 26.3 m-85 -102.1 40.02 1.4 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.179 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.7 ptm -56.54 -24.33 46.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.361 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.39 4.7 83.35 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.198 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 HD23 ' A' ' 90' ' ' LEU . 69.5 t -89.56 149.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.902 0.351 . . . . 0.0 110.477 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.17 -70.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 110.878 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.72 105.38 4.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.626 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 84' ' ' PHE . 80.8 mt -60.17 107.59 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.341 0.591 . . . . 0.0 110.392 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -128.27 167.52 16.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.26 140.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.05 2.43 77.86 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.483 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 mmm -89.21 135.53 33.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.101 0.476 . . . . 0.0 109.718 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.83 135.39 54.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.691 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -164.15 167.45 20.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.112 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.3 tp -84.33 130.6 34.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -113.16 142.72 45.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.994 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.62 132.95 35.45 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.3 p -146.81 -175.64 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.81 -30.88 70.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.592 0.71 . . . . 0.0 109.901 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -86.71 24.45 1.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.636 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.79 -171.67 55.15 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.185 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 32.6 Cg_exo -58.63 128.57 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.231 1.954 . . . . 0.0 111.631 170.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -128.85 116.43 19.23 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 14.8 Cg_exo -70.74 102.7 1.22 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.939 2.426 . . . . 0.0 111.861 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.5 m -118.37 172.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.777 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.98 131.53 40.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.82 128.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 120' ' ' ASP . 39.4 p -113.66 0.31 14.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.323 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -175.52 153.27 1.45 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.093 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.766 HG13 HG12 ' A' ' 117' ' ' VAL . 57.5 t -140.78 106.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.84 -172.61 3.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.31 -49.03 65.81 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.225 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.547 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 10.0 m-20 -104.83 -14.35 15.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -143.53 149.04 36.89 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.574 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -104.58 168.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.114 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.2 t -124.0 122.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m -115.63 133.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 112.012 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 110' ' ' THR . 14.3 t70 -144.36 106.83 4.39 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.797 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.97 14.2 55.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.431 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -113.09 168.86 9.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -109.2 136.23 49.01 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.24 -5.69 5.46 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.901 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.0 mp -84.17 11.5 8.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.149 0.499 . . . . 0.0 110.216 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.33 148.31 35.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.759 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 106.01 -29.96 10.42 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.67 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.0 mt-30 -72.74 162.98 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -96.93 162.5 13.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -128.17 145.77 50.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.028 -169.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -117.11 128.54 55.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 3.5 m-85 -119.71 133.77 55.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.472 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -104.33 108.69 20.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.737 HG13 HD23 ' A' ' 11' ' ' LEU . 5.6 t -98.67 142.5 14.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.505 0.669 . . . . 0.0 112.145 -170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.742 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 44.0 mt-10 -130.93 90.85 2.96 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.192 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -68.86 114.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.854 0.835 . . . . 0.0 111.957 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 31' ' ' PRO . 15.8 t -71.54 -51.9 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.047 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -158.58 158.45 33.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.885 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.682 HG23 HG12 ' A' ' 9' ' ' VAL . 75.9 mt -137.35 134.58 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 41.6 ttm180 -154.38 138.99 16.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' HD22 ' A' ' 7' ' ' LEU . 16.1 pt-20 -70.85 123.34 21.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -62.75 164.23 8.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.2 p -97.54 25.27 5.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' LEU . 38.7 mt-10 72.81 -36.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.369 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.0 -48.71 79.1 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.565 0.221 . . . . 0.0 110.693 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 12.7 mp0 -55.68 -39.42 70.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.625 HD23 HD11 ' A' ' 35' ' ' LEU . 19.2 mt -68.76 -47.32 66.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.168 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.2 73.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.19 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -84.58 -19.28 33.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.239 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 81.93 10.24 84.27 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.007 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.02 172.93 1.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 155' ' ' ALA . 21.0 t -65.44 -65.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.522 ' HA ' ' OD2' ' A' ' 157' ' ' ASP . 43.0 t60 59.15 86.64 0.09 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.409 0.623 . . . . 0.0 109.908 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.36 2.38 1.55 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.387 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -109.2 -74.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.005 0.431 . . . . 0.0 110.584 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -80.36 -10.36 59.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.573 0.702 . . . . 0.0 109.833 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 153' ' ' HIS . 20.0 p-10 -128.05 69.53 1.34 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.987 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -117.01 -23.27 8.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.387 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -81.77 122.1 27.25 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.16 -27.42 0.07 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -170.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -73.38 -24.47 60.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.686 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -85.38 135.74 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.097 0.475 . . . . 0.0 109.739 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.98 40.58 0.73 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.619 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.36 110.81 1.17 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 111.124 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -110.03 34.1 4.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.189 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -97.33 -36.65 10.32 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.784 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 170' ' ' HIS . 1.8 m170 58.53 78.99 0.23 Allowed 'General case' 0 C--O 1.237 0.423 0 O-C-N 123.723 0.64 . . . . 0.0 111.197 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.09 45.14 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.546 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 168' ' ' HIS . 54.6 t-80 -157.76 124.27 4.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 107.633 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.497 -178.63 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 19.2 ptmt -133.14 166.18 23.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.3 p -72.42 115.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.068 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.32 -171.0 3.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.008 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 83.3 tttt -64.97 158.04 26.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.223 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' O ' HD21 ' A' ' 147' ' ' LEU . 3.6 p30 55.69 0.3 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 113.907 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 141' ' ' GLU . 15.6 mt -96.45 110.51 22.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.044 0.45 . . . . 0.0 111.295 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 HD13 ' A' ' 35' ' ' LEU . 49.7 t -53.73 143.43 5.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.708 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -141.89 134.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -111.99 111.7 22.81 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD13 HG13 ' A' ' 134' ' ' VAL . 2.3 pp -128.76 161.12 30.48 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.854 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.6 147.31 42.96 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.667 ' CE1' HD12 ' A' ' 32' ' ' LEU . 36.7 p90 -160.93 162.19 31.91 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.436 -0.905 . . . . 0.0 111.452 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.0 tt0 -133.57 121.07 21.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.4 p -113.7 125.93 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.598 0.713 . . . . 0.0 111.361 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -144.07 176.03 9.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.335 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.3 p -98.03 178.05 5.22 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.528 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.2 -20.86 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.263 0.554 . . . . 0.0 110.153 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' HG23 ' A' ' 21' ' ' VAL . 18.2 t70 -78.26 -18.07 55.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.384 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.39 6.02 53.65 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 19' ' ' ASP . 5.2 t -77.04 112.92 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 15' ' ' VAL . 58.3 tp -68.97 119.43 13.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 15' ' ' VAL . 31.0 m -96.52 -39.19 8.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 32.5 t70 -156.56 160.15 39.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 43.1 tt0 -159.05 133.54 7.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 0.0 111.971 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 m -116.25 105.08 51.28 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.26 168.27 18.14 Favored 'Trans proline' 0 CA--C 1.523 -0.068 0 C-N-CA 122.91 2.407 . . . . 0.0 113.035 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.02 -19.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.548 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.4 p -75.83 -38.95 57.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -133.93 112.65 12.47 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.237 0.541 . . . . 0.0 109.873 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.493 ' HB3' HG21 ' A' ' 137' ' ' VAL . 12.9 Cg_exo -75.53 169.76 21.68 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.994 3.13 . . . . 0.0 114.723 -175.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -86.6 131.49 34.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.603 168.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.57 118.28 26.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.645 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 23.1 m-85 -160.15 -179.72 7.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.263 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 147' ' ' LEU . 60.2 tp -107.98 115.74 30.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.65 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 14.9 t60 -73.99 130.87 40.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 109.45 6.38 29.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.774 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -148.15 9.66 0.87 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.12 104.34 2.51 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -167.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 34' ' ' TYR . 39.4 t -118.33 -50.85 2.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.2 pt? -158.09 -168.89 2.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.817 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 10.7 pt -39.77 144.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -66.51 -39.46 88.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.076 -1.874 . . . . 0.0 112.185 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.506 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -65.53 -39.48 95.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.352 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 134' ' ' VAL . 16.5 tp -74.37 -49.79 21.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 109.864 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 49' ' ' LEU . 23.3 mt-10 -48.5 -47.2 39.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.4 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.9 m -66.48 -32.97 74.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.7 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.41 74.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.8 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -57.91 -45.13 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.161 175.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.2 mt-10 -46.55 152.35 0.47 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.949 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 79.11 -23.59 3.17 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 114.428 -1.26 . . . . 0.0 114.594 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.2 m-70 -84.49 177.55 8.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.664 0.732 . . . . 0.0 111.163 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 1' ' ' MET . 39.5 mt-10 -128.72 164.57 22.66 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.1 m -52.04 142.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.819 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.87 -13.11 66.66 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.473 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.52 131.38 44.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.941 0.4 . . . . 0.0 110.327 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.565 ' CG ' ' HG2' ' A' ' 135' ' ' GLU . 1.9 tmtp? -137.96 130.33 29.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.913 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.5 p90 -167.4 162.01 14.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.037 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.77 144.11 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.626 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -134.32 142.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.31 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.95 113.2 11.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG11 ' HA3' ' A' ' 44' ' ' GLY . 80.3 t -120.78 138.22 51.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.876 0.37 . . . . 0.0 110.652 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.85 150.32 50.37 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.367 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.54 -31.39 4.33 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -65.16 -21.11 66.73 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -117.06 3.69 12.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 176.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -132.15 -152.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HB2' HD11 ' A' ' 130' ' ' LEU . 44.6 m-85 -76.32 157.45 32.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.11 22.2 10.96 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.604 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -57.45 120.6 8.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.202 1.001 . . . . 0.0 112.731 -169.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' HB2' ' OD1' ' A' ' 122' ' ' ASN . 54.9 p90 -63.4 152.54 37.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.06 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.51 116.09 14.8 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 76' ' ' VAL . 2.9 tt0 -73.32 -13.28 61.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -66.31 -3.67 6.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 122' ' ' ASN . 88.0 mt -112.66 -10.41 13.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.227 0.536 . . . . 0.0 110.975 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 73' ' ' GLU . 2.5 p -100.46 154.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.336 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -161.7 171.86 17.19 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 118' ' ' VAL . 8.4 mpt_? -116.26 105.36 12.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 109.737 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.17 128.62 36.28 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.952 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.32 137.1 72.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.592 2.862 . . . . 0.0 112.216 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.903 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -56.1 -25.57 46.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.113 175.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.04 -36.42 81.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.462 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -43.16 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.316 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.7 m-85 -90.4 40.21 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 14.7 ptm -52.13 -36.54 51.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.144 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -92.32 13.94 65.92 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.984 -175.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.781 HG11 ' HG ' ' A' ' 90' ' ' LEU . 7.4 p -75.79 159.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.272 0.536 . . . . 0.0 111.129 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 87' ' ' VAL . 19.5 t70 -68.67 -76.03 0.1 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.859 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -149.77 110.51 4.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.217 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HG ' HG11 ' A' ' 87' ' ' VAL . 5.6 mt -64.58 119.54 10.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.652 0.739 . . . . 0.0 111.45 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 30.5 tt0 -147.03 164.89 31.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.471 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 111' ' ' ALA . 53.3 t -81.21 132.68 30.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.04 1.82 56.0 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.83 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.42 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 mmm -91.09 141.86 28.37 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.226 0.536 . . . . 0.0 111.292 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 10.7 mtp180 -118.24 134.54 54.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.043 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -162.01 167.09 25.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.078 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 104' ' ' PRO . 44.6 tp -91.31 137.3 32.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.192 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.84 138.14 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.09 146.91 28.42 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.5 p -145.74 -175.55 4.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.17 -23.57 67.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.84 0.828 . . . . 0.0 110.514 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.84 26.84 10.27 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.549 -171.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.89 -179.31 48.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.135 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 97' ' ' LEU . 42.3 Cg_exo -57.82 133.39 55.83 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.375 2.05 . . . . 0.0 112.903 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 88.9 t -129.53 116.39 18.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.549 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.9 Cg_exo -79.75 112.97 2.98 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.889 2.393 . . . . 0.0 111.19 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.8 m -118.23 178.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.743 0.306 . . . . 0.0 111.196 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' C ' HG12 ' A' ' 119' ' ' VAL . 36.7 tt0 -134.53 130.84 37.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 112' ' ' VAL . 40.7 mt -71.89 130.44 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.327 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.9 p -112.05 -1.87 15.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 0.0 110.382 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . -175.34 150.24 1.11 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.485 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.624 HG13 HG12 ' A' ' 117' ' ' VAL . 60.8 t -139.08 106.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 6.9 mm-40 -86.0 -157.31 0.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -71.33 -54.09 11.97 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.866 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.492 ' C ' ' HG2' ' A' ' 81' ' ' LYS . 18.5 m-20 -118.14 5.86 12.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.41 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 33.1 p-80 -145.1 148.03 33.2 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.461 -0.774 . . . . 0.0 111.574 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.755 HG13 ' HZ3' ' A' ' 81' ' ' LYS . 30.7 m -116.35 167.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.5 t -122.53 115.88 47.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.967 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -119.05 130.57 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.069 0.462 . . . . 0.0 110.333 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -108.38 153.19 23.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.986 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.17 2.73 40.55 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.62 ' ND2' ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -127.39 162.2 26.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.8 -35.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.5 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -8.3 56.96 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.393 -0.192 . . . . 0.0 111.511 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.62 ' HB2' ' ND2' ' A' ' 122' ' ' ASN . 7.3 mp -83.37 -10.95 58.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.416 0.627 . . . . 0.0 109.489 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -137.42 -153.6 0.5 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.96 -12.99 59.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.17 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.15 106.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.92 0.39 . . . . 0.0 111.053 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -82.52 126.55 32.39 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 68' ' ' TYR . 92.1 mt -106.08 154.99 19.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.742 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -124.17 122.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 110.048 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 1.6 m-85 -117.83 139.81 50.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.704 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.9 m120 -109.36 106.67 16.57 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 45' ' ' LEU . 2.5 t -99.61 135.62 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.565 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 25.9 mt-10 -135.54 90.83 2.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.272 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 54' ' ' VAL . 2.9 p -72.69 115.0 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.846 0.831 . . . . 0.0 112.446 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.2 t -72.91 -47.91 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.124 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.03 157.59 31.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.751 0.31 . . . . 0.0 111.147 -171.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 54' ' ' VAL . 63.5 mt -140.34 123.46 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -146.97 137.05 23.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.999 0.428 . . . . 0.0 111.351 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.449 ' HB3' HD22 ' A' ' 7' ' ' LEU . 7.9 pt-20 -75.49 138.66 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -80.51 176.77 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.682 0.754 . . . . 0.0 112.589 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p -96.34 23.43 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.269 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 70.17 -43.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.365 0.666 . . . . 0.0 111.444 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.79 -40.26 91.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.365 0.602 . . . . 0.0 109.38 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.581 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 42.4 mt-10 -63.15 -34.27 77.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.381 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 35' ' ' LEU . 47.2 mt -71.98 -47.4 52.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.139 176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.48 69.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.52 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.04 -16.76 18.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.87 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.79 40.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 114.243 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -169.87 166.0 9.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.373 0.587 . . . . 0.0 110.635 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.2 133.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 123.576 0.548 . . . . 0.0 111.007 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -124.67 80.07 1.82 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 153.74 43.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.949 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -99.08 -76.06 0.55 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.12 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.0 t60 66.45 120.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.728 0.643 . . . . 0.0 110.952 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.83 132.66 35.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.179 0.514 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -121.19 86.36 2.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.04 0.924 . . . . 0.0 109.157 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -87.67 157.86 18.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.36 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -113.36 123.1 49.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.177 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -106.96 177.23 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.476 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -150.09 147.56 27.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.014 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 65.58 31.57 9.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.212 171.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.41 151.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.87 171.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -155.67 126.36 6.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.834 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -127.19 29.06 5.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -116.78 -21.05 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.51 98.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.527 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -166.04 -40.98 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.035 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -135.15 97.36 3.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.553 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.569 -177.192 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 51' ' ' GLY . 15.2 ptpt -111.11 170.83 7.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.481 0.657 . . . . 0.0 111.729 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -84.94 131.96 32.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.16 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.12 -174.12 4.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.527 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 79.5 tttt -65.96 155.86 35.28 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 147' ' ' LEU . 28.7 m-20 60.37 -5.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 141' ' ' GLU . 19.3 mt -90.71 109.66 20.84 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.613 -0.679 . . . . 0.0 111.454 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.0 144.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.046 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -151.16 137.75 12.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -168.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 10.9 m -102.45 121.24 41.95 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 134' ' ' VAL . 2.1 tt -136.9 154.31 50.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.425 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . . . -124.36 151.24 44.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.48 161.33 21.28 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.04 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 51.8 tt0 -132.15 118.94 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.557 HG11 ' OH ' ' A' ' 68' ' ' TYR . 2.9 p -110.32 124.4 67.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.536 0.684 . . . . 0.0 111.388 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -145.41 -179.84 6.92 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 p -99.91 174.58 6.12 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.253 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 43.6 mt-10 -65.43 -19.22 65.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.421 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.07 -18.72 55.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.577 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.36 -12.01 43.59 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.515 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.53 126.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 117.427 0.614 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 15' ' ' VAL . 51.5 tp -76.96 127.97 33.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.86 -35.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -167.47 167.06 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.665 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -165.64 159.35 16.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.5 0.667 . . . . 0.0 111.212 169.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -126.07 114.59 24.04 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.42 166.06 26.86 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.789 2.326 . . . . 0.0 113.218 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.94 -22.89 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.436 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.2 p -71.41 -38.95 71.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.871 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -135.34 113.05 11.14 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-O 121.269 0.557 . . . . 0.0 110.151 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.3 Cg_exo -75.81 166.58 27.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.9 3.067 . . . . 0.0 114.439 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD11 ' HE2' ' A' ' 34' ' ' TYR . 14.8 tp -85.62 134.17 34.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.485 170.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.07 118.18 30.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.167 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' HD11 ' A' ' 32' ' ' LEU . 50.0 m-85 -160.69 179.75 8.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.195 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.93 117.95 35.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 31.9 t60 -70.79 128.99 37.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 96.48 8.19 57.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.889 172.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -134.31 14.58 3.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.15 103.29 2.3 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -167.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 36' ' ' HIS . 33.4 t -116.61 -52.31 2.56 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.39 -82.81 0.24 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.122 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.585 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 15.5 pt -122.59 -163.43 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 t -98.02 -50.09 4.52 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.492 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.05 -34.81 29.11 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.956 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.693 HD11 HG21 ' A' ' 134' ' ' VAL . 55.5 tp -74.24 -46.55 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 109.988 -172.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 48.3 mt-10 -50.79 -41.74 57.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.259 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -65.15 -33.23 75.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.72 -35.57 65.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.015 0.912 . . . . 0.0 109.273 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.916 HD21 HG11 ' A' ' 134' ' ' VAL . 96.2 mt -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.953 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.74 152.57 5.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.997 0.903 . . . . 0.0 112.772 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' O ' ' HE2' ' A' ' 2' ' ' LYS . . . 77.9 -18.39 5.02 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.749 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 4.7 p-80 -128.65 157.31 41.67 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.377 2.089 . . . . 0.0 112.921 -173.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 1' ' ' MET . 41.4 mt-10 -101.98 166.32 10.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -157.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.628 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.6 m -48.12 144.21 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.046 -1.433 . . . . 0.0 112.714 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.58 -10.34 66.75 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.286 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.749 ' OD2' ' HD2' ' A' ' 52' ' ' HIS . 2.8 t0 -75.43 137.06 40.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.166 0.507 . . . . 0.0 110.171 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 2.1 tmtp? -137.76 132.37 32.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.921 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 60' ' ' VAL . 7.2 p90 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.045 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.39 139.84 33.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.779 0.799 . . . . 0.0 111.305 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.661 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.4 t -125.67 150.42 30.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.428 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.48 113.96 11.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.037 0.381 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.85 144.66 37.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.189 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.36 152.64 49.89 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.155 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' A' ' 70' ' ' GLN . . . -55.2 -28.35 52.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.979 0.512 . . . . 0.0 112.258 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -71.43 -20.74 62.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.949 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -111.73 1.35 16.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.519 0.676 . . . . 0.0 110.416 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -128.01 -98.99 0.37 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.51 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.557 ' OH ' HG11 ' A' ' 15' ' ' VAL . 3.3 p90 -179.42 -173.68 0.28 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.5 19.57 51.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.622 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.702 ' HG3' ' HB1' ' A' ' 64' ' ' ALA . 21.1 mp0 -65.09 111.18 2.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 2.1 t80 -108.0 110.78 22.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 165.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' HB3' ' HA ' ' A' ' 122' ' ' ASN . 12.8 t0 -101.07 80.59 2.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.114 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 76' ' ' VAL . 6.1 pt-20 -74.76 -11.36 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -87.04 -19.66 28.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.191 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.55 -11.19 38.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.991 0.424 . . . . 0.0 111.64 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 73' ' ' GLU . 14.2 p -79.15 142.27 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -158.74 176.67 12.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.455 0.645 . . . . 0.0 111.606 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.611 ' HG3' HG22 ' A' ' 118' ' ' VAL . 4.8 mpt_? -115.16 148.93 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.17 129.46 12.31 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -171.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.5 Cg_exo -57.21 136.57 77.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.051 2.5 . . . . 0.0 112.422 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -54.44 -31.6 55.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.495 178.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.93 -35.14 79.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 80' ' ' PRO . 88.1 t -57.01 -36.3 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.156 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HB2' HD11 ' A' ' 90' ' ' LEU . 45.6 m-85 -104.81 39.87 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.405 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.3 ptm -53.65 -27.22 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.527 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 3.07 85.7 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.387 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 95.0 t -92.78 144.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.091 0.446 . . . . 0.0 111.098 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.01 -77.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.076 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -134.2 106.64 7.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.722 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 117' ' ' VAL . 96.8 mt -59.68 105.52 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.438 0.637 . . . . 0.0 109.622 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -128.91 167.81 16.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.085 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 111' ' ' ALA . 43.8 t -79.83 135.24 25.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.5 1.19 68.98 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.137 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mmm -83.93 134.57 34.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.405 0.622 . . . . 0.0 109.688 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -119.33 136.08 54.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.09 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -163.65 165.27 23.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 104' ' ' PRO . 5.6 mt -88.44 132.76 34.34 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.54 0.686 . . . . 0.0 110.518 172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -112.61 114.07 26.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.079 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 26.2 mt-10 -87.32 96.64 10.42 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 110.788 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 p -94.67 -174.52 3.32 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.577 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.33 -43.54 61.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.308 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.5 pt20 -98.47 32.01 2.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.034 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.23 179.83 39.59 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.76 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HB2' HD22 ' A' ' 97' ' ' LEU . 6.2 Cg_exo -66.77 147.77 81.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.516 2.144 . . . . 0.0 112.03 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -134.22 117.09 13.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.801 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.5 Cg_exo -74.01 102.34 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 111.722 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 6.2 m -118.73 151.84 20.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 110.721 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.62 137.85 51.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.225 0.536 . . . . 0.0 110.318 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.5 mt -81.57 129.26 37.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.086 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.3 p -115.53 5.27 14.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 151.45 0.17 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 117' ' ' VAL . 49.1 t -140.91 109.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -91.22 -154.1 0.34 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.05 -36.2 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -133.27 -14.83 2.58 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.179 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -139.38 157.59 45.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.536 0.208 . . . . 0.0 110.725 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 112' ' ' VAL . 30.5 m -112.77 167.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 78' ' ' ARG . 41.4 t -117.19 117.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.7 m -120.39 140.03 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.638 0.733 . . . . 0.0 112.302 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.89 145.85 47.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.536 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.27 46.49 0.54 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 111.942 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.657 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 58.4 m-20 -38.65 130.24 1.4 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.949 0.9 . . . . 0.0 112.929 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.657 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 11.2 t-80 -156.88 -81.42 0.07 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.88 ' HG3' ' HG ' ' A' ' 125' ' ' LEU . 23.3 ptt? -84.27 -49.64 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -162.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.88 ' HG ' ' HG3' ' A' ' 124' ' ' MET . 39.9 mt -108.92 32.98 4.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -165.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 71' ' ' TYR . . . -47.79 -66.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.678 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.14 -3.68 82.54 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.396 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -55.17 121.14 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -97.08 125.62 41.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.7 mt -104.23 152.73 21.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 23.0 mtpp -122.04 125.63 46.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 2.8 m-85 -116.02 134.54 54.85 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.355 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -105.44 106.62 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.916 HG11 HD21 ' A' ' 49' ' ' LEU . 4.0 t -99.09 139.65 20.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.725 0.774 . . . . 0.0 112.286 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.697 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 37.0 mt-10 -131.48 91.49 3.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.811 -1.541 . . . . 0.0 109.465 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.628 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.5 p -63.56 154.27 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 11' ' ' LEU . 76.0 t -129.44 -55.31 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 -153.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.91 38.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 110.419 -3.082 . . . . 0.0 109.876 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 54' ' ' VAL . 74.9 mt -138.91 133.51 41.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.9 ttp-105 -139.52 154.18 47.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.0 110.171 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.651 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.1 pt-20 -91.55 132.38 36.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.2 163.81 27.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.749 . . . . 0.0 112.243 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -94.64 24.51 4.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.972 -171.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 70.52 -38.71 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.06 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -40.22 82.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.684 ' HG2' ' HA ' ' A' ' 152' ' ' VAL . 25.7 mt-10 -58.97 -37.12 76.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.999 175.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 142' ' ' ALA . 23.0 mt -71.07 -46.02 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.084 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.92 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.425 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -89.76 -14.85 33.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.335 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.67 90.37 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.714 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -169.12 169.36 9.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.684 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 38.9 t -53.32 -71.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 123.697 0.623 . . . . 0.0 112.452 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.3 t60 56.91 72.61 0.5 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.561 -174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.6 -99.93 2.07 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.731 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 59.68 -168.15 0.16 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.829 0.452 . . . . 0.0 110.838 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -142.14 110.43 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -146.07 -70.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.896 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.51 119.43 39.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.026 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -142.22 148.83 38.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.374 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.616 ' HB3' ' HB2' ' A' ' 163' ' ' ASP . 31.7 m170 -106.96 135.52 48.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.374 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -131.76 123.93 28.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 56.32 41.17 29.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 109.85 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.616 ' HB2' ' HB3' ' A' ' 160' ' ' HIS . 19.1 t70 -77.74 -40.77 39.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -104.32 139.3 39.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.68 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 168' ' ' HIS . 33.9 t70 60.59 65.97 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.945 0.778 . . . . 0.0 110.709 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -106.63 -19.21 13.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.666 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -97.55 17.77 16.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.717 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 92.3 m-70 -136.49 160.07 39.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.8 m80 73.42 -53.79 0.69 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.873 0.733 . . . . 0.0 111.783 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -135.14 126.83 29.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.693 0.283 . . . . 0.0 110.444 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 119.034 -0.508 . . . . 0.0 110.096 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.537 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 ptpt -111.73 174.63 5.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.43 0.633 . . . . 0.0 111.268 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -83.51 125.05 40.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.188 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.09 -171.08 3.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.781 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 34.9 tttm -63.86 151.18 43.12 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.639 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' OD1' HD22 ' A' ' 147' ' ' LEU . 30.8 m-20 52.74 7.84 0.08 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.57 100.47 11.2 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 34' ' ' TYR . 14.6 p -69.77 141.09 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG12 HG23 ' A' ' 139' ' ' ILE . 4.5 m -136.46 159.04 38.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.873 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.787 ' O ' HG22 ' A' ' 137' ' ' VAL . 19.5 m -117.37 118.26 31.75 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -134.96 161.08 36.28 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.775 -177.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.24 107.82 13.01 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.0 p90 -120.52 158.48 27.2 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.407 -173.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.903 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 tt0 -127.28 119.4 26.24 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 23' ' ' VAL . 2.4 p -102.0 119.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 122.199 1.0 . . . . 0.0 111.021 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 13.7 ttm180 -134.51 145.97 49.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.95 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 p -87.14 179.44 6.65 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -64.05 -29.99 71.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 0.0 109.929 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.69 -19.25 65.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.02 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.73 66.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.532 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.37 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.498 . . . . 0.0 110.252 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 25' ' ' GLU . 5.0 tt -83.49 124.27 30.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.659 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG23 HG13 ' A' ' 15' ' ' VAL . 27.0 m -94.3 -39.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.373 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -162.73 159.53 24.34 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.903 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -166.0 148.17 7.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.25 0.548 . . . . 0.0 111.226 174.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -102.32 113.98 65.63 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.84 163.72 29.72 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 m -67.24 -13.88 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.327 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.2 p -82.28 -30.49 30.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.96 114.88 5.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.342 0.591 . . . . 0.0 110.976 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.775 ' HG3' HG11 ' A' ' 137' ' ' VAL . 8.9 Cg_exo -75.03 154.36 42.28 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.729 2.952 . . . . 0.0 113.374 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 13' ' ' TYR . 15.2 tp -76.57 134.9 39.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.359 170.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -110.04 120.28 41.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 7.5 p90 -150.77 148.37 28.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.292 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 41.9 tp -81.34 110.1 16.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.91 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.468 ' CE1' ' HG3' ' A' ' 50' ' ' GLU . 14.3 t60 -71.76 140.77 49.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.083 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 108.37 -27.03 14.75 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.158 -1.496 . . . . 0.0 113.85 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.45 55.48 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 35' ' ' LEU . . . -141.29 -105.71 0.59 Allowed Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.117 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 15.5 m -114.39 -54.84 2.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -166.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.942 HD22 HD23 ' A' ' 45' ' ' LEU . 84.6 mt -65.44 136.48 56.51 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.796 1.284 . . . . 0.0 112.651 173.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 67' ' ' ALA . 21.7 pt -53.33 175.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 111.749 -2.478 . . . . 0.0 114.581 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 m -66.26 -48.41 70.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.185 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.17 -45.33 96.26 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.428 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.942 HD23 HD22 ' A' ' 41' ' ' LEU . 23.7 tp -74.58 -53.33 9.61 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.809 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 6.9 mt-10 -48.29 -42.45 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 124.062 0.851 . . . . 0.0 111.834 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 m -65.53 -29.73 70.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.61 55.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 8.2 mt -65.43 -38.42 89.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.407 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 3.9 mt-10 -53.66 153.23 4.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.561 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 77.29 -14.71 8.01 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.87 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' VAL . 82.3 m-70 -88.78 165.52 14.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.265 0.533 . . . . 0.0 110.07 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 69.1 mt-10 -123.11 162.5 22.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 1.5 m -46.56 143.64 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.826 0.822 . . . . 0.0 112.697 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.04 -2.88 72.55 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 114.703 -1.135 . . . . 0.0 114.079 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.45 134.01 35.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.464 0.632 . . . . 0.0 110.771 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.703 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 1.8 tmtp? -135.24 128.63 32.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.725 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 60' ' ' VAL . 22.8 p90 -155.57 -178.2 7.1 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.81 149.69 40.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.4 t -137.47 142.54 36.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.61 -172.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.64 113.53 13.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.18 132.63 70.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.77 154.05 48.02 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.756 ' HB1' ' HA2' ' A' ' 69' ' ' GLY . . . -49.63 -26.13 3.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.62 -34.0 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.13 -0.357 . . . . 0.0 111.614 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.73 -24.38 18.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.393 0.616 . . . . 0.0 109.942 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 42' ' ' ILE . . . -87.14 -138.51 0.09 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.412 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -76.3 -83.29 0.07 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.756 ' HA2' ' HB1' ' A' ' 64' ' ' ALA . . . 86.97 -32.25 4.1 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 116.218 -0.447 . . . . 0.0 112.45 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -94.96 -178.14 4.39 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.8 ' HD2' HD21 ' A' ' 122' ' ' ASN . 14.0 p90 -44.96 144.22 1.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.622 0.576 . . . . 0.0 109.949 172.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.54 96.27 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.226 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.715 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 3.8 pt-20 -67.93 -0.73 4.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.63 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -86.07 -11.61 52.33 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.119 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 21.3 tp -86.5 -10.21 54.58 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 122.377 1.084 . . . . 0.0 108.395 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.715 ' HB ' ' O ' ' A' ' 73' ' ' GLU . 83.9 t -72.64 146.99 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -153.08 170.05 21.43 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.742 -1.583 . . . . 0.0 111.035 -170.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -98.73 140.84 32.32 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.152 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -136.06 124.92 15.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -60.11 126.91 21.5 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.386 2.057 . . . . 0.0 111.632 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 22.8 mtmt -58.74 -17.26 21.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.826 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.77 -29.87 70.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 0.0 110.24 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -67.05 -45.64 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.904 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 90' ' ' LEU . 60.3 m-85 -87.74 40.86 0.96 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.0 ptm -50.82 -29.8 12.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 6.19 81.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.915 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 75.0 t -94.14 145.46 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.424 0.612 . . . . 0.0 111.224 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.81 -74.32 0.05 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.542 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -142.08 116.88 9.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.463 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.56 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.8 mt -62.33 105.97 0.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.42 176.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -128.77 166.21 19.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.13 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.41 74.57 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.82 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.0 mmm -89.2 135.03 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.141 0.471 . . . . 0.0 110.038 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 49.9 mtt180 -115.49 135.5 54.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.87 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.17 171.37 13.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.003 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' PRO . 64.3 tp -98.09 150.98 20.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 100' ' ' THR . . . -148.88 90.97 1.81 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 112.041 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 16.2 mt-10 -49.11 111.16 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.367 1.08 . . . . 0.0 112.87 162.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 98' ' ' ALA . 68.2 p -113.18 -172.63 2.1 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.747 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -50.83 -35.24 31.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.973 0.416 . . . . 0.0 111.005 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.469 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.1 pt20 -98.55 28.32 4.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.04 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.21 -177.25 45.81 Favored Glycine 0 C--N 1.322 -0.203 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.453 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.781 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.7 Cg_endo -69.79 121.93 8.61 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 122.379 2.053 . . . . 0.0 112.411 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.83 116.1 47.95 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.931 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.8 120.94 8.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.011 1.807 . . . . 0.0 109.99 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 10.8 m -142.77 154.21 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.833 0.825 . . . . 0.0 112.524 -168.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 28.6 tt0 -130.44 127.8 40.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.866 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 119' ' ' VAL . 62.8 mt -66.01 129.1 30.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -116.34 0.7 12.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -175.34 152.65 1.42 Allowed 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.525 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 117' ' ' VAL . 45.9 t -139.67 111.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -87.62 -166.63 1.63 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 5.1 m-20 -63.36 -53.54 50.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.307 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 5.0 m-20 -99.71 -18.3 17.32 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -143.25 146.76 33.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.704 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 112' ' ' VAL . 33.1 m -92.44 168.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.388 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 76' ' ' VAL . 2.3 t -129.68 108.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.4 m -115.66 141.6 32.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.889 0.852 . . . . 0.0 112.872 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.569 ' HA ' HG22 ' A' ' 76' ' ' VAL . 8.7 t70 -87.09 147.22 25.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.169 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.4 10.25 1.72 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.061 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.8 HD21 ' HD2' ' A' ' 71' ' ' TYR . 1.4 p30 -105.56 168.25 9.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.246 0.546 . . . . 0.0 110.948 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -132.89 169.25 17.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.605 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -67.43 0.3 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.847 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.23 20.45 1.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.09 -126.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . 83.24 1.79 90.42 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.002 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -78.41 129.88 35.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.01 143.92 37.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 167.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.9 mt -130.62 152.65 49.76 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -115.39 133.81 55.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.735 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 36.9 m-85 -121.02 142.09 50.13 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.404 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 2.8 m-20 -108.84 106.71 16.83 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 166.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.725 HG11 HD22 ' A' ' 49' ' ' LEU . 3.1 t -100.85 140.28 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.95 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.703 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 59.1 mt-10 -138.14 100.7 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.968 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 p -80.42 110.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.13 0.49 . . . . 0.0 110.928 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 10' ' ' SER . 2.7 m -75.92 -39.53 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.013 0.435 . . . . 0.0 111.538 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.41 156.95 21.84 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -168.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 9' ' ' VAL . 73.3 mt -136.63 131.96 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -146.76 141.31 26.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.789 0.328 . . . . 0.0 110.144 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -87.71 125.31 34.34 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.74 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -63.61 165.5 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.774 -170.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 145' ' ' GLU . 56.3 p -79.49 15.36 1.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.422 -170.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 69.94 -35.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 111.481 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 143' ' ' THR . 46.4 mt-10 -62.23 -46.89 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 109.708 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.4 mt-10 -59.22 -35.53 73.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.237 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 142' ' ' ALA . 24.0 mt -71.92 -46.89 56.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.401 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.87 70.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.211 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -88.93 -11.92 43.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.789 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.23 4.21 84.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.994 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -174.03 167.4 4.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 155' ' ' ALA . 41.4 t -55.99 -73.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 123.732 0.645 . . . . 0.0 112.159 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 50.92 48.94 22.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.532 0.682 . . . . 0.0 109.72 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.83 -101.84 0.16 Allowed Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.554 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.481 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . 55.06 72.3 0.48 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.073 0.463 . . . . 0.0 111.166 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -146.09 93.39 2.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.895 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.14 123.5 34.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -147.8 55.45 1.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.947 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -57.31 -42.02 80.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.745 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -107.88 73.7 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.504 . . . . 0.0 110.178 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.62 142.18 35.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.174 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -147.59 76.35 1.39 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.872 0.367 . . . . 0.0 111.7 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -81.7 151.48 27.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 167.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -134.25 122.45 22.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.978 0.418 . . . . 0.0 110.849 -173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -86.17 -26.35 25.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.763 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -98.14 105.52 17.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.883 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -128.53 121.44 28.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.482 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -98.22 -51.24 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -137.61 160.11 40.09 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.048 -0.408 . . . . 0.0 110.71 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 58.52 71.73 0.57 Allowed 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 109.618 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.388 -171.867 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.7 ptpt -129.59 179.48 5.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -85.56 116.06 28.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.383 0.611 . . . . 0.0 111.563 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -149.89 -167.37 2.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.084 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' LEU . 20.2 tttm -61.56 153.31 28.0 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.108 0.255 . . . . 0.0 110.691 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 50.3 3.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.145 1.378 . . . . 0.0 114.519 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 2' ' ' LYS . 1.2 mt -93.91 98.43 11.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -63.61 144.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.204 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 139' ' ' ILE . 2.1 m -148.84 152.29 12.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.473 0.654 . . . . 0.0 111.24 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.0 m -103.03 117.72 35.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 134' ' ' VAL . 9.5 tt -133.01 147.59 52.26 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.522 -172.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.8 152.4 37.32 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.621 ' HE1' HD22 ' A' ' 32' ' ' LEU . 52.1 p90 -161.77 157.51 24.33 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.168 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.438 ' CG ' HD13 ' A' ' 22' ' ' LEU . 36.1 tt0 -131.08 122.86 27.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.385 172.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.431 HG13 ' CE1' ' A' ' 132' ' ' PHE . 37.2 t -103.83 119.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.581 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -139.29 155.46 47.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 p -78.08 179.8 6.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.012 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.64 -31.68 26.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.543 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -19.0 63.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.151 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.34 -2.54 81.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.538 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.63 136.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.486 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 25' ' ' GLU . 58.8 tp -72.8 131.37 42.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.733 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.84 -40.56 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.688 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -144.93 149.45 35.27 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.1 tt0 -164.12 139.51 6.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.1 m -119.18 114.84 34.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 167.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.37 167.44 26.3 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.588 2.192 . . . . 0.0 113.389 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -18.96 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.215 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -73.15 -34.83 66.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.99 112.72 5.74 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.2 Cg_exo -75.44 159.7 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.285 2.657 . . . . 0.0 113.952 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 41' ' ' LEU . 14.0 tp -79.57 126.19 30.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.046 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.2 120.78 42.96 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.512 ' CD2' ' HA ' ' A' ' 40' ' ' SER . 46.2 p90 -144.54 161.86 38.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 147' ' ' LEU . 46.7 tp -108.29 105.64 15.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 6.4 t60 -61.14 130.51 46.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 101.46 -7.81 56.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.219 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -134.62 2.8 3.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 94.73 0.14 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.779 ' O ' HD13 ' A' ' 41' ' ' LEU . 12.7 m -116.11 15.21 16.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.512 1.149 . . . . 0.0 108.511 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 40' ' ' SER 0.396 0.0 OUTLIER 41.81 109.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.473 2.709 . . . . 0.0 115.397 -170.467 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.812 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 pt 51.57 127.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 110.148 -3.205 . . . . 0.0 115.61 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.545 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 43.5 t -50.66 -47.63 58.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.564 -2.107 . . . . 0.0 113.387 -170.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.607 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -67.97 -36.54 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.345 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 44.8 tp -75.03 -46.96 31.48 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HG3' ' O ' ' A' ' 42' ' ' ILE . 31.8 mt-10 -48.9 -49.51 39.47 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.911 0.757 . . . . 0.0 109.989 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.4 m -60.57 -37.41 81.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.954 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.15 63.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.696 0.76 . . . . 0.0 110.039 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 88.0 mt -62.46 -36.57 82.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.724 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -54.54 153.98 5.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 78.17 -15.2 9.13 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 113.498 -1.683 . . . . 0.0 117.096 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 3' ' ' VAL . 14.4 p80 -102.19 174.24 6.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.661 1.731 . . . . 0.0 110.263 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 139' ' ' ILE . 4.1 mp0 -119.82 171.48 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.73 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 139' ' ' ILE . 2.0 m -52.16 142.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.309 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.457 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 97.56 -15.26 62.28 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.007 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 136' ' ' VAL . 32.5 m-20 -74.32 130.65 40.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.341 0.591 . . . . 0.0 111.42 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 5.5 tmtm? -133.24 124.6 27.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.052 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.3 p90 -148.85 -178.26 6.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.392 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.54 145.85 39.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -135.22 142.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 113.09 12.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.128 0.49 . . . . 0.0 110.341 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG11 ' HA3' ' A' ' 44' ' ' GLY . 58.2 t -126.57 144.17 37.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.421 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.64 153.24 50.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -56.96 -20.6 24.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.15 -19.65 53.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 110.817 -176.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -115.71 -18.45 10.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . -113.89 -151.03 0.47 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.931 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.606 ' HB2' ' CD1' ' A' ' 130' ' ' LEU . 6.8 m-85 -78.14 -170.88 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.28 19.02 43.58 Favored Glycine 0 CA--C 1.502 -0.735 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -76.71 -179.57 5.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.36 -0.92 . . . . 0.0 110.762 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.441 ' HB2' ' CG ' ' A' ' 122' ' ' ASN . 17.2 p90 -58.42 152.2 18.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.291 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -75.0 105.28 5.93 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.971 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.648 ' HA ' HG12 ' A' ' 76' ' ' VAL . 8.5 pt-20 -72.17 -0.52 12.17 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -62.61 -9.67 9.72 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.575 -0.703 . . . . 0.0 111.292 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 122' ' ' ASN . 19.2 mt -111.01 -11.0 14.35 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.098 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 73' ' ' GLU . 3.1 p -127.78 130.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.571 0.7 . . . . 0.0 110.908 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -146.36 169.0 19.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 118' ' ' VAL . 6.5 mpt_? -107.62 114.7 28.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.886 -175.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -111.95 129.23 24.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.639 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 12.3 Cg_exo -61.91 134.41 49.83 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 111.426 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 18.8 mtmt -59.39 -14.66 12.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.09 -28.12 65.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.525 0.679 . . . . 0.0 110.259 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.22 -38.08 77.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.128 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.2 m-85 -90.85 41.38 1.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -176.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 ptm -51.37 -25.82 6.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.093 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.33 11.01 73.16 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 84' ' ' PHE . 2.6 p -100.5 160.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.258 0.529 . . . . 0.0 109.922 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -75.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -145.41 121.57 10.81 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.12 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.0 mt -62.12 103.88 0.42 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.934 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -125.61 155.62 40.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.562 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.679 ' HA ' HG22 ' A' ' 109' ' ' ILE . 42.7 t -67.1 134.07 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.055 0.455 . . . . 0.0 110.922 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.62 -28.44 15.97 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.51 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.6 mmm -52.92 135.53 36.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 20.2 mtp85 -116.72 137.35 52.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.943 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -163.26 167.57 21.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.423 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 104' ' ' PRO . 52.0 tp -82.7 143.75 30.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.0 110.015 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -131.76 147.53 52.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.778 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -97.64 142.66 29.17 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.7 p -148.92 -175.92 5.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.82 -27.47 69.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.565 0.698 . . . . 0.0 109.696 171.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -89.72 23.23 2.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.861 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.99 -173.71 52.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.495 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 39.8 Cg_exo -59.25 125.61 18.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 111.568 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.54 109.28 30.78 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.014 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.88 107.11 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.62 2.213 . . . . 0.0 110.694 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.4 m -117.75 176.22 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.187 0.517 . . . . 0.0 111.782 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 39.2 tt0 -137.06 129.6 30.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.592 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 92' ' ' VAL . 32.1 mt -70.95 122.58 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -103.6 -7.42 20.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -173.1 156.73 3.3 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 117' ' ' VAL . 88.1 t -136.75 104.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.235 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 24.1 mm-40 -75.8 -166.82 0.61 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.769 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.22 -56.14 24.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.691 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.527 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 24.6 t70 -128.08 16.96 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.894 176.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.492 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 50.9 p-80 -146.22 146.33 30.74 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 121.436 -0.79 . . . . 0.0 111.68 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 90' ' ' LEU . 26.9 m -104.54 167.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.999 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.3 t -130.86 119.53 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 5.0 m -114.35 131.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.865 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.607 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 11.3 m-20 -110.99 147.7 34.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.74 13.46 6.47 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.47 ' HB3' HD12 ' A' ' 75' ' ' LEU . 27.9 p30 -130.77 166.56 20.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.01 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 179.64 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.629 0.58 . . . . 0.0 111.252 166.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -83.45 -8.85 59.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.702 0.287 . . . . 0.0 111.438 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.9 mt -91.33 18.91 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.342 . . . . 0.0 111.78 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.35 179.61 3.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.689 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.42 0.88 33.0 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.049 171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -88.86 120.39 30.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.54 1.17 . . . . 0.0 110.589 177.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -78.79 163.02 25.7 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.606 ' CD1' ' HB2' ' A' ' 68' ' ' TYR . 57.5 mt -132.74 152.13 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 112.679 -173.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -112.07 132.37 54.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.163 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.554 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 11.6 m-85 -121.17 142.19 50.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.903 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 3.5 m-20 -108.61 107.61 18.16 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 167.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 HD21 ' A' ' 11' ' ' LEU . 3.6 t -100.29 137.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.558 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 33.4 mt-10 -134.03 98.08 4.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.494 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' H ' ' A' ' 55' ' ' GLY . 3.8 p -78.57 114.63 19.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.693 . . . . 0.0 111.669 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 31' ' ' PRO . 5.5 t -71.67 -50.31 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.47 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -162.82 154.48 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.762 HG23 HG12 ' A' ' 9' ' ' VAL . 66.7 mt -132.94 138.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -149.25 140.92 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.07 126.28 34.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.714 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.75 166.16 13.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.449 -168.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.1 p -82.05 20.74 0.96 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.477 -170.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 147' ' ' LEU . 45.0 mt-10 67.71 -37.88 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.363 0.665 . . . . 0.0 111.327 -174.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 143' ' ' THR . 45.7 mt-10 -64.28 -45.2 89.1 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.714 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 37.6 mt-10 -59.54 -34.91 73.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.508 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 142' ' ' ALA . 35.6 mt -74.14 -44.27 54.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.688 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.73 -29.6 70.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.346 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -94.99 -32.08 13.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.93 13.03 35.25 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.594 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -153.12 170.91 19.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.565 0.682 . . . . 0.0 111.455 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.8 t -78.29 135.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.107 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -97.95 -36.13 10.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.897 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -137.93 110.29 0.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.424 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -151.34 -56.08 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -121.38 85.37 2.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 158' ' ' HIS . 24.5 m-20 -84.3 -71.1 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.213 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 95.3 m-70 65.71 -168.58 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -171.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 64.39 50.46 2.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 110.935 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -72.41 -8.16 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.266 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -54.39 -44.82 72.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.143 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -96.4 82.71 3.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.59 112.13 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.877 0.846 . . . . 0.0 111.044 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -79.47 64.57 4.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.156 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.98 -56.38 22.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.812 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.39 83.45 6.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.335 0.588 . . . . 0.0 112.28 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -132.2 82.16 2.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.219 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 171' ' ' HIS . 8.4 p-80 -61.46 135.26 57.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.358 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.066 -172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 47.4 t60 68.72 107.79 0.05 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.042 0.838 . . . . 0.0 112.37 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.422 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . 44.9 t-80 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.226 172.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 12.4 ptmt -106.21 156.14 18.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.332 0.586 . . . . 0.0 111.187 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -64.68 126.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.786 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.68 -169.78 3.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.168 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 7' ' ' LEU . 60.8 tttp -65.23 153.9 39.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.358 . . . . 0.0 111.662 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.469 ' O ' HD21 ' A' ' 147' ' ' LEU . 79.2 m-20 51.63 6.1 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 141' ' ' GLU . 17.9 mt -92.85 149.42 21.28 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -115.59 142.95 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HG23 ' A' ' 139' ' ' ILE . 3.2 m -142.31 155.74 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.787 0.803 . . . . 0.0 111.716 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . 16.5 m -117.9 117.59 29.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.175 -1.375 . . . . 0.0 107.962 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.76 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -127.84 158.52 37.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.82 112.67 16.95 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HE1' HD22 ' A' ' 32' ' ' LEU . 41.0 p90 -126.58 160.89 29.34 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.453 -171.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.5 tt0 -129.54 118.67 22.42 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p -106.33 122.46 60.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.62 0.724 . . . . 0.0 111.553 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -139.12 161.19 37.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.0 p -90.28 175.94 6.93 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.164 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.93 -21.5 66.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.19 -18.6 61.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.938 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.47 44.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.925 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.07 138.83 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 15' ' ' VAL . 55.3 tp -79.71 134.38 36.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.09 -38.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -156.93 168.49 27.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -165.54 137.49 4.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.143 0.497 . . . . 0.0 111.971 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 m -113.03 111.41 50.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -68.36 165.79 27.68 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 122.807 2.338 . . . . 0.0 113.339 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.56 -16.07 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.78 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -79.22 -33.73 43.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.07 113.01 6.27 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.327 0.584 . . . . 0.0 109.601 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 137' ' ' VAL . 9.6 Cg_exo -75.59 169.22 22.79 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.572 2.848 . . . . 0.0 113.741 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.507 HD22 ' HE1' ' A' ' 13' ' ' TYR . 14.0 tp -84.1 126.35 33.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -104.85 120.6 41.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.732 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 5.4 p90 -150.34 157.39 43.0 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.169 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 147' ' ' LEU . 57.7 tp -102.69 114.61 29.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.511 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 48.6 t60 -69.84 142.39 53.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.384 0.611 . . . . 0.0 111.915 -169.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.91 56.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.473 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -129.52 -7.93 4.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.773 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.55 41.23 8.45 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.975 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.732 ' CB ' ' HB2' ' A' ' 34' ' ' TYR . 51.8 m -71.86 -38.86 70.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -113.43 -102.99 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.262 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.596 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 20.8 pt -116.35 -163.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.035 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.7 t -94.77 -49.06 5.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.391 0.615 . . . . 0.0 110.64 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -79.19 -26.45 57.69 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.984 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.704 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 mt -74.41 -52.76 11.14 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.165 -171.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 23.1 mt-10 -50.63 -49.79 55.94 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.518 0.511 . . . . 0.0 111.384 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.7 m -64.9 -31.8 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.685 0.279 . . . . 0.0 111.737 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.44 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 76.6 mt -61.62 -33.42 73.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.518 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.3 mt-10 -52.14 152.85 3.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.018 0.913 . . . . 0.0 112.819 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.447 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 78.89 -22.6 3.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.932 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.692 ' O ' HG12 ' A' ' 3' ' ' VAL . 96.8 m-70 -82.6 164.45 20.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.591 0.695 . . . . 0.0 110.782 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 46.0 mt-10 -127.2 160.47 31.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.412 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -49.69 143.85 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.563 0.697 . . . . 0.0 112.489 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.03 -15.64 62.61 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.149 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.04 133.91 47.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.904 0.383 . . . . 0.0 110.29 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 6.2 tmmm? -132.14 128.77 38.78 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.259 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.0 p90 -165.43 157.17 14.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.147 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 4.8 p-10 -96.43 141.47 29.69 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.822 0.82 . . . . 0.0 110.198 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 58' ' ' PHE . 8.7 t -117.1 143.91 26.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.13 -173.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -126.5 111.99 15.06 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.882 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' HA3' ' A' ' 44' ' ' GLY . 72.7 t -125.74 137.65 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.045 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.96 152.85 52.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.154 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.58 -20.94 3.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.3 -30.36 70.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.67 8.2 11.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.491 0.663 . . . . 0.0 111.352 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.155 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.763 179.036 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 6.3 mpt_? -115.33 114.29 24.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.737 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG1' HG21 ' A' ' 83' ' ' VAL . 5.2 t -106.49 132.94 20.49 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.994 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 83' ' ' VAL . 29.8 Cg_exo -59.18 131.88 43.74 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.12 2.547 . . . . 0.0 111.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 26.4 mtmt -58.29 -24.41 59.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.78 -43.39 85.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.422 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 80' ' ' PRO . 3.4 m -55.67 -32.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HB2' HD11 ' A' ' 90' ' ' LEU . 71.0 m-85 -90.61 40.24 1.01 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.207 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -57.47 -29.07 63.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.355 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.07 -15.43 77.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.958 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.43 HG11 HD23 ' A' ' 90' ' ' LEU . 91.9 t -73.34 142.26 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.849 0.324 . . . . 0.0 110.459 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.13 -67.99 0.35 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.035 0.445 . . . . 0.0 110.952 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -142.37 115.63 8.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.397 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 117' ' ' VAL . 88.6 mt -66.57 98.87 0.54 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.155 0.502 . . . . 0.0 110.161 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 5.4 tt0 -121.5 165.7 15.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.196 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 109' ' ' ILE . 48.2 t -80.24 139.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.03 1.23 79.87 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.255 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 mmm -87.63 135.23 33.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.528 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -111.21 139.58 46.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.333 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.56 154.41 16.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.792 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.65 131.27 37.68 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -119.8 134.94 55.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -88.84 137.24 32.49 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.0 p -145.42 -176.19 5.01 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.024 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -35.6 65.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 110.309 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.01 25.45 6.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.313 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.66 -173.45 53.85 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.789 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 31.4 Cg_exo -58.89 123.97 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.939 . . . . 0.0 112.055 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 107' ' ' VAL . 88.0 t -124.63 113.68 27.19 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.566 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.1 101.46 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.876 2.384 . . . . 0.0 111.347 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.1 m -117.78 173.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 111.211 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.0 136.39 40.28 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.117 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 90' ' ' LEU . 27.2 mt -77.48 129.59 37.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.05 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.6 p -114.79 1.6 14.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.402 0.62 . . . . 0.0 109.937 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.35 153.86 0.35 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.595 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.741 HG13 HG12 ' A' ' 117' ' ' VAL . 61.3 t -139.39 108.55 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -87.42 -156.04 0.32 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.36 -43.97 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 8.5 p-10 -131.94 -15.1 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.007 -170.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -136.58 159.29 42.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.741 HG12 HG13 ' A' ' 112' ' ' VAL . 33.8 m -112.66 162.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.33 116.52 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.198 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -122.59 138.77 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 121.215 0.531 . . . . 0.0 111.376 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.917 177.598 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 64.1 mt . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.2 mtpp -114.89 122.72 47.17 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.2 m-85 -115.29 121.19 42.11 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.546 ' N ' HD22 ' A' ' 133' ' ' ASN . 0.8 OUTLIER -92.86 107.21 19.04 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.76 HG13 HD23 ' A' ' 11' ' ' LEU . 4.0 t -99.66 139.73 20.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.369 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 42.4 mt-10 -132.96 90.84 2.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.899 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 55' ' ' GLY . 2.9 p -66.76 107.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.039 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 31' ' ' PRO . 8.1 t -72.41 -47.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.86 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.59 157.27 27.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.891 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 9' ' ' VAL . 66.0 mt -137.73 134.33 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -143.54 142.76 31.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.3 pt-20 -79.67 126.48 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.78 166.56 12.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 113.017 -166.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p -92.19 23.06 4.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.7 -170.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 69.71 -42.65 0.51 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.184 0.594 . . . . 0.0 111.151 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -63.37 -42.25 98.84 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.486 0.66 . . . . 0.0 109.645 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.59 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.0 mt-10 -61.82 -35.02 77.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.527 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 142' ' ' ALA . 28.7 mt -73.46 -46.5 47.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.144 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.38 -31.89 70.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.536 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -93.39 -31.69 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.907 0.384 . . . . 0.0 110.802 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.16 8.35 41.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.27 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 p80 . . . . . 0 C--N 1.328 -0.333 0 O-C-N 122.667 -0.313 . . . . 0.0 110.599 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.551 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 16.7 ptpt -106.61 168.94 8.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.883 0.849 . . . . 0.0 112.064 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.672 HG11 ' O ' ' A' ' 49' ' ' LEU . 1.1 p -83.43 121.43 36.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.35 -171.62 3.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.945 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 42.1 tttp -63.91 153.5 36.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.762 0.315 . . . . 0.0 110.417 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 147' ' ' LEU . 32.7 m-20 57.57 -5.89 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 141' ' ' GLU . 34.2 mt -90.81 104.44 17.03 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.792 -0.567 . . . . 0.0 110.425 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.4 143.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.45 0.643 . . . . 0.0 111.043 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 139' ' ' ILE . 3.6 m -143.04 153.03 16.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.448 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -111.46 122.51 48.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.532 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -143.64 143.72 31.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -100.99 153.75 19.27 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.717 ' HE2' HD22 ' A' ' 32' ' ' LEU . 51.5 p90 -151.82 159.78 43.78 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.029 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' HD13 ' A' ' 22' ' ' LEU . 42.7 tt0 -126.8 119.45 26.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.435 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.9 t -102.21 119.45 50.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.505 -175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.54 151.68 50.74 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.0 p -82.02 -179.75 7.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -56.56 -26.31 54.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.202 0.525 . . . . 0.0 109.922 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.0 m-20 -67.39 -18.81 65.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.15 -11.24 72.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.469 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 19' ' ' ASP . 10.4 p -78.4 136.44 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 111.245 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 25' ' ' GLU . 34.4 tp -69.7 131.1 44.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.478 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.45 -45.94 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.213 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -140.07 149.81 43.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 22' ' ' LEU . 32.9 tt0 -156.21 134.7 11.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.301 0.572 . . . . 0.0 111.861 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.3 m -108.05 116.92 56.22 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 169.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.69 164.34 35.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.744 2.296 . . . . 0.0 113.589 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.91 -14.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.609 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.7 p -80.88 -31.56 35.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.712 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.26 113.3 5.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 109.938 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' A' ' 137' ' ' VAL . 8.8 Cg_exo -75.63 169.16 22.89 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.625 2.883 . . . . 0.0 113.548 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD22 ' HE2' ' A' ' 13' ' ' TYR . 12.4 tp -88.89 129.51 35.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -121.57 119.85 33.11 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.543 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 24.8 m-85 -153.69 162.08 41.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.287 0.565 . . . . 0.0 111.924 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.7 tp -89.18 105.79 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.878 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.559 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 22.6 t60 -65.73 142.98 57.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.43 . . . . 0.0 110.676 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 85.77 18.81 59.21 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.183 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -136.68 18.54 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.456 0.17 . . . . 0.0 110.679 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.67 35.82 92.52 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.56 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 42.2 m -64.78 -39.63 93.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.879 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 1.1 pt? -120.53 -89.1 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.401 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.879 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 12.6 pt -129.32 -166.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 t -97.38 -49.34 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.732 0.777 . . . . 0.0 110.705 -168.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.32 29.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 114.781 -1.1 . . . . 0.0 113.376 -172.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.697 HD11 HG21 ' A' ' 134' ' ' VAL . 28.7 tp -73.34 -46.62 48.24 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 24.0 mt-10 -52.11 -45.23 64.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.127 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -63.49 -38.31 90.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.11 80.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.817 HD21 HG11 ' A' ' 134' ' ' VAL . 95.9 mt -56.88 -33.46 66.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.558 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HA ' HG13 ' A' ' 3' ' ' VAL . 5.8 mt-10 -56.3 153.62 9.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.969 0.89 . . . . 0.0 113.043 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.48 -29.02 2.95 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 114.222 -1.354 . . . . 0.0 116.153 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -120.02 148.45 43.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.319 1.559 . . . . 0.0 112.852 -174.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 1' ' ' MET . 31.3 mt-10 -99.52 173.96 6.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.059 -164.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.9 m -48.94 140.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.885 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.46 61.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.746 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.07 128.79 34.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.063 176.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 2.5 tmmt? -133.63 126.06 30.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.25 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.1 p90 -165.95 160.64 16.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.196 0.522 . . . . 0.0 111.413 -175.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.612 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.691 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.1 t -133.36 142.93 40.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.026 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.6 113.05 10.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.911 0.386 . . . . 0.0 110.201 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 t -127.79 142.47 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.76 155.33 52.97 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.95 -30.5 46.95 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.77 -32.39 73.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 111.303 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.55 0.8 14.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 111.302 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . . . . . . 0 C--N 1.311 -1.1 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.547 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.678 0.752 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.7 mpt_? -113.0 109.31 18.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.632 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.5 t -101.59 128.51 28.84 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.511 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.0 Cg_exo -60.42 134.6 56.05 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.829 2.353 . . . . 0.0 112.028 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -50.8 -19.43 0.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.219 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.14 -28.92 65.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.991 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.56 -41.17 63.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.126 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.3 m-85 -98.04 39.94 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 ptm -53.66 -30.45 43.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.809 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.36 13.46 61.92 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.931 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.6 p -93.63 162.32 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.439 0.62 . . . . 0.0 109.743 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.83 -74.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 0.0 110.322 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -153.16 118.08 5.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.841 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.617 ' HB3' HG11 ' A' ' 117' ' ' VAL . 86.5 mt -60.01 109.89 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 110.958 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.421 HE21 ' HB2' ' A' ' 91' ' ' GLN . 5.3 tt0 -138.77 162.47 34.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.944 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.03 146.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.988 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.58 2.27 88.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.431 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.5 mmm -91.69 134.41 34.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.604 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 82.3 mtt180 -113.86 134.71 54.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.196 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -164.33 170.4 16.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.342 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.877 HD11 ' HB2' ' A' ' 104' ' ' PRO . 67.7 tp -87.35 150.22 23.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 100' ' ' THR . . . -144.22 89.48 2.03 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.833 0.825 . . . . 0.0 111.621 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 12.9 mt-10 -38.78 129.9 1.47 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.064 -1.425 . . . . 0.0 112.034 157.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 98' ' ' ALA . 61.2 p -145.96 -174.12 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.65 -44.77 63.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.479 0.657 . . . . 0.0 110.774 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' GLN . 7.4 pt20 -91.64 30.23 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.787 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.62 -176.84 48.18 Favored Glycine 0 C--N 1.319 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.708 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.877 ' HB2' HD11 ' A' ' 97' ' ' LEU . 34.5 Cg_endo -73.84 125.38 9.9 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.456 2.104 . . . . 0.0 112.693 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 107' ' ' VAL . 13.5 t -117.98 113.87 37.47 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.04 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 14.8 Cg_exo -70.56 97.29 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.611 2.208 . . . . 0.0 111.072 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.8 m -117.99 174.64 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.315 -173.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.55 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 24.5 tt0 -134.49 131.44 38.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.259 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.89 124.76 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.953 0.406 . . . . 0.0 110.337 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 p -106.84 -4.6 19.09 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -172.54 155.61 3.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.915 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.573 HG13 HG12 ' A' ' 117' ' ' VAL . 61.8 t -137.43 105.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.034 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.08 -175.94 4.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.8 -53.32 58.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.209 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -121.71 5.18 10.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -146.29 139.91 26.09 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 120.831 -1.168 . . . . 0.0 112.365 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 90' ' ' LEU . 35.3 m -93.58 167.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.189 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 78' ' ' ARG . 43.4 t -131.26 118.44 40.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.5 m -113.74 138.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.062 0.458 . . . . 0.0 111.144 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.825 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.233 0.233 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 18.9 mtpp -118.02 132.75 56.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.087 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.719 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 2.5 m-85 -123.4 134.96 53.91 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.493 ' N ' HD22 ' A' ' 133' ' ' ASN . 0.9 OUTLIER -105.84 107.74 18.89 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.817 HG11 HD21 ' A' ' 49' ' ' LEU . 4.4 t -99.81 142.93 14.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.45 0.643 . . . . 0.0 112.211 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 37.2 mt-10 -131.84 92.09 3.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.576 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -69.72 110.46 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.833 0.825 . . . . 0.0 111.685 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.3 t -71.95 -47.66 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.13 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.06 158.56 33.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.925 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.757 HG23 HG12 ' A' ' 9' ' ' VAL . 65.5 mt -137.59 132.78 45.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -133.17 138.09 46.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.047 0.451 . . . . 0.0 110.667 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.766 ' HA ' HD22 ' A' ' 7' ' ' LEU . 9.7 pt-20 -77.44 119.29 20.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -64.59 169.51 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.748 -171.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p -113.26 29.51 7.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.761 -167.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.89 ' HA ' HD23 ' A' ' 147' ' ' LEU . 31.1 mt-10 73.31 -33.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.466 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.39 -44.15 72.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.55 -178.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 8.0 mp0 -54.95 -45.65 74.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.66 0.743 . . . . 0.0 109.756 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -65.5 -49.14 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.228 178.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.25 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.847 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -98.08 -9.09 26.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.44 2.74 90.66 Favored Glycine 0 C--N 1.329 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.865 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.925 0.363 . . . . 0.0 110.071 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -123.65 169.16 11.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 111.247 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -79.29 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.793 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.58 -172.39 4.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.432 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 87.1 tttt -67.48 161.27 25.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 45.18 9.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.716 HD22 ' HA ' ' A' ' 141' ' ' GLU . 24.3 mt -97.63 108.21 20.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.957 -0.464 . . . . 0.0 110.187 170.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -55.52 144.01 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 110.596 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -150.86 139.34 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.755 -170.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -117.72 148.27 42.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.714 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -165.63 158.0 15.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.01 0.433 . . . . 0.0 110.33 -176.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.38 112.59 18.28 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 32' ' ' LEU . 46.5 p90 -123.82 154.19 39.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.924 -172.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 45.6 tt0 -125.29 118.85 26.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG13 HG23 ' A' ' 23' ' ' VAL . 2.8 p -101.33 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.257 1.027 . . . . 0.0 111.141 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 10.6 ttm180 -135.66 157.15 47.59 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.681 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.611 ' OG1' HG12 ' A' ' 21' ' ' VAL . 40.8 p -78.34 169.87 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.841 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.986 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 48.7 mt-10 -65.44 -20.22 66.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.975 0.416 . . . . 0.0 110.876 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.11 -16.16 30.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 16' ' ' ARG . . . 106.63 27.48 5.47 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.78 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.8 p -105.42 136.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.035 0.917 . . . . 0.0 109.829 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 15' ' ' VAL . 57.0 tp -90.53 127.36 36.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.418 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 15' ' ' VAL . 22.2 m -102.93 -35.88 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.671 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -162.14 169.76 20.29 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.42 129.87 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 m -99.45 106.1 37.41 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.29 163.27 36.99 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.65 2.233 . . . . 0.0 112.882 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.31 -14.77 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.205 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 p -79.43 -30.6 42.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.626 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.47 113.74 5.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.671 ' HB3' HG21 ' A' ' 137' ' ' VAL . 10.1 Cg_exo -75.32 164.7 32.27 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 -174.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.674 ' HB3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -73.9 139.03 44.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.408 166.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -122.25 120.2 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 13.1 p90 -157.6 168.3 27.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.141 0.496 . . . . 0.0 111.409 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -107.94 114.4 28.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.043 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 28.6 t60 -68.29 137.4 54.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.383 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 80.66 26.62 53.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.914 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.95 18.33 4.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 110.86 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.67 36.68 93.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.955 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 69.4 m -65.78 -39.94 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.142 0.496 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.87 160.87 42.31 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 45' ' ' LEU . 5.0 pt -27.93 137.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 123.048 1.404 . . . . 0.0 114.373 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -64.46 -35.75 81.94 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.936 -1.938 . . . . 0.0 111.299 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.602 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -64.07 -34.6 90.36 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.139 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 21.6 tp -75.46 -50.58 15.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.05 -45.6 68.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.337 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.2 m -59.35 -35.71 74.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.434 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -33.98 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.622 0.725 . . . . 0.0 110.438 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 86.9 mt -64.61 -31.71 73.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.896 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.85 155.65 4.22 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.18 -29.1 4.85 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HG12 ' A' ' 3' ' ' VAL . 27.0 p80 -106.33 178.29 4.6 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.172 1.486 . . . . 0.0 110.787 -171.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 1' ' ' MET . 81.8 mt-10 -117.35 170.82 8.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.685 0.278 . . . . 0.0 110.725 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -53.11 144.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.76 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.503 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.29 -20.33 49.89 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.971 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 136' ' ' VAL . 3.4 m-20 -67.42 136.62 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.919 0.359 . . . . 0.0 110.527 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.682 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 4.3 tmmm? -136.98 125.21 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.738 ' CE2' HG22 ' A' ' 60' ' ' VAL . 15.9 p90 -154.51 -179.75 8.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.15 143.5 38.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.738 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -126.91 142.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -134.18 113.07 11.64 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG11 ' HA3' ' A' ' 44' ' ' GLY . 60.8 t -123.97 141.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.565 -174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.77 150.0 48.75 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.127 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.53 -20.42 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.74 -21.78 57.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.295 -0.253 . . . . 0.0 111.442 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -114.34 -9.46 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.954 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.264 -178.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.205 0 CA-C-O 121.116 0.484 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 11.3 mpt_? -110.23 113.35 25.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.764 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.39 132.24 21.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.873 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.61 143.57 99.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.429 2.753 . . . . 0.0 112.692 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 90' ' ' LEU . 6.5 mmmm -54.02 -39.53 66.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.386 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.75 -37.67 79.64 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.683 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.22 -35.3 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.957 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB2' HD11 ' A' ' 90' ' ' LEU . 64.4 m-85 -100.51 40.0 1.31 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.2 ptm -49.15 -32.75 10.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.421 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.78 13.18 65.02 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.617 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.63 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.6 p -85.88 162.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 117.313 0.556 . . . . 0.0 110.21 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.61 -77.86 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.42 119.67 7.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.614 171.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.63 ' HG ' HG11 ' A' ' 87' ' ' VAL . 89.9 mt -60.09 103.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.303 0.573 . . . . 0.0 110.536 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.476 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.2 tt0 -123.57 166.3 15.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.156 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.6 t -81.55 140.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.86 1.42 85.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.846 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.476 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.0 mtm -85.88 135.05 33.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 109.938 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -114.02 139.54 49.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.082 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -163.38 170.45 17.49 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.998 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -92.69 126.74 37.91 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.36 127.44 56.01 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.35 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.12 140.39 41.77 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 p -145.0 -175.66 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.999 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.3 -36.71 84.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.528 0.68 . . . . 0.0 110.623 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.2 pt20 -95.61 27.54 3.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.266 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 179.44 46.09 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.14 140.93 94.11 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 122.171 1.914 . . . . 0.0 112.603 174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 99.0 t -135.43 117.49 12.31 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.573 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 7.1 Cg_exo -73.83 108.8 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.783 2.322 . . . . 0.0 111.246 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 11.2 m -118.48 154.6 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.778 0.323 . . . . 0.0 111.084 -174.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 40.8 tt0 -115.37 132.14 56.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.25 0.548 . . . . 0.0 110.336 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 90' ' ' LEU . 23.8 mt -77.53 127.9 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.02 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.401 ' C ' HG13 ' A' ' 92' ' ' VAL . 62.4 p -114.69 1.2 14.12 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.455 0.645 . . . . 0.0 109.53 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 153.52 0.21 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.3 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 117' ' ' VAL . 49.0 t -136.32 107.7 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.25 -157.24 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.12 -50.97 71.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.29 -6.24 3.81 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.825 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 p-80 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.024 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.697 HG12 HG13 ' A' ' 112' ' ' VAL . 30.3 m -107.89 161.71 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.02 110.23 31.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.673 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 12.0 m -113.63 135.12 54.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.615 0.721 . . . . 0.0 112.133 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.666 -177.009 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 61' ' ' ALA . 26.3 mt . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.986 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 18.4 mtpp -116.18 131.57 56.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 26.4 m-85 -117.11 137.59 52.19 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.179 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.1 m120 -104.66 106.72 17.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 171.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.714 HG13 HD23 ' A' ' 11' ' ' LEU . 8.3 t -102.94 138.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.529 -172.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 17.4 mt-10 -137.47 93.83 2.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.546 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -77.31 116.86 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.058 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 31' ' ' PRO . 11.4 t -75.84 -45.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.975 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.58 152.9 16.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.41 . . . . 0.0 111.282 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 54' ' ' VAL . 81.6 mt -136.71 133.07 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -150.89 139.95 21.07 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.803 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.716 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.3 pt-20 -73.17 125.85 28.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 109.864 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.01 164.96 25.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.002 -176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p -97.02 23.19 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.537 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.595 ' HA ' HD12 ' A' ' 147' ' ' LEU . 44.7 mt-10 73.17 -31.46 0.23 Allowed 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.635 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.81 -46.64 81.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.836 0.35 . . . . 0.0 111.054 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 36.6 mp0 -54.78 -37.44 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.67 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 142' ' ' ALA . 11.4 mt -74.37 -47.43 34.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.74 -32.55 63.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.688 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -98.77 -25.76 14.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.283 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.02 29.58 25.36 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.617 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 . . . . . 0 C--N 1.328 -0.366 0 O-C-N 122.701 -0.293 . . . . 0.0 110.505 -175.094 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 9.9 ptpt -96.13 168.35 10.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.53 0.681 . . . . 0.0 111.08 -176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -87.28 116.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.524 175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.64 -170.06 3.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.184 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 54.9 tttm -64.46 162.96 14.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 51.27 7.29 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 141' ' ' GLU . 22.2 mt -107.63 155.68 19.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 34' ' ' TYR . 7.4 p -116.31 143.16 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 139' ' ' ILE . 3.7 m -136.86 161.18 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.486 0.66 . . . . 0.0 111.906 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.1 m -125.72 107.75 10.85 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -120.93 161.81 20.93 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.855 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.49 108.09 10.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.1 p90 -126.39 163.77 22.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.154 0.502 . . . . 0.0 110.367 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 59.9 tt0 -128.83 116.88 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.485 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 p -102.94 122.71 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.794 0.807 . . . . 0.0 111.169 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -142.42 164.03 31.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.311 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.509 ' OG1' HG12 ' A' ' 21' ' ' VAL . 58.7 p -83.49 174.19 10.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.461 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.1 -23.23 61.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 110.452 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -15.57 51.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.596 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.58 -16.73 40.47 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.96 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.725 ' HB ' ' HG2' ' A' ' 106' ' ' PRO . 11.4 p -67.31 133.99 30.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 117.906 0.853 . . . . 0.0 111.051 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 25' ' ' GLU . 57.0 tp -81.03 127.79 32.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.695 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 15' ' ' VAL . 29.7 m -103.33 -33.99 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.094 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.6 163.15 32.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.674 ' HB2' HD11 ' A' ' 22' ' ' LEU . 29.1 tt0 -165.3 130.29 2.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.266 0.555 . . . . 0.0 112.063 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 31' ' ' PRO . 28.7 t -103.06 107.72 56.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.95 166.75 25.49 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.364 2.043 . . . . 0.0 111.704 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.39 -17.78 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.435 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 p -79.09 -32.32 44.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.356 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.15 114.09 5.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.068 0.461 . . . . 0.0 110.628 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.759 ' HG3' HG21 ' A' ' 137' ' ' VAL . 7.8 Cg_exo -76.35 169.07 22.68 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.934 3.09 . . . . 0.0 114.38 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.434 HD11 ' HE2' ' A' ' 34' ' ' TYR . 12.0 tp -86.13 128.4 34.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.19 168.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -118.38 119.55 34.93 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 37.1 m-85 -162.3 157.13 22.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.466 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 147' ' ' LEU . 64.0 tp -86.36 113.3 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.23 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -71.32 142.31 50.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 -170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 89.6 24.98 29.11 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.073 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.56 -18.16 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.6 0.238 . . . . 0.0 111.284 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.25 40.67 0.94 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB3' ' CB ' ' A' ' 34' ' ' TYR . 14.6 m -63.86 -45.59 88.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.326 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 45' ' ' LEU . 1.8 pt? -151.65 179.25 8.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 67' ' ' ALA . 11.0 pt -42.13 148.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.462 1.125 . . . . 0.0 112.989 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.1 t -76.53 -40.73 49.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.943 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.24 -32.16 60.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.025 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tp -77.01 -52.71 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.154 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 49' ' ' LEU . 27.4 mt-10 -55.26 -46.03 76.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.062 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.7 m -61.25 -29.58 69.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.052 0.453 . . . . 0.0 111.492 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.84 -34.34 57.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.785 0.802 . . . . 0.0 109.609 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 64.3 mt -69.58 -38.06 77.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.153 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.39 125.26 22.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 112.836 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.73 0.42 34.37 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.338 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 3' ' ' VAL . 98.3 m-70 -101.38 169.2 9.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 54.9 mt-10 -123.15 166.31 15.4 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -47.55 145.73 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 122.066 0.936 . . . . 0.0 112.835 -177.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 85.21 -0.76 88.83 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 114.105 -1.407 . . . . 0.0 114.202 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.98 153.35 42.72 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.877 0.838 . . . . 0.0 109.297 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -149.15 128.52 12.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.245 0.545 . . . . 0.0 109.76 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.662 ' CE2' HG22 ' A' ' 60' ' ' VAL . 25.6 p90 -162.96 177.87 8.85 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -120.1 147.51 44.77 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.662 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -133.39 143.01 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -169.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.0 11.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.952 0.406 . . . . 0.0 110.119 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 44' ' ' GLY . 69.5 t -120.03 142.29 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.21 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.84 152.0 36.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.658 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.19 -21.59 66.31 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -68.57 -18.29 64.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.0 110.751 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.87 -52.95 2.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.453 -172.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 120.804 0.335 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.583 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.3 mpt_? -107.75 106.56 16.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.617 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.555 ' CG1' HG21 ' A' ' 83' ' ' VAL . 2.8 t -105.46 133.14 20.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.313 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 83' ' ' VAL . 21.4 Cg_exo -61.94 133.79 46.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.851 2.367 . . . . 0.0 111.566 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 37.4 mtmt -56.47 -24.61 46.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.41 -43.27 83.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 80' ' ' PRO . 5.8 m -53.31 -30.03 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.091 0.472 . . . . 0.0 112.101 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HD11 ' A' ' 90' ' ' LEU . 43.4 m-85 -103.1 39.13 1.61 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.605 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -60.8 -30.99 70.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.57 -7.44 88.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.048 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 70.1 t -76.17 146.43 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.913 0.356 . . . . 0.0 110.858 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.48 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.557 0.535 . . . . 0.0 110.884 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -152.7 120.26 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.853 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 84' ' ' PHE . 97.3 mt -68.23 109.36 3.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.288 0.566 . . . . 0.0 111.076 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.8 tt0 -127.2 171.05 11.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.861 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 111' ' ' ALA . 55.6 t -83.13 138.43 19.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.01 1.13 88.9 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.732 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.581 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.9 mmm -84.24 134.82 34.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.609 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 5.8 ttt180 -131.91 134.35 45.58 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -159.78 162.76 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.403 HD11 ' CB ' ' A' ' 104' ' ' PRO . 35.1 tp -80.89 127.32 32.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.46 116.22 26.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 40.1 mt-10 -93.37 100.57 12.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.964 0.888 . . . . 0.0 110.096 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.8 p -95.61 -175.79 3.56 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.192 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.27 -30.11 62.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.399 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.0 pt20 -104.63 25.03 10.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.95 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.61 173.27 33.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.382 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 31.2 Cg_exo -62.1 138.26 71.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.993 2.462 . . . . 0.0 112.867 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.65 108.76 12.04 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.725 ' HG2' ' HB ' ' A' ' 21' ' ' VAL . 16.5 Cg_exo -69.2 103.63 1.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.664 2.243 . . . . 0.0 111.215 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.612 ' HB ' HG13 ' A' ' 119' ' ' VAL . 20.6 m -118.13 155.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.121 0.486 . . . . 0.0 111.136 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 38.3 tt0 -122.92 139.41 54.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.756 0.789 . . . . 0.0 109.846 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.672 HG12 HG23 ' A' ' 119' ' ' VAL . 19.9 mt -85.81 132.16 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.471 -173.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 64.9 p -113.98 0.9 14.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.268 0.556 . . . . 0.0 109.866 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.493 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 172.77 156.07 0.1 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.86 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 117' ' ' VAL . 48.1 t -139.94 114.98 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.68 -162.39 0.9 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.17 -26.39 62.95 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.247 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.758 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 24.4 m-20 -131.06 -26.03 2.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -133.11 167.15 20.85 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.98 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 112' ' ' VAL . 35.8 m -114.39 165.04 9.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.663 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.4 t -113.79 104.57 17.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.672 HG23 HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -113.24 140.17 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.2 t0 . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 5.2 mtpp -116.45 132.08 56.77 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -119.96 126.0 49.78 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 16.9 m120 -100.61 107.24 18.85 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 49' ' ' LEU . 6.6 t -101.22 145.92 10.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.063 -165.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -149.29 97.14 2.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.777 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -76.05 117.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.314 0.578 . . . . 0.0 111.53 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.3 t -76.98 -45.87 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.331 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.2 155.94 23.53 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.186 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 9' ' ' VAL . 62.0 mt -139.7 137.97 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -145.88 142.87 29.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.106 0.479 . . . . 0.0 110.934 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.598 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 pt-20 -80.75 124.82 29.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.094 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -71.4 168.15 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.453 -174.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -103.01 23.28 12.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 147' ' ' LEU . 32.3 mt-10 73.8 -33.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.101 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.99 -41.71 97.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.619 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.647 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 13.8 mp0 -57.65 -39.51 77.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.891 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 142' ' ' ALA . 16.6 mt -70.48 -44.89 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.961 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.08 -34.22 68.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.837 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -100.71 -31.22 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.182 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.16 15.78 50.06 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.286 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -174.345 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.08 174.69 5.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.58 0.705 . . . . 0.0 111.021 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -88.05 127.63 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.769 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.2 -177.64 6.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 76.6 tttt -55.75 152.0 10.28 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.083 0.24 . . . . 0.0 110.884 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 57.32 -5.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 141' ' ' GLU . 28.1 mt -95.94 104.75 16.71 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.704 -0.622 . . . . 0.0 110.89 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 34' ' ' TYR . 12.1 p -65.55 142.78 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.712 0.768 . . . . 0.0 111.816 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.865 HG12 HG23 ' A' ' 139' ' ' ILE . 1.3 m -145.32 154.93 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.832 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -120.36 119.11 32.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD13 HG13 ' A' ' 134' ' ' VAL . 4.5 pp -141.13 147.99 39.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -97.85 153.75 18.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.69 160.4 42.73 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.663 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 44.5 tt0 -132.46 118.33 19.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 23' ' ' VAL . 2.6 p -106.92 124.38 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.722 0.772 . . . . 0.0 111.522 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -139.93 165.69 26.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.101 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -81.47 179.28 7.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.319 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 42.9 mt-10 -66.0 -11.76 50.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.626 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -80.41 -19.3 46.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.105 0.478 . . . . 0.0 110.41 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.32 -17.4 53.79 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.382 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.97 132.32 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.24 140.61 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.315 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 15' ' ' VAL . 2.8 p -113.66 -35.54 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.991 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -168.89 172.16 7.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.663 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 2.9 pt-20 -166.73 159.66 14.09 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.177 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 52.8 m -108.33 110.06 61.73 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 162.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 38.3 Cg_endo -61.02 155.81 48.13 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 C-N-CA 122.78 2.32 . . . . 0.0 113.287 -165.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.45 -7.06 7.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 27' ' ' PRO . 5.8 p -91.21 -26.27 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.32 114.59 5.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.827 ' HG3' HG21 ' A' ' 137' ' ' VAL . 6.6 Cg_exo -74.81 166.03 30.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.465 2.777 . . . . 0.0 114.366 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.06 130.28 35.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.461 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -116.33 127.98 55.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.165 0.507 . . . . 0.0 110.228 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' VAL . 54.6 p90 -160.1 164.61 32.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.416 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' A' ' 147' ' ' LEU . 54.4 tp -103.1 111.15 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.56 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.77 124.06 17.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.569 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 93.35 0.23 67.75 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.943 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -136.54 3.25 2.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.79 92.73 0.09 OUTLIER Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.693 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 m -114.36 8.84 16.76 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.938 0.875 . . . . 0.0 109.449 -166.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 53.17 -89.05 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.454 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 45' ' ' LEU . 23.5 pt -124.5 136.25 61.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 122.265 1.031 . . . . 0.0 110.627 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -48.21 -42.76 30.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.444 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 66' ' ' ASP . . . -69.25 -37.77 81.19 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.443 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 HG21 ' A' ' 134' ' ' VAL . 16.2 tp -75.39 -52.23 11.25 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -173.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.693 ' HG3' ' O ' ' A' ' 40' ' ' SER . 2.5 mm-40 -53.16 -45.11 68.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.26 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.4 m -57.77 -35.78 71.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.257 0.551 . . . . 0.0 111.331 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 -36.1 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.819 0.819 . . . . 0.0 109.606 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.573 ' CD2' HG11 ' A' ' 134' ' ' VAL . 83.4 mt -61.63 -35.64 78.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.014 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -53.86 152.62 5.38 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.11 -6.64 48.86 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 113.408 -1.723 . . . . 0.0 116.65 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.701 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.6 p80 -117.93 -177.29 3.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 119.417 1.608 . . . . 0.0 111.109 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 1' ' ' MET . 45.3 mt-10 -124.06 174.66 7.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -169.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 139' ' ' ILE . 1.4 m -54.41 145.65 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.311 172.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.73 -15.66 56.67 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.852 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.48 143.48 42.55 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 4.0 tmmm? -145.61 131.52 19.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.103 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.756 ' CE2' HG22 ' A' ' 60' ' ' VAL . 17.9 p90 -162.69 159.81 24.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.007 0.432 . . . . 0.0 110.305 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.71 141.11 32.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.014 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.756 HG22 ' CE2' ' A' ' 58' ' ' PHE . 10.5 t -127.95 143.3 41.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.09 112.99 7.75 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.664 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' A' ' 132' ' ' PHE . 14.6 m -127.82 169.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.734 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.26 158.88 29.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.187 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.48 -25.02 9.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.18 0.592 . . . . 0.0 112.563 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -59.86 -27.77 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 111.06 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.447 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 1.5 m-20 -115.94 -5.76 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.422 0.629 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HG2' HG22 ' A' ' 118' ' ' VAL . 68.1 mtt180 -99.12 150.0 22.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.82 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 t -143.23 129.0 10.15 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.51 139.09 87.66 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.17 2.58 . . . . 0.0 112.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.674 ' HD3' HD12 ' A' ' 90' ' ' LEU . 20.2 mmtp -52.07 -32.42 34.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.287 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.36 -41.64 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.706 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.18 -37.48 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.052 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HD2' HD11 ' A' ' 90' ' ' LEU . 59.1 m-85 -100.78 40.01 1.32 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.731 0.3 . . . . 0.0 111.224 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.411 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 16.3 ptm -49.67 -37.21 27.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -88.21 13.53 61.48 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.948 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.4 p -90.01 165.79 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 117.388 0.594 . . . . 0.0 110.064 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.79 -71.19 0.12 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -166.16 128.37 1.92 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.674 HD12 ' HD3' ' A' ' 81' ' ' LYS . 92.0 mt -63.9 112.16 2.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.808 0.814 . . . . 0.0 111.359 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.532 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -125.71 161.39 27.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.648 -177.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 109' ' ' ILE . 59.1 t -80.82 136.0 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 1.37 66.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.314 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -87.49 135.79 33.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.094 0.473 . . . . 0.0 110.634 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -113.93 134.42 54.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.728 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -163.21 173.79 12.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.006 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 104' ' ' PRO . 31.2 tp -90.91 120.94 32.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -90.1 174.0 7.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.669 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -128.19 121.79 30.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.328 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.5 p -145.52 175.27 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.731 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -55.1 -36.97 66.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.262 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.0 pt20 -92.27 30.74 1.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.62 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.08 -177.51 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.584 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.0 Cg_exo -58.1 143.72 96.14 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.435 2.09 . . . . 0.0 112.476 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 107' ' ' VAL . 88.1 t -133.78 116.91 13.83 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.05 101.88 0.74 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.65 2.233 . . . . 0.0 111.854 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 5.0 m -118.83 178.31 2.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.005 0.431 . . . . 0.0 111.734 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -135.66 137.41 41.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.32 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 90' ' ' LEU . 23.0 mt -78.01 126.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.813 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 p -110.95 1.54 17.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.426 0.632 . . . . 0.0 109.591 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 179.94 153.11 0.49 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.032 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 117' ' ' VAL . 94.2 t -141.37 109.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.05 -165.05 1.26 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.12 -54.28 15.81 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.491 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -109.21 -3.93 16.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -141.69 147.78 38.04 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.647 -0.658 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 112' ' ' VAL . 35.2 m -111.38 167.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 78' ' ' ARG . 58.8 t -121.58 114.87 44.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.7 m -113.97 137.99 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.545 0.688 . . . . 0.0 111.704 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 C--N 1.312 -1.061 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.717 175.573 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 67' ' ' ALA . 45.4 mt . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 40.7 mtpt -115.52 129.02 56.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -118.14 139.78 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.271 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -108.58 108.14 18.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.1 t -99.2 137.44 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.289 -172.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 9.3 mt-10 -136.52 96.11 3.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.86 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 52' ' ' HIS . 38.9 t -76.24 115.85 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.576 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.827 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.0 t -72.96 -49.5 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.892 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.57 156.28 20.64 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.347 -0.22 . . . . 0.0 111.24 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.865 HG23 HG12 ' A' ' 9' ' ' VAL . 67.8 mt -138.99 141.96 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -147.21 141.08 25.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.976 0.417 . . . . 0.0 110.619 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.2 pt-20 -76.23 117.14 17.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.717 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -62.18 155.28 24.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.803 0.811 . . . . 0.0 112.714 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 145' ' ' GLU . 43.2 p -84.19 18.86 1.99 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.223 -1.353 . . . . 0.0 112.066 -171.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 147' ' ' LEU . 30.1 mt-10 68.87 -33.0 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.082 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 143' ' ' THR . 0.4 OUTLIER -66.46 -40.43 89.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.717 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -58.06 -39.9 79.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.02 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 142' ' ' ALA . 14.9 mt -69.1 -45.55 69.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.898 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.66 67.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.853 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -97.52 -6.25 34.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.8 0.71 85.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.832 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 16.0 ptmt -106.19 171.17 7.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.27 0.557 . . . . 0.0 110.49 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -87.02 120.47 36.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.251 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.19 -172.95 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 7' ' ' LEU . 56.8 tttm -57.73 147.41 27.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.812 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 54.65 -5.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.0 mt -85.34 104.3 15.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.807 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.766 HG22 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -60.55 143.85 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.586 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.835 ' O ' ' HB3' ' A' ' 34' ' ' TYR . 2.3 m -153.18 131.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.217 1.008 . . . . 0.0 111.999 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 2.3 m -100.2 120.92 40.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.737 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -139.35 143.77 37.92 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.619 -0.833 . . . . 0.0 109.786 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -104.33 154.27 20.02 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.796 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 52.9 p90 -149.09 165.04 32.92 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.278 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 31.3 tt0 -131.91 120.77 22.99 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.5 t -103.84 119.64 52.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.5 ptp180 -132.58 151.67 51.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 p -81.95 175.98 9.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.137 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -58.7 -32.07 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.261 0.553 . . . . 0.0 109.721 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.28 -18.23 63.82 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.933 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.89 26.72 15.84 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.563 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 9.1 t -105.17 126.32 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.786 -0.244 . . . . 0.0 110.554 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' GLU . 35.1 tp -67.04 123.35 19.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -109.6 -38.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.565 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.18 152.41 39.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 22' ' ' LEU . 30.8 tt0 -157.1 137.43 12.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 111.753 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 27.1 m -116.7 114.3 39.87 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.17 167.52 19.94 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 C-N-CA 122.824 2.349 . . . . 0.0 112.227 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.18 -17.71 22.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.269 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -78.0 -32.53 51.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.242 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.8 112.83 9.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.277 0.561 . . . . 0.0 110.75 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.726 ' HG3' HG21 ' A' ' 137' ' ' VAL . 10.6 Cg_exo -76.86 169.45 21.66 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 124.271 3.314 . . . . 0.0 114.644 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.796 ' HG ' ' HE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -70.0 158.67 35.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.383 169.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.536 ' H ' HD23 ' A' ' 32' ' ' LEU . 3.9 m-20 -91.43 149.62 21.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.085 0.945 . . . . 0.0 110.949 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.835 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.08 126.91 42.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -161.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.625 HD11 HD23 ' A' ' 147' ' ' LEU . 14.7 tp -148.44 98.54 2.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 146.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.515 ' HA ' ' OG ' ' A' ' 40' ' ' SER . 21.2 t60 -70.82 136.19 48.6 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.412 -164.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.55 27.32 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.471 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.14 18.32 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.671 0.748 . . . . 0.0 110.173 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.83 90.8 0.18 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.98 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 41' ' ' LEU . 11.0 m -116.63 -52.27 2.56 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.726 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.75 -173.42 2.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 111.568 -2.56 . . . . 0.0 108.518 170.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 41' ' ' LEU . 13.7 pt -33.14 143.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -66.47 -41.08 89.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.741 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.14 -41.41 94.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.773 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 134' ' ' VAL . 29.8 tp -73.95 -48.89 27.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.6 mt-10 -50.74 -47.86 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.113 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.5 m -63.45 -36.83 85.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.656 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.1 72.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.467 0.651 . . . . 0.0 110.015 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 134' ' ' VAL . 83.9 mt -59.0 -37.07 76.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.664 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.0 mt-10 -53.32 152.04 4.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . 82.82 -22.49 6.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.371 -1.286 . . . . 0.0 114.183 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.509 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.8 m-70 -83.39 179.26 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.451 0.643 . . . . 0.0 111.954 -175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.6 mt-10 -134.73 161.85 34.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.483 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.2 m -52.61 143.26 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.691 0.619 . . . . 0.0 111.11 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 97.39 -17.13 59.56 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.689 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -64.94 132.54 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.742 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 13.7 tmtt? -137.17 130.19 30.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.656 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 60' ' ' VAL . 21.0 p90 -166.57 163.49 16.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.993 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.11 143.38 26.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.598 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.713 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.9 t -131.43 142.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.122 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.97 113.49 13.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.035 0.445 . . . . 0.0 109.893 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 44' ' ' GLY . 99.7 t -125.9 136.88 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.508 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.52 148.23 45.03 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.12 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.82 -21.61 66.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -68.95 -19.64 64.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.019 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.3 -42.02 4.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.922 0.391 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.9 mpt_? -111.02 111.5 22.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.207 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.49 133.28 20.25 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.461 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -60.98 135.01 56.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.76 2.307 . . . . 0.0 111.836 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 23.8 mtmt -59.11 -17.52 27.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.327 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.52 -27.37 64.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.42 0.629 . . . . 0.0 110.154 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.9 -36.4 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HB2' HD11 ' A' ' 90' ' ' LEU . 26.3 m-85 -102.1 40.02 1.4 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.179 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.7 ptm -56.54 -24.33 46.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.361 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.39 4.7 83.35 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.198 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 HD23 ' A' ' 90' ' ' LEU . 69.5 t -89.56 149.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.902 0.351 . . . . 0.0 110.477 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.17 -70.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 110.878 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.72 105.38 4.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.626 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 84' ' ' PHE . 80.8 mt -60.17 107.59 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.341 0.591 . . . . 0.0 110.392 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.27 167.52 16.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.26 140.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.05 2.43 77.86 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.483 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 mmm -89.21 135.53 33.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.101 0.476 . . . . 0.0 109.718 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.83 135.39 54.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.691 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -164.15 167.45 20.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.112 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.3 tp -84.33 130.6 34.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -113.16 142.72 45.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.994 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.62 132.95 35.45 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.3 p -146.81 -175.64 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.81 -30.88 70.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.592 0.71 . . . . 0.0 109.901 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -86.71 24.45 1.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.636 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.79 -171.67 55.15 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.185 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 32.6 Cg_exo -58.63 128.57 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.231 1.954 . . . . 0.0 111.631 170.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -128.85 116.43 19.23 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 14.8 Cg_exo -70.74 102.7 1.22 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.939 2.426 . . . . 0.0 111.861 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.5 m -118.37 172.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.777 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.98 131.53 40.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.82 128.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 120' ' ' ASP . 39.4 p -113.66 0.31 14.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.323 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -175.52 153.27 1.45 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.093 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.766 HG13 HG12 ' A' ' 117' ' ' VAL . 57.5 t -140.78 106.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.84 -172.61 3.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.31 -49.03 65.81 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.225 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.547 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 10.0 m-20 -104.83 -14.35 15.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -143.53 149.04 36.89 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.574 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -104.58 168.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.114 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.2 t -124.0 122.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m -115.63 133.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 112.012 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 110' ' ' THR . 14.3 t70 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.797 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.996 0.427 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -117.11 128.54 55.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 3.5 m-85 -119.71 133.77 55.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.472 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 133' ' ' ASN . 1.0 OUTLIER -104.33 108.69 20.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.737 HG13 HD23 ' A' ' 11' ' ' LEU . 5.6 t -98.67 142.5 14.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.505 0.669 . . . . 0.0 112.145 -170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.742 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 44.0 mt-10 -130.93 90.85 2.96 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.192 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -68.86 114.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.854 0.835 . . . . 0.0 111.957 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 31' ' ' PRO . 15.8 t -71.54 -51.9 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.047 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -158.58 158.45 33.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.885 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.682 HG23 HG12 ' A' ' 9' ' ' VAL . 75.9 mt -137.35 134.58 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 41.6 ttm180 -154.38 138.99 16.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' HD22 ' A' ' 7' ' ' LEU . 16.1 pt-20 -70.85 123.34 21.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -62.75 164.23 8.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.2 p -97.54 25.27 5.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' LEU . 38.7 mt-10 72.81 -36.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.369 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.0 -48.71 79.1 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.565 0.221 . . . . 0.0 110.693 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 12.7 mp0 -55.68 -39.42 70.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.625 HD23 HD11 ' A' ' 35' ' ' LEU . 19.2 mt -68.76 -47.32 66.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.168 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.2 73.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.19 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -84.58 -19.28 33.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.239 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 81.93 10.24 84.27 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.007 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 19.2 ptmt -133.14 166.18 23.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.3 p -72.42 115.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.068 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.32 -171.0 3.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.008 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 83.3 tttt -64.97 158.04 26.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.223 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' O ' HD21 ' A' ' 147' ' ' LEU . 3.6 p30 55.69 0.3 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 113.907 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 141' ' ' GLU . 15.6 mt -96.45 110.51 22.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.044 0.45 . . . . 0.0 111.295 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 HD13 ' A' ' 35' ' ' LEU . 49.7 t -53.73 143.43 5.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.708 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -141.89 134.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -111.99 111.7 22.81 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.522 HD13 HG13 ' A' ' 134' ' ' VAL . 2.3 pp -128.76 161.12 30.48 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.854 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.6 147.31 42.96 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.667 ' CE1' HD12 ' A' ' 32' ' ' LEU . 36.7 p90 -160.93 162.19 31.91 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.436 -0.905 . . . . 0.0 111.452 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.0 tt0 -133.57 121.07 21.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.4 p -113.7 125.93 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.598 0.713 . . . . 0.0 111.361 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -144.07 176.03 9.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.335 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.3 p -98.03 178.05 5.22 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.528 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.2 -20.86 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.263 0.554 . . . . 0.0 110.153 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' HG23 ' A' ' 21' ' ' VAL . 18.2 t70 -78.26 -18.07 55.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.384 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.39 6.02 53.65 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 19' ' ' ASP . 5.2 t -77.04 112.92 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 15' ' ' VAL . 58.3 tp -68.97 119.43 13.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 15' ' ' VAL . 31.0 m -96.52 -39.19 8.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 32.5 t70 -156.56 160.15 39.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 43.1 tt0 -159.05 133.54 7.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 0.0 111.971 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 m -116.25 105.08 51.28 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.26 168.27 18.14 Favored 'Trans proline' 0 CA--C 1.523 -0.068 0 C-N-CA 122.91 2.407 . . . . 0.0 113.035 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.02 -19.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.548 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.4 p -75.83 -38.95 57.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -133.93 112.65 12.47 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.237 0.541 . . . . 0.0 109.873 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.493 ' HB3' HG21 ' A' ' 137' ' ' VAL . 12.9 Cg_exo -75.53 169.76 21.68 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.994 3.13 . . . . 0.0 114.723 -175.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -86.6 131.49 34.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.603 168.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.57 118.28 26.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.645 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 23.1 m-85 -160.15 -179.72 7.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.263 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 147' ' ' LEU . 60.2 tp -107.98 115.74 30.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.65 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 14.9 t60 -73.99 130.87 40.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 109.45 6.38 29.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.774 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -148.15 9.66 0.87 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.12 104.34 2.51 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -167.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 34' ' ' TYR . 39.4 t -118.33 -50.85 2.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.2 pt? -158.09 -168.89 2.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.817 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 10.7 pt -39.77 144.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -66.51 -39.46 88.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.076 -1.874 . . . . 0.0 112.185 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.506 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -65.53 -39.48 95.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.352 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 134' ' ' VAL . 16.5 tp -74.37 -49.79 21.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 109.864 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 49' ' ' LEU . 23.3 mt-10 -48.5 -47.2 39.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.4 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.9 m -66.48 -32.97 74.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.7 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.41 74.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.8 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -57.91 -45.13 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.161 175.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.2 mt-10 -46.55 152.35 0.47 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.949 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 79.11 -23.59 3.17 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 114.428 -1.26 . . . . 0.0 114.594 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.2 m-70 -84.49 177.55 8.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.664 0.732 . . . . 0.0 111.163 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 1' ' ' MET . 39.5 mt-10 -128.72 164.57 22.66 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.1 m -52.04 142.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.819 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.87 -13.11 66.66 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.473 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.52 131.38 44.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.941 0.4 . . . . 0.0 110.327 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.565 ' CG ' ' HG2' ' A' ' 135' ' ' GLU . 1.9 tmtp? -137.96 130.33 29.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.913 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.5 p90 -167.4 162.01 14.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.037 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.77 144.11 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.626 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -134.32 142.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.31 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.95 113.2 11.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG11 ' HA3' ' A' ' 44' ' ' GLY . 80.3 t -120.78 138.22 51.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.876 0.37 . . . . 0.0 110.652 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.85 150.32 50.37 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.367 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.54 -31.39 4.33 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -65.16 -21.11 66.73 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -117.06 3.69 12.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 176.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 118' ' ' VAL . 8.4 mpt_? -116.26 105.36 12.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 109.737 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.17 128.62 36.28 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.952 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.32 137.1 72.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.592 2.862 . . . . 0.0 112.216 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.903 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -56.1 -25.57 46.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.113 175.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.04 -36.42 81.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.462 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -43.16 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.316 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.7 m-85 -90.4 40.21 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 14.7 ptm -52.13 -36.54 51.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.144 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -92.32 13.94 65.92 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.984 -175.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.781 HG11 ' HG ' ' A' ' 90' ' ' LEU . 7.4 p -75.79 159.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.272 0.536 . . . . 0.0 111.129 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 87' ' ' VAL . 19.5 t70 -68.67 -76.03 0.1 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.859 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -149.77 110.51 4.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.217 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HG ' HG11 ' A' ' 87' ' ' VAL . 5.6 mt -64.58 119.54 10.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.652 0.739 . . . . 0.0 111.45 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.3 tt0 -147.03 164.89 31.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.471 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 111' ' ' ALA . 53.3 t -81.21 132.68 30.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.04 1.82 56.0 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.83 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.42 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 mmm -91.09 141.86 28.37 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.226 0.536 . . . . 0.0 111.292 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 10.7 mtp180 -118.24 134.54 54.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.043 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -162.01 167.09 25.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.078 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 104' ' ' PRO . 44.6 tp -91.31 137.3 32.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.192 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.84 138.14 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.09 146.91 28.42 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.5 p -145.74 -175.55 4.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.17 -23.57 67.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.84 0.828 . . . . 0.0 110.514 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.84 26.84 10.27 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.549 -171.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.89 -179.31 48.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.135 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 97' ' ' LEU . 42.3 Cg_exo -57.82 133.39 55.83 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.375 2.05 . . . . 0.0 112.903 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 88.9 t -129.53 116.39 18.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.549 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.9 Cg_exo -79.75 112.97 2.98 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.889 2.393 . . . . 0.0 111.19 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.8 m -118.23 178.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.743 0.306 . . . . 0.0 111.196 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' C ' HG12 ' A' ' 119' ' ' VAL . 36.7 tt0 -134.53 130.84 37.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 112' ' ' VAL . 40.7 mt -71.89 130.44 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.327 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.9 p -112.05 -1.87 15.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 0.0 110.382 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . -175.34 150.24 1.11 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.485 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.624 HG13 HG12 ' A' ' 117' ' ' VAL . 60.8 t -139.08 106.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 6.9 mm-40 -86.0 -157.31 0.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -71.33 -54.09 11.97 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.866 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.492 ' C ' ' HG2' ' A' ' 81' ' ' LYS . 18.5 m-20 -118.14 5.86 12.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.41 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 33.1 p-80 -145.1 148.03 33.2 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.461 -0.774 . . . . 0.0 111.574 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.755 HG13 ' HZ3' ' A' ' 81' ' ' LYS . 30.7 m -116.35 167.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.5 t -122.53 115.88 47.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.967 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -119.05 130.57 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.069 0.462 . . . . 0.0 110.333 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t0 . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.986 -177.245 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -124.17 122.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 110.048 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 1.6 m-85 -117.83 139.81 50.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.704 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.9 m120 -109.36 106.67 16.57 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 45' ' ' LEU . 2.5 t -99.61 135.62 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.565 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 25.9 mt-10 -135.54 90.83 2.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.272 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 54' ' ' VAL . 2.9 p -72.69 115.0 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.846 0.831 . . . . 0.0 112.446 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.2 t -72.91 -47.91 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.124 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.03 157.59 31.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.751 0.31 . . . . 0.0 111.147 -171.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 54' ' ' VAL . 63.5 mt -140.34 123.46 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -146.97 137.05 23.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.999 0.428 . . . . 0.0 111.351 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.449 ' HB3' HD22 ' A' ' 7' ' ' LEU . 7.9 pt-20 -75.49 138.66 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -80.51 176.77 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.682 0.754 . . . . 0.0 112.589 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p -96.34 23.43 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.269 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 70.17 -43.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.365 0.666 . . . . 0.0 111.444 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.79 -40.26 91.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.365 0.602 . . . . 0.0 109.38 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.581 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 42.4 mt-10 -63.15 -34.27 77.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.381 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 35' ' ' LEU . 47.2 mt -71.98 -47.4 52.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.139 176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.48 69.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.52 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.04 -16.76 18.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.87 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.79 40.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 114.243 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.373 0.587 . . . . 0.0 110.635 176.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 51' ' ' GLY . 15.2 ptpt -111.11 170.83 7.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.481 0.657 . . . . 0.0 111.729 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -84.94 131.96 32.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.16 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.12 -174.12 4.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.527 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 79.5 tttt -65.96 155.86 35.28 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 147' ' ' LEU . 28.7 m-20 60.37 -5.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 141' ' ' GLU . 19.3 mt -90.71 109.66 20.84 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.613 -0.679 . . . . 0.0 111.454 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.0 144.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.046 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -151.16 137.75 12.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -168.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 10.9 m -102.45 121.24 41.95 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 134' ' ' VAL . 2.1 tt -136.9 154.31 50.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.425 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . . . -124.36 151.24 44.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.48 161.33 21.28 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.04 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 51.8 tt0 -132.15 118.94 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.496 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.9 p -110.32 124.4 67.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.536 0.684 . . . . 0.0 111.388 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -145.41 -179.84 6.92 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 p -99.91 174.58 6.12 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.253 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 43.6 mt-10 -65.43 -19.22 65.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.421 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.07 -18.72 55.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.577 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.36 -12.01 43.59 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.515 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.53 126.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 117.427 0.614 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 15' ' ' VAL . 51.5 tp -76.96 127.97 33.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.86 -35.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -167.47 167.06 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.665 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -165.64 159.35 16.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.5 0.667 . . . . 0.0 111.212 169.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -126.07 114.59 24.04 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.42 166.06 26.86 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.789 2.326 . . . . 0.0 113.218 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.94 -22.89 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.436 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.2 p -71.41 -38.95 71.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.871 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -135.34 113.05 11.14 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-O 121.269 0.557 . . . . 0.0 110.151 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.3 Cg_exo -75.81 166.58 27.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.9 3.067 . . . . 0.0 114.439 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD11 ' HE2' ' A' ' 34' ' ' TYR . 14.8 tp -85.62 134.17 34.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.485 170.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.07 118.18 30.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.167 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' HD11 ' A' ' 32' ' ' LEU . 50.0 m-85 -160.69 179.75 8.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.195 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.93 117.95 35.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 31.9 t60 -70.79 128.99 37.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 96.48 8.19 57.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.889 172.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -134.31 14.58 3.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.15 103.29 2.3 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -167.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 36' ' ' HIS . 33.4 t -116.61 -52.31 2.56 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.39 -82.81 0.24 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.122 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.585 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 15.5 pt -122.59 -163.43 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 t -98.02 -50.09 4.52 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.492 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.05 -34.81 29.11 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.956 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.693 HD11 HG21 ' A' ' 134' ' ' VAL . 55.5 tp -74.24 -46.55 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 109.988 -172.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 48.3 mt-10 -50.79 -41.74 57.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.259 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -65.15 -33.23 75.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.72 -35.57 65.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.015 0.912 . . . . 0.0 109.273 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.916 HD21 HG11 ' A' ' 134' ' ' VAL . 96.2 mt -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.953 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.74 152.57 5.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.997 0.903 . . . . 0.0 112.772 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' O ' ' HE2' ' A' ' 2' ' ' LYS . . . 77.9 -18.39 5.02 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.549 ' HE1' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -128.65 157.31 41.67 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.377 2.089 . . . . 0.0 112.921 -173.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 1' ' ' MET . 41.4 mt-10 -101.98 166.32 10.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -157.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.628 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.6 m -48.12 144.21 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.046 -1.433 . . . . 0.0 112.714 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.58 -10.34 66.75 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.286 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -75.43 137.06 40.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.166 0.507 . . . . 0.0 110.171 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 2.1 tmtp? -137.76 132.37 32.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.921 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 60' ' ' VAL . 7.2 p90 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.045 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.39 139.84 33.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.779 0.799 . . . . 0.0 111.305 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.661 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.4 t -125.67 150.42 30.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.428 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.48 113.96 11.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.037 0.381 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.85 144.66 37.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.189 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.36 152.64 49.89 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.155 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.2 -28.35 52.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.979 0.512 . . . . 0.0 112.258 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -71.43 -20.74 62.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.949 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -111.73 1.35 16.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.519 0.676 . . . . 0.0 110.416 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.51 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.455 0.645 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.611 ' HG3' HG22 ' A' ' 118' ' ' VAL . 4.8 mpt_? -115.16 148.93 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.17 129.46 12.31 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -171.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.5 Cg_exo -57.21 136.57 77.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.051 2.5 . . . . 0.0 112.422 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -54.44 -31.6 55.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.495 178.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.93 -35.14 79.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 80' ' ' PRO . 88.1 t -57.01 -36.3 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.156 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HB2' HD11 ' A' ' 90' ' ' LEU . 45.6 m-85 -104.81 39.87 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.405 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.3 ptm -53.65 -27.22 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.527 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 3.07 85.7 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.387 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 95.0 t -92.78 144.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.091 0.446 . . . . 0.0 111.098 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.01 -77.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.076 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -134.2 106.64 7.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.722 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 117' ' ' VAL . 96.8 mt -59.68 105.52 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.438 0.637 . . . . 0.0 109.622 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 91' ' ' GLN . 5.9 tt0 -128.91 167.81 16.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.085 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 111' ' ' ALA . 43.8 t -79.83 135.24 25.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.5 1.19 68.98 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.137 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mmm -83.93 134.57 34.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.405 0.622 . . . . 0.0 109.688 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -119.33 136.08 54.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.09 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -163.65 165.27 23.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 104' ' ' PRO . 5.6 mt -88.44 132.76 34.34 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.54 0.686 . . . . 0.0 110.518 172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -112.61 114.07 26.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.079 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 26.2 mt-10 -87.32 96.64 10.42 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 110.788 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 p -94.67 -174.52 3.32 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.577 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.33 -43.54 61.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.308 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.5 pt20 -98.47 32.01 2.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.034 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.23 179.83 39.59 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.76 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HB2' HD22 ' A' ' 97' ' ' LEU . 6.2 Cg_exo -66.77 147.77 81.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.516 2.144 . . . . 0.0 112.03 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -134.22 117.09 13.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.801 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.5 Cg_exo -74.01 102.34 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 111.722 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 6.2 m -118.73 151.84 20.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 110.721 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.62 137.85 51.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.225 0.536 . . . . 0.0 110.318 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.5 mt -81.57 129.26 37.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.086 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.3 p -115.53 5.27 14.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 151.45 0.17 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 117' ' ' VAL . 49.1 t -140.91 109.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -91.22 -154.1 0.34 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.05 -36.2 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -133.27 -14.83 2.58 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.179 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -139.38 157.59 45.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.536 0.208 . . . . 0.0 110.725 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 112' ' ' VAL . 30.5 m -112.77 167.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 78' ' ' ARG . 41.4 t -117.19 117.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.7 m -120.39 140.03 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.638 0.733 . . . . 0.0 112.302 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.536 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 23.0 mtpp -122.04 125.63 46.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 2.8 m-85 -116.02 134.54 54.85 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.355 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -105.44 106.62 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.916 HG11 HD21 ' A' ' 49' ' ' LEU . 4.0 t -99.09 139.65 20.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.725 0.774 . . . . 0.0 112.286 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.697 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 37.0 mt-10 -131.48 91.49 3.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.811 -1.541 . . . . 0.0 109.465 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.628 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.5 p -63.56 154.27 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 11' ' ' LEU . 76.0 t -129.44 -55.31 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 -153.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.91 38.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 110.419 -3.082 . . . . 0.0 109.876 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 54' ' ' VAL . 74.9 mt -138.91 133.51 41.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.9 ttp-105 -139.52 154.18 47.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.0 110.171 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.651 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.1 pt-20 -91.55 132.38 36.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.2 163.81 27.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.749 . . . . 0.0 112.243 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -94.64 24.51 4.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.972 -171.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 70.52 -38.71 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.06 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -40.22 82.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.67 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.7 mt-10 -58.97 -37.12 76.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.999 175.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 142' ' ' ALA . 23.0 mt -71.07 -46.02 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.084 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.92 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.425 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -89.76 -14.85 33.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.335 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.67 90.37 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.714 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.537 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 ptpt -111.73 174.63 5.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.43 0.633 . . . . 0.0 111.268 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -83.51 125.05 40.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.188 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.09 -171.08 3.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.781 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 34.9 tttm -63.86 151.18 43.12 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.639 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' OD1' HD22 ' A' ' 147' ' ' LEU . 30.8 m-20 52.74 7.84 0.08 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.57 100.47 11.2 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 34' ' ' TYR . 14.6 p -69.77 141.09 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG12 HG23 ' A' ' 139' ' ' ILE . 4.5 m -136.46 159.04 38.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.873 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.787 ' O ' HG22 ' A' ' 137' ' ' VAL . 19.5 m -117.37 118.26 31.75 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -134.96 161.08 36.28 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.775 -177.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.24 107.82 13.01 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.0 p90 -120.52 158.48 27.2 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.407 -173.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.903 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 tt0 -127.28 119.4 26.24 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 23' ' ' VAL . 2.4 p -102.0 119.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 122.199 1.0 . . . . 0.0 111.021 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 13.7 ttm180 -134.51 145.97 49.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.95 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 p -87.14 179.44 6.65 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -64.05 -29.99 71.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 0.0 109.929 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.69 -19.25 65.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.02 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.73 66.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.532 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.37 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.498 . . . . 0.0 110.252 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 25' ' ' GLU . 5.0 tt -83.49 124.27 30.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.659 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.487 HG23 HG13 ' A' ' 15' ' ' VAL . 27.0 m -94.3 -39.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.373 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -162.73 159.53 24.34 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.903 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -166.0 148.17 7.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.25 0.548 . . . . 0.0 111.226 174.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -102.32 113.98 65.63 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.84 163.72 29.72 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 m -67.24 -13.88 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.327 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.2 p -82.28 -30.49 30.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.96 114.88 5.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.342 0.591 . . . . 0.0 110.976 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.775 ' HG3' HG11 ' A' ' 137' ' ' VAL . 8.9 Cg_exo -75.03 154.36 42.28 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.729 2.952 . . . . 0.0 113.374 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 13' ' ' TYR . 15.2 tp -76.57 134.9 39.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.359 170.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -110.04 120.28 41.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 7.5 p90 -150.77 148.37 28.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.292 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 41.9 tp -81.34 110.1 16.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.91 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.468 ' CE1' ' HG3' ' A' ' 50' ' ' GLU . 14.3 t60 -71.76 140.77 49.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.083 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 108.37 -27.03 14.75 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.158 -1.496 . . . . 0.0 113.85 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.45 55.48 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 35' ' ' LEU . . . -141.29 -105.71 0.59 Allowed Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.117 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 15.5 m -114.39 -54.84 2.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -166.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.942 HD22 HD23 ' A' ' 45' ' ' LEU . 84.6 mt -65.44 136.48 56.51 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.796 1.284 . . . . 0.0 112.651 173.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 67' ' ' ALA . 21.7 pt -53.33 175.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 111.749 -2.478 . . . . 0.0 114.581 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 m -66.26 -48.41 70.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.185 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.17 -45.33 96.26 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.428 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.942 HD23 HD22 ' A' ' 41' ' ' LEU . 23.7 tp -74.58 -53.33 9.61 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.809 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 6.9 mt-10 -48.29 -42.45 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 124.062 0.851 . . . . 0.0 111.834 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 m -65.53 -29.73 70.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.61 55.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 8.2 mt -65.43 -38.42 89.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.407 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 3.9 mt-10 -53.66 153.23 4.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.561 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 77.29 -14.71 8.01 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.87 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' VAL . 82.3 m-70 -88.78 165.52 14.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.265 0.533 . . . . 0.0 110.07 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 69.1 mt-10 -123.11 162.5 22.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 1.5 m -46.56 143.64 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.826 0.822 . . . . 0.0 112.697 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.04 -2.88 72.55 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 114.703 -1.135 . . . . 0.0 114.079 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.45 134.01 35.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.464 0.632 . . . . 0.0 110.771 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.703 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 1.8 tmtp? -135.24 128.63 32.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.725 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 60' ' ' VAL . 22.8 p90 -155.57 -178.2 7.1 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.81 149.69 40.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.4 t -137.47 142.54 36.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.61 -172.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.64 113.53 13.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.18 132.63 70.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.77 154.05 48.02 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -49.63 -26.13 3.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.62 -34.0 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.13 -0.357 . . . . 0.0 111.614 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.73 -24.38 18.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.393 0.616 . . . . 0.0 109.942 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 42' ' ' ILE . . . . . . . . 0 N--CA 1.446 -0.66 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.412 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.201 0 CA-C-O 121.916 0.865 . . . . 0.0 111.035 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -98.73 140.84 32.32 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.152 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -136.06 124.92 15.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -60.11 126.91 21.5 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.386 2.057 . . . . 0.0 111.632 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 22.8 mtmt -58.74 -17.26 21.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.826 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.77 -29.87 70.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 0.0 110.24 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -67.05 -45.64 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.904 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 90' ' ' LEU . 60.3 m-85 -87.74 40.86 0.96 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.0 ptm -50.82 -29.8 12.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 6.19 81.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.915 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 75.0 t -94.14 145.46 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.424 0.612 . . . . 0.0 111.224 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.81 -74.32 0.05 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.542 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -142.08 116.88 9.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.463 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.56 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.8 mt -62.33 105.97 0.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.42 176.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -128.77 166.21 19.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.13 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.41 74.57 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.82 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.0 mmm -89.2 135.03 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.141 0.471 . . . . 0.0 110.038 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 49.9 mtt180 -115.49 135.5 54.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.87 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.17 171.37 13.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.003 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' PRO . 64.3 tp -98.09 150.98 20.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 100' ' ' THR . . . -148.88 90.97 1.81 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 112.041 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 16.2 mt-10 -49.11 111.16 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.367 1.08 . . . . 0.0 112.87 162.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 98' ' ' ALA . 68.2 p -113.18 -172.63 2.1 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.747 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -50.83 -35.24 31.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.973 0.416 . . . . 0.0 111.005 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.469 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.1 pt20 -98.55 28.32 4.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.04 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.21 -177.25 45.81 Favored Glycine 0 C--N 1.322 -0.203 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.453 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.781 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.7 Cg_endo -69.79 121.93 8.61 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 122.379 2.053 . . . . 0.0 112.411 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.83 116.1 47.95 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.931 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.8 120.94 8.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.011 1.807 . . . . 0.0 109.99 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 10.8 m -142.77 154.21 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.833 0.825 . . . . 0.0 112.524 -168.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 28.6 tt0 -130.44 127.8 40.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.866 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 119' ' ' VAL . 62.8 mt -66.01 129.1 30.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -116.34 0.7 12.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -175.34 152.65 1.42 Allowed 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.525 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 117' ' ' VAL . 45.9 t -139.67 111.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -87.62 -166.63 1.63 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 5.1 m-20 -63.36 -53.54 50.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.307 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 5.0 m-20 -99.71 -18.3 17.32 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -143.25 146.76 33.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.704 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 112' ' ' VAL . 33.1 m -92.44 168.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.388 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.68 108.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.4 m -115.66 141.6 32.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.889 0.852 . . . . 0.0 112.872 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.169 -175.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -115.39 133.81 55.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.735 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 36.9 m-85 -121.02 142.09 50.13 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.404 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -108.84 106.71 16.83 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 166.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.725 HG11 HD22 ' A' ' 49' ' ' LEU . 3.1 t -100.85 140.28 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.95 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.703 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 59.1 mt-10 -138.14 100.7 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.968 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 p -80.42 110.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.13 0.49 . . . . 0.0 110.928 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 10' ' ' SER . 2.7 m -75.92 -39.53 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.013 0.435 . . . . 0.0 111.538 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.41 156.95 21.84 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -168.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 9' ' ' VAL . 73.3 mt -136.63 131.96 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -146.76 141.31 26.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.789 0.328 . . . . 0.0 110.144 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -87.71 125.31 34.34 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.74 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -63.61 165.5 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.774 -170.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 145' ' ' GLU . 56.3 p -79.49 15.36 1.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.422 -170.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 69.94 -35.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 111.481 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 143' ' ' THR . 46.4 mt-10 -62.23 -46.89 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 109.708 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.4 mt-10 -59.22 -35.53 73.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.237 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 142' ' ' ALA . 24.0 mt -71.92 -46.89 56.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.401 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.87 70.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.211 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -88.93 -11.92 43.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.789 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.23 4.21 84.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.994 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.322 -0.592 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.7 ptpt -129.59 179.48 5.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -85.56 116.06 28.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.383 0.611 . . . . 0.0 111.563 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -149.89 -167.37 2.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.084 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' LEU . 20.2 tttm -61.56 153.31 28.0 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.108 0.255 . . . . 0.0 110.691 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 50.3 3.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.145 1.378 . . . . 0.0 114.519 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 2' ' ' LYS . 1.2 mt -93.91 98.43 11.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -63.61 144.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.204 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 139' ' ' ILE . 2.1 m -148.84 152.29 12.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.473 0.654 . . . . 0.0 111.24 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.0 m -103.03 117.72 35.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 134' ' ' VAL . 9.5 tt -133.01 147.59 52.26 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.522 -172.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.8 152.4 37.32 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.621 ' HE1' HD22 ' A' ' 32' ' ' LEU . 52.1 p90 -161.77 157.51 24.33 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.168 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.438 ' CG ' HD13 ' A' ' 22' ' ' LEU . 36.1 tt0 -131.08 122.86 27.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.385 172.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.431 HG13 ' CE1' ' A' ' 132' ' ' PHE . 37.2 t -103.83 119.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.581 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -139.29 155.46 47.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 p -78.08 179.8 6.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.012 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.64 -31.68 26.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.543 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -19.0 63.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.151 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.34 -2.54 81.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.538 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.63 136.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.486 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 25' ' ' GLU . 58.8 tp -72.8 131.37 42.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.733 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.84 -40.56 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.688 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -144.93 149.45 35.27 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.1 tt0 -164.12 139.51 6.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.1 m -119.18 114.84 34.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 167.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.37 167.44 26.3 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.588 2.192 . . . . 0.0 113.389 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -18.96 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.215 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -73.15 -34.83 66.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.99 112.72 5.74 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.2 Cg_exo -75.44 159.7 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.285 2.657 . . . . 0.0 113.952 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 41' ' ' LEU . 14.0 tp -79.57 126.19 30.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.046 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.2 120.78 42.96 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.512 ' CD2' ' HA ' ' A' ' 40' ' ' SER . 46.2 p90 -144.54 161.86 38.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 147' ' ' LEU . 46.7 tp -108.29 105.64 15.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 6.4 t60 -61.14 130.51 46.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 101.46 -7.81 56.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.219 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -134.62 2.8 3.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 94.73 0.14 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.779 ' O ' HD13 ' A' ' 41' ' ' LEU . 12.7 m -116.11 15.21 16.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.512 1.149 . . . . 0.0 108.511 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 40' ' ' SER 0.396 0.0 OUTLIER 41.81 109.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.473 2.709 . . . . 0.0 115.397 -170.467 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.812 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 pt 51.57 127.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 110.148 -3.205 . . . . 0.0 115.61 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.545 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 43.5 t -50.66 -47.63 58.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.564 -2.107 . . . . 0.0 113.387 -170.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.607 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -67.97 -36.54 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.345 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 44.8 tp -75.03 -46.96 31.48 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HG3' ' O ' ' A' ' 42' ' ' ILE . 31.8 mt-10 -48.9 -49.51 39.47 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.911 0.757 . . . . 0.0 109.989 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.4 m -60.57 -37.41 81.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.954 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.15 63.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.696 0.76 . . . . 0.0 110.039 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 88.0 mt -62.46 -36.57 82.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.724 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -54.54 153.98 5.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 78.17 -15.2 9.13 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 113.498 -1.683 . . . . 0.0 117.096 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 3' ' ' VAL . 14.4 p80 -102.19 174.24 6.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.661 1.731 . . . . 0.0 110.263 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 139' ' ' ILE . 4.1 mp0 -119.82 171.48 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.73 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 139' ' ' ILE . 2.0 m -52.16 142.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.309 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.457 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 97.56 -15.26 62.28 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.007 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 136' ' ' VAL . 32.5 m-20 -74.32 130.65 40.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.341 0.591 . . . . 0.0 111.42 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 5.5 tmtm? -133.24 124.6 27.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.052 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.3 p90 -148.85 -178.26 6.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.392 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.54 145.85 39.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -135.22 142.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 113.09 12.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.128 0.49 . . . . 0.0 110.341 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG11 ' HA3' ' A' ' 44' ' ' GLY . 58.2 t -126.57 144.17 37.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.421 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.64 153.24 50.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.96 -20.6 24.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.15 -19.65 53.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 110.817 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -115.71 -18.45 10.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.931 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 118' ' ' VAL . 6.5 mpt_? -107.62 114.7 28.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.886 -175.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -111.95 129.23 24.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.639 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 12.3 Cg_exo -61.91 134.41 49.83 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 111.426 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 18.8 mtmt -59.39 -14.66 12.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.09 -28.12 65.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.525 0.679 . . . . 0.0 110.259 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.22 -38.08 77.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.128 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.2 m-85 -90.85 41.38 1.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -176.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 ptm -51.37 -25.82 6.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.093 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.33 11.01 73.16 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 84' ' ' PHE . 2.6 p -100.5 160.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.258 0.529 . . . . 0.0 109.922 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -75.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -145.41 121.57 10.81 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.12 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.58 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.0 mt -62.12 103.88 0.42 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.934 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.61 155.62 40.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.562 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.679 ' HA ' HG22 ' A' ' 109' ' ' ILE . 42.7 t -67.1 134.07 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.055 0.455 . . . . 0.0 110.922 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.62 -28.44 15.97 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.51 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.6 mmm -52.92 135.53 36.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 20.2 mtp85 -116.72 137.35 52.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.943 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -163.26 167.57 21.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.423 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 104' ' ' PRO . 52.0 tp -82.7 143.75 30.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.0 110.015 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -131.76 147.53 52.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.778 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -97.64 142.66 29.17 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.7 p -148.92 -175.92 5.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.82 -27.47 69.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.565 0.698 . . . . 0.0 109.696 171.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -89.72 23.23 2.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.861 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.99 -173.71 52.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.495 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 39.8 Cg_exo -59.25 125.61 18.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 111.568 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.54 109.28 30.78 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.014 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.88 107.11 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.62 2.213 . . . . 0.0 110.694 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.4 m -117.75 176.22 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.187 0.517 . . . . 0.0 111.782 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 39.2 tt0 -137.06 129.6 30.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.592 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 92' ' ' VAL . 32.1 mt -70.95 122.58 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -103.6 -7.42 20.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -173.1 156.73 3.3 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 117' ' ' VAL . 88.1 t -136.75 104.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.235 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 24.1 mm-40 -75.8 -166.82 0.61 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.769 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.22 -56.14 24.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.691 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.527 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 24.6 t70 -128.08 16.96 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.894 176.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.492 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 50.9 p-80 -146.22 146.33 30.74 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 121.436 -0.79 . . . . 0.0 111.68 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 90' ' ' LEU . 26.9 m -104.54 167.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.999 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.3 t -130.86 119.53 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 5.0 m -114.35 131.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.865 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -175.442 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.407 HD13 ' CG1' ' A' ' 15' ' ' VAL . 57.5 mt . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.459 0.647 . . . . 0.0 112.679 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -112.07 132.37 54.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.163 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.554 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 11.6 m-85 -121.17 142.19 50.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.903 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -108.61 107.61 18.16 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 167.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 HD21 ' A' ' 11' ' ' LEU . 3.6 t -100.29 137.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.558 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 33.4 mt-10 -134.03 98.08 4.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.494 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' H ' ' A' ' 55' ' ' GLY . 3.8 p -78.57 114.63 19.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.693 . . . . 0.0 111.669 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 31' ' ' PRO . 5.5 t -71.67 -50.31 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.47 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -162.82 154.48 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.762 HG23 HG12 ' A' ' 9' ' ' VAL . 66.7 mt -132.94 138.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -149.25 140.92 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.07 126.28 34.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.714 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.75 166.16 13.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.449 -168.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.1 p -82.05 20.74 0.96 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.477 -170.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 147' ' ' LEU . 45.0 mt-10 67.71 -37.88 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.363 0.665 . . . . 0.0 111.327 -174.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 143' ' ' THR . 45.7 mt-10 -64.28 -45.2 89.1 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.714 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 37.6 mt-10 -59.54 -34.91 73.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.508 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 142' ' ' ALA . 35.6 mt -74.14 -44.27 54.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.688 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.73 -29.6 70.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.346 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -94.99 -32.08 13.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.93 13.03 35.25 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.594 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 p80 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 117.565 0.682 . . . . 0.0 111.455 -178.737 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 12.4 ptmt -106.21 156.14 18.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.332 0.586 . . . . 0.0 111.187 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -64.68 126.93 24.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.786 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.68 -169.78 3.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.168 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 7' ' ' LEU . 60.8 tttp -65.23 153.9 39.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.358 . . . . 0.0 111.662 -177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.469 ' O ' HD21 ' A' ' 147' ' ' LEU . 79.2 m-20 51.63 6.1 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD22 ' HA ' ' A' ' 141' ' ' GLU . 17.9 mt -92.85 149.42 21.28 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 166.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.8 p -115.59 142.95 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG12 HG23 ' A' ' 139' ' ' ILE . 3.2 m -142.31 155.74 18.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.787 0.803 . . . . 0.0 111.716 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . 16.5 m -117.9 117.59 29.69 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.175 -1.375 . . . . 0.0 107.962 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.76 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -127.84 158.52 37.51 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.82 112.67 16.95 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HE1' HD22 ' A' ' 32' ' ' LEU . 41.0 p90 -126.58 160.89 29.34 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.453 -171.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.5 tt0 -129.54 118.67 22.42 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.538 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.7 p -106.33 122.46 60.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.62 0.724 . . . . 0.0 111.553 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -139.12 161.19 37.99 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.0 p -90.28 175.94 6.93 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.164 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.93 -21.5 66.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.248 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.19 -18.6 61.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.938 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.47 44.94 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.925 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.9 p -79.07 138.83 19.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.14 0.495 . . . . 0.0 111.356 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 15' ' ' VAL . 55.3 tp -79.71 134.38 36.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.0 m -109.09 -38.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -156.93 168.49 27.33 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -165.54 137.49 4.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.143 0.497 . . . . 0.0 111.971 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.6 m -113.03 111.41 50.69 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 168.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -68.36 165.79 27.68 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 122.807 2.338 . . . . 0.0 113.339 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.56 -16.07 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.78 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -79.22 -33.73 43.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.07 113.01 6.27 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.327 0.584 . . . . 0.0 109.601 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 137' ' ' VAL . 9.6 Cg_exo -75.59 169.22 22.79 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 C-N-CA 123.572 2.848 . . . . 0.0 113.741 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.507 HD22 ' HE1' ' A' ' 13' ' ' TYR . 14.0 tp -84.1 126.35 33.0 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 152' ' ' VAL . 20.5 m-20 -104.85 120.6 41.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.732 ' HB2' ' CB ' ' A' ' 40' ' ' SER . 5.4 p90 -150.34 157.39 43.0 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.169 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 147' ' ' LEU . 57.7 tp -102.69 114.61 29.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.511 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 48.6 t60 -69.84 142.39 53.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.384 0.611 . . . . 0.0 111.915 -169.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.77 23.91 56.86 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.473 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -129.52 -7.93 4.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.773 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.55 41.23 8.45 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.975 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.732 ' CB ' ' HB2' ' A' ' 34' ' ' TYR . 51.8 m -71.86 -38.86 70.01 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.8 OUTLIER -113.43 -102.99 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.262 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.596 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 20.8 pt -116.35 -163.65 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.035 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.7 t -94.77 -49.06 5.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.391 0.615 . . . . 0.0 110.64 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -79.19 -26.45 57.69 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.984 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.704 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 1.8 mt -74.41 -52.76 11.14 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.165 -171.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 23.1 mt-10 -50.63 -49.79 55.94 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.518 0.511 . . . . 0.0 111.384 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.7 m -64.9 -31.8 73.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.685 0.279 . . . . 0.0 111.737 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.91 -40.44 68.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 109.809 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 76.6 mt -61.62 -33.42 73.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.518 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.3 mt-10 -52.14 152.85 3.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.018 0.913 . . . . 0.0 112.819 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.447 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 78.89 -22.6 3.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.932 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.692 ' O ' HG12 ' A' ' 3' ' ' VAL . 96.8 m-70 -82.6 164.45 20.79 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.591 0.695 . . . . 0.0 110.782 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 46.0 mt-10 -127.2 160.47 31.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.412 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -49.69 143.85 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.563 0.697 . . . . 0.0 112.489 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.03 -15.64 62.61 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.149 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.04 133.91 47.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.904 0.383 . . . . 0.0 110.29 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 6.2 tmmm? -132.14 128.77 38.78 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.259 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.0 p90 -165.43 157.17 14.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.147 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 133' ' ' ASN . 4.8 p-10 -96.43 141.47 29.69 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.822 0.82 . . . . 0.0 110.198 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 58' ' ' PHE . 8.7 t -117.1 143.91 26.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.13 -173.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -126.5 111.99 15.06 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.882 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG11 ' HA3' ' A' ' 44' ' ' GLY . 72.7 t -125.74 137.65 57.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.045 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 129' ' ' ASN . . . -67.96 152.85 52.76 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.154 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -52.58 -20.94 3.35 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.3 -30.36 70.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.904 0.383 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -118.67 8.2 11.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.491 0.663 . . . . 0.0 111.352 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.9 -156.09 0.65 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.763 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.5 ' HB2' HD11 ' A' ' 130' ' ' LEU . 1.5 m-85 -80.56 -169.35 2.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 169.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.21 20.91 12.47 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 119.359 -1.401 . . . . 0.0 112.805 173.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -59.0 168.57 1.26 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.557 ' OH ' ' HB3' ' A' ' 73' ' ' GLU . 20.3 t80 -44.74 123.15 3.54 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.965 -174.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -130.6 113.36 14.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.102 172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HB3' ' OH ' ' A' ' 71' ' ' TYR . 8.8 pt-20 -74.91 -2.54 27.42 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -77.89 -12.24 59.96 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.3 tp -91.79 -9.99 41.56 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.383 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' HB ' ' OD1' ' A' ' 120' ' ' ASP . 4.7 p -106.37 132.61 53.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.398 176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -157.98 177.39 11.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.248 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 6.3 mpt_? -115.33 114.29 24.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.737 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG1' HG21 ' A' ' 83' ' ' VAL . 5.2 t -106.49 132.94 20.49 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.994 -174.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 83' ' ' VAL . 29.8 Cg_exo -59.18 131.88 43.74 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.12 2.547 . . . . 0.0 111.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 26.4 mtmt -58.29 -24.41 59.42 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -57.78 -43.39 85.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.422 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 80' ' ' PRO . 3.4 m -55.67 -32.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.287 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HB2' HD11 ' A' ' 90' ' ' LEU . 71.0 m-85 -90.61 40.24 1.01 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.207 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -57.47 -29.07 63.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.355 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.07 -15.43 77.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.958 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.43 HG11 HD23 ' A' ' 90' ' ' LEU . 91.9 t -73.34 142.26 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.849 0.324 . . . . 0.0 110.459 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.13 -67.99 0.35 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.035 0.445 . . . . 0.0 110.952 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -142.37 115.63 8.93 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.397 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.481 ' HB3' HG11 ' A' ' 117' ' ' VAL . 88.6 mt -66.57 98.87 0.54 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.155 0.502 . . . . 0.0 110.161 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 5.4 tt0 -121.5 165.7 15.25 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.196 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 109' ' ' ILE . 48.2 t -80.24 139.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.03 1.23 79.87 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.255 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 4.8 mmm -87.63 135.23 33.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.094 0.473 . . . . 0.0 110.528 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -111.21 139.58 46.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.333 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.56 154.41 16.19 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.792 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.65 131.27 37.68 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -119.8 134.94 55.05 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -88.84 137.24 32.49 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.0 p -145.42 -176.19 5.01 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.024 -169.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.22 -35.6 65.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.889 0.852 . . . . 0.0 110.309 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -98.01 25.45 6.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.313 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.66 -173.45 53.85 Favored Glycine 0 CA--C 1.507 -0.456 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.789 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 31.4 Cg_exo -58.89 123.97 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.939 . . . . 0.0 112.055 171.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 107' ' ' VAL . 88.0 t -124.63 113.68 27.19 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.566 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.1 101.46 1.22 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.876 2.384 . . . . 0.0 111.347 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.1 m -117.78 173.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 111.211 -175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -136.0 136.39 40.28 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.117 176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.443 HD11 HD22 ' A' ' 90' ' ' LEU . 27.2 mt -77.48 129.59 37.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.05 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.6 p -114.79 1.6 14.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.402 0.62 . . . . 0.0 109.937 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 178.35 153.86 0.35 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.595 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.741 HG13 HG12 ' A' ' 117' ' ' VAL . 61.3 t -139.39 108.55 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -87.42 -156.04 0.32 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.36 -43.97 92.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.588 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 8.5 p-10 -131.94 -15.1 3.04 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.679 -0.408 . . . . 0.0 112.007 -170.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -136.58 159.29 42.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.741 HG12 HG13 ' A' ' 112' ' ' VAL . 33.8 m -112.66 162.28 10.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.045 0.45 . . . . 0.0 109.835 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.33 116.52 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.198 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -122.59 138.77 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 121.215 0.531 . . . . 0.0 111.376 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 76' ' ' VAL . 57.9 t0 -124.2 126.44 46.13 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.917 177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.66 -22.03 78.74 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.115 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 126' ' ' ALA . 12.8 m-80 -87.21 111.17 20.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -95.1 -82.18 0.38 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.794 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.69 ' HG3' ' H ' ' A' ' 125' ' ' LEU . 19.6 ptt? -76.79 -61.98 1.79 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.24 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.69 ' H ' ' HG3' ' A' ' 124' ' ' MET . 4.8 mp -118.98 -20.34 8.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 170.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 122' ' ' ASN . . . 179.97 -61.36 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 113.316 -1.765 . . . . 0.0 107.23 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.75 -32.42 4.82 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.858 165.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -55.78 136.41 51.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -89.52 156.41 18.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.046 0.451 . . . . 0.0 109.92 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 68' ' ' TYR . 64.1 mt -112.46 147.44 36.5 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 19.2 mtpp -114.89 122.72 47.17 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.2 m-85 -115.29 121.19 42.11 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.546 ' N ' HD22 ' A' ' 133' ' ' ASN . 0.8 OUTLIER -92.86 107.21 19.04 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.76 HG13 HD23 ' A' ' 11' ' ' LEU . 4.0 t -99.66 139.73 20.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.369 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 42.4 mt-10 -132.96 90.84 2.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.899 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 55' ' ' GLY . 2.9 p -66.76 107.6 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.039 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' A' ' 31' ' ' PRO . 8.1 t -72.41 -47.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.86 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.59 157.27 27.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.891 -173.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.651 HG23 HG12 ' A' ' 9' ' ' VAL . 66.0 mt -137.73 134.33 45.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -143.54 142.76 31.25 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.3 pt-20 -79.67 126.48 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.78 166.56 12.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.933 0.873 . . . . 0.0 113.017 -166.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.0 p -92.19 23.06 4.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.7 -170.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 69.71 -42.65 0.51 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.184 0.594 . . . . 0.0 111.151 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -63.37 -42.25 98.84 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.486 0.66 . . . . 0.0 109.645 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.59 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.0 mt-10 -61.82 -35.02 77.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.527 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 142' ' ' ALA . 28.7 mt -73.46 -46.5 47.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.144 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.38 -31.89 70.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.536 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -93.39 -31.69 14.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.907 0.384 . . . . 0.0 110.802 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.16 8.35 41.7 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.27 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -161.53 179.16 8.43 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.667 -0.313 . . . . 0.0 110.599 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.613 HG11 ' HB2' ' A' ' 155' ' ' ALA . 2.1 t -67.23 152.9 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -113.08 -5.02 13.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.779 0.323 . . . . 0.0 111.676 -172.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -168.88 64.79 0.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.613 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -104.31 -38.54 6.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.833 0.349 . . . . 0.0 111.426 -174.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -78.95 122.88 26.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.138 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.7 159.29 19.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.506 . . . . 0.0 110.899 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -96.35 -3.79 43.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.651 -172.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -147.0 -70.15 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.739 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 169.28 -46.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -160.41 159.88 31.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.326 -1.306 . . . . 0.0 108.633 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -117.6 -46.21 2.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 109.836 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.08 47.69 1.5 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.488 -169.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -73.74 123.35 23.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.831 0.348 . . . . 0.0 110.396 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -128.21 22.77 6.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.331 0.586 . . . . 0.0 110.239 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -106.4 -166.22 1.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.644 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -94.57 100.66 12.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -73.42 -23.05 60.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.637 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -85.36 130.91 34.49 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.763 -176.511 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.551 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 16.7 ptpt -106.61 168.94 8.83 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.883 0.849 . . . . 0.0 112.064 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.672 HG11 ' O ' ' A' ' 49' ' ' LEU . 1.1 p -83.43 121.43 36.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.35 -171.62 3.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.945 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 42.1 tttp -63.91 153.5 36.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.762 0.315 . . . . 0.0 110.417 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 147' ' ' LEU . 32.7 m-20 57.57 -5.89 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 141' ' ' GLU . 34.2 mt -90.81 104.44 17.03 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.792 -0.567 . . . . 0.0 110.425 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.4 143.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.45 0.643 . . . . 0.0 111.043 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 139' ' ' ILE . 3.6 m -143.04 153.03 16.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.448 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -111.46 122.51 48.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.532 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.695 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -143.64 143.72 31.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -100.99 153.75 19.27 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.717 ' HE2' HD22 ' A' ' 32' ' ' LEU . 51.5 p90 -151.82 159.78 43.78 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.029 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.474 ' HG2' HD13 ' A' ' 22' ' ' LEU . 42.7 tt0 -126.8 119.45 26.88 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.9 t -102.21 119.45 50.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.505 -175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.54 151.68 50.74 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.0 p -82.02 -179.75 7.51 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -56.56 -26.31 54.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.202 0.525 . . . . 0.0 109.922 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 21' ' ' VAL . 3.0 m-20 -67.39 -18.81 65.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.15 -11.24 72.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.469 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 19' ' ' ASP . 10.4 p -78.4 136.44 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 111.245 -176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 25' ' ' GLU . 34.4 tp -69.7 131.1 44.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.478 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.45 -45.94 5.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.213 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -140.07 149.81 43.58 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.658 ' HB2' HD11 ' A' ' 22' ' ' LEU . 32.9 tt0 -156.21 134.7 11.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.301 0.572 . . . . 0.0 111.861 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.485 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 28.3 m -108.05 116.92 56.22 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 169.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.69 164.34 35.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.744 2.296 . . . . 0.0 113.589 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 m -70.91 -14.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.609 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.469 ' O ' ' HE1' ' A' ' 159' ' ' HIS . 23.7 p -80.88 -31.56 35.22 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.712 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.26 113.3 5.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.054 0.454 . . . . 0.0 109.938 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HG21 ' A' ' 137' ' ' VAL . 8.8 Cg_exo -75.63 169.16 22.89 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.625 2.883 . . . . 0.0 113.548 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD22 ' HE2' ' A' ' 13' ' ' TYR . 12.4 tp -88.89 129.51 35.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -121.57 119.85 33.11 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.543 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.752 ' HB3' ' HB3' ' A' ' 40' ' ' SER . 24.8 m-85 -153.69 162.08 41.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.287 0.565 . . . . 0.0 111.924 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.7 tp -89.18 105.79 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.878 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.559 ' HE1' ' O ' ' A' ' 46' ' ' GLU . 22.6 t60 -65.73 142.98 57.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.002 0.43 . . . . 0.0 110.676 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 85.77 18.81 59.21 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.183 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -136.68 18.54 3.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.456 0.17 . . . . 0.0 110.679 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.67 35.82 92.52 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.56 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.752 ' HB3' ' HB3' ' A' ' 34' ' ' TYR . 42.2 m -64.78 -39.63 93.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.879 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 1.1 pt? -120.53 -89.1 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.401 175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.879 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 12.6 pt -129.32 -166.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 t -97.38 -49.34 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.732 0.777 . . . . 0.0 110.705 -168.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.4 -35.32 29.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 114.781 -1.1 . . . . 0.0 113.376 -172.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.697 HD11 HG21 ' A' ' 134' ' ' VAL . 28.7 tp -73.34 -46.62 48.24 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.559 ' O ' ' HE1' ' A' ' 36' ' ' HIS . 24.0 mt-10 -52.11 -45.23 64.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.127 174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.0 m -63.49 -38.31 90.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.85 -43.11 80.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 109.959 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.817 HD21 HG11 ' A' ' 134' ' ' VAL . 95.9 mt -56.88 -33.46 66.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.558 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HA ' HG13 ' A' ' 3' ' ' VAL . 5.8 mt-10 -56.3 153.62 9.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.969 0.89 . . . . 0.0 113.043 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.48 -29.02 2.95 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 114.222 -1.354 . . . . 0.0 116.153 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -120.02 148.45 43.55 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.319 1.559 . . . . 0.0 112.852 -174.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 1' ' ' MET . 31.3 mt-10 -99.52 173.96 6.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.524 -1.217 . . . . 0.0 112.059 -164.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.9 m -48.94 140.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.885 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.46 61.58 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.746 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.07 128.79 34.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.322 0.582 . . . . 0.0 110.063 176.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 2.5 tmmt? -133.63 126.06 30.06 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.25 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' A' ' 60' ' ' VAL . 18.1 p90 -165.95 160.64 16.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.196 0.522 . . . . 0.0 111.413 -175.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.612 175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.691 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.1 t -133.36 142.93 40.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.026 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.6 113.05 10.0 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.911 0.386 . . . . 0.0 110.201 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 t -127.79 142.47 43.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.726 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.76 155.33 52.97 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.95 -30.5 46.95 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -63.77 -32.39 73.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.966 0.412 . . . . 0.0 111.303 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.55 0.8 14.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.325 0.583 . . . . 0.0 111.302 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . -126.83 -157.05 0.78 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.547 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.647 ' HB2' ' CD1' ' A' ' 130' ' ' LEU . 9.4 m-85 -79.91 -161.93 0.39 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.65 19.08 53.3 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.182 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -79.97 -178.77 6.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.761 -0.72 . . . . 0.0 109.484 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.454 ' CD1' HG21 ' A' ' 76' ' ' VAL . 54.0 p90 -48.75 151.16 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.286 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -69.75 90.54 0.59 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.173 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -74.58 -0.67 18.51 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.26 -8.3 57.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 119.175 0.898 . . . . 0.0 110.518 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.847 HD23 ' HB3' ' A' ' 122' ' ' ASN . 33.1 tp -95.07 -10.16 31.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.649 1.214 . . . . 0.0 109.057 167.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG21 ' CD1' ' A' ' 71' ' ' TYR . 42.1 t -108.65 150.78 11.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.892 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -164.25 173.03 12.81 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.678 0.752 . . . . 0.0 110.98 174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.704 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.7 mpt_? -113.0 109.31 18.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.632 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.5 t -101.59 128.51 28.84 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.511 -169.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 17.0 Cg_exo -60.42 134.6 56.05 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.829 2.353 . . . . 0.0 112.028 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -50.8 -19.43 0.97 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.219 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.14 -28.92 65.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.991 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -72.56 -41.17 63.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.126 -171.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 87' ' ' VAL . 49.3 m-85 -98.04 39.94 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.568 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.0 ptm -53.66 -30.45 43.25 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.809 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.36 13.46 61.92 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 121.146 -0.549 . . . . 0.0 113.931 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.6 p -93.63 162.32 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 117.439 0.62 . . . . 0.0 109.743 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -55.83 -74.51 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.725 0.298 . . . . 0.0 110.322 175.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -153.16 118.08 5.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.841 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.617 ' HB3' HG11 ' A' ' 117' ' ' VAL . 86.5 mt -60.01 109.89 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 110.958 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.421 HE21 ' HB2' ' A' ' 91' ' ' GLN . 5.3 tt0 -138.77 162.47 34.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.944 -175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.03 146.04 11.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.988 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.58 2.27 88.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.431 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.5 mmm -91.69 134.41 34.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.604 -174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 82.3 mtt180 -113.86 134.71 54.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.196 -175.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -164.33 170.4 16.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.342 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.877 HD11 ' HB2' ' A' ' 104' ' ' PRO . 67.7 tp -87.35 150.22 23.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 100' ' ' THR . . . -144.22 89.48 2.03 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.833 0.825 . . . . 0.0 111.621 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 12.9 mt-10 -38.78 129.9 1.47 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.064 -1.425 . . . . 0.0 112.034 157.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 98' ' ' ALA . 61.2 p -145.96 -174.12 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -51.65 -44.77 63.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.479 0.657 . . . . 0.0 110.774 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' GLN . 7.4 pt20 -91.64 30.23 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.787 -175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.62 -176.84 48.18 Favored Glycine 0 C--N 1.319 -0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.708 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.877 ' HB2' HD11 ' A' ' 97' ' ' LEU . 34.5 Cg_endo -73.84 125.38 9.9 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.456 2.104 . . . . 0.0 112.693 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 107' ' ' VAL . 13.5 t -117.98 113.87 37.47 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.04 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 97' ' ' LEU . 14.8 Cg_exo -70.56 97.29 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.611 2.208 . . . . 0.0 111.072 177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 2.8 m -117.99 174.64 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.315 -173.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.55 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 24.5 tt0 -134.49 131.44 38.05 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.259 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.0 mt -69.89 124.76 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.953 0.406 . . . . 0.0 110.337 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 p -106.84 -4.6 19.09 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.024 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -172.54 155.61 3.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.915 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.573 HG13 HG12 ' A' ' 117' ' ' VAL . 61.8 t -137.43 105.37 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.034 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -78.08 -175.94 4.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.8 -53.32 58.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.209 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -121.71 5.18 10.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -146.29 139.91 26.09 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 120.831 -1.168 . . . . 0.0 112.365 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 90' ' ' LEU . 35.3 m -93.58 167.83 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.189 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 78' ' ' ARG . 43.4 t -131.26 118.44 40.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.5 m -113.74 138.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.062 0.458 . . . . 0.0 111.144 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -136.56 142.75 43.42 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.825 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.07 7.04 2.34 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.346 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.847 ' HB3' HD23 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -130.8 135.35 47.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.989 0.423 . . . . 0.0 110.738 -177.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -147.58 -42.05 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.206 -0.309 . . . . 0.0 110.953 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -68.08 -5.73 19.16 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.701 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 122' ' ' ASN . 3.6 mm? -79.46 -12.8 59.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.9 0.381 . . . . 0.0 110.577 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.57 -178.25 6.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.905 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.94 0.45 33.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 114.322 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.7 123.08 39.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.748 0.774 . . . . 0.0 110.644 176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -79.52 158.9 27.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.237 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.647 ' CD1' ' HB2' ' A' ' 68' ' ' TYR . 90.3 mt -128.46 156.99 42.33 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 18.9 mtpp -118.02 132.75 56.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.087 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.719 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 2.5 m-85 -123.4 134.96 53.91 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.493 ' N ' HD22 ' A' ' 133' ' ' ASN . 0.9 OUTLIER -105.84 107.74 18.89 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.817 HG11 HD21 ' A' ' 49' ' ' LEU . 4.4 t -99.81 142.93 14.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.45 0.643 . . . . 0.0 112.211 -170.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 37.2 mt-10 -131.84 92.09 3.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.576 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.593 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -69.72 110.46 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.833 0.825 . . . . 0.0 111.685 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.3 t -71.95 -47.66 54.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.704 -1.135 . . . . 0.0 112.13 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.06 158.56 33.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.869 -0.333 . . . . 0.0 110.925 -171.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.757 HG23 HG12 ' A' ' 9' ' ' VAL . 65.5 mt -137.59 132.78 45.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -133.17 138.09 46.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.047 0.451 . . . . 0.0 110.667 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.766 ' HA ' HD22 ' A' ' 7' ' ' LEU . 9.7 pt-20 -77.44 119.29 20.84 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -64.59 169.51 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.748 -171.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.5 p -113.26 29.51 7.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.761 -167.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.89 ' HA ' HD23 ' A' ' 147' ' ' LEU . 31.1 mt-10 73.31 -33.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.466 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -69.39 -44.15 72.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.867 0.365 . . . . 0.0 110.55 -178.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 8.0 mp0 -54.95 -45.65 74.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.66 0.743 . . . . 0.0 109.756 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.89 HD23 ' HA ' ' A' ' 144' ' ' GLU . 1.0 OUTLIER -65.5 -49.14 70.11 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.228 178.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -49.82 -37.25 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.679 -1.6 . . . . 0.0 111.847 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -98.08 -9.09 26.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.086 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 82.44 2.74 90.66 Favored Glycine 0 C--N 1.329 0.189 0 CA-C-N 116.051 -0.522 . . . . 0.0 113.865 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.29 179.79 6.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.925 0.363 . . . . 0.0 110.071 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 155' ' ' ALA . 10.6 t -57.59 -48.31 83.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.213 0.321 . . . . 0.0 111.641 -173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 75.16 -21.09 0.31 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.581 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.91 125.52 1.16 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -145.62 172.08 13.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.561 -176.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.1 m170 61.53 30.74 18.86 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.267 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -70.54 -49.9 43.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 110.733 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -103.03 42.2 1.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.296 0.569 . . . . 0.0 110.775 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.469 ' HE1' ' O ' ' A' ' 29' ' ' SER . 25.9 t-80 -120.22 106.54 12.02 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -76.0 144.43 40.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 111.142 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.95 151.09 27.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.046 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -98.2 83.62 3.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.698 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.9 t70 60.94 70.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.587 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -53.74 131.75 39.95 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.189 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.89 147.48 33.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.838 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 68.4 m80 69.26 116.65 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.043 0.839 . . . . 0.0 111.181 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.41 -19.97 21.51 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -93.99 99.84 12.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.855 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.2 -43.37 2.85 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -90.95 92.12 8.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.735 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.943 0 O-C-N 123.8 0.688 . . . . 0.0 110.062 -172.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -123.65 169.16 11.75 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.45 0.643 . . . . 0.0 111.247 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.2 p -79.29 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.793 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.58 -172.39 4.08 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.432 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 87.1 tttt -67.48 161.27 25.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 45.18 9.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.716 HD22 ' HA ' ' A' ' 141' ' ' GLU . 24.3 mt -97.63 108.21 20.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.957 -0.464 . . . . 0.0 110.187 170.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.561 HG21 HG23 ' A' ' 152' ' ' VAL . 14.6 p -55.52 144.01 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.301 0.572 . . . . 0.0 110.596 174.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -150.86 139.34 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.755 -170.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -117.72 148.27 42.17 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.714 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -165.63 158.0 15.1 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.01 0.433 . . . . 0.0 110.33 -176.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.38 112.59 18.28 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 32' ' ' LEU . 46.5 p90 -123.82 154.19 39.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.924 -172.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 45.6 tt0 -125.29 118.85 26.88 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG13 HG23 ' A' ' 23' ' ' VAL . 2.8 p -101.33 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 122.257 1.027 . . . . 0.0 111.141 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HD3' ' HA2' ' A' ' 20' ' ' GLY . 10.6 ttm180 -135.66 157.15 47.59 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.681 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.611 ' OG1' HG12 ' A' ' 21' ' ' VAL . 40.8 p -78.34 169.87 17.55 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.841 173.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.986 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 48.7 mt-10 -65.44 -20.22 66.27 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.975 0.416 . . . . 0.0 110.876 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -90.11 -16.16 30.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 16' ' ' ARG . . . 106.63 27.48 5.47 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.913 -1.137 . . . . 0.0 114.78 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.8 p -105.42 136.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 118.035 0.917 . . . . 0.0 109.829 172.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 15' ' ' VAL . 57.0 tp -90.53 127.36 36.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.418 -173.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.495 HG23 HG13 ' A' ' 15' ' ' VAL . 22.2 m -102.93 -35.88 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.671 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -162.14 169.76 20.29 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -165.42 129.87 2.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 m -99.45 106.1 37.41 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 166.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.29 163.27 36.99 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.65 2.233 . . . . 0.0 112.882 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 m -70.31 -14.77 18.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.205 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 p -79.43 -30.6 42.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.626 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.47 113.74 5.61 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.97 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.671 ' HB3' HG21 ' A' ' 137' ' ' VAL . 10.1 Cg_exo -75.32 164.7 32.27 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 -174.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.674 ' HB3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -73.9 139.03 44.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.075 -1.42 . . . . 0.0 107.408 166.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.454 ' HB3' HG11 ' A' ' 152' ' ' VAL . 41.9 m-20 -122.25 120.2 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 40' ' ' SER . 13.1 p90 -157.6 168.3 27.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.141 0.496 . . . . 0.0 111.409 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.3 tp -107.94 114.4 28.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.043 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 28.6 t60 -68.29 137.4 54.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.383 -172.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 80.66 26.62 53.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.914 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -132.95 18.33 4.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.663 0.268 . . . . 0.0 110.86 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.67 36.68 93.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.955 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 69.4 m -65.78 -39.94 91.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.142 0.496 . . . . 0.0 111.407 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.565 ' HG ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -147.87 160.87 42.31 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 173.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 45' ' ' LEU . 5.0 pt -27.93 137.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 123.048 1.404 . . . . 0.0 114.373 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -64.46 -35.75 81.94 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.936 -1.938 . . . . 0.0 111.299 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.602 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -64.07 -34.6 90.36 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.139 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 21.6 tp -75.46 -50.58 15.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -53.05 -45.6 68.13 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.337 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.2 m -59.35 -35.71 74.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.434 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.15 -33.98 59.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.622 0.725 . . . . 0.0 110.438 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 86.9 mt -64.61 -31.71 73.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.896 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.85 155.65 4.22 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.18 -29.1 4.85 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HG12 ' A' ' 3' ' ' VAL . 27.0 p80 -106.33 178.29 4.6 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.172 1.486 . . . . 0.0 110.787 -171.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 1' ' ' MET . 81.8 mt-10 -117.35 170.82 8.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.685 0.278 . . . . 0.0 110.725 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 139' ' ' ILE . 1.3 m -53.11 144.64 3.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.76 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.503 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.29 -20.33 49.89 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.971 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 136' ' ' VAL . 3.4 m-20 -67.42 136.62 54.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.919 0.359 . . . . 0.0 110.527 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.682 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 4.3 tmmm? -136.98 125.21 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.738 ' CE2' HG22 ' A' ' 60' ' ' VAL . 15.9 p90 -154.51 -179.75 8.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.15 143.5 38.46 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.738 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -126.91 142.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 130' ' ' LEU . . . -134.18 113.07 11.64 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG11 ' HA3' ' A' ' 44' ' ' GLY . 60.8 t -123.97 141.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.565 -174.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.77 150.0 48.75 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.127 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -52.53 -20.42 2.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.74 -21.78 57.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.295 -0.253 . . . . 0.0 111.442 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -114.34 -9.46 12.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.954 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.08 -155.68 0.7 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.264 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.556 ' HB2' HD11 ' A' ' 130' ' ' LEU . 7.4 m-85 -81.5 -168.29 1.81 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.83 20.59 12.58 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.402 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -65.19 170.99 4.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.822 0.311 . . . . 0.0 111.299 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' HIS . 76.4 t80 -44.19 123.73 3.58 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -132.1 126.49 33.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.019 166.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.31 -10.11 59.26 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -81.44 -9.1 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.728 -0.607 . . . . 0.0 110.877 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 122' ' ' ASN . 54.1 tp -87.73 -10.33 51.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.991 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' HB ' HD21 ' A' ' 122' ' ' ASN . 8.8 p -106.17 132.25 53.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.159 0.504 . . . . 0.0 110.665 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -157.78 173.02 17.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.98 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 11.3 mpt_? -110.23 113.35 25.96 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.764 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.39 132.24 21.62 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.873 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -59.61 143.57 99.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.429 2.753 . . . . 0.0 112.692 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 90' ' ' LEU . 6.5 mmmm -54.02 -39.53 66.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.386 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.75 -37.67 79.64 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.683 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.1 t -53.22 -35.3 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.957 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB2' HD11 ' A' ' 90' ' ' LEU . 64.4 m-85 -100.51 40.0 1.31 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 14.2 ptm -49.15 -32.75 10.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.421 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.78 13.18 65.02 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.617 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.63 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.6 p -85.88 162.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 117.313 0.556 . . . . 0.0 110.21 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.61 -77.86 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.42 119.67 7.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.614 171.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.63 ' HG ' HG11 ' A' ' 87' ' ' VAL . 89.9 mt -60.09 103.33 0.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.303 0.573 . . . . 0.0 110.536 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.476 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.2 tt0 -123.57 166.3 15.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.156 -175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 111' ' ' ALA . 42.6 t -81.55 140.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.86 1.42 85.06 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.846 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.476 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.0 mtm -85.88 135.05 33.85 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 109.938 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -114.02 139.54 49.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.082 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -163.38 170.45 17.49 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.998 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -92.69 126.74 37.91 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.36 127.44 56.01 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.35 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.12 140.39 41.77 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.0 p -145.0 -175.66 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.999 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -63.3 -36.71 84.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.528 0.68 . . . . 0.0 110.623 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.2 pt20 -95.61 27.54 3.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.266 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 179.44 46.09 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.14 140.93 94.11 Favored 'Trans proline' 0 C--N 1.328 -0.537 0 C-N-CA 122.171 1.914 . . . . 0.0 112.603 174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 99.0 t -135.43 117.49 12.31 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.573 177.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 7.1 Cg_exo -73.83 108.8 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.783 2.322 . . . . 0.0 111.246 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 11.2 m -118.48 154.6 20.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.778 0.323 . . . . 0.0 111.084 -174.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 40.8 tt0 -115.37 132.14 56.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.25 0.548 . . . . 0.0 110.336 174.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 90' ' ' LEU . 23.8 mt -77.53 127.9 38.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.02 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.401 ' C ' HG13 ' A' ' 92' ' ' VAL . 62.4 p -114.69 1.2 14.12 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.455 0.645 . . . . 0.0 109.53 -177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 153.52 0.21 Allowed 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.3 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 117' ' ' VAL . 49.0 t -136.32 107.7 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -90.25 -157.24 0.46 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -173.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.12 -50.97 71.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.29 -6.24 3.81 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.825 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 p-80 -139.78 158.41 44.14 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.024 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.697 HG12 HG13 ' A' ' 112' ' ' VAL . 30.3 m -107.89 161.71 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.02 110.23 31.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.673 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 12.0 m -113.63 135.12 54.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.615 0.721 . . . . 0.0 112.133 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -135.79 141.32 44.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.666 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.43 18.47 3.06 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.612 ' HB3' HD23 ' A' ' 75' ' ' LEU . 1.6 p-10 -130.51 111.56 12.38 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.945 0.878 . . . . 0.0 111.34 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.895 ' H ' ' HA ' ' A' ' 126' ' ' ALA . 91.3 m-70 -133.04 -174.97 3.63 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.504 ' HG2' HD22 ' A' ' 125' ' ' LEU . 22.8 ttt -54.83 -48.73 72.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 118.622 0.646 . . . . 0.0 110.717 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.504 HD22 ' HG2' ' A' ' 124' ' ' MET . 4.1 mm? -87.91 -12.69 43.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 175.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.895 ' HA ' ' H ' ' A' ' 123' ' ' HIS . . . 62.99 -69.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.445 1.098 . . . . 0.0 112.849 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.58 -8.68 37.55 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.831 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -80.28 143.9 33.28 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' HB2' ' CD ' ' A' ' 18' ' ' GLU . 39.4 m-80 -103.25 162.15 13.22 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 121.351 0.596 . . . . 0.0 110.595 -177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 68' ' ' TYR . 26.3 mt -115.67 147.79 40.45 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.465 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.986 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 18.4 mtpp -116.18 131.57 56.91 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 26.4 m-85 -117.11 137.59 52.19 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.179 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.1 m120 -104.66 106.72 17.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 171.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.714 HG13 HD23 ' A' ' 11' ' ' LEU . 8.3 t -102.94 138.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.529 -172.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.682 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 17.4 mt-10 -137.47 93.83 2.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.546 -178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -77.31 116.86 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.058 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 31' ' ' PRO . 11.4 t -75.84 -45.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.975 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.58 152.9 16.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.41 . . . . 0.0 111.282 -171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 54' ' ' VAL . 81.6 mt -136.71 133.07 48.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -150.89 139.95 21.07 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.803 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.716 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.3 pt-20 -73.17 125.85 28.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.124 0.488 . . . . 0.0 109.864 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.01 164.96 25.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.002 -176.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 28.7 p -97.02 23.19 7.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.537 -171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.595 ' HA ' HD12 ' A' ' 147' ' ' LEU . 44.7 mt-10 73.17 -31.46 0.23 Allowed 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.635 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -64.81 -46.64 81.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.836 0.35 . . . . 0.0 111.054 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.639 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 36.6 mp0 -54.78 -37.44 66.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.67 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 142' ' ' ALA . 11.4 mt -74.37 -47.43 34.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.617 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.74 -32.55 63.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.688 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -98.77 -25.76 14.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.283 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.02 29.58 25.36 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.617 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.84 164.36 30.41 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.701 -0.293 . . . . 0.0 110.505 -175.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 8' ' ' VAL . 3.3 p -74.9 -28.07 20.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.276 176.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.3 t60 73.61 -75.3 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.666 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.58 -37.82 9.31 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.179 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 56.48 -104.08 0.21 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.963 0.505 . . . . 0.0 111.051 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -144.77 -62.08 0.36 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -120.48 84.16 2.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.309 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -62.53 115.83 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.968 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -67.25 104.16 1.41 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.084 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -84.29 96.43 9.01 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.6 162.14 29.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.784 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -141.36 -18.23 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.747 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -80.19 152.52 29.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.083 0.468 . . . . 0.0 111.057 -175.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -157.64 35.66 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.636 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -69.61 114.27 7.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.946 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.73 42.85 3.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -81.69 39.26 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.135 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -95.58 69.43 2.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.171 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.575 ' HD2' ' HB2' ' A' ' 170' ' ' HIS . 8.5 t60 -109.09 137.27 47.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.706 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 169' ' ' HIS . 3.7 t60 73.33 2.09 4.2 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.943 0.777 . . . . 0.0 111.168 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.289 -178.881 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 53' ' ' GLU . 9.9 ptpt -96.13 168.35 10.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.53 0.681 . . . . 0.0 111.08 -176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -87.28 116.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.524 175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.64 -170.06 3.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.184 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 54.9 tttm -64.46 162.96 14.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p30 51.27 7.29 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 141' ' ' GLU . 22.2 mt -107.63 155.68 19.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 34' ' ' TYR . 7.4 p -116.31 143.16 27.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 139' ' ' ILE . 3.7 m -136.86 161.18 36.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.486 0.66 . . . . 0.0 111.906 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.1 m -125.72 107.75 10.85 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -120.93 161.81 20.93 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.855 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -126.49 108.09 10.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.1 p90 -126.39 163.77 22.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.154 0.502 . . . . 0.0 110.367 -172.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 59.9 tt0 -128.83 116.88 20.14 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.485 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 p -102.94 122.71 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.794 0.807 . . . . 0.0 111.169 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -142.42 164.03 31.24 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.311 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.509 ' OG1' HG12 ' A' ' 21' ' ' VAL . 58.7 p -83.49 174.19 10.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.461 -177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.1 -23.23 61.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.055 0.455 . . . . 0.0 110.452 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.83 -15.57 51.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.596 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.58 -16.73 40.47 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.96 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.725 ' HB ' ' HG2' ' A' ' 106' ' ' PRO . 11.4 p -67.31 133.99 30.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 117.906 0.853 . . . . 0.0 111.051 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 25' ' ' GLU . 57.0 tp -81.03 127.79 32.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.695 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 15' ' ' VAL . 29.7 m -103.33 -33.99 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.094 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -160.6 163.15 32.85 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.674 ' HB2' HD11 ' A' ' 22' ' ' LEU . 29.1 tt0 -165.3 130.29 2.51 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.266 0.555 . . . . 0.0 112.063 -175.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 31' ' ' PRO . 28.7 t -103.06 107.72 56.24 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 167.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.95 166.75 25.49 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.364 2.043 . . . . 0.0 111.704 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 m -67.39 -17.78 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.435 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 p -79.09 -32.32 44.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.356 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.15 114.09 5.78 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.068 0.461 . . . . 0.0 110.628 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.759 ' HG3' HG21 ' A' ' 137' ' ' VAL . 7.8 Cg_exo -76.35 169.07 22.68 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.934 3.09 . . . . 0.0 114.38 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.434 HD11 ' HE2' ' A' ' 34' ' ' TYR . 12.0 tp -86.13 128.4 34.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.19 168.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -118.38 119.55 34.93 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.108 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CB ' ' HB3' ' A' ' 40' ' ' SER . 37.1 m-85 -162.3 157.13 22.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.466 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 147' ' ' LEU . 64.0 tp -86.36 113.3 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.23 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -71.32 142.31 50.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 -170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 89.6 24.98 29.11 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.073 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.56 -18.16 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.6 0.238 . . . . 0.0 111.284 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.25 40.67 0.94 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB3' ' CB ' ' A' ' 34' ' ' TYR . 14.6 m -63.86 -45.59 88.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.54 0.686 . . . . 0.0 111.326 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 45' ' ' LEU . 1.8 pt? -151.65 179.25 8.56 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD12 ' HB1' ' A' ' 67' ' ' ALA . 11.0 pt -42.13 148.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.462 1.125 . . . . 0.0 112.989 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.1 t -76.53 -40.73 49.1 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 113.775 -1.557 . . . . 0.0 110.943 -171.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -56.24 -32.16 60.01 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.025 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 11.7 tp -77.01 -52.71 8.87 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.154 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 49' ' ' LEU . 27.4 mt-10 -55.26 -46.03 76.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.062 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.7 m -61.25 -29.58 69.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.052 0.453 . . . . 0.0 111.492 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.84 -34.34 57.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.785 0.802 . . . . 0.0 109.609 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 64.3 mt -69.58 -38.06 77.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.153 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.39 125.26 22.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.648 0.737 . . . . 0.0 112.836 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.73 0.42 34.37 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.771 -1.104 . . . . 0.0 112.338 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 3' ' ' VAL . 98.3 m-70 -101.38 169.2 9.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 174.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 54.9 mt-10 -123.15 166.31 15.4 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 0.6 OUTLIER -47.55 145.73 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 122.066 0.936 . . . . 0.0 112.835 -177.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 85.21 -0.76 88.83 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 114.105 -1.407 . . . . 0.0 114.202 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -70.98 153.35 42.72 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.877 0.838 . . . . 0.0 109.297 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -149.15 128.52 12.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.245 0.545 . . . . 0.0 109.76 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.662 ' CE2' HG22 ' A' ' 60' ' ' VAL . 25.6 p90 -162.96 177.87 8.85 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -120.1 147.51 44.77 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.662 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -133.39 143.01 40.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -169.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.23 113.0 11.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.952 0.406 . . . . 0.0 110.119 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.401 HG11 ' HA3' ' A' ' 44' ' ' GLY . 69.5 t -120.03 142.29 36.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.21 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.84 152.0 36.35 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.658 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.19 -21.59 66.31 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -68.57 -18.29 64.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.0 110.751 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.87 -52.95 2.72 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . -76.97 -92.19 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.453 -172.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -178.62 -166.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.34 20.29 14.02 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.83 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -64.68 171.74 3.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.0 111.795 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.539 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 74.3 t80 -68.28 123.48 20.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.265 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -122.18 110.49 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.03 -1.7 21.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.12 -16.64 61.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.549 0.69 . . . . 0.0 109.183 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.674 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 6.9 mp -85.29 -10.72 56.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.643 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.25 124.41 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.42 166.24 25.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.365 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.583 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.3 mpt_? -107.75 106.56 16.92 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.617 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.555 ' CG1' HG21 ' A' ' 83' ' ' VAL . 2.8 t -105.46 133.14 20.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.313 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.645 ' O ' HG22 ' A' ' 83' ' ' VAL . 21.4 Cg_exo -61.94 133.79 46.37 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.851 2.367 . . . . 0.0 111.566 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 37.4 mtmt -56.47 -24.61 46.94 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -57.41 -43.27 83.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 80' ' ' PRO . 5.8 m -53.31 -30.03 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.091 0.472 . . . . 0.0 112.101 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HB2' HD11 ' A' ' 90' ' ' LEU . 43.4 m-85 -103.1 39.13 1.61 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.605 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.1 ptm -60.8 -30.99 70.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.57 -7.44 88.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.048 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 70.1 t -76.17 146.43 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.913 0.356 . . . . 0.0 110.858 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.48 -73.34 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.557 0.535 . . . . 0.0 110.884 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -152.7 120.26 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.853 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 84' ' ' PHE . 97.3 mt -68.23 109.36 3.55 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.288 0.566 . . . . 0.0 111.076 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.8 tt0 -127.2 171.05 11.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.861 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 111' ' ' ALA . 55.6 t -83.13 138.43 19.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.01 1.13 88.9 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.732 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.581 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 3.9 mmm -84.24 134.82 34.53 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.609 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 5.8 ttt180 -131.91 134.35 45.58 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -159.78 162.76 34.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.106 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.403 HD11 ' CB ' ' A' ' 104' ' ' PRO . 35.1 tp -80.89 127.32 32.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.663 176.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.46 116.22 26.24 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 40.1 mt-10 -93.37 100.57 12.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.964 0.888 . . . . 0.0 110.096 -172.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.8 p -95.61 -175.79 3.56 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.192 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -56.27 -30.11 62.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.399 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.0 pt20 -104.63 25.03 10.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.95 -175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.61 173.27 33.59 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.382 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 31.2 Cg_exo -62.1 138.26 71.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.993 2.462 . . . . 0.0 112.867 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.65 108.76 12.04 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.725 ' HG2' ' HB ' ' A' ' 21' ' ' VAL . 16.5 Cg_exo -69.2 103.63 1.1 Allowed 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.664 2.243 . . . . 0.0 111.215 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.612 ' HB ' HG13 ' A' ' 119' ' ' VAL . 20.6 m -118.13 155.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.121 0.486 . . . . 0.0 111.136 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 95' ' ' ARG . 38.3 tt0 -122.92 139.41 54.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.756 0.789 . . . . 0.0 109.846 178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.672 HG12 HG23 ' A' ' 119' ' ' VAL . 19.9 mt -85.81 132.16 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.471 -173.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.635 HG22 ' SD ' ' A' ' 124' ' ' MET . 64.9 p -113.98 0.9 14.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.268 0.556 . . . . 0.0 109.866 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.493 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 172.77 156.07 0.1 Allowed 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.86 -175.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.661 HG13 HG12 ' A' ' 117' ' ' VAL . 48.1 t -139.94 114.98 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -90.68 -162.39 0.9 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.17 -26.39 62.95 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.247 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.758 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 24.4 m-20 -131.06 -26.03 2.19 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -133.11 167.15 20.85 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.98 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 112' ' ' VAL . 35.8 m -114.39 165.04 9.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.663 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.4 t -113.79 104.57 17.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.672 HG23 HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -113.24 140.17 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.367 -173.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -109.14 145.43 35.76 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.674 ' H ' ' HB3' ' A' ' 75' ' ' LEU . . . -82.29 -5.5 89.55 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -120.4 167.17 12.61 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -73.63 115.29 12.87 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.635 ' SD ' HG22 ' A' ' 110' ' ' THR . 20.4 ptt? -61.58 -28.74 69.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.706 -172.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.5 mt -92.19 -3.66 55.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.465 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 50.14 -148.77 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.856 0.722 . . . . 0.0 110.809 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.05 0.85 84.0 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.031 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 161.76 29.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.334 0.588 . . . . 0.0 111.415 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.427 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -108.43 148.12 30.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.535 173.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.3 mt -108.88 147.85 31.53 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 5.2 mtpp -116.45 132.08 56.77 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -119.96 126.0 49.78 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 16.9 m120 -100.61 107.24 18.85 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 176.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 49' ' ' LEU . 6.6 t -101.22 145.92 10.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.063 -165.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -149.29 97.14 2.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.777 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 55' ' ' GLY . 3.2 p -76.05 117.12 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.314 0.578 . . . . 0.0 111.53 -175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.3 t -76.98 -45.87 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.331 -177.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.2 155.94 23.53 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.186 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 9' ' ' VAL . 62.0 mt -139.7 137.97 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -145.88 142.87 29.19 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.106 0.479 . . . . 0.0 110.934 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.598 ' HA ' HD22 ' A' ' 7' ' ' LEU . 3.6 pt-20 -80.75 124.82 29.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.094 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -71.4 168.15 18.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.453 -174.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.1 p -103.01 23.28 12.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 147' ' ' LEU . 32.3 mt-10 73.8 -33.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.101 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -63.99 -41.71 97.42 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.619 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.647 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 13.8 mp0 -57.65 -39.51 77.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.891 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.535 HD21 ' HB3' ' A' ' 142' ' ' ALA . 16.6 mt -70.48 -44.89 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.961 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.08 -34.22 68.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.837 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -100.71 -31.22 11.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.009 0.433 . . . . 0.0 110.182 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.16 15.78 50.06 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.286 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -140.01 148.97 42.63 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.4 p -91.45 -35.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.38 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.1 m80 64.13 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.03 31.03 5.8 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.529 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -114.5 165.82 12.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.3 t60 65.35 43.73 3.4 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.404 0.621 . . . . 0.0 109.957 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -101.13 140.81 34.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.732 -176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -134.31 -48.52 0.78 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.4 m170 61.03 75.64 0.4 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.981 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -122.69 140.24 53.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.241 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.19 81.62 6.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.145 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.07 86.49 0.1 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.642 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -72.49 125.23 26.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.192 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -125.66 40.85 3.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.97 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -73.27 -24.74 60.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.059 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -71.67 109.49 5.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.15 0.5 . . . . 0.0 111.582 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -140.06 118.88 12.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.085 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -130.53 -26.79 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.759 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -142.38 -76.1 0.27 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.631 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 55.73 89.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.775 0.672 . . . . 0.0 112.138 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.209 176.466 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -108.08 174.69 5.77 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.58 0.705 . . . . 0.0 111.021 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -88.05 127.63 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.769 176.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.2 -177.64 6.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 76.6 tttt -55.75 152.0 10.28 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.083 0.24 . . . . 0.0 110.884 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 57.32 -5.67 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.577 HD22 ' HA ' ' A' ' 141' ' ' GLU . 28.1 mt -95.94 104.75 16.71 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.704 -0.622 . . . . 0.0 110.89 177.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.657 HG21 HG22 ' A' ' 152' ' ' VAL . 12.1 p -65.55 142.78 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.712 0.768 . . . . 0.0 111.816 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.865 HG12 HG23 ' A' ' 139' ' ' ILE . 1.3 m -145.32 154.93 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.832 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -120.36 119.11 32.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 171.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD13 HG13 ' A' ' 134' ' ' VAL . 4.5 pp -141.13 147.99 39.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -97.85 153.75 18.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.69 160.4 42.73 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.663 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 44.5 tt0 -132.46 118.33 19.18 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 23' ' ' VAL . 2.6 p -106.92 124.38 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.722 0.772 . . . . 0.0 111.522 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -139.93 165.69 26.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.101 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -81.47 179.28 7.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.319 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' CD ' ' HB2' ' A' ' 129' ' ' ASN . 42.9 mt-10 -66.0 -11.76 50.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.626 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -80.41 -19.3 46.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.105 0.478 . . . . 0.0 110.41 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.32 -17.4 53.79 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.382 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.97 132.32 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.054 0.454 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.24 140.61 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.315 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 15' ' ' VAL . 2.8 p -113.66 -35.54 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 109.991 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -168.89 172.16 7.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.663 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 2.9 pt-20 -166.73 159.66 14.09 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.177 172.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.4 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 52.8 m -108.33 110.06 61.73 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 162.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 38.3 Cg_endo -61.02 155.81 48.13 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 C-N-CA 122.78 2.32 . . . . 0.0 113.287 -165.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 m -69.45 -7.06 7.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.264 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 27' ' ' PRO . 5.8 p -91.21 -26.27 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.888 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -143.32 114.59 5.75 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.827 ' HG3' HG21 ' A' ' 137' ' ' VAL . 6.6 Cg_exo -74.81 166.03 30.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.465 2.777 . . . . 0.0 114.366 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 tp -88.06 130.28 35.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.461 167.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -116.33 127.98 55.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.165 0.507 . . . . 0.0 110.228 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' VAL . 54.6 p90 -160.1 164.61 32.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.416 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' A' ' 147' ' ' LEU . 54.4 tp -103.1 111.15 23.37 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.56 174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -56.77 124.06 17.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.569 -174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 93.35 0.23 67.75 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.943 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -136.54 3.25 2.77 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.79 92.73 0.09 OUTLIER Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 105.697 -2.961 . . . . 0.0 105.697 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.693 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 2.4 m -114.36 8.84 16.76 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.938 0.875 . . . . 0.0 109.449 -166.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 53.17 -89.05 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.454 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 45' ' ' LEU . 23.5 pt -124.5 136.25 61.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 122.265 1.031 . . . . 0.0 110.627 175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -48.21 -42.76 30.95 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.444 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 66' ' ' ASP . . . -69.25 -37.77 81.19 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.98 -0.628 . . . . 0.0 113.443 -176.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.6 HD11 HG21 ' A' ' 134' ' ' VAL . 16.2 tp -75.39 -52.23 11.25 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.425 -173.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.693 ' HG3' ' O ' ' A' ' 40' ' ' SER . 2.5 mm-40 -53.16 -45.11 68.32 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.26 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.4 m -57.77 -35.78 71.23 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.257 0.551 . . . . 0.0 111.331 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.11 -36.1 55.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.819 0.819 . . . . 0.0 109.606 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.573 ' CD2' HG11 ' A' ' 134' ' ' VAL . 83.4 mt -61.63 -35.64 78.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.014 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -53.86 152.62 5.38 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.11 -6.64 48.86 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 113.408 -1.723 . . . . 0.0 116.65 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.701 ' O ' HG12 ' A' ' 3' ' ' VAL . 17.6 p80 -117.93 -177.29 3.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 119.417 1.608 . . . . 0.0 111.109 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 1' ' ' MET . 45.3 mt-10 -124.06 174.66 7.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -169.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 139' ' ' ILE . 1.4 m -54.41 145.65 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.311 172.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.73 -15.66 56.67 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.852 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -75.48 143.48 42.55 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.123 0.487 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 4.0 tmmm? -145.61 131.52 19.16 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.103 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.756 ' CE2' HG22 ' A' ' 60' ' ' VAL . 17.9 p90 -162.69 159.81 24.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.007 0.432 . . . . 0.0 110.305 -178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.71 141.11 32.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.014 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.756 HG22 ' CE2' ' A' ' 58' ' ' PHE . 10.5 t -127.95 143.3 41.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.09 112.99 7.75 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.664 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' A' ' 132' ' ' PHE . 14.6 m -127.82 169.1 19.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.734 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -88.26 158.88 29.36 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.187 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.48 -25.02 9.06 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.18 0.592 . . . . 0.0 112.563 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -59.86 -27.77 66.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 111.06 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.447 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 1.5 m-20 -115.94 -5.76 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -172.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 42' ' ' ILE . . . -145.72 61.31 1.27 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 p90 39.34 -151.39 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.352 0.661 . . . . 0.0 111.976 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.21 20.49 48.99 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 119.592 -1.289 . . . . 0.0 111.833 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -59.93 -179.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -44.6 127.23 5.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.683 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -131.15 119.17 21.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.407 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.93 -8.31 56.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.67 -14.07 52.69 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.665 ' HG ' ' HA3' ' A' ' 121' ' ' GLY . 52.7 tp -88.32 -9.82 51.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.913 -176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.14 129.76 60.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.869 174.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -163.18 177.64 8.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.422 0.629 . . . . 0.0 112.341 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HG2' HG22 ' A' ' 118' ' ' VAL . 68.1 mtt180 -99.12 150.0 22.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.82 176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 t -143.23 129.0 10.15 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -59.51 139.09 87.66 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.17 2.58 . . . . 0.0 112.514 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.674 ' HD3' HD12 ' A' ' 90' ' ' LEU . 20.2 mmtp -52.07 -32.42 34.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.287 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -60.36 -41.64 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.706 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.18 -37.48 35.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.052 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HD2' HD11 ' A' ' 90' ' ' LEU . 59.1 m-85 -100.78 40.01 1.32 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.731 0.3 . . . . 0.0 111.224 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.411 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 16.3 ptm -49.67 -37.21 27.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -88.21 13.53 61.48 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.948 -175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 84' ' ' PHE . 3.4 p -90.01 165.79 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 117.388 0.594 . . . . 0.0 110.064 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.79 -71.19 0.12 Allowed 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -166.16 128.37 1.92 Allowed 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.674 HD12 ' HD3' ' A' ' 81' ' ' LYS . 92.0 mt -63.9 112.16 2.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.808 0.814 . . . . 0.0 111.359 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.532 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -125.71 161.39 27.39 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.648 -177.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.404 ' HA ' HG22 ' A' ' 109' ' ' ILE . 59.1 t -80.82 136.0 24.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 1.37 66.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.314 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -87.49 135.79 33.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.094 0.473 . . . . 0.0 110.634 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -113.93 134.42 54.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.728 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -163.21 173.79 12.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.006 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 104' ' ' PRO . 31.2 tp -90.91 120.94 32.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -90.1 174.0 7.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.669 -175.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -128.19 121.79 30.29 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.328 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.5 p -145.52 175.27 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.731 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -55.1 -36.97 66.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.618 0.723 . . . . 0.0 111.262 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.453 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.0 pt20 -92.27 30.74 1.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.62 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.08 -177.51 53.15 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.584 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 51.0 Cg_exo -58.1 143.72 96.14 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.435 2.09 . . . . 0.0 112.476 172.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 107' ' ' VAL . 88.1 t -133.78 116.91 13.83 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.685 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.05 101.88 0.74 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.65 2.233 . . . . 0.0 111.854 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 5.0 m -118.83 178.31 2.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.005 0.431 . . . . 0.0 111.734 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -135.66 137.41 41.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.32 172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 90' ' ' LEU . 23.0 mt -78.01 126.18 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.813 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.1 p -110.95 1.54 17.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.426 0.632 . . . . 0.0 109.591 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 179.94 153.11 0.49 Allowed 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.032 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 117' ' ' VAL . 94.2 t -141.37 109.49 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -90.05 -165.05 1.26 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.12 -54.28 15.81 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.491 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -109.21 -3.93 16.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -141.69 147.78 38.04 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 121.647 -0.658 . . . . 0.0 111.149 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.657 HG12 HG13 ' A' ' 112' ' ' VAL . 35.2 m -111.38 167.79 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 78' ' ' ARG . 58.8 t -121.58 114.87 44.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.7 m -113.97 137.99 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.545 0.688 . . . . 0.0 111.704 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -118.41 134.2 55.26 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.717 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.665 ' HA3' ' HG ' ' A' ' 75' ' ' LEU . . . -85.16 -20.58 57.05 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.042 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 1.01 ' HB2' ' HA ' ' A' ' 126' ' ' ALA . 5.3 p30 -100.49 135.37 42.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -91.66 -81.35 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.586 -171.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.565 ' HG3' ' H ' ' A' ' 125' ' ' LEU . 26.9 ptt? -83.85 -61.54 1.8 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.599 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.565 ' H ' ' HG3' ' A' ' 124' ' ' MET . 3.1 mm? -119.55 -20.24 7.83 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.492 0.663 . . . . 0.0 109.321 170.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 1.01 ' HA ' ' HB2' ' A' ' 122' ' ' ASN . . . -171.45 -71.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.542 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.53 -22.0 4.18 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.97 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -57.39 134.51 56.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.446 ' HB2' ' CD ' ' A' ' 18' ' ' GLU . 49.0 m-80 -87.51 156.3 19.6 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.693 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 67' ' ' ALA . 45.4 mt -124.39 143.14 50.77 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.677 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 40.7 mtpt -115.52 129.02 56.4 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 4.2 m-85 -118.14 139.78 50.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.271 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -108.58 108.14 18.92 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 57' ' ' LYS . 9.1 t -99.2 137.44 26.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.289 -172.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.647 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 9.3 mt-10 -136.52 96.11 3.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.86 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.542 HG21 ' CE1' ' A' ' 52' ' ' HIS . 38.9 t -76.24 115.85 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.576 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.827 HG21 ' HG3' ' A' ' 31' ' ' PRO . 6.0 t -72.96 -49.5 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.892 176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.57 156.28 20.64 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.347 -0.22 . . . . 0.0 111.24 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.865 HG23 HG12 ' A' ' 9' ' ' VAL . 67.8 mt -138.99 141.96 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -147.21 141.08 25.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.976 0.417 . . . . 0.0 110.619 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.577 ' HA ' HD22 ' A' ' 7' ' ' LEU . 8.2 pt-20 -76.23 117.14 17.61 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.717 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -62.18 155.28 24.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.803 0.811 . . . . 0.0 112.714 -168.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 145' ' ' GLU . 43.2 p -84.19 18.86 1.99 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.223 -1.353 . . . . 0.0 112.066 -171.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 147' ' ' LEU . 30.1 mt-10 68.87 -33.0 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.082 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 143' ' ' THR . 0.4 OUTLIER -66.46 -40.43 89.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 174.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.717 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 32.7 mt-10 -58.06 -39.9 79.65 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.02 175.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 142' ' ' ALA . 14.9 mt -69.1 -45.55 69.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.898 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.66 67.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.853 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -97.52 -6.25 34.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.8 0.71 85.69 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.832 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -168.79 173.34 7.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 8' ' ' VAL . 22.8 t -50.23 -61.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.854 0.722 . . . . 0.0 112.62 -172.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 152' ' ' VAL . 19.4 t-80 70.18 91.89 0.09 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.254 0.549 . . . . 0.0 110.508 -174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 113.4 -103.61 1.4 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.29 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . 67.1 19.69 10.42 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.968 0.507 . . . . 0.0 111.287 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -168.25 39.24 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.397 0.618 . . . . 0.0 109.511 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.8 47.1 1.1 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.549 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -91.45 24.19 3.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.446 0.641 . . . . 0.0 110.014 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -107.05 0.94 23.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -120.33 78.34 1.35 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.527 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -107.5 -43.68 4.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.873 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -103.93 64.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.247 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -141.75 88.84 2.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.53 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -168.88 155.75 7.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.976 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -130.46 168.55 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 43.2 m80 69.72 -179.54 0.23 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.659 0.6 . . . . 0.0 111.479 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -134.26 18.38 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.496 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -107.74 105.4 15.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.036 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -100.9 151.12 22.12 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.843 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -120.12 -25.34 5.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 167.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 11.5 m80 . . . . . 0 C--O 1.246 0.876 0 CA-C-N 113.26 -1.791 . . . . 0.0 108.562 172.653 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 51' ' ' GLY . 16.0 ptmt -106.19 171.17 7.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.27 0.557 . . . . 0.0 110.49 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -87.02 120.47 36.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.251 178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.19 -172.95 4.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 7' ' ' LEU . 56.8 tttm -57.73 147.41 27.93 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.812 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 54.65 -5.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 5' ' ' LYS . 15.0 mt -85.34 104.3 15.04 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.206 0.527 . . . . 0.0 109.807 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.766 HG22 ' CD1' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -60.55 143.85 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.586 178.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.835 ' O ' ' HB3' ' A' ' 34' ' ' TYR . 2.3 m -153.18 131.69 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.217 1.008 . . . . 0.0 111.999 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 34' ' ' TYR . 2.3 m -100.2 120.92 40.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.737 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -139.35 143.77 37.92 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.619 -0.833 . . . . 0.0 109.786 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -104.33 154.27 20.02 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.796 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 52.9 p90 -149.09 165.04 32.92 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.278 -175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 31.3 tt0 -131.91 120.77 22.99 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.511 ' O ' HD12 ' A' ' 22' ' ' LEU . 21.5 t -103.84 119.64 52.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.092 0.472 . . . . 0.0 110.491 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 5.5 ptp180 -132.58 151.67 51.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 p -81.95 175.98 9.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.137 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -58.7 -32.07 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.261 0.553 . . . . 0.0 109.721 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -69.28 -18.23 63.82 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.933 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.89 26.72 15.84 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.563 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 16' ' ' ARG . 9.1 t -105.17 126.32 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 122.786 -0.244 . . . . 0.0 110.554 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.594 HD11 ' HB2' ' A' ' 25' ' ' GLU . 35.1 tp -67.04 123.35 19.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 m -109.6 -38.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.565 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.18 152.41 39.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' HB2' HD11 ' A' ' 22' ' ' LEU . 30.8 tt0 -157.1 137.43 12.88 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 111.753 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 12' ' ' ALA . 27.1 m -116.7 114.3 39.87 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.17 167.52 19.94 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 C-N-CA 122.824 2.349 . . . . 0.0 112.227 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.18 -17.71 22.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.211 0.529 . . . . 0.0 110.269 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -78.0 -32.53 51.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.242 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -136.8 112.83 9.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.277 0.561 . . . . 0.0 110.75 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.726 ' HG3' HG21 ' A' ' 137' ' ' VAL . 10.6 Cg_exo -76.86 169.45 21.66 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 124.271 3.314 . . . . 0.0 114.644 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.796 ' HG ' ' HE1' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -70.0 158.67 35.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.383 169.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.536 ' H ' HD23 ' A' ' 32' ' ' LEU . 3.9 m-20 -91.43 149.62 21.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 122.085 0.945 . . . . 0.0 110.949 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.835 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -128.08 126.91 42.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -161.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.625 HD11 HD23 ' A' ' 147' ' ' LEU . 14.7 tp -148.44 98.54 2.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 146.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.515 ' HA ' ' OG ' ' A' ' 40' ' ' SER . 21.2 t60 -70.82 136.19 48.6 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.412 -164.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.27 -25.55 27.32 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.285 -0.871 . . . . 0.0 113.471 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.14 18.32 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.671 0.748 . . . . 0.0 110.173 -177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 140.83 90.8 0.18 Allowed Glycine 0 N--CA 1.432 -1.587 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.98 169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 41' ' ' LEU . 11.0 m -116.63 -52.27 2.56 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.726 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -164.75 -173.42 2.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 111.568 -2.56 . . . . 0.0 108.518 170.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 41' ' ' LEU . 13.7 pt -33.14 143.92 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.5 t -66.47 -41.08 89.54 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.741 -172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -58.14 -41.41 94.68 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.773 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 134' ' ' VAL . 29.8 tp -73.95 -48.89 27.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' HA ' HD12 ' A' ' 49' ' ' LEU . 15.6 mt-10 -50.74 -47.86 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.113 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.5 m -63.45 -36.83 85.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.656 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.1 72.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.467 0.651 . . . . 0.0 110.015 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.674 HD21 HG11 ' A' ' 134' ' ' VAL . 83.9 mt -59.0 -37.07 76.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.664 175.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG3' ' NE2' ' A' ' 36' ' ' HIS . 4.0 mt-10 -53.32 152.04 4.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 -176.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 2' ' ' LYS . . . 82.82 -22.49 6.63 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.371 -1.286 . . . . 0.0 114.183 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.509 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.8 m-70 -83.39 179.26 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.451 0.643 . . . . 0.0 111.954 -175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 1' ' ' MET . 46.6 mt-10 -134.73 161.85 34.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.483 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.2 m -52.61 143.26 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.691 0.619 . . . . 0.0 111.11 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 97.39 -17.13 59.56 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.689 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 0.3 OUTLIER -64.94 132.54 49.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.262 0.554 . . . . 0.0 111.139 177.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.742 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 13.7 tmtt? -137.17 130.19 30.72 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.656 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 60' ' ' VAL . 21.0 p90 -166.57 163.49 16.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.993 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.11 143.38 26.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.598 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.713 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.9 t -131.43 142.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.122 -177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.97 113.49 13.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.035 0.445 . . . . 0.0 109.893 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 44' ' ' GLY . 99.7 t -125.9 136.88 59.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.508 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.52 148.23 45.03 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.12 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 128' ' ' GLN . . . -62.82 -21.61 66.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.915 0.388 . . . . 0.0 111.429 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -68.95 -19.64 64.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.019 -178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -109.3 -42.02 4.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.922 0.391 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 42' ' ' ILE . . . -81.81 -88.35 0.08 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.943 -177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -166.74 172.72 10.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.82 21.05 11.58 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 119.722 -1.227 . . . . 0.0 112.348 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -72.59 148.21 45.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.534 ' CE2' ' HB3' ' A' ' 73' ' ' GLU . 58.4 t80 -95.56 110.0 22.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.093 0.473 . . . . 0.0 110.32 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -85.87 84.66 7.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.47 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 71' ' ' TYR . 4.8 pt-20 -70.54 -14.99 62.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.057 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.09 -4.04 59.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.893 0.378 . . . . 0.0 110.577 174.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 46.6 tp -102.58 -10.41 19.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.461 0.648 . . . . 0.0 110.135 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 73' ' ' GLU . 4.3 p -115.44 117.68 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.454 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -161.81 176.81 10.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.523 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' HG3' HG22 ' A' ' 118' ' ' VAL . 10.9 mpt_? -111.02 111.5 22.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.207 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 t -105.49 133.28 20.25 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.461 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -60.98 135.01 56.46 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.76 2.307 . . . . 0.0 111.836 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 23.8 mtmt -59.11 -17.52 27.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.327 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.52 -27.37 64.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.42 0.629 . . . . 0.0 110.154 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.5 t -67.9 -36.4 75.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HB2' HD11 ' A' ' 90' ' ' LEU . 26.3 m-85 -102.1 40.02 1.4 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.179 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.7 ptm -56.54 -24.33 46.14 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.361 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.39 4.7 83.35 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.198 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 HG11 HD23 ' A' ' 90' ' ' LEU . 69.5 t -89.56 149.84 3.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.902 0.351 . . . . 0.0 110.477 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.17 -70.77 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.962 0.41 . . . . 0.0 110.878 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -142.72 105.38 4.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.626 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 84' ' ' PHE . 80.8 mt -60.17 107.59 0.67 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.341 0.591 . . . . 0.0 110.392 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -128.27 167.52 16.78 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -75.26 140.4 17.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.05 2.43 77.86 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.483 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 mmm -89.21 135.53 33.52 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.101 0.476 . . . . 0.0 109.718 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -115.83 135.39 54.06 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.691 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -164.15 167.45 20.13 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.112 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.3 tp -84.33 130.6 34.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -113.16 142.72 45.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.994 -174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.62 132.95 35.45 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.3 p -146.81 -175.64 4.88 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.81 -30.88 70.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.592 0.71 . . . . 0.0 109.901 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -86.71 24.45 1.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.636 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.79 -171.67 55.15 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.185 -173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 32.6 Cg_exo -58.63 128.57 28.74 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.231 1.954 . . . . 0.0 111.631 170.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -128.85 116.43 19.23 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 14.8 Cg_exo -70.74 102.7 1.22 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.939 2.426 . . . . 0.0 111.861 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 13.5 m -118.37 172.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.777 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.98 131.53 40.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 41.4 mt -68.82 128.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.727 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 120' ' ' ASP . 39.4 p -113.66 0.31 14.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.323 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.556 ' HB3' ' HB ' ' A' ' 118' ' ' VAL . . . -175.52 153.27 1.45 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.093 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.766 HG13 HG12 ' A' ' 117' ' ' VAL . 57.5 t -140.78 106.36 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.84 -172.61 3.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -67.31 -49.03 65.81 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.225 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.547 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 10.0 m-20 -104.83 -14.35 15.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -143.53 149.04 36.89 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.574 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 112' ' ' VAL . 34.9 m -104.58 168.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.114 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.2 t -124.0 122.07 63.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.616 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.8 m -115.63 133.16 62.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 112.012 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' HB3' HG21 ' A' ' 110' ' ' THR . 14.3 t70 -144.36 106.83 4.39 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.797 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.97 14.2 55.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.431 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -113.09 168.86 9.36 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -109.2 136.23 49.01 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.24 -5.69 5.46 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.901 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.0 mp -84.17 11.5 8.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.149 0.499 . . . . 0.0 110.216 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.33 148.31 35.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.759 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 106.01 -29.96 10.42 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.67 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.0 mt-30 -72.74 162.98 28.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.551 ' N ' HD22 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -96.93 162.5 13.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 171.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -128.17 145.77 50.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.028 -169.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -117.11 128.54 55.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.25 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 3.5 m-85 -119.71 133.77 55.49 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.472 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.494 ' N ' HD22 ' A' ' 133' ' ' ASN . 1.0 OUTLIER -104.33 108.69 20.21 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.737 HG13 HD23 ' A' ' 11' ' ' LEU . 5.6 t -98.67 142.5 14.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.505 0.669 . . . . 0.0 112.145 -170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.742 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 44.0 mt-10 -130.93 90.85 2.96 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.192 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.9 p -68.86 114.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.854 0.835 . . . . 0.0 111.957 -177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 31' ' ' PRO . 15.8 t -71.54 -51.9 29.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.491 -1.231 . . . . 0.0 112.047 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -158.58 158.45 33.93 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.885 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.682 HG23 HG12 ' A' ' 9' ' ' VAL . 75.9 mt -137.35 134.58 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 8' ' ' VAL . 41.6 ttm180 -154.38 138.99 16.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.912 0.387 . . . . 0.0 110.609 -177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.467 ' HA ' HD22 ' A' ' 7' ' ' LEU . 16.1 pt-20 -70.85 123.34 21.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -62.75 164.23 8.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.2 p -97.54 25.27 5.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.09 -168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' LEU . 38.7 mt-10 72.81 -36.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.369 -176.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.0 -48.71 79.1 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.565 0.221 . . . . 0.0 110.693 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 12.7 mp0 -55.68 -39.42 70.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.625 HD23 HD11 ' A' ' 35' ' ' LEU . 19.2 mt -68.76 -47.32 66.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.168 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.2 73.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.19 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -84.58 -19.28 33.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.239 -177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 81.93 10.24 84.27 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.007 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.02 172.93 1.91 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 155' ' ' ALA . 21.0 t -65.44 -65.81 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.522 ' HA ' ' OD2' ' A' ' 157' ' ' ASP . 43.0 t60 59.15 86.64 0.09 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.409 0.623 . . . . 0.0 109.908 -171.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.36 2.38 1.55 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.387 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -109.2 -74.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.005 0.431 . . . . 0.0 110.584 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -80.36 -10.36 59.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.573 0.702 . . . . 0.0 109.833 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 153' ' ' HIS . 20.0 p-10 -128.05 69.53 1.34 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.987 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -117.01 -23.27 8.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.387 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.52 143.8 29.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -81.77 122.1 27.25 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -159.16 -27.42 0.07 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.736 -170.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -73.38 -24.47 60.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.686 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -85.38 135.74 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.097 0.475 . . . . 0.0 109.739 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -150.98 40.58 0.73 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.619 -174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.36 110.81 1.17 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.332 0.587 . . . . 0.0 111.124 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -110.03 34.1 4.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.189 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -97.33 -36.65 10.32 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.784 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.426 ' C ' ' H ' ' A' ' 170' ' ' HIS . 1.8 m170 58.53 78.99 0.23 Allowed 'General case' 0 C--O 1.237 0.423 0 O-C-N 123.723 0.64 . . . . 0.0 111.197 178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.09 45.14 0.61 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.546 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 168' ' ' HIS . 54.6 t-80 -157.76 124.27 4.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.32 -1.309 . . . . 0.0 107.633 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.497 -178.63 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HE3' ' HA2' ' A' ' 51' ' ' GLY . 19.2 ptmt -133.14 166.18 23.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.3 p -72.42 115.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.068 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.32 -171.0 3.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.008 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 83.3 tttt -64.97 158.04 26.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.223 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' O ' HD21 ' A' ' 147' ' ' LEU . 3.6 p30 55.69 0.3 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 113.907 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 141' ' ' GLU . 15.6 mt -96.45 110.51 22.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.044 0.45 . . . . 0.0 111.295 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.533 HG23 HD13 ' A' ' 35' ' ' LEU . 49.7 t -53.73 143.43 5.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.708 170.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -141.89 134.47 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.283 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -111.99 111.7 22.81 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.522 HD13 HG13 ' A' ' 134' ' ' VAL . 2.3 pp -128.76 161.12 30.48 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.854 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.6 147.31 42.96 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.667 ' CE1' HD12 ' A' ' 32' ' ' LEU . 36.7 p90 -160.93 162.19 31.91 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 119.436 -0.905 . . . . 0.0 111.452 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 132' ' ' PHE . 40.0 tt0 -133.57 121.07 21.57 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 22' ' ' LEU . 2.4 p -113.7 125.93 71.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.598 0.713 . . . . 0.0 111.361 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -144.07 176.03 9.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.335 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.3 p -98.03 178.05 5.22 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.528 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.2 -20.86 66.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.263 0.554 . . . . 0.0 110.153 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' HG23 ' A' ' 21' ' ' VAL . 18.2 t70 -78.26 -18.07 55.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.384 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.39 6.02 53.65 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 19' ' ' ASP . 5.2 t -77.04 112.92 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.791 -0.077 . . . . 0.0 110.791 -177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 15' ' ' VAL . 58.3 tp -68.97 119.43 13.27 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 15' ' ' VAL . 31.0 m -96.52 -39.19 8.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 32.5 t70 -156.56 160.15 39.2 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 43.1 tt0 -159.05 133.54 7.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.363 0.602 . . . . 0.0 111.971 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 m -116.25 105.08 51.28 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 170.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.26 168.27 18.14 Favored 'Trans proline' 0 CA--C 1.523 -0.068 0 C-N-CA 122.91 2.407 . . . . 0.0 113.035 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 m -68.02 -19.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.548 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.4 p -75.83 -38.95 57.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -133.93 112.65 12.47 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.237 0.541 . . . . 0.0 109.873 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.493 ' HB3' HG21 ' A' ' 137' ' ' VAL . 12.9 Cg_exo -75.53 169.76 21.68 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 123.994 3.13 . . . . 0.0 114.723 -175.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 13' ' ' TYR . 0.0 OUTLIER -86.6 131.49 34.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.603 168.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.57 118.28 26.98 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.916 -0.714 . . . . 0.0 112.645 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 23.1 m-85 -160.15 -179.72 7.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.263 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.592 HD21 HD23 ' A' ' 147' ' ' LEU . 60.2 tp -107.98 115.74 30.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.65 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 46' ' ' GLU . 14.9 t60 -73.99 130.87 40.71 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 109.45 6.38 29.19 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.973 -1.108 . . . . 0.0 112.774 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -148.15 9.66 0.87 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.12 104.34 2.51 Favored Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -167.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 34' ' ' TYR . 39.4 t -118.33 -50.85 2.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.2 pt? -158.09 -168.89 2.62 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.817 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 67' ' ' ALA . 10.7 pt -39.77 144.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -66.51 -39.46 88.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.076 -1.874 . . . . 0.0 112.185 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.506 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -65.53 -39.48 95.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.352 -176.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 134' ' ' VAL . 16.5 tp -74.37 -49.79 21.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 109.864 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' HA ' HD22 ' A' ' 49' ' ' LEU . 23.3 mt-10 -48.5 -47.2 39.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.4 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.9 m -66.48 -32.97 74.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.7 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.7 -42.41 74.1 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.8 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -57.91 -45.13 86.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.161 175.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HA ' HG13 ' A' ' 3' ' ' VAL . 3.2 mt-10 -46.55 152.35 0.47 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.949 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' HA2' ' HE3' ' A' ' 2' ' ' LYS . . . 79.11 -23.59 3.17 Favored Glycine 0 CA--C 1.521 0.453 0 CA-C-N 114.428 -1.26 . . . . 0.0 114.594 -174.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 3' ' ' VAL . 94.2 m-70 -84.49 177.55 8.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.664 0.732 . . . . 0.0 111.163 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 1' ' ' MET . 39.5 mt-10 -128.72 164.57 22.66 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.1 m -52.04 142.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.476 0.655 . . . . 0.0 110.819 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 95.87 -13.11 66.66 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.473 -177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.52 131.38 44.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.941 0.4 . . . . 0.0 110.327 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.565 ' CG ' ' HG2' ' A' ' 135' ' ' GLU . 1.9 tmtp? -137.96 130.33 29.21 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.913 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.5 p90 -167.4 162.01 14.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.037 -177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.77 144.11 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.626 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.689 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.7 t -134.32 142.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.31 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.95 113.2 11.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG11 ' HA3' ' A' ' 44' ' ' GLY . 80.3 t -120.78 138.22 51.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 120.876 0.37 . . . . 0.0 110.652 -174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.85 150.32 50.37 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.367 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -47.54 -31.39 4.33 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -65.16 -21.11 66.73 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 0.5 OUTLIER -117.06 3.69 12.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 176.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.439 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -132.15 -152.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.551 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HB2' HD11 ' A' ' 130' ' ' LEU . 44.6 m-85 -76.32 157.45 32.44 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.11 22.2 10.96 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.604 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -57.45 120.6 8.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.202 1.001 . . . . 0.0 112.731 -169.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.957 ' HB2' HD21 ' A' ' 122' ' ' ASN . 54.9 p90 -63.4 152.54 37.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.06 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.51 116.09 14.8 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 76' ' ' VAL . 2.9 tt0 -73.32 -13.28 61.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -66.31 -3.67 6.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 122' ' ' ASN . 88.0 mt -112.66 -10.41 13.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.227 0.536 . . . . 0.0 110.975 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 73' ' ' GLU . 2.5 p -100.46 154.06 4.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.336 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.513 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -161.7 171.86 17.19 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG3' HG22 ' A' ' 118' ' ' VAL . 8.4 mpt_? -116.26 105.36 12.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 109.737 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.17 128.62 36.28 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.952 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.32 137.1 72.47 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.592 2.862 . . . . 0.0 112.216 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.903 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -56.1 -25.57 46.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.113 175.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.04 -36.42 81.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.462 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -43.16 95.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.316 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.7 m-85 -90.4 40.21 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.476 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.4 ' HG3' ' N ' ' A' ' 86' ' ' GLY . 14.7 ptm -52.13 -36.54 51.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.144 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . -92.32 13.94 65.92 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.984 -175.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.781 HG11 ' HG ' ' A' ' 90' ' ' LEU . 7.4 p -75.79 159.8 5.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.272 0.536 . . . . 0.0 111.129 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 87' ' ' VAL . 19.5 t70 -68.67 -76.03 0.1 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.859 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -149.77 110.51 4.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.217 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.781 ' HG ' HG11 ' A' ' 87' ' ' VAL . 5.6 mt -64.58 119.54 10.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.652 0.739 . . . . 0.0 111.45 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HB3' ' HG3' ' A' ' 94' ' ' MET . 6.3 tt0 -147.03 164.89 31.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.471 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 111' ' ' ALA . 53.3 t -81.21 132.68 30.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.04 1.82 56.0 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.83 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.42 ' HG3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 mmm -91.09 141.86 28.37 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.226 0.536 . . . . 0.0 111.292 -173.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 10.7 mtp180 -118.24 134.54 54.93 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.043 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -162.01 167.09 25.05 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.078 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 104' ' ' PRO . 44.6 tp -91.31 137.3 32.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.192 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.84 138.14 54.54 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -83.09 146.91 28.42 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.5 p -145.74 -175.55 4.78 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.17 -23.57 67.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.84 0.828 . . . . 0.0 110.514 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.84 26.84 10.27 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.549 -171.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.89 -179.31 48.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.135 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 97' ' ' LEU . 42.3 Cg_exo -57.82 133.39 55.83 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.375 2.05 . . . . 0.0 112.903 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 88.9 t -129.53 116.39 18.43 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.549 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.9 Cg_exo -79.75 112.97 2.98 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.889 2.393 . . . . 0.0 111.19 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 3.8 m -118.23 178.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.743 0.306 . . . . 0.0 111.196 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' C ' HG12 ' A' ' 119' ' ' VAL . 36.7 tt0 -134.53 130.84 37.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.046 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.433 HG21 ' CG2' ' A' ' 112' ' ' VAL . 40.7 mt -71.89 130.44 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.327 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.9 p -112.05 -1.87 15.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.971 0.415 . . . . 0.0 110.382 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . -175.34 150.24 1.11 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.485 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.624 HG13 HG12 ' A' ' 117' ' ' VAL . 60.8 t -139.08 106.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 6.9 mm-40 -86.0 -157.31 0.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -71.33 -54.09 11.97 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.866 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.492 ' C ' ' HG2' ' A' ' 81' ' ' LYS . 18.5 m-20 -118.14 5.86 12.01 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.41 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 33.1 p-80 -145.1 148.03 33.2 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.461 -0.774 . . . . 0.0 111.574 178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.755 HG13 ' HZ3' ' A' ' 81' ' ' LYS . 30.7 m -116.35 167.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.5 t -122.53 115.88 47.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.967 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 2.6 m -119.05 130.57 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.069 0.462 . . . . 0.0 110.333 175.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -108.38 153.19 23.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.986 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -105.17 2.73 40.55 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.957 HD21 ' HB2' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -127.39 162.2 26.87 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -164.8 -35.61 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.5 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.62 -8.3 56.96 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 122.393 -0.192 . . . . 0.0 111.511 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.471 ' HB2' ' OD1' ' A' ' 122' ' ' ASN . 7.3 mp -83.37 -10.95 58.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.416 0.627 . . . . 0.0 109.489 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -137.42 -153.6 0.5 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.96 -12.99 59.14 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.17 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.15 106.33 1.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.92 0.39 . . . . 0.0 111.053 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 -82.52 126.55 32.39 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 68' ' ' TYR . 92.1 mt -106.08 154.99 19.87 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.742 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -124.17 122.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 110.048 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 1.6 m-85 -117.83 139.81 50.58 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.704 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 13.9 m120 -109.36 106.67 16.57 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 45' ' ' LEU . 2.5 t -99.61 135.62 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.565 ' HG2' ' CG ' ' A' ' 57' ' ' LYS . 25.9 mt-10 -135.54 90.83 2.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.272 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 54' ' ' VAL . 2.9 p -72.69 115.0 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.846 0.831 . . . . 0.0 112.446 -173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 31' ' ' PRO . 3.2 t -72.91 -47.91 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.124 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -159.03 157.59 31.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.751 0.31 . . . . 0.0 111.147 -171.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.451 HG13 HG12 ' A' ' 54' ' ' VAL . 63.5 mt -140.34 123.46 16.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -146.97 137.05 23.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.999 0.428 . . . . 0.0 111.351 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.449 ' HB3' HD22 ' A' ' 7' ' ' LEU . 7.9 pt-20 -75.49 138.66 41.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -80.51 176.77 9.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.682 0.754 . . . . 0.0 112.589 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 22.5 p -96.34 23.43 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.269 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 70.17 -43.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.365 0.666 . . . . 0.0 111.444 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.79 -40.26 91.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.365 0.602 . . . . 0.0 109.38 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.581 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 42.4 mt-10 -63.15 -34.27 77.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.381 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.592 HD23 HD21 ' A' ' 35' ' ' LEU . 47.2 mt -71.98 -47.4 52.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.11 0.481 . . . . 0.0 110.139 176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.48 69.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.52 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -99.04 -16.76 18.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.87 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 84.66 25.79 40.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 114.243 170.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -169.87 166.0 9.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.373 0.587 . . . . 0.0 110.635 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.2 133.56 30.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 123.576 0.548 . . . . 0.0 111.007 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -124.67 80.07 1.82 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 153.74 43.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.949 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -99.08 -76.06 0.55 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.961 -0.12 . . . . 0.0 110.883 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 84.0 t60 66.45 120.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.728 0.643 . . . . 0.0 110.952 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.83 132.66 35.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.179 0.514 . . . . 0.0 110.132 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -121.19 86.36 2.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.04 0.924 . . . . 0.0 109.157 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -87.67 157.86 18.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.36 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -113.36 123.1 49.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.177 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.417 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . 5.8 m-20 -106.96 177.23 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.476 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -150.09 147.56 27.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.014 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 65.58 31.57 9.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.212 171.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 161' ' ' ASP . 1.5 p-80 -107.41 151.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.266 -0.573 . . . . 0.0 109.87 171.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -155.67 126.36 6.89 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.994 0.426 . . . . 0.0 110.834 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -127.19 29.06 5.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -116.78 -21.05 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.521 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -60.51 98.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.527 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -166.04 -40.98 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.035 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -135.15 97.36 3.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.553 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.569 -177.192 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 51' ' ' GLY . 15.2 ptpt -111.11 170.83 7.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.481 0.657 . . . . 0.0 111.729 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -84.94 131.96 32.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.16 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.12 -174.12 4.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.527 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 79.5 tttt -65.96 155.86 35.28 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 147' ' ' LEU . 28.7 m-20 60.37 -5.05 0.1 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 141' ' ' GLU . 19.3 mt -90.71 109.66 20.84 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.613 -0.679 . . . . 0.0 111.454 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.0 144.27 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.046 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -151.16 137.75 12.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -168.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.507 ' O ' ' HB ' ' A' ' 137' ' ' VAL . 10.9 m -102.45 121.24 41.95 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 134' ' ' VAL . 2.1 tt -136.9 154.31 50.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.425 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 135' ' ' GLU . . . -124.36 151.24 44.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.48 161.33 21.28 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.04 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 51.8 tt0 -132.15 118.94 20.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.557 HG11 ' OH ' ' A' ' 68' ' ' TYR . 2.9 p -110.32 124.4 67.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.536 0.684 . . . . 0.0 111.388 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -145.41 -179.84 6.92 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.6 p -99.91 174.58 6.12 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.253 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 43.6 mt-10 -65.43 -19.22 65.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.421 175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.07 -18.72 55.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.577 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.36 -12.01 43.59 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.515 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.53 126.29 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 117.427 0.614 . . . . 0.0 110.588 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 15' ' ' VAL . 51.5 tp -76.96 127.97 33.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.708 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 33.2 m -98.86 -35.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.928 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -167.47 167.06 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.665 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -165.64 159.35 16.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.5 0.667 . . . . 0.0 111.212 169.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -126.07 114.59 24.04 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.42 166.06 26.86 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.789 2.326 . . . . 0.0 113.218 -170.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.94 -22.89 30.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.436 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.2 p -71.41 -38.95 71.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.871 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -135.34 113.05 11.14 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-O 121.269 0.557 . . . . 0.0 110.151 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.3 Cg_exo -75.81 166.58 27.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.9 3.067 . . . . 0.0 114.439 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD11 ' HE2' ' A' ' 34' ' ' TYR . 14.8 tp -85.62 134.17 34.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.945 -1.48 . . . . 0.0 108.485 170.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.07 118.18 30.74 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.167 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' HD11 ' A' ' 32' ' ' LEU . 50.0 m-85 -160.69 179.75 8.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.195 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -104.93 117.95 35.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.341 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 31.9 t60 -70.79 128.99 37.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.989 -176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 96.48 8.19 57.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.889 172.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -134.31 14.58 3.81 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.15 103.29 2.3 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -167.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 36' ' ' HIS . 33.4 t -116.61 -52.31 2.56 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.39 -82.81 0.24 Allowed 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.122 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.585 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 15.5 pt -122.59 -163.43 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.9 t -98.02 -50.09 4.52 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.492 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.05 -34.81 29.11 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 114.94 -1.027 . . . . 0.0 113.956 -172.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.693 HD11 HG21 ' A' ' 134' ' ' VAL . 55.5 tp -74.24 -46.55 40.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 109.988 -172.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 48.3 mt-10 -50.79 -41.74 57.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.259 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -65.15 -33.23 75.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.72 -35.57 65.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.015 0.912 . . . . 0.0 109.273 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.916 HD21 HG11 ' A' ' 134' ' ' VAL . 96.2 mt -65.52 -35.68 81.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.953 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -53.74 152.57 5.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.997 0.903 . . . . 0.0 112.772 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' O ' ' HE2' ' A' ' 2' ' ' LYS . . . 77.9 -18.39 5.02 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 117.239 1.656 . . . . 0.0 117.239 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.549 ' HE1' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -128.65 157.31 41.67 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 120.377 2.089 . . . . 0.0 112.921 -173.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 1' ' ' MET . 41.4 mt-10 -101.98 166.32 10.7 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -157.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.628 ' HA ' HG13 ' A' ' 136' ' ' VAL . 1.6 m -48.12 144.21 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 114.046 -1.433 . . . . 0.0 112.714 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.517 ' N ' HG13 ' A' ' 136' ' ' VAL . . . 96.58 -10.34 66.75 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.286 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -75.43 137.06 40.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.166 0.507 . . . . 0.0 110.171 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.697 ' HG2' ' HG2' ' A' ' 135' ' ' GLU . 2.1 tmtp? -137.76 132.37 32.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.921 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 60' ' ' VAL . 7.2 p90 -172.94 162.94 4.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.045 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.39 139.84 33.55 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.779 0.799 . . . . 0.0 111.305 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.661 HG22 ' CE2' ' A' ' 58' ' ' PHE . 3.4 t -125.67 150.42 30.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.187 -1.369 . . . . 0.0 108.428 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.48 113.96 11.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.037 0.381 . . . . 0.0 110.143 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.85 144.66 37.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.189 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.36 152.64 49.89 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.155 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.702 ' HB1' ' HG3' ' A' ' 70' ' ' GLN . . . -55.2 -28.35 52.41 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.979 0.512 . . . . 0.0 112.258 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -71.43 -20.74 62.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.862 0.363 . . . . 0.0 110.949 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -111.73 1.35 16.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.519 0.676 . . . . 0.0 110.416 175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -128.01 -98.99 0.37 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.51 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.557 ' OH ' HG11 ' A' ' 15' ' ' VAL . 3.3 p90 -179.42 -173.68 0.28 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.5 19.57 51.66 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.622 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.702 ' HG3' ' HB1' ' A' ' 64' ' ' ALA . 21.1 mp0 -65.09 111.18 2.79 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' ALA . 2.1 t80 -108.0 110.78 22.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 165.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' HB2' ' H ' ' A' ' 123' ' ' HIS . 12.8 t0 -101.07 80.59 2.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.114 -173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 76' ' ' VAL . 6.1 pt-20 -74.76 -11.36 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -174.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.702 HD21 ' HB2' ' A' ' 125' ' ' LEU . 8.4 p30 -87.04 -19.66 28.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.191 174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.3 tp -91.55 -11.19 38.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.991 0.424 . . . . 0.0 111.64 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 73' ' ' GLU . 14.2 p -79.15 142.27 14.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -158.74 176.67 12.07 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.455 0.645 . . . . 0.0 111.606 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.611 ' HG3' HG22 ' A' ' 118' ' ' VAL . 4.8 mpt_? -115.16 148.93 38.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.17 129.46 12.31 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -171.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 83' ' ' VAL . 29.5 Cg_exo -57.21 136.57 77.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.051 2.5 . . . . 0.0 112.422 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -54.44 -31.6 55.78 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.495 178.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.93 -35.14 79.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.296 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 80' ' ' PRO . 88.1 t -57.01 -36.3 50.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.156 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HB2' HD11 ' A' ' 90' ' ' LEU . 45.6 m-85 -104.81 39.87 1.61 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.405 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.3 ptm -53.65 -27.22 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.527 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.1 3.07 85.7 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.387 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 95.0 t -92.78 144.12 10.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 117.091 0.446 . . . . 0.0 111.098 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -57.01 -77.96 0.03 OUTLIER 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.076 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -134.2 106.64 7.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.722 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.452 ' HB3' HG11 ' A' ' 117' ' ' VAL . 96.8 mt -59.68 105.52 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.438 0.637 . . . . 0.0 109.622 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.411 HE21 ' HB2' ' A' ' 91' ' ' GLN . 5.9 tt0 -128.91 167.81 16.86 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.085 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 111' ' ' ALA . 43.8 t -79.83 135.24 25.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.5 1.19 68.98 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.137 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.6 mmm -83.93 134.57 34.66 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.405 0.622 . . . . 0.0 109.688 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -119.33 136.08 54.42 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.09 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -163.65 165.27 23.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.427 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.792 HD22 ' HB2' ' A' ' 104' ' ' PRO . 5.6 mt -88.44 132.76 34.34 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 121.54 0.686 . . . . 0.0 110.518 172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -112.61 114.07 26.52 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.079 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.698 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 26.2 mt-10 -87.32 96.64 10.42 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.28 1.038 . . . . 0.0 110.788 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.3 p -94.67 -174.52 3.32 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.577 -175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.33 -43.54 61.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.308 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 7.5 pt20 -98.47 32.01 2.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.034 -175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.23 179.83 39.59 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.76 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.792 ' HB2' HD22 ' A' ' 97' ' ' LEU . 6.2 Cg_exo -66.77 147.77 81.61 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.516 2.144 . . . . 0.0 112.03 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 64.8 t -134.22 117.09 13.42 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.801 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 105' ' ' VAL . 4.5 Cg_exo -74.01 102.34 1.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.675 2.25 . . . . 0.0 111.722 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 6.2 m -118.73 151.84 20.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.868 0.366 . . . . 0.0 110.721 -177.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.62 137.85 51.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.225 0.536 . . . . 0.0 110.318 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.5 mt -81.57 129.26 37.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.086 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.3 p -115.53 5.27 14.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.296 0.57 . . . . 0.0 110.186 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 92' ' ' VAL . . . 176.77 151.45 0.17 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.729 -177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 HG12 ' A' ' 117' ' ' VAL . 49.1 t -140.91 109.61 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -91.22 -154.1 0.34 Allowed 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -71.05 -36.2 72.24 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -133.27 -14.83 2.58 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.429 -0.508 . . . . 0.0 112.179 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -139.38 157.59 45.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 120.536 0.208 . . . . 0.0 110.725 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.743 HG12 HG13 ' A' ' 112' ' ' VAL . 30.5 m -112.77 167.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 78' ' ' ARG . 41.4 t -117.19 117.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.66 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.7 m -120.39 140.03 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.638 0.733 . . . . 0.0 112.302 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -120.89 145.85 47.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.536 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.27 46.49 0.54 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 111.942 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.657 ' HA ' ' HB3' ' A' ' 72' ' ' ASP . 9.7 m120 -38.65 130.24 1.4 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.949 0.9 . . . . 0.0 112.929 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.657 ' H ' ' HB2' ' A' ' 72' ' ' ASP . 11.2 t-80 -156.88 -81.42 0.07 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.88 ' HG3' ' HG ' ' A' ' 125' ' ' LEU . 23.3 ptt? -84.27 -49.64 8.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 -162.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.88 ' HG ' ' HG3' ' A' ' 124' ' ' MET . 39.9 mt -108.92 32.98 4.49 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -165.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 71' ' ' TYR . . . -47.79 -66.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.678 170.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.14 -3.68 82.54 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.396 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -55.17 121.14 8.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.08 125.62 41.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.7 mt -104.23 152.73 21.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 23.0 mtpp -122.04 125.63 46.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 2.8 m-85 -116.02 134.54 54.85 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.355 -177.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -105.44 106.62 17.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.916 HG11 HD21 ' A' ' 49' ' ' LEU . 4.0 t -99.09 139.65 20.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.725 0.774 . . . . 0.0 112.286 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.697 ' HG2' ' HG2' ' A' ' 57' ' ' LYS . 37.0 mt-10 -131.48 91.49 3.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.811 -1.541 . . . . 0.0 109.465 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.628 HG13 ' HA ' ' A' ' 54' ' ' VAL . 3.5 p -63.56 154.27 6.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 11' ' ' LEU . 76.0 t -129.44 -55.31 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 -153.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.91 157.91 38.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 110.419 -3.082 . . . . 0.0 109.876 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 54' ' ' VAL . 74.9 mt -138.91 133.51 41.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.9 ttp-105 -139.52 154.18 47.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.0 110.171 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.651 ' HA ' HD22 ' A' ' 7' ' ' LEU . 10.1 pt-20 -91.55 132.38 36.33 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.67 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -73.2 163.81 27.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.674 0.749 . . . . 0.0 112.243 -172.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -94.64 24.51 4.59 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.972 -171.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 70.52 -38.71 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.06 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -40.22 82.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.684 ' HG2' ' HA ' ' A' ' 152' ' ' VAL . 25.7 mt-10 -58.97 -37.12 76.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.999 175.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' A' ' 142' ' ' ALA . 23.0 mt -71.07 -46.02 62.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.084 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -55.33 -35.92 65.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.425 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -89.76 -14.85 33.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.335 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.11 0.67 90.37 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.714 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -169.12 169.36 9.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.684 ' HA ' ' HG2' ' A' ' 146' ' ' GLU . 38.9 t -53.32 -71.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 123.697 0.623 . . . . 0.0 112.452 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 32.3 t60 56.91 72.61 0.5 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.561 -174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.6 -99.93 2.07 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.731 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 59.68 -168.15 0.16 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.829 0.452 . . . . 0.0 110.838 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -142.14 110.43 6.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -146.07 -70.21 0.26 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.896 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -105.51 119.43 39.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.026 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -142.22 148.83 38.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.374 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.616 ' HB3' ' HB2' ' A' ' 163' ' ' ASP . 31.7 m170 -106.96 135.52 48.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.374 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -131.76 123.93 28.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 56.32 41.17 29.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.365 0.602 . . . . 0.0 109.85 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.616 ' HB2' ' HB3' ' A' ' 160' ' ' HIS . 19.1 t70 -77.74 -40.77 39.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -104.32 139.3 39.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.68 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 168' ' ' HIS . 33.9 t70 60.59 65.97 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.945 0.778 . . . . 0.0 110.709 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -106.63 -19.21 13.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.666 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -97.55 17.77 16.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.717 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.443 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 92.3 m-70 -136.49 160.07 39.87 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 46.8 m80 73.42 -53.79 0.69 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 123.873 0.733 . . . . 0.0 111.783 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -135.14 126.83 29.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.693 0.283 . . . . 0.0 110.444 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 119.034 -0.508 . . . . 0.0 110.096 179.683 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.537 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.4 ptpt -111.73 174.63 5.78 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.43 0.633 . . . . 0.0 111.268 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.625 HG12 ' O ' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -83.51 125.05 40.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.188 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.09 -171.08 3.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.781 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HG3' ' HA3' ' A' ' 37' ' ' GLY . 34.9 tttm -63.86 151.18 43.12 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.639 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' OD1' HD22 ' A' ' 147' ' ' LEU . 30.8 m-20 52.74 7.84 0.08 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.57 100.47 11.2 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 34' ' ' TYR . 14.6 p -69.77 141.09 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG12 HG23 ' A' ' 139' ' ' ILE . 4.5 m -136.46 159.04 38.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.873 178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.787 ' O ' HG22 ' A' ' 137' ' ' VAL . 19.5 m -117.37 118.26 31.75 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -134.96 161.08 36.28 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.775 -177.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.24 107.82 13.01 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' ASN . 31.0 p90 -120.52 158.48 27.2 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.407 -173.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.903 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . 30.0 tt0 -127.28 119.4 26.24 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG13 HG23 ' A' ' 23' ' ' VAL . 2.4 p -102.0 119.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 122.199 1.0 . . . . 0.0 111.021 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 13.7 ttm180 -134.51 145.97 49.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.95 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.5 p -87.14 179.44 6.65 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -64.05 -29.99 71.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.304 0.573 . . . . 0.0 109.929 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -64.69 -19.25 65.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.02 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.73 66.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.532 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -86.37 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.145 0.498 . . . . 0.0 110.252 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 25' ' ' GLU . 5.0 tt -83.49 124.27 30.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.659 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG23 HG13 ' A' ' 15' ' ' VAL . 27.0 m -94.3 -39.19 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.373 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -162.73 159.53 24.34 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.903 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -166.0 148.17 7.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.25 0.548 . . . . 0.0 111.226 174.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.0 m -102.32 113.98 65.63 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.84 163.72 29.72 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.686 2.257 . . . . 0.0 112.868 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 m -67.24 -13.88 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.327 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.2 p -82.28 -30.49 30.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.986 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.96 114.88 5.94 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.342 0.591 . . . . 0.0 110.976 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.775 ' HG3' HG11 ' A' ' 137' ' ' VAL . 8.9 Cg_exo -75.03 154.36 42.28 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.729 2.952 . . . . 0.0 113.374 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 13' ' ' TYR . 15.2 tp -76.57 134.9 39.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.359 170.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -110.04 120.28 41.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 7.5 p90 -150.77 148.37 28.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.292 -177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 41.9 tp -81.34 110.1 16.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.91 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.468 ' CE1' ' HG3' ' A' ' 50' ' ' GLU . 14.3 t60 -71.76 140.77 49.65 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.083 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 108.37 -27.03 14.75 Favored Glycine 0 N--CA 1.439 -1.117 0 C-N-CA 119.158 -1.496 . . . . 0.0 113.85 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.45 55.48 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 35' ' ' LEU . . . -141.29 -105.71 0.59 Allowed Glycine 0 N--CA 1.429 -1.81 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.117 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 34' ' ' TYR . 15.5 m -114.39 -54.84 2.55 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -166.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.942 HD22 HD23 ' A' ' 45' ' ' LEU . 84.6 mt -65.44 136.48 56.51 Favored 'General case' 0 CA--C 1.492 -1.277 0 CA-C-O 122.796 1.284 . . . . 0.0 112.651 173.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.689 HD12 ' HA ' ' A' ' 67' ' ' ALA . 21.7 pt -53.33 175.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 111.749 -2.478 . . . . 0.0 114.581 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.7 m -66.26 -48.41 70.55 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.185 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.17 -45.33 96.26 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.209 -0.519 . . . . 0.0 113.428 -173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.942 HD23 HD22 ' A' ' 41' ' ' LEU . 23.7 tp -74.58 -53.33 9.61 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.809 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 42' ' ' ILE . 6.9 mt-10 -48.29 -42.45 30.9 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 124.062 0.851 . . . . 0.0 111.834 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.8 m -65.53 -29.73 70.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.61 55.92 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.83 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 8.2 mt -65.43 -38.42 89.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.407 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 3.9 mt-10 -53.66 153.23 4.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.561 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 77.29 -14.71 8.01 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 113.88 -1.509 . . . . 0.0 114.87 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' VAL . 82.3 m-70 -88.78 165.52 14.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.265 0.533 . . . . 0.0 110.07 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 2' ' ' LYS . 69.1 mt-10 -123.11 162.5 22.34 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 HG12 HG13 ' A' ' 139' ' ' ILE . 1.5 m -46.56 143.64 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.826 0.822 . . . . 0.0 112.697 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.04 -2.88 72.55 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 114.703 -1.135 . . . . 0.0 114.079 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.45 134.01 35.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.464 0.632 . . . . 0.0 110.771 176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.703 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 1.8 tmtp? -135.24 128.63 32.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.725 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 60' ' ' VAL . 22.8 p90 -155.57 -178.2 7.1 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -117.81 149.69 40.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.676 HG22 ' CE2' ' A' ' 58' ' ' PHE . 2.4 t -137.47 142.54 36.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.61 -172.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.64 113.53 13.13 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -121.18 132.63 70.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.355 -174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.77 154.05 48.02 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.756 ' HB1' ' HA2' ' A' ' 69' ' ' GLY . . . -49.63 -26.13 3.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.62 -34.0 62.69 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.13 -0.357 . . . . 0.0 111.614 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -92.73 -24.38 18.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.393 0.616 . . . . 0.0 109.942 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.689 ' HA ' HD12 ' A' ' 42' ' ' ILE . . . -87.14 -138.51 0.09 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.412 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -76.3 -83.29 0.07 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.756 ' HA2' ' HB1' ' A' ' 64' ' ' ALA . . . 86.97 -32.25 4.1 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 116.218 -0.447 . . . . 0.0 112.45 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -94.96 -178.14 4.39 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 169.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.8 ' HD2' HD21 ' A' ' 122' ' ' ASN . 14.0 p90 -44.96 144.22 1.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 123.622 0.576 . . . . 0.0 109.949 172.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.54 96.27 10.57 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.226 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.715 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 3.8 pt-20 -67.93 -0.73 4.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.63 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -86.07 -11.61 52.33 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.119 172.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 122' ' ' ASN . 21.3 tp -86.5 -10.21 54.58 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 122.377 1.084 . . . . 0.0 108.395 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.715 ' HB ' ' O ' ' A' ' 73' ' ' GLU . 83.9 t -72.64 146.99 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.551 ' OE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -153.08 170.05 21.43 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.742 -1.583 . . . . 0.0 111.035 -170.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -98.73 140.84 32.32 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.152 -173.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.8 t -136.06 124.92 15.63 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -60.11 126.91 21.5 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.386 2.057 . . . . 0.0 111.632 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 22.8 mtmt -58.74 -17.26 21.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.826 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -64.77 -29.87 70.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.307 0.575 . . . . 0.0 110.24 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -67.05 -45.64 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.904 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 90' ' ' LEU . 60.3 m-85 -87.74 40.86 0.96 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.0 ptm -50.82 -29.8 12.64 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 6.19 81.52 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.915 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 84' ' ' PHE . 75.0 t -94.14 145.46 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.424 0.612 . . . . 0.0 111.224 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -55.81 -74.32 0.05 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.542 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -142.08 116.88 9.84 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.463 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.56 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.8 mt -62.33 105.97 0.68 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.42 176.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -128.77 166.21 19.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.13 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.52 1.41 74.57 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.82 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.0 mmm -89.2 135.03 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.141 0.471 . . . . 0.0 110.038 -175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 49.9 mtt180 -115.49 135.5 54.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.87 -176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -165.17 171.37 13.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.003 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.781 HD11 ' HB2' ' A' ' 104' ' ' PRO . 64.3 tp -98.09 150.98 20.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 100' ' ' THR . . . -148.88 90.97 1.81 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 112.041 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 16.2 mt-10 -49.11 111.16 0.44 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.367 1.08 . . . . 0.0 112.87 162.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 98' ' ' ALA . 68.2 p -113.18 -172.63 2.1 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.747 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -50.83 -35.24 31.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.973 0.416 . . . . 0.0 111.005 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.469 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 6.1 pt20 -98.55 28.32 4.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.04 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.21 -177.25 45.81 Favored Glycine 0 C--N 1.322 -0.203 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.453 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.781 ' HB2' HD11 ' A' ' 97' ' ' LEU . 28.7 Cg_endo -69.79 121.93 8.61 Favored 'Trans proline' 0 CA--C 1.506 -0.925 0 C-N-CA 122.379 2.053 . . . . 0.0 112.411 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.83 116.1 47.95 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.931 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.8 120.94 8.8 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.011 1.807 . . . . 0.0 109.99 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 10.8 m -142.77 154.21 17.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.833 0.825 . . . . 0.0 112.524 -168.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 28.6 tt0 -130.44 127.8 40.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.866 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 119' ' ' VAL . 62.8 mt -66.01 129.1 30.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.3 p -116.34 0.7 12.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -175.34 152.65 1.42 Allowed 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.525 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 117' ' ' VAL . 45.9 t -139.67 111.25 4.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -87.62 -166.63 1.63 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 5.1 m-20 -63.36 -53.54 50.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.307 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.584 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 5.0 m-20 -99.71 -18.3 17.32 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -143.25 146.76 33.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.704 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 112' ' ' VAL . 33.1 m -92.44 168.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.388 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 76' ' ' VAL . 2.3 t -129.68 108.95 17.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.737 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 15.4 m -115.66 141.6 32.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.889 0.852 . . . . 0.0 112.872 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.569 ' HA ' HG22 ' A' ' 76' ' ' VAL . 8.7 t70 -87.09 147.22 25.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.169 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -145.4 10.25 1.72 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.061 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.8 HD21 ' HD2' ' A' ' 71' ' ' TYR . 1.4 p30 -105.56 168.25 9.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.246 0.546 . . . . 0.0 110.948 -173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -132.89 169.25 17.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.605 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -67.43 0.3 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.847 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.23 20.45 1.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.09 -126.46 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 69' ' ' GLY . . . 83.24 1.79 90.42 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 119.827 -1.178 . . . . 0.0 113.002 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -78.41 129.88 35.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.01 143.92 37.11 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 167.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 75.9 mt -130.62 152.65 49.76 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -166.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -115.39 133.81 55.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.735 174.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 36.9 m-85 -121.02 142.09 50.13 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.404 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -108.84 106.71 16.83 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 166.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.725 HG11 HD22 ' A' ' 49' ' ' LEU . 3.1 t -100.85 140.28 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.95 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.703 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 59.1 mt-10 -138.14 100.7 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.968 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 p -80.42 110.52 16.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.13 0.49 . . . . 0.0 110.928 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 10' ' ' SER . 2.7 m -75.92 -39.53 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.013 0.435 . . . . 0.0 111.538 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -162.41 156.95 21.84 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.089 -168.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 9' ' ' VAL . 73.3 mt -136.63 131.96 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -146.76 141.31 26.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.789 0.328 . . . . 0.0 110.144 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -87.71 125.31 34.34 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.74 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' HD21 ' A' ' 147' ' ' LEU . . . -63.61 165.5 8.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.774 -170.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 145' ' ' GLU . 56.3 p -79.49 15.36 1.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.422 -170.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.492 ' HA ' HD12 ' A' ' 147' ' ' LEU . 41.6 mt-10 69.94 -35.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.587 0.755 . . . . 0.0 111.481 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 143' ' ' THR . 46.4 mt-10 -62.23 -46.89 86.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.212 0.53 . . . . 0.0 109.708 175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 25.4 mt-10 -59.22 -35.53 73.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.237 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 142' ' ' ALA . 24.0 mt -71.92 -46.89 56.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.401 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.37 -32.87 70.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.211 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -88.93 -11.92 43.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.789 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 86.23 4.21 84.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.994 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -174.03 167.4 4.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 155' ' ' ALA . 41.4 t -55.99 -73.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 123.732 0.645 . . . . 0.0 112.159 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 50.92 48.94 22.12 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.532 0.682 . . . . 0.0 109.72 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.83 -101.84 0.16 Allowed Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.554 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.481 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . 55.06 72.3 0.48 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.073 0.463 . . . . 0.0 111.166 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -146.09 93.39 2.32 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.895 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.14 123.5 34.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -147.8 55.45 1.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.947 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -57.31 -42.02 80.99 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.745 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -107.88 73.7 0.91 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.504 . . . . 0.0 110.178 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -140.62 142.18 35.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.174 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -147.59 76.35 1.39 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.872 0.367 . . . . 0.0 111.7 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -81.7 151.48 27.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 167.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -134.25 122.45 22.75 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.978 0.418 . . . . 0.0 110.849 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -86.17 -26.35 25.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.763 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -98.14 105.52 17.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.146 0.498 . . . . 0.0 110.883 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -128.53 121.44 28.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.482 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -98.22 -51.24 4.07 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -137.61 160.11 40.09 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.048 -0.408 . . . . 0.0 110.71 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 58.52 71.73 0.57 Allowed 'General case' 0 CA--C 1.518 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 109.618 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 117.824 -1.084 . . . . 0.0 109.388 -171.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 16.7 ptpt -129.59 179.48 5.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 52' ' ' HIS . 1.5 p -85.56 116.06 28.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.383 0.611 . . . . 0.0 111.563 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.426 ' O ' ' HB3' ' A' ' 36' ' ' HIS . . . -149.89 -167.37 2.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.084 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' LEU . 20.2 tttm -61.56 153.31 28.0 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 123.108 0.255 . . . . 0.0 110.691 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 50.3 3.96 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.145 1.378 . . . . 0.0 114.519 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 2' ' ' LYS . 1.2 mt -93.91 98.43 11.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.314 0.578 . . . . 0.0 111.229 170.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -63.61 144.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.204 174.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.762 HG12 HG23 ' A' ' 139' ' ' ILE . 2.1 m -148.84 152.29 12.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.473 0.654 . . . . 0.0 111.24 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.0 m -103.03 117.72 35.21 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 134' ' ' VAL . 9.5 tt -133.01 147.59 52.26 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.522 -172.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.8 152.4 37.32 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.621 ' HE1' HD22 ' A' ' 32' ' ' LEU . 52.1 p90 -161.77 157.51 24.33 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.168 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.438 ' CG ' HD13 ' A' ' 22' ' ' LEU . 36.1 tt0 -131.08 122.86 27.46 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.385 172.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.431 HG13 ' CE1' ' A' ' 132' ' ' PHE . 37.2 t -103.83 119.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.581 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -139.29 155.46 47.72 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 p -78.08 179.8 6.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.012 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.64 -31.68 26.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.543 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.62 -19.0 63.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.151 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.34 -2.54 81.12 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.538 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.63 136.07 24.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 110.486 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.666 HD11 ' HB2' ' A' ' 25' ' ' GLU . 58.8 tp -72.8 131.37 42.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.733 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -114.84 -40.56 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.688 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -144.93 149.45 35.27 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.666 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.1 tt0 -164.12 139.51 6.06 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.376 0.608 . . . . 0.0 112.037 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 58.1 m -119.18 114.84 34.76 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 167.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.37 167.44 26.3 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.588 2.192 . . . . 0.0 113.389 -172.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -74.17 -18.96 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.215 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 p -73.15 -34.83 66.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . . . -142.99 112.72 5.74 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' HB3' HG21 ' A' ' 137' ' ' VAL . 11.2 Cg_exo -75.44 159.7 39.5 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.285 2.657 . . . . 0.0 113.952 -174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.708 HD21 ' HG ' ' A' ' 41' ' ' LEU . 14.0 tp -79.57 126.19 30.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.046 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -112.2 120.78 42.96 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.512 ' CD2' ' HA ' ' A' ' 40' ' ' SER . 46.2 p90 -144.54 161.86 38.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.631 -176.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 147' ' ' LEU . 46.7 tp -108.29 105.64 15.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 6.4 t60 -61.14 130.51 46.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.923 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . 101.46 -7.81 56.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.219 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -134.62 2.8 3.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 94.73 0.14 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -170.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.779 ' O ' HD13 ' A' ' 41' ' ' LEU . 12.7 m -116.11 15.21 16.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 122.512 1.149 . . . . 0.0 108.511 -170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.779 HD13 ' O ' ' A' ' 40' ' ' SER 0.396 0.0 OUTLIER 41.81 109.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 128.473 2.709 . . . . 0.0 115.397 -170.467 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.812 ' O ' ' HG3' ' A' ' 46' ' ' GLU . 23.8 pt 51.57 127.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 110.148 -3.205 . . . . 0.0 115.61 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.545 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 43.5 t -50.66 -47.63 58.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 112.564 -2.107 . . . . 0.0 113.387 -170.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.607 ' HA3' HG11 ' A' ' 62' ' ' VAL . . . -67.97 -36.54 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.345 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 44.8 tp -75.03 -46.96 31.48 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.812 ' HG3' ' O ' ' A' ' 42' ' ' ILE . 31.8 mt-10 -48.9 -49.51 39.47 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.911 0.757 . . . . 0.0 109.989 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.4 m -60.57 -37.41 81.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.954 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.15 63.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.696 0.76 . . . . 0.0 110.039 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 45' ' ' LEU . 88.0 mt -62.46 -36.57 82.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.724 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -54.54 153.98 5.22 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' HA2' ' HD3' ' A' ' 2' ' ' LYS . . . 78.17 -15.2 9.13 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 113.498 -1.683 . . . . 0.0 117.096 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 3' ' ' VAL . 14.4 p80 -102.19 174.24 6.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 119.661 1.731 . . . . 0.0 110.263 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 139' ' ' ILE . 4.1 mp0 -119.82 171.48 8.38 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.73 -177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 139' ' ' ILE . 2.0 m -52.16 142.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.309 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.457 ' H ' HG13 ' A' ' 136' ' ' VAL . . . 97.56 -15.26 62.28 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.007 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' O ' HG12 ' A' ' 136' ' ' VAL . 32.5 m-20 -74.32 130.65 40.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.341 0.591 . . . . 0.0 111.42 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 135' ' ' GLU . 5.5 tmtm? -133.24 124.6 27.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.052 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.718 ' CE2' HG22 ' A' ' 60' ' ' VAL . 13.3 p90 -148.85 -178.26 6.26 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.392 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -112.54 145.85 39.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 58' ' ' PHE . 4.8 t -135.22 142.21 40.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -172.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 113.09 12.24 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.128 0.49 . . . . 0.0 110.341 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG11 ' HA3' ' A' ' 44' ' ' GLY . 58.2 t -126.57 144.17 37.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.421 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.64 153.24 50.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 68' ' ' TYR . . . -56.96 -20.6 24.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.15 -19.65 53.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.114 0.483 . . . . 0.0 110.817 -176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -115.71 -18.45 10.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' HB1' ' HZ ' ' A' ' 132' ' ' PHE . . . -113.89 -151.03 0.47 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.931 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.606 ' HB2' ' CD1' ' A' ' 130' ' ' LEU . 6.8 m-85 -78.14 -170.88 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.28 19.02 43.58 Favored Glycine 0 CA--C 1.502 -0.735 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -76.71 -179.57 5.43 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.36 -0.92 . . . . 0.0 110.762 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.441 ' HB2' ' CG ' ' A' ' 122' ' ' ASN . 17.2 p90 -58.42 152.2 18.37 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.291 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -75.0 105.28 5.93 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.712 -0.395 . . . . 0.0 109.971 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.648 ' HA ' HG12 ' A' ' 76' ' ' VAL . 8.5 pt-20 -72.17 -0.52 12.17 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -62.61 -9.67 9.72 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.575 -0.703 . . . . 0.0 111.292 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 122' ' ' ASN . 19.2 mt -111.01 -11.0 14.35 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.098 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 73' ' ' GLU . 3.1 p -127.78 130.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.571 0.7 . . . . 0.0 110.908 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.36 169.0 19.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 118' ' ' VAL . 6.5 mpt_? -107.62 114.7 28.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.886 -175.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -111.95 129.23 24.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.639 -171.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 79' ' ' VAL . 12.3 Cg_exo -61.91 134.41 49.83 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.956 2.437 . . . . 0.0 111.426 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HG3' ' C ' ' A' ' 115' ' ' ASP . 18.8 mtmt -59.39 -14.66 12.85 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.09 -28.12 65.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.525 0.679 . . . . 0.0 110.259 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.22 -38.08 77.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.128 -175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 87' ' ' VAL . 61.2 m-85 -90.85 41.38 1.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -176.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 ptm -51.37 -25.82 6.73 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.093 175.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -92.33 11.01 73.16 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.127 -0.558 . . . . 0.0 113.606 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 84' ' ' PHE . 2.6 p -100.5 160.51 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 117.258 0.529 . . . . 0.0 109.922 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -75.13 0.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -145.41 121.57 10.81 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.12 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.58 ' HB3' HG11 ' A' ' 117' ' ' VAL . 95.0 mt -62.12 103.88 0.42 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.934 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.61 155.62 40.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.562 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.679 ' HA ' HG22 ' A' ' 109' ' ' ILE . 42.7 t -67.1 134.07 30.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.055 0.455 . . . . 0.0 110.922 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.62 -28.44 15.97 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.51 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 11.6 mmm -52.92 135.53 36.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 108' ' ' GLU . 20.2 mtp85 -116.72 137.35 52.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.943 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -163.26 167.57 21.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.423 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 104' ' ' PRO . 52.0 tp -82.7 143.75 30.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.195 0.521 . . . . 0.0 110.015 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 104' ' ' PRO . . . -131.76 147.53 52.5 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.778 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -97.64 142.66 29.17 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.7 p -148.92 -175.92 5.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.82 -27.47 69.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.565 0.698 . . . . 0.0 109.696 171.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -89.72 23.23 2.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.861 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.99 -173.71 52.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.125 -1.036 . . . . 0.0 111.495 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 39.8 Cg_exo -59.25 125.61 18.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 111.568 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.54 109.28 30.78 Favored Pre-proline 0 C--N 1.31 -1.135 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.014 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.88 107.11 1.24 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.62 2.213 . . . . 0.0 110.694 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 4.4 m -117.75 176.22 2.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.187 0.517 . . . . 0.0 111.782 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 39.2 tt0 -137.06 129.6 30.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.592 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 92' ' ' VAL . 32.1 mt -70.95 122.58 23.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.6 p -103.6 -7.42 20.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.466 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -173.1 156.73 3.3 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 117' ' ' VAL . 88.1 t -136.75 104.15 3.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.235 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.492 ' HG3' ' NE2' ' A' ' 116' ' ' HIS . 24.1 mm-40 -75.8 -166.82 0.61 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.769 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.22 -56.14 24.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.691 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.527 ' C ' ' HG3' ' A' ' 81' ' ' LYS . 24.6 t70 -128.08 16.96 6.71 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.868 -0.733 . . . . 0.0 112.894 176.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.492 ' NE2' ' HG3' ' A' ' 113' ' ' GLU . 50.9 p-80 -146.22 146.33 30.74 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 121.436 -0.79 . . . . 0.0 111.68 175.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 90' ' ' LEU . 26.9 m -104.54 167.72 2.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.999 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 78' ' ' ARG . 48.3 t -130.86 119.53 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 107' ' ' VAL . 5.0 m -114.35 131.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.865 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.607 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 11.3 m-20 -110.99 147.7 34.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.016 -175.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -127.74 13.46 6.47 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.47 ' HB3' HD12 ' A' ' 75' ' ' LEU . 27.9 p30 -130.77 166.56 20.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.066 -0.567 . . . . 0.0 111.01 -172.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 179.64 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.629 0.58 . . . . 0.0 111.252 166.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -83.45 -8.85 59.3 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.702 0.287 . . . . 0.0 111.438 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.9 mt -91.33 18.91 6.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.819 0.342 . . . . 0.0 111.78 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.35 179.61 3.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.689 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.42 0.88 33.0 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.372 -0.918 . . . . 0.0 115.049 171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -88.86 120.39 30.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.54 1.17 . . . . 0.0 110.589 177.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -78.79 163.02 25.7 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.606 ' CD1' ' HB2' ' A' ' 68' ' ' TYR . 57.5 mt -132.74 152.13 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 112.679 -173.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -112.07 132.37 54.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.163 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.554 ' HZ ' ' HB1' ' A' ' 67' ' ' ALA . 11.6 m-85 -121.17 142.19 50.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.903 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -108.61 107.61 18.16 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 167.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 HD21 ' A' ' 11' ' ' LEU . 3.6 t -100.29 137.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.558 -175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 57' ' ' LYS . 33.4 mt-10 -134.03 98.08 4.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.494 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.457 HG13 ' H ' ' A' ' 55' ' ' GLY . 3.8 p -78.57 114.63 19.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.693 . . . . 0.0 111.669 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 31' ' ' PRO . 5.5 t -71.67 -50.31 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.223 -0.898 . . . . 0.0 112.47 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -162.82 154.48 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -172.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.762 HG23 HG12 ' A' ' 9' ' ' VAL . 66.7 mt -132.94 138.98 50.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -149.25 140.92 23.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.07 126.28 34.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.714 ' HB1' ' HB2' ' A' ' 146' ' ' GLU . . . -66.75 166.16 13.66 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.449 -168.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 145' ' ' GLU . 23.1 p -82.05 20.74 0.96 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.477 -170.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 147' ' ' LEU . 45.0 mt-10 67.71 -37.88 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.363 0.665 . . . . 0.0 111.327 -174.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 143' ' ' THR . 45.7 mt-10 -64.28 -45.2 89.1 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.714 ' HB2' ' HB1' ' A' ' 142' ' ' ALA . 37.6 mt-10 -59.54 -34.91 73.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.508 177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 142' ' ' ALA . 35.6 mt -74.14 -44.27 54.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.688 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.73 -29.6 70.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.346 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -94.99 -32.08 13.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 110.731 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 100.93 13.03 35.25 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.594 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -153.12 170.91 19.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.565 0.682 . . . . 0.0 111.455 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.8 t -78.29 135.31 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.107 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -97.95 -36.13 10.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.897 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -137.93 110.29 0.74 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.424 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -151.34 -56.08 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -121.38 85.37 2.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 158' ' ' HIS . 24.5 m-20 -84.3 -71.1 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.213 -168.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 157' ' ' ASP . 95.3 m-70 65.71 -168.58 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -171.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 64.39 50.46 2.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.308 0.575 . . . . 0.0 110.935 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -72.41 -8.16 53.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.266 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -54.39 -44.82 72.64 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.261 0.553 . . . . 0.0 110.143 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -96.4 82.71 3.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -63.59 112.13 2.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.877 0.846 . . . . 0.0 111.044 -174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.415 ' CD2' ' H ' ' A' ' 164' ' ' HIS . 3.2 p80 -79.47 64.57 4.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.156 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.98 -56.38 22.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.812 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.39 83.45 6.93 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.335 0.588 . . . . 0.0 112.28 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -132.2 82.16 2.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.219 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.428 ' HE1' ' O ' ' A' ' 171' ' ' HIS . 1.5 p80 -61.46 135.26 57.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.358 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -83.38 82.58 8.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.066 -172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 47.4 t60 68.72 107.79 0.05 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.042 0.838 . . . . 0.0 112.37 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.428 ' O ' ' HE1' ' A' ' 168' ' ' HIS . 44.9 t-80 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.428 -0.796 . . . . 0.0 109.226 172.144 . . . . . . . . 1 1 . 1 stop_ save_